{"meta":{"query_hash":"ea743a271976","filters":{"venue":"The Breast"},"cohort_total":210,"direct_labels_cover":0,"predictions_cover":210,"exported":210,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ea743a271976","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Breast"},"results":[{"id":"W1486057347","doi":"10.1016/j.breast.2015.04.011","title":"Evaluation of effect of self-examination and physical examination on breast cancer","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Breast self-examination; Cancer; Physical examination; Incidence (geometry); Randomized controlled trial; Breast cancer screening; Internal medicine; Gynecology; Mammography","score_opus":0.06934641618294667,"score_gpt":0.36870682776970737,"score_spread":0.2993604115867607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486057347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955531,0.0026140425,0.0000698573,0.00019239407,0.00004276225,0.000043744232,0.00018164502,0.0000074734853,0.0012950245],"genre_scores_gemma":[0.99802643,0.00077601377,0.00017033498,0.00006326851,0.000066085515,0.000017452967,0.00013635315,0.000002657614,0.00074147957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693763,0.0020464384,0.00017752002,0.00019872961,0.0004575024,0.00018206981],"domain_scores_gemma":[0.9859876,0.010763183,0.0010505435,0.0004294898,0.0005848468,0.0011843143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059717926,0.0004275434,0.0009252954,0.000625344,0.0003478747,0.0003780464,0.00053563016,0.00047924352,0.0025907822],"category_scores_gemma":[0.013100092,0.00020817705,0.0021151688,0.0006237479,0.00044293297,0.0006020964,0.0005450285,0.00066234573,0.00016546839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074893065,0.009712356,0.8521088,0.00060144113,0.003103156,0.00017220243,0.00040554095,0.0006659213,0.0007763074,0.00012842735,0.00028428633,0.05714857],"study_design_scores_gemma":[0.00075112225,0.040624063,0.9543568,0.000044591798,0.0024705203,0.00007364772,0.00019008521,0.00044138072,0.00034472728,0.000051676354,0.000639419,0.000011977867],"about_ca_topic_score_codex":0.004034815,"about_ca_topic_score_gemma":0.008274564,"teacher_disagreement_score":0.0059717926,"about_ca_system_score_codex":0.00059585157,"about_ca_system_score_gemma":0.0012557906,"threshold_uncertainty_score":0.031582236},"labels":[],"label_agreement":null},{"id":"W1818272034","doi":"10.1016/j.breast.2015.05.006","title":"Neurological complications of breast cancer: A prospective cohort study","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Fundação Grünenthal","keywords":"Medicine; Breast cancer; Prospective cohort study; Peripheral neuropathy; Cumulative incidence; Incidence (geometry); Cancer; Chemotherapy; Cohort; Internal medicine; Radiation therapy; Surgery; Diabetes mellitus","score_opus":0.03006641433419097,"score_gpt":0.31314583517516453,"score_spread":0.28307942084097354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1818272034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986755,0.0002683617,0.00012502886,0.000026704878,0.000008741879,0.000034619938,0.0006460033,0.000001895487,0.00021321882],"genre_scores_gemma":[0.99842477,0.000337744,0.00019549284,0.000032783926,0.000014329588,0.000042462958,0.0007563891,0.000002361868,0.0001936296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993135,0.00019700562,0.000063848536,0.00021667955,0.00009571821,0.000113302485],"domain_scores_gemma":[0.9987219,0.00021955717,0.00052560744,0.00021817269,0.00013027177,0.00018449397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012609672,0.0003423029,0.00039707683,0.00070674025,0.00062446523,0.00074109156,0.00041483282,0.0004624347,0.0014426626],"category_scores_gemma":[0.0021614558,0.0005036792,0.00074922753,0.001299287,0.00020371268,0.0005219762,0.0005045899,0.0006399622,0.0002582205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022160447,0.00008881258,0.998485,0.000012447261,0.00013318166,0.00009421648,0.00006966108,0.000017978802,0.00010997253,0.000013035999,0.00007324674,0.00068081537],"study_design_scores_gemma":[0.000032320077,0.00030006358,0.9985676,0.00001534042,0.00011211744,0.00040790142,0.00019451854,0.00012153207,0.000029780187,0.000019506888,0.0001926177,0.0000066831863],"about_ca_topic_score_codex":0.0064050984,"about_ca_topic_score_gemma":0.007397896,"teacher_disagreement_score":0.0064050984,"about_ca_system_score_codex":0.00025562107,"about_ca_system_score_gemma":0.00044550054,"threshold_uncertainty_score":0.012735605},"labels":[],"label_agreement":null},{"id":"W1970896527","doi":"10.1016/j.breast.2014.12.005","title":"A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources?","year":2015,"lang":"en","type":"review","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Guideline; Critical appraisal; Health care; Low and middle income countries; Quality (philosophy); Systematic review; Intensive care medicine; MEDLINE; Cancer; Family medicine; Alternative medicine; Developing country; Internal medicine; Pathology","score_opus":0.27971907084183784,"score_gpt":0.5029809274211725,"score_spread":0.22326185657933467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970896527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062171104,0.9574939,0.0048356284,0.0072650425,0.0013061123,0.017269898,0.00345286,0.000074756455,0.0020846727],"genre_scores_gemma":[0.103550665,0.80029345,0.037603207,0.007959161,0.000635242,0.04646949,0.0029260493,0.000079703335,0.00048298767],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.70062464,0.13002843,0.120087795,0.009434243,0.037713863,0.0021110482],"domain_scores_gemma":[0.50189984,0.34776384,0.08047219,0.011215892,0.056073554,0.0025746792],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16034919,0.0022930587,0.014148795,0.029017104,0.0021823964,0.006795752,0.005384379,0.004123489,0.003182783],"category_scores_gemma":[0.54249156,0.0026236249,0.012672041,0.027255261,0.0032557594,0.007578586,0.004335203,0.003224378,0.00046203902],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015864115,0.00002046812,0.0022889872,0.9358447,0.012736215,0.00008975021,0.0012445833,0.00021848825,0.00012998765,0.0006976664,0.003271737,0.043298744],"study_design_scores_gemma":[0.00034940836,0.00011132459,0.0039046088,0.94569576,0.035297893,0.000102758786,0.0007923745,0.00022846636,0.00014830877,0.001000128,0.012309859,0.000059121503],"about_ca_topic_score_codex":0.018281374,"about_ca_topic_score_gemma":0.04623775,"teacher_disagreement_score":0.8396508,"about_ca_system_score_codex":0.016968837,"about_ca_system_score_gemma":0.051856462,"threshold_uncertainty_score":0.8480177},"labels":[],"label_agreement":null},{"id":"W1977983810","doi":"10.1016/s0960-9776(11)70295-8","title":"Reappraising antiangiogenic therapy for breast cancer","year":2011,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; National Health Research Institutes; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institute for Health and Care Research; Canada Research Chairs; GlaxoSmithKline; Pfizer Canada; Cancer Research Institute","keywords":"Medicine; Bevacizumab; Sunitinib; Breast cancer; Oncology; Chemotherapy; Metastatic breast cancer; Internal medicine; Cancer; Angiogenesis; Trastuzumab; Clinical trial; Pharmacology","score_opus":0.055788762876342754,"score_gpt":0.3466847822153159,"score_spread":0.29089601933897313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977983810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010246426,0.925752,0.0076465956,0.03329611,0.007361768,0.00014147957,0.00012448207,0.00017345502,0.0152576985],"genre_scores_gemma":[0.06394769,0.8654618,0.012976906,0.0269379,0.010222792,0.00015400283,0.00038261345,0.00009909006,0.01981713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992003,0.00026535077,0.00006471865,0.00011561502,0.00025031046,0.00010388639],"domain_scores_gemma":[0.99890304,0.0003166289,0.00013263205,0.00007983475,0.00040613516,0.00016169522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025089097,0.0005382008,0.0005899525,0.00078737515,0.00024280095,0.0016711369,0.00069225987,0.0016872889,0.00427305],"category_scores_gemma":[0.001543101,0.00015531109,0.0004779805,0.0006041307,0.0007915956,0.0020950243,0.0007720922,0.0028512012,0.0019396527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005303102,0.00037280115,0.00044579452,0.003004209,0.00006319751,0.0004950121,0.00021331155,0.0005654986,0.03316443,0.015138221,0.051075056,0.89493203],"study_design_scores_gemma":[0.00018601393,0.001355829,0.0011926965,0.00091574324,0.00010783067,0.0011061501,0.00013102476,0.00054446975,0.009533292,0.0058758757,0.9790252,0.000025920459],"about_ca_topic_score_codex":0.0004915536,"about_ca_topic_score_gemma":0.0011881408,"teacher_disagreement_score":0.00427305,"about_ca_system_score_codex":0.0008046596,"about_ca_system_score_gemma":0.0012791777,"threshold_uncertainty_score":0.014294803},"labels":[],"label_agreement":null},{"id":"W1979370923","doi":"10.1016/j.breast.2007.12.004","title":"Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer","year":2008,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"AstraZeneca","keywords":"Fulvestrant; Exemestane; Medicine; Oncology; Breast cancer; Metastatic breast cancer; Internal medicine; Tolerability; Anastrozole; Clinical trial; Tamoxifen; Cancer; Aromatase inhibitor; Adverse effect","score_opus":0.00941036389523718,"score_gpt":0.27771896031029164,"score_spread":0.26830859641505445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979370923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019640275,0.99812883,0.00018715643,0.0004063157,0.00022112839,0.0000038973617,0.000020984517,0.000010579801,0.00082467706],"genre_scores_gemma":[0.0012153535,0.9969055,0.00027907031,0.00048553856,0.0002728148,0.0000058481623,0.000040779105,0.0000018100199,0.00079330173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998821,0.000017932709,0.000014625701,0.000021617941,0.00005030072,0.000013377901],"domain_scores_gemma":[0.99979204,0.00010445841,0.000035475372,0.0000057085276,0.000039778606,0.00002247234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121429,0.0009782284,0.0013919371,0.001414913,0.00019385664,0.0006730478,0.00089790387,0.0009563099,0.0025335466],"category_scores_gemma":[0.00056822563,0.0001885066,0.00035787447,0.0015365704,0.00036533654,0.0009169906,0.00047216823,0.001796988,0.0015590235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012150594,0.000045666737,0.0001468693,0.0035673114,0.000050543364,0.00019165235,0.000014637743,0.00030921435,0.0010379582,0.001004342,0.019738723,0.9737716],"study_design_scores_gemma":[0.00012399557,0.00019052267,0.0014818193,0.0018646382,0.0001905232,0.0027229758,0.0000483243,0.00022040354,0.0008230246,0.0018215047,0.9904881,0.000024234228],"about_ca_topic_score_codex":0.00096007803,"about_ca_topic_score_gemma":0.00244806,"teacher_disagreement_score":0.0025335466,"about_ca_system_score_codex":0.00050260616,"about_ca_system_score_gemma":0.00054687326,"threshold_uncertainty_score":0.008475602},"labels":[],"label_agreement":null},{"id":"W1979489779","doi":"10.1016/j.breast.2005.07.002","title":"Breast screening in the emerging world: High prevalence of breast cancer in Cairo","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European School of Oncology","keywords":"Medicine; Breast cancer; Breast cancer screening; Family medicine; Context (archaeology); Physical examination; Mammography; Primary care; Stage (stratigraphy); Cancer; Gynecology; Internal medicine","score_opus":0.03372545689701683,"score_gpt":0.3262338909180351,"score_spread":0.2925084340210183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979489779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930148,0.00095158146,0.00006356124,0.0026463326,0.000013425912,0.0000141322835,0.0002814463,0.000008300916,0.0030065435],"genre_scores_gemma":[0.9980465,0.0007954627,0.00011656554,0.00029897463,0.000019209181,0.0000068771014,0.00013984983,0.0000036150614,0.00057302567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997004,0.00004548516,0.000024655228,0.000044948087,0.00006794795,0.00011661904],"domain_scores_gemma":[0.9993197,0.00007909837,0.0003039432,0.000020777008,0.00012715558,0.00014951201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031290922,0.00022199706,0.0002692,0.0009154314,0.00086105656,0.00097383227,0.00052783074,0.0008012395,0.0049809343],"category_scores_gemma":[0.0012916735,0.00027066204,0.00018399007,0.0023956217,0.0004834169,0.00079109264,0.000739549,0.00056866393,0.00024719397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005960565,0.00003396244,0.9872759,0.00012509982,0.0000198714,0.0009201596,0.0016709724,0.00005344667,0.00063100096,0.00018659614,0.0008985048,0.00812485],"study_design_scores_gemma":[0.000005951508,0.000023019593,0.9948655,0.000032582306,0.000012891855,0.00048672312,0.003730624,0.00009359309,0.000046437483,0.000038623242,0.0006587395,0.0000054804805],"about_ca_topic_score_codex":0.24304056,"about_ca_topic_score_gemma":0.3867625,"teacher_disagreement_score":0.24304056,"about_ca_system_score_codex":0.002203934,"about_ca_system_score_gemma":0.0026570356,"threshold_uncertainty_score":0.4832518},"labels":[],"label_agreement":null},{"id":"W1983381186","doi":"10.1016/j.breast.2012.01.006","title":"A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Radiation therapy; Population; Demography; Systemic therapy; Demographics; Cancer; Epidemiology; Cancer registry; Endocrine system; Internal medicine; Oncology; Gynecology; Environmental health; Hormone","score_opus":0.19002479147791676,"score_gpt":0.37062475941530476,"score_spread":0.180599967937388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983381186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342525,0.00044896454,0.0021870388,0.00041064483,0.0000115046105,0.000060234855,0.0012031391,0.000041021012,0.0022122478],"genre_scores_gemma":[0.99663,0.00021458436,0.0014204128,0.00006680179,0.0000037213374,0.00003818001,0.00104254,0.000014570293,0.0005692444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985341,0.00063958263,0.000064943124,0.00025526338,0.00021826694,0.00028773042],"domain_scores_gemma":[0.99608266,0.0022077307,0.00045631715,0.00021294225,0.00079167384,0.00024866784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003073965,0.00040612608,0.00049654423,0.0012261921,0.0006092498,0.0015395355,0.0013914488,0.0003932999,0.0015808805],"category_scores_gemma":[0.0107332785,0.00046653804,0.00080768095,0.0017295067,0.00065506017,0.0005198197,0.00066733925,0.0005140493,0.00015058923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077090657,0.00018480825,0.64412063,0.00019251757,0.0006126826,0.00023338456,0.0008626534,0.3254761,0.00021062893,0.0045592557,0.0035080577,0.019268263],"study_design_scores_gemma":[0.00011511788,0.00023393428,0.39137095,0.0001102991,0.00024405598,0.00019946299,0.0014878066,0.5998667,0.0002464515,0.002597338,0.0034549811,0.00007282793],"about_ca_topic_score_codex":0.94008905,"about_ca_topic_score_gemma":0.8939503,"teacher_disagreement_score":0.059910953,"about_ca_system_score_codex":0.018792538,"about_ca_system_score_gemma":0.011293674,"threshold_uncertainty_score":0.13635004},"labels":[],"label_agreement":null},{"id":"W1984199328","doi":"10.1016/j.breast.2013.07.011","title":"Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Sunitinib; Bevacizumab; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Internal medicine; Context (archaeology); Clinical trial; Paclitaxel; Chemotherapy","score_opus":0.3010749332658669,"score_gpt":0.5013807287201687,"score_spread":0.20030579545430183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984199328","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700655,0.0041482667,0.015031329,0.0004209998,0.00029187385,0.0008479393,0.0036365138,0.00047109422,0.0050864154],"genre_scores_gemma":[0.9771952,0.0033592908,0.0081316205,0.00019802785,0.00004830104,0.0008076211,0.003676928,0.00010402047,0.006478967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996948,0.00006338974,0.00003693188,0.000050477345,0.000071650065,0.00008278051],"domain_scores_gemma":[0.99966395,0.00006571203,0.00007125991,0.00006439798,0.00004246031,0.00009220142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005908118,0.0006070047,0.0006247289,0.00045348753,0.00019341722,0.0005384522,0.00044790277,0.0004836102,0.0023890815],"category_scores_gemma":[0.00026608258,0.0002444821,0.00045742886,0.00021675993,0.0002433646,0.00045707423,0.00021849689,0.0023157387,0.00072297273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006215964,0.0018232226,0.00039034444,0.00014632837,0.000033732318,0.00006337677,0.000046209003,0.00083230325,0.99001116,0.0003929125,0.0005705422,0.005068353],"study_design_scores_gemma":[0.0001645654,0.018018086,0.0026910105,0.000018663617,0.000072962524,0.00034668337,0.000039667335,0.002276555,0.9699126,0.00014918888,0.00629481,0.000015228153],"about_ca_topic_score_codex":0.00091750704,"about_ca_topic_score_gemma":0.0018988629,"teacher_disagreement_score":0.0023890815,"about_ca_system_score_codex":0.00057572866,"about_ca_system_score_gemma":0.00055869314,"threshold_uncertainty_score":0.007992268},"labels":[],"label_agreement":null},{"id":"W1984366888","doi":"10.1016/s0960-9776(02)00284-9","title":"A case–control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Population and Public Health; University of Ottawa; Institut Universitaire de Gériatrie de Montréal; Université de Montréal","funders":"National Cancer Institute; Medical Research Council Canada","keywords":"Medicine; Breast cancer; Odds ratio; Polyunsaturated fatty acid; Quartile; Case-control study; Confidence interval; Arachidonic acid; Internal medicine; Physiology; Cancer; Vitamin E; Endocrinology; Population; Fatty acid; Antioxidant; Environmental health; Biochemistry","score_opus":0.008559678380930254,"score_gpt":0.22581398235553576,"score_spread":0.21725430397460552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984366888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868015,0.0035973506,0.00096925406,0.0004328588,0.000045432116,0.00044508514,0.0041813375,0.00004687371,0.0034803632],"genre_scores_gemma":[0.9932508,0.00087218574,0.0010844382,0.0002038366,0.0000191784,0.00012956529,0.0013468221,0.000007954477,0.0030852417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869484,0.00024013458,0.00006467235,0.00028387204,0.00035931668,0.000357273],"domain_scores_gemma":[0.9990256,0.000078953024,0.00013842291,0.000068179346,0.0004580653,0.00023082776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093041797,0.0007160048,0.0006654705,0.0016917984,0.0039048991,0.00081312057,0.0012994398,0.0006016458,0.0024324534],"category_scores_gemma":[0.00180822,0.0006423175,0.00060482585,0.0034818256,0.0008534132,0.00025357524,0.00057555333,0.00061598065,0.00022062717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004655847,0.00014611887,0.9854865,0.00009280425,0.0003890625,0.001004737,0.00088678976,0.00016661364,0.00142353,0.0003372837,0.002619631,0.00698139],"study_design_scores_gemma":[0.00009643006,0.00013190274,0.9957302,0.000022887576,0.00010111462,0.00036205168,0.0002956726,0.00022358782,0.00010727359,0.000038231672,0.0028760808,0.000014478082],"about_ca_topic_score_codex":0.9876687,"about_ca_topic_score_gemma":0.98979807,"teacher_disagreement_score":0.017815549,"about_ca_system_score_codex":0.017815549,"about_ca_system_score_gemma":0.011693621,"threshold_uncertainty_score":0.12926143},"labels":[],"label_agreement":null},{"id":"W1987049740","doi":"10.1016/j.breast.2014.01.003","title":"Lack of association between breast reconstructive surgery and the development of chronic pain after mastectomy: A propensity matched retrospective cohort analysis","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Northwestern University","keywords":"Medicine; Mastectomy; Breast reconstruction; Breast cancer; Propensity score matching; Chronic pain; Retrospective cohort study; Incidence (geometry); Surgery; Reconstructive surgery; Cohort; Breast surgery; Cancer; Internal medicine; Physical therapy","score_opus":0.014795730296576865,"score_gpt":0.22600580914037652,"score_spread":0.21121007884379966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987049740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988632,0.00032342924,0.00031417,0.000029071427,0.000011004203,0.000022564283,0.00023676491,0.000003145567,0.00019668769],"genre_scores_gemma":[0.9995521,0.00006862138,0.000096427124,0.000017474063,0.000009961759,0.000011946749,0.00019138162,0.000001339993,0.000050759616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986119,0.00038266904,0.00020735628,0.0003871399,0.0002392294,0.00017162724],"domain_scores_gemma":[0.9966704,0.0006005911,0.0017349297,0.00054306723,0.00023227817,0.000218808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002093682,0.00019907605,0.0003781307,0.0007967941,0.00041157022,0.0005620139,0.0003486699,0.000383161,0.0015987235],"category_scores_gemma":[0.004749911,0.00032908085,0.000703505,0.0010455865,0.0002839494,0.00043635498,0.00036222333,0.00031273236,0.0001521772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028045505,0.000030528074,0.9982851,0.000010360428,0.0001873045,0.00007302237,0.000027900556,0.000026928656,0.0001300315,0.000024805853,0.000058036512,0.00086553977],"study_design_scores_gemma":[0.00003767164,0.00030358174,0.9982455,0.000009645277,0.00014885732,0.00050510897,0.00009511126,0.00035740936,0.00006332931,0.000038955415,0.00018977596,0.000005094642],"about_ca_topic_score_codex":0.0018681703,"about_ca_topic_score_gemma":0.0016455483,"teacher_disagreement_score":0.002093682,"about_ca_system_score_codex":0.0002055626,"about_ca_system_score_gemma":0.000368473,"threshold_uncertainty_score":0.011072636},"labels":[],"label_agreement":null},{"id":"W1988818641","doi":"10.1016/j.breast.2007.10.003","title":"Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Letrozole; Tamoxifen; Anastrozole; Oncology; Aromatase inhibitor; Adjuvant therapy; Internal medicine; Aromatase; Breast cancer; Adjuvant; Adverse effect; Cancer","score_opus":0.027117066628117737,"score_gpt":0.29414762728639915,"score_spread":0.2670305606582814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988818641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018700665,0.99898344,0.000114825016,0.00019863858,0.00014694076,0.0000028013624,0.000015599686,0.0000038672774,0.00034679892],"genre_scores_gemma":[0.0012213966,0.99776626,0.00020374157,0.00019058405,0.00020186185,0.000004518312,0.000029280212,0.0000011198708,0.00038124225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986386,0.00002145877,0.000018254563,0.000024811647,0.000058254158,0.000013333664],"domain_scores_gemma":[0.999764,0.000119787815,0.000039646944,0.0000065961067,0.000052259602,0.000017675984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005106289,0.00081728894,0.0019372947,0.0009135572,0.00014358795,0.0006355412,0.0010172238,0.0010791128,0.002148338],"category_scores_gemma":[0.0006426674,0.00022758367,0.0004011539,0.0013807018,0.0003579004,0.00056440406,0.0003152373,0.0015347119,0.001063249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026134975,0.00010401724,0.00028923235,0.0070384983,0.0001434595,0.00022411806,0.0000151900385,0.0005015013,0.0013061133,0.0010867206,0.018427556,0.9706022],"study_design_scores_gemma":[0.00022569805,0.0004060814,0.0037528877,0.0027755313,0.0005474213,0.003819771,0.000065323744,0.0003136219,0.0014402672,0.0022859264,0.98433244,0.00003490601],"about_ca_topic_score_codex":0.0012917768,"about_ca_topic_score_gemma":0.0026048822,"teacher_disagreement_score":0.002148338,"about_ca_system_score_codex":0.0004555918,"about_ca_system_score_gemma":0.0006508336,"threshold_uncertainty_score":0.0071868896},"labels":[],"label_agreement":null},{"id":"W1995011952","doi":"10.1016/j.breast.2005.09.005","title":"A case of axillary web syndrome with subcutaneous nodules following axillary surgery","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Axilla; Surgery; Breast cancer; Subcutaneous tissue; Axillary vein; Pain syndrome; Radiology; Cancer; Internal medicine","score_opus":0.011214561300843423,"score_gpt":0.2241166447661991,"score_spread":0.2129020834653557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995011952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964996,0.0025538162,0.004535898,0.0036124536,0.00065444346,0.00023440197,0.0002989054,0.0003837238,0.022730371],"genre_scores_gemma":[0.9953361,0.0005025188,0.0012626575,0.00061486673,0.0008517644,0.000045579363,0.000070386166,0.000026809243,0.0012892679],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99892235,0.00014219592,0.00010246395,0.00021076875,0.00021057426,0.00041172604],"domain_scores_gemma":[0.99491715,0.0021191388,0.000719865,0.0006085748,0.00019994259,0.0014352493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060277537,0.0028137378,0.0017063332,0.0038850154,0.0033967756,0.0019037114,0.0025599527,0.0070787477,0.004421513],"category_scores_gemma":[0.008138523,0.0015083122,0.0020816461,0.0032864658,0.0026115521,0.0026236349,0.0029139414,0.004552763,0.0012205424],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003215896,0.000021753618,0.0014418827,0.000012863087,0.0000041734606,0.9976688,0.000039432394,0.000033259817,0.00028741037,0.000085455235,0.00004725979,0.00032555967],"study_design_scores_gemma":[0.00003204699,0.000056042474,0.0019395599,0.000004937157,0.000012299479,0.99724436,0.00005386115,0.00018627668,0.00024593307,0.00014026268,0.000078348305,0.0000061213286],"about_ca_topic_score_codex":0.001875856,"about_ca_topic_score_gemma":0.0017469367,"teacher_disagreement_score":0.0070787477,"about_ca_system_score_codex":0.0014463636,"about_ca_system_score_gemma":0.0011421846,"threshold_uncertainty_score":0.014791369},"labels":[],"label_agreement":null},{"id":"W1998162370","doi":"10.1016/j.breast.2012.07.003","title":"Does breast cancer tumor size really matter that much?","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Université Laval","funders":"","keywords":"Breast cancer; Cancer; Breast tumor; Medicine; Medical physics; Oncology; Computer science; Internal medicine","score_opus":0.006909877168312911,"score_gpt":0.23864804288550356,"score_spread":0.23173816571719066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998162370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42720345,0.4102559,0.0033747677,0.12562056,0.010544625,0.0000951704,0.0015575023,0.000097191674,0.021250775],"genre_scores_gemma":[0.9089638,0.050547548,0.001072028,0.025706135,0.008752942,0.000044170047,0.000642683,0.00012236027,0.0041482374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973295,0.0015207289,0.00020271512,0.00032833975,0.00045825375,0.0001605238],"domain_scores_gemma":[0.97911924,0.014823025,0.002927424,0.0011264826,0.0010112425,0.0009924863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007337764,0.0005567775,0.0018778596,0.000659241,0.0004227875,0.001659989,0.0007346429,0.0016785981,0.0049929423],"category_scores_gemma":[0.020633362,0.0003052034,0.0013526125,0.0012553086,0.0019062519,0.0024183253,0.0005490771,0.0017636637,0.0009977852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009803303,0.00043294328,0.629819,0.0036673318,0.0088321185,0.0008240927,0.0007789246,0.00055420544,0.007848792,0.0059843976,0.031981464,0.2994734],"study_design_scores_gemma":[0.0004778939,0.0034164959,0.9057335,0.0012904528,0.005843553,0.0024366074,0.0025371367,0.00048321995,0.0033814474,0.019401953,0.054903053,0.000094696894],"about_ca_topic_score_codex":0.0013414109,"about_ca_topic_score_gemma":0.002494037,"teacher_disagreement_score":0.007337764,"about_ca_system_score_codex":0.00064205646,"about_ca_system_score_gemma":0.0010021094,"threshold_uncertainty_score":0.03880626},"labels":[],"label_agreement":null},{"id":"W1998788444","doi":"10.1016/j.breast.2015.02.011","title":"Predictors of responses and sexual function for women in the St George breast boost randomized trial (StGBBT)","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; George (robot); Sexual function; Randomized controlled trial; Internal medicine; Gynecology; Oncology; Artificial intelligence","score_opus":0.015465782158125232,"score_gpt":0.2556419737831769,"score_spread":0.24017619162505166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998788444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98355615,0.010896862,0.00014873178,0.0017672844,0.0003179942,0.00018506263,0.000889241,0.00003348433,0.002205146],"genre_scores_gemma":[0.99450386,0.0018757428,0.00019631415,0.00073549076,0.00018749335,0.00026117335,0.0009042969,0.0000061646315,0.0013293627],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960905,0.00026132955,0.000014897814,0.00003352363,0.000034006993,0.000047293528],"domain_scores_gemma":[0.9994469,0.0001899453,0.00016226643,0.000040537103,0.000020252312,0.00014006182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010683745,0.00031641097,0.0011406668,0.00023609596,0.00016783652,0.00048429111,0.00035366544,0.0008485791,0.00524217],"category_scores_gemma":[0.0017843863,0.00017422409,0.0010538418,0.0003092457,0.0002990145,0.00034019965,0.00024115643,0.0015147806,0.00032965327],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72887415,0.0044661677,0.14237605,0.0027514987,0.0064725284,0.00018874892,0.00016584547,0.0017335637,0.0011467837,0.0013137944,0.015362144,0.095148884],"study_design_scores_gemma":[0.41710728,0.0961357,0.4551288,0.0012961263,0.008361284,0.0005209504,0.0003720692,0.0071679684,0.0007813515,0.0028936155,0.010155283,0.000079549165],"about_ca_topic_score_codex":0.0013207789,"about_ca_topic_score_gemma":0.002256634,"teacher_disagreement_score":0.00524217,"about_ca_system_score_codex":0.00030527325,"about_ca_system_score_gemma":0.0006216665,"threshold_uncertainty_score":0.017536819},"labels":[],"label_agreement":null},{"id":"W2000462699","doi":"10.1016/s0960-9776(09)70002-5","title":"Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Aromatase; Adjuvant; Breast cancer; Oncology; Internal medicine; Gynecology; Aromatase inhibitor; Cancer","score_opus":0.0392571597724751,"score_gpt":0.36747072665262104,"score_spread":0.3282135668801459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000462699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006997548,0.9986229,0.000093113296,0.00043737594,0.00020992314,0.0000019055549,0.000010276173,0.0000029232428,0.00055154203],"genre_scores_gemma":[0.00055414834,0.9982071,0.00015801226,0.00034938118,0.0003108603,0.000003020545,0.000019890476,9.0910476e-7,0.0003966583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998072,0.00004011017,0.000025437772,0.00003286252,0.0000756823,0.000018828307],"domain_scores_gemma":[0.9994848,0.00028369017,0.000055322256,0.000012485391,0.00012582507,0.000037952617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009953585,0.0008162336,0.0015549888,0.001427695,0.0002277378,0.00092469074,0.0011304246,0.0013156822,0.0038583444],"category_scores_gemma":[0.001042836,0.00023588222,0.0004141092,0.0016772592,0.00060478196,0.0011209218,0.00056228874,0.0023033714,0.0018701319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023268141,0.00008706269,0.00017876766,0.00848712,0.00008666753,0.00038605128,0.000031294065,0.00047034954,0.0022426734,0.003908874,0.04035529,0.94353306],"study_design_scores_gemma":[0.00007840979,0.00013886736,0.00071051955,0.0017939478,0.00011424682,0.0014834048,0.000040392166,0.00012304337,0.00042341792,0.0023627293,0.992714,0.000017109336],"about_ca_topic_score_codex":0.0010658182,"about_ca_topic_score_gemma":0.0028146396,"teacher_disagreement_score":0.0038583444,"about_ca_system_score_codex":0.00070017215,"about_ca_system_score_gemma":0.0008453988,"threshold_uncertainty_score":0.012907505},"labels":[],"label_agreement":null},{"id":"W2001293348","doi":"10.1016/j.breast.2013.04.002","title":"A pilot study of prospective memory functioning in early breast cancer survivors","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Carleton University","funders":"Canadian Cancer Society","keywords":"Medicine; Depression (economics); Breast cancer; Cancer-related fatigue; Prospective cohort study; Cancer; Psychological intervention; Odds ratio; Center for Epidemiologic Studies Depression Scale; Physical therapy; Internal medicine; Clinical psychology; Oncology; Psychiatry; Cognition; Depressive symptoms","score_opus":0.0171175662123762,"score_gpt":0.25976573128747354,"score_spread":0.24264816507509734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001293348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948275,0.000059482834,0.000033151322,0.000014114029,0.0000043264713,0.0000951215,0.00006498735,0.0000013356454,0.00024477456],"genre_scores_gemma":[0.99880266,0.00010661663,0.00015538272,0.00007723927,0.0000147735045,0.00018648327,0.0002259553,0.0000013572783,0.00042948968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995449,0.00020796133,0.000039037903,0.00004799739,0.000063337044,0.00009664121],"domain_scores_gemma":[0.9984725,0.00033303938,0.00023555005,0.00012774054,0.0002784907,0.0005525693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014834893,0.0004960546,0.0004272008,0.0007004901,0.0008614151,0.000486244,0.00032118047,0.0004766574,0.001841901],"category_scores_gemma":[0.0025157447,0.00032622548,0.00035169686,0.0004485182,0.00042731036,0.0004793116,0.0005533187,0.00066541496,0.00051715143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025678326,0.008064682,0.97328657,0.00008421638,0.0000878488,0.00097049185,0.003242805,0.000045266424,0.0019962694,0.000041722426,0.0003499755,0.009262433],"study_design_scores_gemma":[0.00041335388,0.031088483,0.962969,0.000020910562,0.000087319575,0.0011598784,0.0026459657,0.0000952064,0.00043725726,0.000049536306,0.0010195243,0.0000135823875],"about_ca_topic_score_codex":0.004053614,"about_ca_topic_score_gemma":0.0041181585,"teacher_disagreement_score":0.004053614,"about_ca_system_score_codex":0.0002791545,"about_ca_system_score_gemma":0.0006119647,"threshold_uncertainty_score":0.008060038},"labels":[],"label_agreement":null},{"id":"W2003862238","doi":"10.1016/j.breast.2010.06.004","title":"Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Malignancy; Core biopsy; Biopsy; Hyperplasia; Core (optical fiber); General surgery; Radiology; Pathology; Internal medicine; Cancer; Breast cancer","score_opus":0.05039637274487417,"score_gpt":0.25628790448620653,"score_spread":0.20589153174133235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003862238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988477,0.00024472314,0.00004714084,0.00003986478,0.000010779891,0.000003724958,0.000069177724,0.0000043663786,0.0007324644],"genre_scores_gemma":[0.99970275,0.000053646392,0.00003362665,0.0000106724665,0.000016545579,0.000001390228,0.0000616262,0.0000013861624,0.00011839278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996443,0.000081971826,0.000046614558,0.000054912907,0.000084091655,0.00008808243],"domain_scores_gemma":[0.9951303,0.0019138266,0.0012131794,0.00029373702,0.00036202563,0.0010868276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005232293,0.0002974473,0.00038462708,0.00093890826,0.0003484225,0.00053445564,0.00046107662,0.00054185017,0.0030952385],"category_scores_gemma":[0.0050765174,0.00020222139,0.0005009947,0.0010865451,0.00035679425,0.0004501197,0.00032160114,0.0008527438,0.00021411976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020004867,0.000021568114,0.9983437,0.00000558604,0.000024253733,0.00016568886,0.000027071137,0.000034729677,0.0003386425,0.000010876544,0.000032878983,0.00079507945],"study_design_scores_gemma":[0.0000037040068,0.00008253855,0.99890065,0.0000028585794,0.000027143802,0.00056192547,0.000105305684,0.00015692969,0.00006424849,0.000024816578,0.000067175024,0.000002703005],"about_ca_topic_score_codex":0.0038047722,"about_ca_topic_score_gemma":0.0039274935,"teacher_disagreement_score":0.0038047722,"about_ca_system_score_codex":0.0003024124,"about_ca_system_score_gemma":0.00045165792,"threshold_uncertainty_score":0.0103545785},"labels":[],"label_agreement":null},{"id":"W2004864041","doi":"10.1054/brst.2001.0404","title":"Surveillance mammography after treatment of primary breast cancer: a systematic review","year":2002,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Mammography; Breast cancer; Systematic review; Observational study; Randomized controlled trial; Regimen; Stage (stratigraphy); Oncology; Cancer; Internal medicine; MEDLINE; Medical physics","score_opus":0.016771224713844304,"score_gpt":0.2724177705024511,"score_spread":0.2556465457886068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004864041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094852626,0.9983323,0.00006618816,0.00012277553,0.00007900327,0.00014297474,0.000120984274,0.0000038753938,0.00018340962],"genre_scores_gemma":[0.011354485,0.987608,0.00036974438,0.00021729496,0.000044571636,0.00023184108,0.000087612265,0.0000015204523,0.00008493161],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99640757,0.0017219759,0.0009691002,0.0002374007,0.0005729638,0.000090854315],"domain_scores_gemma":[0.98493713,0.010937869,0.0026551245,0.00014834551,0.0011173205,0.00020433393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004595807,0.0009927077,0.005653807,0.0038743452,0.0003260812,0.0011939751,0.0011450546,0.0013268921,0.003559937],"category_scores_gemma":[0.025446668,0.0006487627,0.0039985687,0.0061961543,0.00045163513,0.0011179402,0.0005679942,0.0006095582,0.00027659952],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004849874,0.00004041209,0.0010756464,0.8992267,0.007081817,0.0002154135,0.00015131393,0.00015899993,0.00013440849,0.00014509632,0.0025381017,0.08874718],"study_design_scores_gemma":[0.0012405785,0.0009086078,0.011284173,0.8667187,0.08646551,0.0012889928,0.0004110128,0.00018148334,0.0004251148,0.00033052795,0.030696956,0.0000482719],"about_ca_topic_score_codex":0.007668929,"about_ca_topic_score_gemma":0.023285553,"teacher_disagreement_score":0.007668929,"about_ca_system_score_codex":0.00222558,"about_ca_system_score_gemma":0.0065202774,"threshold_uncertainty_score":0.024305224},"labels":[],"label_agreement":null},{"id":"W2008333014","doi":"10.1016/j.breast.2005.08.026","title":"Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy","year":2005,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Krebsliga Schweiz; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canadian Institutes of Health Research; European Commission","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Tamoxifen; Lung cancer; Pharmacology","score_opus":0.035890944529173616,"score_gpt":0.3396441336567344,"score_spread":0.3037531891275608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008333014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038223152,0.9981311,0.0002858402,0.00015396556,0.00016777865,0.0000059808913,0.000012082539,0.000010156156,0.0008509532],"genre_scores_gemma":[0.0027735776,0.9954698,0.00037680834,0.00018722532,0.00016896341,0.000010936906,0.00003763036,0.0000021495991,0.0009728971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998847,0.000019774967,0.000014745232,0.000020736956,0.000045630855,0.000014268429],"domain_scores_gemma":[0.9998764,0.0000562107,0.000021823886,0.00000452099,0.000028096225,0.000012894119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040640222,0.0006370306,0.0013713111,0.0011397755,0.00018549635,0.0006026013,0.00083497894,0.0007342968,0.0016472301],"category_scores_gemma":[0.00039904646,0.00019629828,0.00031524748,0.0013359173,0.0003020839,0.0005727316,0.00030327422,0.0013041972,0.0010623413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002039269,0.00013705152,0.00015932345,0.0053827134,0.00008600456,0.00029049523,0.000026556794,0.00045168662,0.0038986949,0.0017028319,0.017201504,0.9704592],"study_design_scores_gemma":[0.00015547445,0.00044650363,0.0023451184,0.0016295675,0.00024598566,0.003961037,0.00004569023,0.0004527498,0.0039503006,0.0015429355,0.98519117,0.000033485787],"about_ca_topic_score_codex":0.0007717586,"about_ca_topic_score_gemma":0.0017186736,"teacher_disagreement_score":0.0016472301,"about_ca_system_score_codex":0.0005568505,"about_ca_system_score_gemma":0.00045058265,"threshold_uncertainty_score":0.0055105686},"labels":[],"label_agreement":null},{"id":"W2009740420","doi":"10.1016/j.breast.2007.09.001","title":"Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Taxane; Medicine; Oncology; Internal medicine; Adjuvant; Breast cancer; Cancer; Chemotherapy; Clinical trial; Retrospective cohort study","score_opus":0.02650017942233748,"score_gpt":0.33056835277771524,"score_spread":0.3040681733553778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009740420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013184958,0.99911207,0.00004737097,0.00026003542,0.000100312835,0.0000015964955,0.000015541507,0.0000020333866,0.00032930108],"genre_scores_gemma":[0.0010393057,0.9980787,0.00010157876,0.00028347757,0.00020718253,0.000004219133,0.000026114592,9.20978e-7,0.00025858107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983776,0.000041043422,0.000025722582,0.000031476437,0.000051779552,0.000012211195],"domain_scores_gemma":[0.9995209,0.00034402017,0.000049383503,0.000009601444,0.000056146364,0.000019990755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008937279,0.00056852825,0.0018393026,0.000867511,0.00014721711,0.00072567794,0.0007331343,0.00089645956,0.0022067272],"category_scores_gemma":[0.0013483674,0.00019318296,0.000382608,0.0015013802,0.00048145413,0.00061292603,0.00034849244,0.0014583055,0.0008928715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034861322,0.000062836465,0.00044147836,0.009125988,0.000170309,0.00022044266,0.000016029297,0.0002940274,0.0009431049,0.0018724666,0.02264396,0.9638607],"study_design_scores_gemma":[0.00026761158,0.0003022605,0.0056504156,0.0063331975,0.000736945,0.0028998351,0.00008906151,0.00017131698,0.0009785744,0.0051478385,0.97738874,0.000034105837],"about_ca_topic_score_codex":0.0010836853,"about_ca_topic_score_gemma":0.0025259869,"teacher_disagreement_score":0.0022067272,"about_ca_system_score_codex":0.00066742074,"about_ca_system_score_gemma":0.0007492076,"threshold_uncertainty_score":0.007382214},"labels":[],"label_agreement":null},{"id":"W2012535287","doi":"10.1016/j.breast.2011.04.009","title":"The low uptake of breast screening in cities is a major public health issue and may be due to organisational factors: A Census-based record linkage study","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health and Social Care Research and Development Division; Queen's University; Economic and Social Research Council; Public Health Agency; Queen's University Belfast","keywords":"Census; Medicine; Linkage (software); Record linkage; Public health; Environmental health; Family medicine; Population; Nursing; Genetics; Gene","score_opus":0.13912669738673927,"score_gpt":0.3322318786566331,"score_spread":0.19310518126989384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012535287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641365,0.00014132397,0.00044316304,0.00040030852,0.000010616851,0.000057838508,0.0014250583,0.000010752586,0.001097403],"genre_scores_gemma":[0.9978771,0.000140527,0.00030958708,0.0001986494,0.000013000298,0.00008178658,0.00079574645,0.000017897022,0.00056570896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98971444,0.0056705927,0.0012580801,0.0009266077,0.001573736,0.00085645076],"domain_scores_gemma":[0.9653036,0.009188275,0.012886612,0.0051768012,0.005842426,0.0016023192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062626074,0.0003691308,0.0006638583,0.0019594212,0.0023140735,0.0019493512,0.0015273917,0.0009410026,0.0033298638],"category_scores_gemma":[0.02920598,0.0010328827,0.0008214762,0.0077208607,0.000928426,0.0020224333,0.0019931383,0.0010146275,0.00080443727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011376668,0.000065081906,0.99706894,0.000027754773,0.00006747501,0.000054072138,0.00088503666,0.00002813507,0.00010001677,0.000046398967,0.0003485609,0.0011948075],"study_design_scores_gemma":[0.000014565993,0.000092464405,0.99728096,0.000014783274,0.00006535576,0.000114688155,0.0018016656,0.00015060743,0.00008711147,0.000030692772,0.00033614854,0.000010846736],"about_ca_topic_score_codex":0.09344304,"about_ca_topic_score_gemma":0.14832391,"teacher_disagreement_score":0.09344304,"about_ca_system_score_codex":0.0019063306,"about_ca_system_score_gemma":0.0029747442,"threshold_uncertainty_score":0.18579829},"labels":[],"label_agreement":null},{"id":"W2014818610","doi":"10.1016/j.breast.2007.07.011","title":"Application of aromatase inhibitors in endocrine responsive breast cancers","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Aromatase; Tamoxifen; Breast cancer; Oncology; Adjuvant; Pharmacogenomics; Letrozole; Anastrozole; Internal medicine; PI3K/AKT/mTOR pathway; Bioinformatics; Cancer; Pharmacology; Signal transduction","score_opus":0.010421762561595962,"score_gpt":0.30452407708163126,"score_spread":0.2941023145200353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014818610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001846285,0.99777883,0.0003043455,0.0002632605,0.00028498573,0.0000051639595,0.000019777592,0.0000103058655,0.001148705],"genre_scores_gemma":[0.0011080237,0.996863,0.0003494164,0.00027226668,0.00023775306,0.00000662948,0.000042641044,0.000002262105,0.0011180125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999843,0.00002187279,0.000020097437,0.00002678949,0.000070813716,0.000017349426],"domain_scores_gemma":[0.9997286,0.00012700942,0.00003844986,0.000010639449,0.000070865535,0.000024263209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061337656,0.00094591145,0.0015405912,0.001740987,0.00021874516,0.0008326656,0.0010336436,0.00095349265,0.002804448],"category_scores_gemma":[0.0007211469,0.00030531923,0.0004703839,0.0017581768,0.00046079647,0.0008623797,0.00045702502,0.0018080213,0.0019717324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001460448,0.0001027242,0.00018735882,0.005573722,0.00009754974,0.0003916212,0.000026498681,0.00055769226,0.0038642485,0.0027752763,0.032484256,0.95379305],"study_design_scores_gemma":[0.000057451645,0.00010676069,0.0008044219,0.00087717123,0.00013527398,0.0017598061,0.000027071932,0.00012492615,0.0013504957,0.0011948863,0.99354607,0.000015562302],"about_ca_topic_score_codex":0.0010771003,"about_ca_topic_score_gemma":0.0025246367,"teacher_disagreement_score":0.002804448,"about_ca_system_score_codex":0.00063310884,"about_ca_system_score_gemma":0.0006077862,"threshold_uncertainty_score":0.009381831},"labels":[],"label_agreement":null},{"id":"W2019134258","doi":"10.1016/j.breast.2007.07.023","title":"Adjuvant therapy of the very young woman","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Radiation therapy; Cancer; Hormonal therapy; Hormone therapy; Gynecology","score_opus":0.03405988825776794,"score_gpt":0.3165928460238964,"score_spread":0.28253295776612847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019134258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001003826,0.99910235,0.00008470177,0.00013741574,0.00014580975,0.0000015261899,0.000006716741,0.0000024431556,0.000418707],"genre_scores_gemma":[0.0006738848,0.99848086,0.00012266093,0.00018901034,0.00018419666,0.0000030417036,0.000014683049,8.108707e-7,0.00033075275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998907,0.000025861078,0.000016159422,0.000022382945,0.000033575987,0.000011233748],"domain_scores_gemma":[0.9997646,0.00014644898,0.000033057582,0.0000063945477,0.000031494947,0.000018035214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041587636,0.0006701883,0.0014254908,0.0010684808,0.00019326292,0.00059101597,0.0006575885,0.00096241565,0.0013612638],"category_scores_gemma":[0.0007428055,0.00021667645,0.00033410365,0.0012431549,0.00034836505,0.00055782264,0.00039980473,0.0012613619,0.0009822441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009621338,0.00005338392,0.00043489545,0.006597544,0.000058519152,0.00063775876,0.00002259189,0.0002571206,0.0011091548,0.0012541711,0.02254754,0.966931],"study_design_scores_gemma":[0.00005292028,0.00012484458,0.0028984542,0.0050686165,0.00022307485,0.008351541,0.000079881334,0.00015076419,0.0008714099,0.0017062135,0.98044854,0.000023726761],"about_ca_topic_score_codex":0.0011506765,"about_ca_topic_score_gemma":0.0027460326,"teacher_disagreement_score":0.0014254908,"about_ca_system_score_codex":0.00045982172,"about_ca_system_score_gemma":0.00065039704,"threshold_uncertainty_score":0.0045538545},"labels":[],"label_agreement":null},{"id":"W2025143483","doi":"10.1016/j.breast.2012.04.006","title":"Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Monash University; Victoria University; University of Victoria","keywords":"Medicine; Breast reconstruction; Mastectomy; Logistic regression; Breast cancer; Demography; Gynecology; Cancer; Internal medicine","score_opus":0.016659051475937166,"score_gpt":0.2667565143855638,"score_spread":0.25009746290962664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025143483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988305,0.0002845628,0.000019845585,0.00021514347,0.0000057849084,0.000005840035,0.00006178866,9.081235e-7,0.00057563686],"genre_scores_gemma":[0.999231,0.00028875232,0.00003793441,0.000051707677,0.000004651996,0.0000049873415,0.000036952046,0.000001128918,0.00034280657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953914,0.00014118373,0.000057202622,0.00005110143,0.00008475392,0.00012670277],"domain_scores_gemma":[0.99867225,0.00015454406,0.0006472148,0.00003249748,0.00016466668,0.00032886904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028764666,0.00012251922,0.00023205073,0.00035923644,0.00081613206,0.00057975977,0.00046604726,0.00041935718,0.0013933583],"category_scores_gemma":[0.00263377,0.00035760502,0.0002833042,0.00078889634,0.00039915106,0.0002758821,0.0007175458,0.0006328235,0.0001740856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049685907,0.00003487216,0.99556845,0.000027550706,0.000021259588,0.0001758767,0.001501581,0.000017999571,0.00021091783,0.000026559108,0.00013226797,0.002233035],"study_design_scores_gemma":[9.392686e-7,0.000022353437,0.99852484,0.000009857067,0.0000052534133,0.000084867745,0.0011642466,0.000033760087,0.0000067668375,0.0000094343995,0.00013567157,0.0000020018379],"about_ca_topic_score_codex":0.21843208,"about_ca_topic_score_gemma":0.3693786,"teacher_disagreement_score":0.21843208,"about_ca_system_score_codex":0.0013722145,"about_ca_system_score_gemma":0.0013707678,"threshold_uncertainty_score":0.43432128},"labels":[],"label_agreement":null},{"id":"W2028619707","doi":"10.1016/j.breast.2015.01.005","title":"Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Pregnancy; Infertility; Fertility; Cancer; Gynecology; Obstetrics; Fertility preservation; Population; Disease; Endocrine system; Prospective cohort study; Family medicine; Internal medicine; Hormone; Environmental health","score_opus":0.1148903504952607,"score_gpt":0.4107326383296403,"score_spread":0.2958422878343796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028619707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89259434,0.032240283,0.0007162083,0.057456687,0.0006744903,0.00039983823,0.0008808596,0.00003253068,0.015004791],"genre_scores_gemma":[0.9724243,0.011005052,0.0008132253,0.013448497,0.0004786172,0.00027743372,0.0003186085,0.00001108934,0.0012231299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608254,0.0024053138,0.00045158272,0.00018836927,0.0004748129,0.00039735128],"domain_scores_gemma":[0.9678517,0.015991116,0.0076640216,0.00074007845,0.0015834859,0.0061695855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007833362,0.0001199476,0.000495771,0.0006558288,0.00078672334,0.0018827029,0.00031001025,0.0017536193,0.0049087913],"category_scores_gemma":[0.04139397,0.00022945354,0.00028012283,0.00095589634,0.00074558053,0.001766595,0.00086476107,0.0011588986,0.00083236815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009423446,0.00030738156,0.87831044,0.0005609359,0.000080202706,0.0012140545,0.004086798,0.000035738605,0.0006208816,0.00042853723,0.010198056,0.10321468],"study_design_scores_gemma":[0.00021969089,0.0013972842,0.92397016,0.0019437277,0.00015531051,0.005398698,0.024167199,0.00024667528,0.00033156062,0.0021120366,0.03997091,0.00008665354],"about_ca_topic_score_codex":0.0011701409,"about_ca_topic_score_gemma":0.0020124738,"teacher_disagreement_score":0.007833362,"about_ca_system_score_codex":0.00038651968,"about_ca_system_score_gemma":0.0011874189,"threshold_uncertainty_score":0.041427255},"labels":[],"label_agreement":null},{"id":"W2028642805","doi":"10.1016/j.breast.2012.07.017","title":"Practice patterns and perceptions of margin status for breast conserving surgery for breast carcinoma: National Survey of Canadian General Surgeons","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Health Sciences Centre; Foothills Medical Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Margin (machine learning); General surgery; Surgery; Cancer; Mastectomy; Internal medicine","score_opus":0.02967323559985989,"score_gpt":0.2808620864148288,"score_spread":0.2511888508149689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028642805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955499,0.00045721582,0.000045606717,0.0010393468,0.0000076131846,0.000028126251,0.0007933911,0.0000037097434,0.002075254],"genre_scores_gemma":[0.9986951,0.00040751486,0.00013186746,0.00021011336,0.000004277373,0.000011233592,0.00025894592,0.0000013895382,0.00027948015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983699,0.00023982601,0.000145278,0.00012259491,0.0007729941,0.000349357],"domain_scores_gemma":[0.99414366,0.0011627106,0.001570276,0.00009953188,0.0017553684,0.0012684906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00221002,0.00017133498,0.0001897252,0.001124269,0.001533201,0.0007364436,0.00076469965,0.0004538119,0.0026024573],"category_scores_gemma":[0.007942794,0.00022922765,0.00024033857,0.0020339524,0.0009009646,0.00033020152,0.0006465726,0.0004274091,0.00018563772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004672595,0.000024675503,0.9893811,0.00007277177,0.000015808067,0.00006446964,0.003749412,0.000058583388,0.00017828195,0.000048874786,0.0011464013,0.0052129254],"study_design_scores_gemma":[0.00000488086,0.00003754538,0.9930854,0.000052180905,0.0000059094978,0.00007098857,0.005688393,0.000106639774,0.000032185,0.00001221084,0.0008951906,0.000008456912],"about_ca_topic_score_codex":0.9518559,"about_ca_topic_score_gemma":0.96499056,"teacher_disagreement_score":0.9518559,"about_ca_system_score_codex":0.01029411,"about_ca_system_score_gemma":0.01287396,"threshold_uncertainty_score":0.09685522},"labels":[],"label_agreement":null},{"id":"W2030822657","doi":"10.1016/j.breast.2010.03.002","title":"Hypofractionation should be the new ‘standard’ for radiation therapy after breast conserving surgery","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast-conserving surgery; Randomized controlled trial; Standard of care; Medical prescription; Breast cancer; Radiation therapy; Surgery; Medical physics; Radiology; Mastectomy; Internal medicine; Cancer; Nursing","score_opus":0.04846224254649399,"score_gpt":0.3284188276487383,"score_spread":0.2799565851022443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030822657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007037688,0.99783355,0.00013157514,0.00096868677,0.00038545314,0.0000027632816,0.000014509025,0.0000068754302,0.0005862984],"genre_scores_gemma":[0.0008520153,0.99639624,0.00037763602,0.0011078565,0.00056082034,0.0000056670397,0.000038165956,0.0000036231302,0.0006579852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996536,0.00007832217,0.00005824018,0.00007225106,0.0001120939,0.000025473066],"domain_scores_gemma":[0.9992005,0.00041504114,0.00011171596,0.000035054698,0.00019488181,0.00004282345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015458858,0.0009034067,0.0019958643,0.0012331229,0.0002839513,0.0010005997,0.001373942,0.0017992542,0.0029982661],"category_scores_gemma":[0.0015687563,0.00028588346,0.0004971173,0.0016150922,0.0011071918,0.0017965544,0.00056280213,0.0033541291,0.0021979597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016380045,0.00005559573,0.00020055725,0.00855276,0.00008239083,0.00011979991,0.000022794518,0.00025129115,0.0013171663,0.0036375048,0.037675105,0.94792134],"study_design_scores_gemma":[0.0000516822,0.0001088949,0.0011854575,0.0027518007,0.00012128448,0.0009725451,0.000043045547,0.00006612108,0.000671349,0.0025470392,0.9914561,0.000024718202],"about_ca_topic_score_codex":0.0015289169,"about_ca_topic_score_gemma":0.003221919,"teacher_disagreement_score":0.0029982661,"about_ca_system_score_codex":0.0011678615,"about_ca_system_score_gemma":0.001352121,"threshold_uncertainty_score":0.01003021},"labels":[],"label_agreement":null},{"id":"W2031654328","doi":"10.1016/j.breast.2010.03.007","title":"What are the minimal standards of radiotherapy planning and dosimetry for “hypofractionated” radiotherapy in breast cancer?","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Radiation treatment planning; Medical physics; Dosimetry; Oncology; Cancer; Radiology; Internal medicine","score_opus":0.019894914244793012,"score_gpt":0.34891364133891273,"score_spread":0.3290187270941197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031654328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003721593,0.9865117,0.0033923143,0.00666847,0.00066749146,0.000016221937,0.000045493118,0.000028238323,0.0022979171],"genre_scores_gemma":[0.0037919106,0.98340905,0.009730166,0.0015107443,0.0007293881,0.000059570357,0.00009049777,0.000021646758,0.00065712165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736917,0.0009036531,0.0004843147,0.00019827901,0.0009467313,0.0000978608],"domain_scores_gemma":[0.99379224,0.0038328425,0.0008730591,0.00026267668,0.0010645277,0.00017467594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078825075,0.00068775576,0.0028849754,0.0013932721,0.00046665006,0.001904924,0.0033145738,0.0027050402,0.0014523552],"category_scores_gemma":[0.009489715,0.0005610291,0.00074457476,0.0015466455,0.0026171843,0.0036508956,0.0008278279,0.003924344,0.0017752167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011539782,0.00007803712,0.0004571572,0.014617908,0.00010117049,0.000170709,0.00019272642,0.0010699918,0.002500189,0.024758866,0.020284973,0.93565285],"study_design_scores_gemma":[0.000057653153,0.00023940684,0.0028295873,0.014037715,0.00023751476,0.0026270677,0.00046437365,0.00039661388,0.0027161394,0.029264633,0.94702923,0.00009998414],"about_ca_topic_score_codex":0.002591561,"about_ca_topic_score_gemma":0.0035633233,"teacher_disagreement_score":0.0078825075,"about_ca_system_score_codex":0.0019878952,"about_ca_system_score_gemma":0.004187484,"threshold_uncertainty_score":0.04168719},"labels":[],"label_agreement":null},{"id":"W2036457189","doi":"10.1016/j.breast.2012.02.014","title":"A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Guideline; Demography; Mastectomy; Population; Cancer; Epidemiology; Surgery; Family medicine; Internal medicine; Environmental health","score_opus":0.0692755109281876,"score_gpt":0.3809497262237102,"score_spread":0.31167421529552264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036457189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954072,0.00024368652,0.0017110764,0.00029759452,0.0000092180235,0.00005253246,0.00072623196,0.000029754245,0.0015226393],"genre_scores_gemma":[0.9970709,0.00013513776,0.001402728,0.000061686755,0.000003066318,0.000040318504,0.00083537505,0.000012863313,0.0004379359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984137,0.00068328803,0.000074587835,0.00027810648,0.0002475961,0.0003027207],"domain_scores_gemma":[0.9956291,0.0024385953,0.0005583851,0.00025114202,0.0008560329,0.0002667871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032660516,0.00044385987,0.00049527455,0.0012365874,0.00063324976,0.0017059994,0.0014860576,0.0004378072,0.0013389105],"category_scores_gemma":[0.011406284,0.00053652993,0.0008926113,0.0016240544,0.0007305973,0.0005428859,0.0007241319,0.00047072457,0.00013698866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006779701,0.00021769623,0.65242153,0.00015183422,0.0006478022,0.00022569088,0.0009415866,0.3217175,0.00025384536,0.0040295417,0.0029269506,0.015788],"study_design_scores_gemma":[0.00009668809,0.00022151489,0.38988444,0.00008786307,0.0002099532,0.00016714507,0.0013512198,0.60299593,0.00023426305,0.002206275,0.0024715236,0.000073142655],"about_ca_topic_score_codex":0.9108414,"about_ca_topic_score_gemma":0.8429509,"teacher_disagreement_score":0.98236144,"about_ca_system_score_codex":0.017638579,"about_ca_system_score_gemma":0.010254945,"threshold_uncertainty_score":0.1793673},"labels":[],"label_agreement":null},{"id":"W2038762495","doi":"10.1016/s0960-9776(03)00100-0","title":"Socioeconomic status & returning for a second screen in the Ontario breast screening program","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Rurality; Socioeconomic status; Mammography; Attendance; Breast cancer screening; Demography; Breast cancer; Referral; Retrospective cohort study; Cohort; Rural area; Gerontology; Family medicine; Environmental health; Cancer; Population; Internal medicine","score_opus":0.06510922564897673,"score_gpt":0.33041081432893127,"score_spread":0.26530158867995457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038762495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978067,0.00016478055,0.000023073848,0.000121847355,0.0000040279265,0.000022378512,0.00082904176,0.0000031169604,0.0010249608],"genre_scores_gemma":[0.99872154,0.000089674504,0.000026479436,0.000036025496,0.000003185723,0.000011840349,0.00047160173,0.0000013472396,0.00063819886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993806,0.000051182473,0.000027080498,0.0000670188,0.00024966348,0.00022443982],"domain_scores_gemma":[0.9989127,0.000043342865,0.00047703192,0.00006989446,0.00018511331,0.00031186335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044868156,0.00017116942,0.00027092645,0.00055581384,0.0011674289,0.00062456226,0.0005808004,0.00028840566,0.001446821],"category_scores_gemma":[0.0019791978,0.0002910552,0.00035970198,0.0013322688,0.00038528966,0.00026307773,0.00051245594,0.00048438646,0.0001692714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039635674,0.000013371702,0.9988538,0.0000033985075,0.0000131534,0.000055536708,0.00019235366,0.0000080392165,0.000038599133,0.000010829262,0.00018445394,0.0005869122],"study_design_scores_gemma":[0.0000031247027,0.000014226228,0.99963295,0.0000032578275,0.0000048450515,0.000033280583,0.00010711594,0.000021653817,0.0000066865728,0.0000034208651,0.00016815164,0.0000013045913],"about_ca_topic_score_codex":0.804101,"about_ca_topic_score_gemma":0.8893997,"teacher_disagreement_score":0.19589901,"about_ca_system_score_codex":0.0041864323,"about_ca_system_score_gemma":0.0041641835,"threshold_uncertainty_score":0.39410537},"labels":[],"label_agreement":null},{"id":"W2040018931","doi":"10.1016/j.breast.2013.07.052","title":"Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Fogarty International Center; Pan American Health Organization; American Society of Clinical Oncology; Fred Hutchinson Cancer Research Center; European School of Oncology; Sanofi; Livestrong Foundation; Amgen; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Open Society Foundations","keywords":"Medicine; Palliative care; Psychosocial; Breast cancer; Psychological intervention; Nursing; Health care; Metastatic breast cancer; Family medicine; Intensive care medicine; Cancer; Internal medicine; Psychiatry; Economic growth","score_opus":0.15776208105951905,"score_gpt":0.4522439182843418,"score_spread":0.29448183722482274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040018931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076473225,0.99792236,0.000059427875,0.0012775139,0.00018357641,0.0000149241105,0.00005667198,0.0000025132683,0.00040658686],"genre_scores_gemma":[0.0006569301,0.9985096,0.0001848663,0.00042210758,0.0000757538,0.000023088052,0.000050157334,9.4500814e-7,0.000076548145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882776,0.0003854696,0.00026977656,0.000073399024,0.00034575505,0.0000977628],"domain_scores_gemma":[0.9977743,0.0011821316,0.00041413063,0.000025148627,0.00050220324,0.00010207675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040440136,0.0009402708,0.0021876676,0.0032385928,0.00039146756,0.0014675726,0.0015726434,0.001457036,0.0032763754],"category_scores_gemma":[0.0055234185,0.00045463632,0.0015766151,0.004449966,0.00044334776,0.0017670047,0.0015427485,0.0017862695,0.00057833537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008155353,0.00003458292,0.00027502963,0.08485559,0.00029808504,0.00006552642,0.00009711285,0.00043400208,0.00021449926,0.0028804706,0.05094669,0.85981697],"study_design_scores_gemma":[0.00011701308,0.00014315185,0.0029360473,0.23179801,0.0014690629,0.00073705334,0.00047034697,0.00021809946,0.00026733373,0.0030858892,0.7587195,0.00003844841],"about_ca_topic_score_codex":0.006827391,"about_ca_topic_score_gemma":0.020973755,"teacher_disagreement_score":0.006827391,"about_ca_system_score_codex":0.0022965644,"about_ca_system_score_gemma":0.008257075,"threshold_uncertainty_score":0.02138704},"labels":[],"label_agreement":null},{"id":"W2040696193","doi":"10.1016/j.breast.2014.02.002","title":"Evaluation of eligibility and recruitment in breast cancer clinical trials","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Breast cancer; Oncology; Clinical trial; Cancer; Family medicine; Internal medicine; Medical physics","score_opus":0.8792104055012392,"score_gpt":0.7332901491485581,"score_spread":0.14592025635268113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040696193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7262074,0.022042098,0.081069924,0.023029067,0.0014302761,0.108375184,0.001838717,0.00044732032,0.03556007],"genre_scores_gemma":[0.9061634,0.0014674847,0.04575428,0.0031548673,0.0005338718,0.04118179,0.0005575859,0.000075412274,0.0011113026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.13710646,0.73108256,0.08347568,0.0058785826,0.039125495,0.003331182],"domain_scores_gemma":[0.075658046,0.7012877,0.16197601,0.030502837,0.024520775,0.006054749],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7347196,0.0011373141,0.0027842463,0.006517594,0.0031450284,0.0063874065,0.0038541257,0.004955706,0.0035757022],"category_scores_gemma":[0.858136,0.0012645279,0.0027615905,0.0059063584,0.0056098024,0.008985071,0.0059672287,0.00370835,0.0011194487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026355831,0.0019675547,0.6905276,0.006945616,0.0025507133,0.0007189877,0.012776554,0.0028282357,0.0010631521,0.015300472,0.008273858,0.23069139],"study_design_scores_gemma":[0.009476223,0.028880287,0.7708981,0.011252917,0.002861117,0.0034937358,0.00681456,0.04265804,0.007047687,0.05344614,0.062470466,0.0007007538],"about_ca_topic_score_codex":0.00051123986,"about_ca_topic_score_gemma":0.00069295726,"teacher_disagreement_score":0.26528043,"about_ca_system_score_codex":0.0046547255,"about_ca_system_score_gemma":0.013411469,"threshold_uncertainty_score":0.32713807},"labels":[],"label_agreement":null},{"id":"W2043733527","doi":"10.1016/s0960-9776(09)70113-4","title":"0068 Elevated bone resorption predicts shorter recurrence-free survival (RFS) for bone metastasis in breast cancer (BC)","year":2009,"lang":"en","type":"article","venue":"The Breast","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bone metastasis; Breast cancer; Resorption; Oncology; Bone resorption; Internal medicine; Cancer; Metastasis","score_opus":0.03314797552869088,"score_gpt":0.31194719606514093,"score_spread":0.27879922053645007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043733527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734145,0.0011850409,0.0000729619,0.0001843676,0.000022770475,0.0000034595541,0.00030792752,0.0000087903945,0.0008731404],"genre_scores_gemma":[0.9986687,0.00021916766,0.00006449758,0.000047093657,0.000043596276,0.0000036568983,0.0002828979,0.000003931197,0.00066650636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982494,0.00004788641,0.000019565548,0.000023398568,0.00003696171,0.000047260724],"domain_scores_gemma":[0.99878234,0.00031143185,0.00047803254,0.000078901736,0.0000894531,0.00025985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044438505,0.00026524067,0.00040548487,0.00047551334,0.0002971012,0.00057983276,0.0003879122,0.0006950082,0.0049267397],"category_scores_gemma":[0.00233026,0.00025130273,0.00055224204,0.00061393017,0.00026351732,0.0002533307,0.0002717706,0.0007769291,0.00057957054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007566174,0.000049662714,0.9941334,0.000014694781,0.00007347797,0.00010570429,0.000022555161,0.000060403818,0.0006774087,0.000019349905,0.00021010364,0.0038767469],"study_design_scores_gemma":[0.00002379718,0.00022313326,0.9981804,0.000005037683,0.00010829462,0.0007072425,0.000045333396,0.00020491604,0.00013191946,0.00006659772,0.00029999157,0.000003392859],"about_ca_topic_score_codex":0.0042099208,"about_ca_topic_score_gemma":0.0054433704,"teacher_disagreement_score":0.0049267397,"about_ca_system_score_codex":0.00018468627,"about_ca_system_score_gemma":0.00032899177,"threshold_uncertainty_score":0.016481578},"labels":[],"label_agreement":null},{"id":"W2046319455","doi":"10.1016/j.breast.2011.12.013","title":"Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis","year":2012,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Breast reconstruction; Cancer; Meta-analysis; Prophylactic Mastectomy; Oncology; Adjuvant therapy; Inclusion and exclusion criteria; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.074247150691652,"score_gpt":0.325369091730187,"score_spread":0.251121941038535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046319455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024401762,0.97429013,0.00037210618,0.000112832866,0.00014925888,0.000027529164,0.00036303204,0.0000142134595,0.0002691453],"genre_scores_gemma":[0.4938389,0.5021628,0.0009948955,0.00087708206,0.0003686974,0.00009573781,0.00078539626,0.00002995355,0.0008465556],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985832,0.000426384,0.000351943,0.00036552225,0.00017530759,0.00009752667],"domain_scores_gemma":[0.9964857,0.002221103,0.00075267866,0.00020505293,0.0002313754,0.00010407703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023115,0.0014994701,0.005897537,0.0014545213,0.00030172613,0.0011365494,0.001248201,0.0012412298,0.0032633643],"category_scores_gemma":[0.0054264185,0.0009254572,0.017901443,0.0028082083,0.00033365455,0.0009461093,0.0008328898,0.001448063,0.00026168834],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062943306,0.00006650576,0.054293092,0.10086665,0.80585575,0.0003715274,0.00013493715,0.0006248186,0.00069750735,0.000117199415,0.0013998725,0.029277792],"study_design_scores_gemma":[0.00061589485,0.00036395612,0.03176341,0.003590053,0.9604156,0.0003300281,0.00009573008,0.00016979854,0.00016421692,0.00015838031,0.0022969393,0.00003603238],"about_ca_topic_score_codex":0.0041031917,"about_ca_topic_score_gemma":0.014657517,"teacher_disagreement_score":0.005897537,"about_ca_system_score_codex":0.0006594754,"about_ca_system_score_gemma":0.0007078943,"threshold_uncertainty_score":0.012224495},"labels":[],"label_agreement":null},{"id":"W2047708827","doi":"10.1016/j.breast.2005.10.011","title":"Intraductal papilloma in a reconstructed breast: Mammographic and sonographic appearance with pathologic correlation","year":2006,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Radiology; Mastectomy; Intraductal papilloma; Breast reconstruction; Fat necrosis; Mammography; Occult; Carcinoma; Papilloma; Ductal carcinoma; Breast cancer; Surgery; Cancer; Pathology; Internal medicine","score_opus":0.0036492203756254174,"score_gpt":0.17711520828110636,"score_spread":0.17346598790548093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047708827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887129,0.0010168919,0.0016196666,0.0003219023,0.00006466536,0.00006581368,0.00019815908,0.000112176305,0.007887852],"genre_scores_gemma":[0.9984238,0.00021050489,0.0007099908,0.000058332862,0.00009762164,0.000010259674,0.00006339023,0.000012224934,0.0004137798],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995078,0.00007455771,0.000076608165,0.00009592857,0.00010204135,0.00014310706],"domain_scores_gemma":[0.9970675,0.0011504891,0.00048319425,0.0005730401,0.00023246225,0.0004933636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008094608,0.0012159252,0.0007015985,0.0028221433,0.00085706566,0.0013202778,0.0011231365,0.0022588144,0.0031852545],"category_scores_gemma":[0.006005593,0.0010146666,0.0006744418,0.0014953278,0.0018479994,0.0016560506,0.0010568092,0.0010773476,0.0012411193],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012349925,0.00020801413,0.09108568,0.00011665441,0.00004255368,0.88708615,0.0003395059,0.00031605375,0.014313518,0.0006575897,0.00017374595,0.0044256086],"study_design_scores_gemma":[0.00007672407,0.0005894092,0.05811107,0.000022082673,0.000093419556,0.929703,0.000432253,0.0012202795,0.0086543895,0.00024870838,0.00082336634,0.00002532904],"about_ca_topic_score_codex":0.0009796004,"about_ca_topic_score_gemma":0.00074256054,"teacher_disagreement_score":0.0031852545,"about_ca_system_score_codex":0.0005046389,"about_ca_system_score_gemma":0.0005209975,"threshold_uncertainty_score":0.010655701},"labels":[],"label_agreement":null},{"id":"W2050437076","doi":"10.1016/s0960-9776(11)70291-0","title":"Obesity and insulin resistance in breast cancer – Chemoprevention strategies with a focus on metformin","year":2011,"lang":"en","type":"review","venue":"The Breast","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Metformin; Breast cancer; Insulin resistance; PI3K/AKT/mTOR pathway; Oncology; Insulin; Internal medicine; Cancer; Diabetes mellitus; Cancer research; Endocrinology; Signal transduction","score_opus":0.01618575017774309,"score_gpt":0.2700540664694002,"score_spread":0.2538683162916571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050437076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077411896,0.9989473,0.000091477545,0.00032222338,0.00018731368,0.0000026030216,0.000009562389,0.0000046349564,0.00035748363],"genre_scores_gemma":[0.00041902493,0.99854505,0.00015316665,0.0002578467,0.00024157908,0.000004653646,0.000019562282,0.0000010788311,0.00035810782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998363,0.00003067558,0.000023005201,0.00002881951,0.00006245404,0.000018702971],"domain_scores_gemma":[0.9997191,0.00012884795,0.00004139361,0.000010834571,0.00007424733,0.00002563703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006215418,0.0008972748,0.001658043,0.0013983132,0.00021645303,0.0008331362,0.0009838983,0.0011785772,0.0028427746],"category_scores_gemma":[0.0006653021,0.000342053,0.00046564208,0.001694483,0.00040468862,0.0011026595,0.00066540897,0.0024785672,0.0015770737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018948354,0.00014507605,0.00016176411,0.008388975,0.00013378996,0.00021052954,0.00002313634,0.00042249425,0.0018575031,0.0033833098,0.042437714,0.94264627],"study_design_scores_gemma":[0.00007779481,0.0001522171,0.001224406,0.0030511522,0.00024104796,0.0010920424,0.000043537708,0.00018135938,0.0006665413,0.0025296726,0.9907093,0.000030926018],"about_ca_topic_score_codex":0.0011945661,"about_ca_topic_score_gemma":0.0033905727,"teacher_disagreement_score":0.0028427746,"about_ca_system_score_codex":0.00059159327,"about_ca_system_score_gemma":0.0008433882,"threshold_uncertainty_score":0.00951004},"labels":[],"label_agreement":null},{"id":"W2058536228","doi":"10.1016/j.breast.2012.12.005","title":"Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; York University; Public Health Ontario; Cancer Care Ontario","funders":"","keywords":"Medicine; Breast cancer; Mammography; Family history; Gynecology; Cancer; Family medicine; Breast cancer screening; Oncology; Internal medicine","score_opus":0.025928654574798086,"score_gpt":0.3060044109428364,"score_spread":0.28007575636803833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058536228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016617416,0.999663,0.000011278493,0.000058810874,0.000018350027,0.0000041543317,0.000013089944,7.679715e-7,0.00006440756],"genre_scores_gemma":[0.0014173378,0.9984175,0.00005026164,0.00004900012,0.000020517446,0.00000853895,0.000013372555,3.109399e-7,0.000023197817],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988959,0.00027531647,0.00036672136,0.00013281665,0.00028243195,0.000046692625],"domain_scores_gemma":[0.9955284,0.0031967286,0.0007928203,0.00003577792,0.00037999763,0.00006622129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019365757,0.0009456943,0.0027290636,0.005849933,0.00032268345,0.0013238713,0.001081689,0.0012995803,0.0023900908],"category_scores_gemma":[0.006938822,0.0005335273,0.0016487875,0.0065790364,0.0004018348,0.0011457627,0.00058474217,0.0007189551,0.00029283995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017166704,0.00006481813,0.0026983744,0.5360101,0.002163849,0.0003976659,0.00035977294,0.00018047016,0.00032896243,0.00056299963,0.006373498,0.45068786],"study_design_scores_gemma":[0.00013501615,0.0005086782,0.037940532,0.74276,0.022971302,0.006365917,0.0011478879,0.00024745418,0.00050917105,0.0011712348,0.18613279,0.00010998278],"about_ca_topic_score_codex":0.0041707535,"about_ca_topic_score_gemma":0.0070220283,"teacher_disagreement_score":0.005849933,"about_ca_system_score_codex":0.0010448955,"about_ca_system_score_gemma":0.0028511416,"threshold_uncertainty_score":0.010241687},"labels":[],"label_agreement":null},{"id":"W2059216229","doi":"10.1054/brst.1999.0118","title":"Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen","year":2000,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Kræftens Bekæmpelse","keywords":"Megestrol acetate; Medicine; Megestrol; Tamoxifen; Internal medicine; Ovarian cancer; Gynecology; Breast cancer; Cancer; Urology","score_opus":0.007305348898281031,"score_gpt":0.2593504333474157,"score_spread":0.25204508444913465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059216229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416476,0.0027078795,0.0002563044,0.00033419425,0.00031566172,0.0009569709,0.00039168933,0.00003525828,0.0008371518],"genre_scores_gemma":[0.99241066,0.0019165578,0.00062046124,0.00047034278,0.00070686993,0.0013814676,0.00062546716,0.000011617572,0.0018565342],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990827,0.0006039511,0.000066030916,0.00008860299,0.000048654998,0.000110044326],"domain_scores_gemma":[0.9983382,0.0006965798,0.00028345556,0.00014052208,0.00007238274,0.0004688664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018535295,0.0012323874,0.0036104475,0.000570279,0.0003664512,0.0008980215,0.00075102143,0.0020781495,0.0053876764],"category_scores_gemma":[0.0023352324,0.0005684215,0.0014589992,0.00047713786,0.0012197904,0.001283083,0.0003932585,0.0021352244,0.00086434424],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9877649,0.004555786,0.00036092463,0.000111429326,0.00019961256,0.00003337671,0.000025694158,0.00010193987,0.0016717523,0.000038045604,0.000077309924,0.005059359],"study_design_scores_gemma":[0.66732544,0.3292531,0.001607948,0.000015161206,0.00026637295,0.00005557047,0.000034120065,0.0002950249,0.0005432026,0.00011695293,0.00047412148,0.000012980117],"about_ca_topic_score_codex":0.00038878113,"about_ca_topic_score_gemma":0.0009278785,"teacher_disagreement_score":0.0053876764,"about_ca_system_score_codex":0.0004466003,"about_ca_system_score_gemma":0.0007315072,"threshold_uncertainty_score":0.01802355},"labels":[],"label_agreement":null},{"id":"W2065173866","doi":"10.1016/j.breast.2011.06.010","title":"Hypofractionated radiotherapy of the breast may be safer for the heart","year":2011,"lang":"en","type":"letter","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Scopus; Randomized controlled trial; Oncology; Internal medicine; Cancer; MEDLINE","score_opus":0.017961385640546303,"score_gpt":0.25178587776229816,"score_spread":0.23382449212175185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065173866","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05849706,0.5010803,0.0073528606,0.32067022,0.021686213,0.0001273929,0.0016314427,0.0005003933,0.0884541],"genre_scores_gemma":[0.46550247,0.3306634,0.008081658,0.119096875,0.022638265,0.00026984734,0.001876296,0.0006299172,0.05124122],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99911636,0.00044480796,0.000061102706,0.00009862883,0.0001947569,0.0000843976],"domain_scores_gemma":[0.99645716,0.0018658543,0.00061168737,0.00034860158,0.0004298366,0.00028682896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002992698,0.0002404202,0.0007220884,0.00052200904,0.00066870556,0.0022321078,0.0005485516,0.0013646765,0.03779683],"category_scores_gemma":[0.011714129,0.00017810904,0.0015136033,0.0007201017,0.00076506805,0.0022556344,0.00078877906,0.0030029153,0.0040112934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005434654,0.00045015503,0.005748657,0.0068614264,0.00075856555,0.0004537103,0.0007786256,0.000856396,0.004712982,0.026634742,0.21715428,0.73015594],"study_design_scores_gemma":[0.0021147914,0.0030176542,0.037534628,0.0055371854,0.001106755,0.00210517,0.0011391039,0.0002692322,0.0049948813,0.052139223,0.8898733,0.00016815665],"about_ca_topic_score_codex":0.0012133792,"about_ca_topic_score_gemma":0.0025630335,"teacher_disagreement_score":0.03779683,"about_ca_system_score_codex":0.00074869866,"about_ca_system_score_gemma":0.0010213334,"threshold_uncertainty_score":0.12644297},"labels":[],"label_agreement":null},{"id":"W2068690776","doi":"10.1016/j.breast.2013.07.050","title":"Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Pan American Health Organization; Genentech; European School of Oncology; National Cancer Institute; Strong; American Society of Clinical Oncology; Livestrong Foundation; Fred Hutchinson Cancer Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; Roche; Novartis; Avon Foundation for Women; Amgen; Open Society Foundations; Susan G. Komen for the Cure","keywords":"Breast cancer; Psychosocial; Medicine; Health care; Family medicine; Nursing; Cancer; Psychiatry; Internal medicine; Political science","score_opus":0.046458089879992615,"score_gpt":0.35454955078040984,"score_spread":0.3080914609004172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068690776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100897785,0.99842876,0.00005379255,0.00081834407,0.00013677441,0.000017227612,0.00007754531,0.0000023576624,0.00036433892],"genre_scores_gemma":[0.0009603572,0.9982975,0.00019001296,0.00032206107,0.00006412433,0.000031556643,0.00006782432,0.0000010904421,0.00006553328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869186,0.0004760667,0.00032106994,0.000080503756,0.00033373196,0.00009676901],"domain_scores_gemma":[0.9977787,0.0012606338,0.00044904082,0.00002769019,0.00040399935,0.00007990179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035901333,0.0008831489,0.002195699,0.002655175,0.00032124476,0.0013066598,0.0016500988,0.0012500987,0.003070333],"category_scores_gemma":[0.005844813,0.00039968945,0.0017911189,0.0038766463,0.00038275777,0.0012982127,0.001262728,0.001514803,0.0004954231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012843074,0.000030818526,0.00031438255,0.10741534,0.0005267508,0.00005093444,0.00008741443,0.00034727564,0.00017736123,0.0019026849,0.03535811,0.85366046],"study_design_scores_gemma":[0.0002590387,0.00019573605,0.0050899023,0.34132138,0.0031347722,0.0007343749,0.0004638023,0.00023043292,0.00036502123,0.002648892,0.645511,0.000045707442],"about_ca_topic_score_codex":0.008274712,"about_ca_topic_score_gemma":0.01984924,"teacher_disagreement_score":0.008274712,"about_ca_system_score_codex":0.0020550808,"about_ca_system_score_gemma":0.0065368246,"threshold_uncertainty_score":0.018986702},"labels":[],"label_agreement":null},{"id":"W2068699420","doi":"10.1016/j.breast.2015.12.010","title":"Second international consensus guidelines for breast cancer in young women (BCY2)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Family medicine; Gynecology; Cancer; Internal medicine","score_opus":0.01974951529995675,"score_gpt":0.30549981597038456,"score_spread":0.28575030067042784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068699420","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065134633,0.30694333,0.068825334,0.39879397,0.08081475,0.014215185,0.026641255,0.0016175754,0.09563515],"genre_scores_gemma":[0.039232265,0.22070876,0.37307858,0.15021273,0.02183304,0.048988476,0.055073086,0.0013483188,0.08952461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96237576,0.01366066,0.010604219,0.0015164287,0.009168753,0.002674214],"domain_scores_gemma":[0.93264174,0.019630443,0.009138175,0.002241652,0.03128851,0.0050595165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0471478,0.002676266,0.003945195,0.010174214,0.0032316025,0.005021522,0.0076736775,0.013719752,0.00845301],"category_scores_gemma":[0.068804115,0.0018067128,0.00939661,0.0058718454,0.0021900784,0.0019787927,0.007554509,0.011029834,0.006402353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035659346,0.00033280067,0.0043867286,0.013487621,0.00045950976,0.0006112125,0.00078452396,0.0010271581,0.0009777618,0.0074796965,0.7095406,0.2605558],"study_design_scores_gemma":[0.00040620792,0.0001815242,0.011293587,0.047282234,0.0008781763,0.0011631628,0.0006619047,0.0005202469,0.0011000182,0.0063791093,0.9300309,0.00010294875],"about_ca_topic_score_codex":0.034322225,"about_ca_topic_score_gemma":0.03746271,"teacher_disagreement_score":0.0471478,"about_ca_system_score_codex":0.0075826864,"about_ca_system_score_gemma":0.03774626,"threshold_uncertainty_score":0.24934435},"labels":[],"label_agreement":null},{"id":"W2071959976","doi":"10.1016/s0960-9776(14)70079-7","title":"PO69 Breast cancer in young women in Canada – a needs assessment","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cancer; Family medicine; Gynecology; Internal medicine; Gerontology","score_opus":0.00606339186726763,"score_gpt":0.2536424989890219,"score_spread":0.2475791071217543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071959976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95987105,0.0044593895,0.00013372267,0.007886697,0.00009937947,0.0006893501,0.008971965,0.000016954074,0.017871445],"genre_scores_gemma":[0.9831071,0.006437564,0.0005399787,0.0017579753,0.000048289738,0.00026327927,0.0024248664,0.000006149119,0.005414945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883467,0.000070182745,0.00009106155,0.0000402835,0.0004369275,0.0005268658],"domain_scores_gemma":[0.99787927,0.000110194625,0.00020904568,0.000018736562,0.0012005932,0.00058220007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006561436,0.0002559625,0.0003416437,0.0019948673,0.0039684703,0.0014624859,0.0009836035,0.0008524875,0.002574562],"category_scores_gemma":[0.0023202465,0.00033960145,0.0005688854,0.005087784,0.00046711892,0.00069072645,0.001177649,0.0006863379,0.00030504633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012214636,0.00028808264,0.9494344,0.00059645734,0.00003536703,0.00088716956,0.0059338594,0.00021457294,0.00021979364,0.0004255694,0.006231235,0.03561137],"study_design_scores_gemma":[0.000016177823,0.000111337584,0.9682187,0.00041374387,0.000036903184,0.00021789758,0.024679543,0.0002240193,0.00007483382,0.00008496434,0.0059016584,0.000020198418],"about_ca_topic_score_codex":0.9912655,"about_ca_topic_score_gemma":0.9960705,"teacher_disagreement_score":0.032618616,"about_ca_system_score_codex":0.032618616,"about_ca_system_score_gemma":0.08716198,"threshold_uncertainty_score":0.23666573},"labels":[],"label_agreement":null},{"id":"W2072860180","doi":"10.1016/j.breast.2014.04.001","title":"Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the Breast Cancer Family Registry","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; York University; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Canadian Cancer Society","keywords":"Medicine; Breast cancer; Prospective cohort study; Cohort; Oncology; Cancer; Cancer registry; Gynecology; Cohort study; Internal medicine; Demography; Obstetrics","score_opus":0.026373491753905683,"score_gpt":0.27354454327350514,"score_spread":0.24717105151959945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072860180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986664,0.00027706014,0.000036045567,0.00009453433,0.0000027646201,0.000008521829,0.00050204503,0.0000019490399,0.00041069085],"genre_scores_gemma":[0.9995159,0.000106467014,0.000028632836,0.000015878015,0.0000024727399,0.000004432776,0.00020804713,7.436665e-7,0.00011742742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994929,0.00011193637,0.000040300205,0.000087113964,0.00014685246,0.00012090022],"domain_scores_gemma":[0.99808997,0.000223002,0.0009125972,0.00020826313,0.00024573042,0.00032046236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080803735,0.00019390267,0.0002484214,0.00047412314,0.0006573109,0.00068201916,0.0005179686,0.00033003502,0.0011764364],"category_scores_gemma":[0.0034801667,0.0002825131,0.00043815875,0.0010348492,0.0003833539,0.00026660724,0.0003972404,0.00044020746,0.00015757879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032936732,0.00000926832,0.9993259,0.0000037256823,0.000020295409,0.000026746235,0.00020407251,0.0000052040173,0.000030720268,0.0000052671585,0.000040768165,0.00029519072],"study_design_scores_gemma":[0.0000022070512,0.000013049618,0.9996836,0.000003403599,0.000009223231,0.000031095205,0.0001615998,0.000024468269,0.0000041770945,0.0000036276622,0.00006219998,0.000001319596],"about_ca_topic_score_codex":0.553207,"about_ca_topic_score_gemma":0.6409178,"teacher_disagreement_score":0.44679302,"about_ca_system_score_codex":0.0016047781,"about_ca_system_score_gemma":0.0014234261,"threshold_uncertainty_score":0.89884853},"labels":[],"label_agreement":null},{"id":"W2080950316","doi":"10.1016/j.breast.2015.07.025","title":"Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Hyperfractionation; Breast cancer; Medicine; Radiation therapy; Nuclear medicine; Cancer; Fractionation; Adverse effect; Dose fractionation; Oncology; Internal medicine; Chemistry","score_opus":0.024873775794235296,"score_gpt":0.3216234450921101,"score_spread":0.29674966929787483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080950316","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010445922,0.9750093,0.0018019798,0.008565145,0.0002869893,0.000057158275,0.00009083093,0.000014304238,0.0037282952],"genre_scores_gemma":[0.15830301,0.82435966,0.0050672465,0.0053473543,0.002761896,0.00018098045,0.00023572647,0.000040104027,0.0037040273],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997542,0.0016095948,0.00014949791,0.00018674714,0.00044311603,0.00006907516],"domain_scores_gemma":[0.99357784,0.004733487,0.0008680022,0.00018786638,0.00047973546,0.0001530894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010063807,0.00038495098,0.0013313466,0.00077284157,0.00023790846,0.0010879989,0.0012356127,0.0011994193,0.0027503949],"category_scores_gemma":[0.005214216,0.00017640286,0.00038877205,0.002258462,0.0012481945,0.0008550211,0.00047289566,0.0016251688,0.0006404916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028784007,0.00032290435,0.0063349707,0.009531164,0.00023365217,0.0002959824,0.00022848093,0.0016873974,0.0035294648,0.009052684,0.006310086,0.9595948],"study_design_scores_gemma":[0.0009834357,0.013801428,0.10190228,0.012893779,0.0013739573,0.0068932157,0.00088513887,0.001757991,0.0072219027,0.039885145,0.8122612,0.00014059637],"about_ca_topic_score_codex":0.0018320192,"about_ca_topic_score_gemma":0.0046770517,"teacher_disagreement_score":0.010063807,"about_ca_system_score_codex":0.0018691613,"about_ca_system_score_gemma":0.001466793,"threshold_uncertainty_score":0.053223133},"labels":[],"label_agreement":null},{"id":"W2083442629","doi":"10.1016/j.breast.2014.06.017","title":"A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Oncology; Bevacizumab; Hazard ratio; Breast cancer; Anthracycline; Taxane; Chemotherapy; Cancer; Confidence interval","score_opus":0.010220535074357972,"score_gpt":0.2683287439906438,"score_spread":0.25810820891628583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083442629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830351,0.0095010605,0.00081343146,0.0007044185,0.00016272491,0.00026032297,0.0034436367,0.00003967867,0.0020395985],"genre_scores_gemma":[0.991706,0.0011591656,0.0008880366,0.0003019386,0.00020370656,0.00036258384,0.0045610555,0.000017548975,0.0007999005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769443,0.0015658265,0.00014270798,0.00027010543,0.00021142328,0.000115375515],"domain_scores_gemma":[0.99517596,0.002299191,0.0013518954,0.0005818196,0.00017095891,0.00042023518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055268873,0.00074804074,0.0017668229,0.0005746377,0.00022002198,0.001118084,0.00067896396,0.00064428896,0.0018574904],"category_scores_gemma":[0.008382721,0.00022806917,0.0030016692,0.0008899863,0.00038598484,0.00067772303,0.00077770086,0.0011709237,0.0002542177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3055605,0.00065282633,0.59800065,0.001410883,0.040173613,0.00017962058,0.00013548984,0.0035254098,0.0015560216,0.00061677105,0.005500603,0.04268752],"study_design_scores_gemma":[0.053783905,0.011300973,0.8840585,0.00039886392,0.03289933,0.0004369994,0.00013158293,0.0078069787,0.0006310676,0.0021392175,0.006302244,0.00011036858],"about_ca_topic_score_codex":0.001283223,"about_ca_topic_score_gemma":0.0025522509,"teacher_disagreement_score":0.0055268873,"about_ca_system_score_codex":0.00056986173,"about_ca_system_score_gemma":0.0006736793,"threshold_uncertainty_score":0.029229283},"labels":[],"label_agreement":null},{"id":"W2083540373","doi":"10.1016/j.breast.2005.01.001","title":"Correlation between nutritional biomarkers and breast cancer: a case-control study","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa; Hôtel-Dieu de Montréal; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Adipose tissue; Internal medicine; Odds ratio; Cancer; Case-control study; Population; Body mass index; Endocrinology; Gastroenterology; Physiology; Oncology","score_opus":0.015282486482466372,"score_gpt":0.2774175445126021,"score_spread":0.2621350580301357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083540373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982534,0.0007550738,0.0003200048,0.000046779423,0.00002884584,0.0000491285,0.00021352766,0.000007744452,0.0003255737],"genre_scores_gemma":[0.9980903,0.00038349582,0.00040545233,0.00007616292,0.000050062357,0.00006725681,0.00031310375,0.000007621388,0.0006063993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976667,0.0009363218,0.00024803693,0.00060955,0.0003208796,0.00021846306],"domain_scores_gemma":[0.99633104,0.001351272,0.00068792474,0.0007295196,0.00042186156,0.00047839116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024072349,0.0010696413,0.0016804833,0.0021008842,0.0022597807,0.0013595588,0.001190589,0.0017604866,0.0036247135],"category_scores_gemma":[0.0055812406,0.0019572228,0.0011564592,0.0026092662,0.0013478724,0.0009726005,0.0007555438,0.0013033747,0.0006310428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005463166,0.0020720363,0.9849454,0.00011586802,0.0009777842,0.0011580588,0.0005219598,0.000048444395,0.0023551735,0.0001314455,0.00023826846,0.001972466],"study_design_scores_gemma":[0.0006682486,0.004372098,0.9887102,0.00002951319,0.0011188108,0.0028331205,0.00063655333,0.00032633453,0.00042487445,0.00010462028,0.0007410462,0.00003455391],"about_ca_topic_score_codex":0.006131742,"about_ca_topic_score_gemma":0.0058106114,"teacher_disagreement_score":0.006131742,"about_ca_system_score_codex":0.0006004511,"about_ca_system_score_gemma":0.0006764843,"threshold_uncertainty_score":0.012730837},"labels":[],"label_agreement":null},{"id":"W2085214163","doi":"10.1016/s0960-9776(09)70271-1","title":"Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Sunitinib; Oncology; Sorafenib; Internal medicine; Breast cancer; Drug; Antiangiogenic therapy; Metastatic breast cancer; Cancer; Taxane; Chemotherapy; Pharmacology","score_opus":0.027058376072951803,"score_gpt":0.35307949426084895,"score_spread":0.32602111818789714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085214163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060830058,0.9983588,0.00009958102,0.00074881356,0.00024919186,0.000002306444,0.000007581322,0.0000042075176,0.00046880275],"genre_scores_gemma":[0.00044518893,0.99831367,0.00018425014,0.00041702308,0.0002983462,0.00000341826,0.000013703181,9.985475e-7,0.00032333328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996753,0.00006344106,0.000044819055,0.00004653596,0.0001365284,0.000033341177],"domain_scores_gemma":[0.9990036,0.000533346,0.000106332605,0.000019809462,0.0002698755,0.000067123474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014093791,0.0007811286,0.0019376286,0.001553048,0.000387044,0.0012903898,0.0012284343,0.0023810181,0.0034543541],"category_scores_gemma":[0.0016868544,0.00029557332,0.0004876944,0.0019851243,0.0007423381,0.0020052944,0.00063528,0.0032607412,0.0017634446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014991322,0.00009653737,0.00014238089,0.00835235,0.00007123679,0.00026571655,0.000038385853,0.00041601437,0.0016931796,0.004780487,0.053870253,0.93012357],"study_design_scores_gemma":[0.000056532903,0.00012019052,0.0007519968,0.0023616606,0.00014441153,0.0014215271,0.00006526829,0.00016746648,0.00059760833,0.0026921926,0.99159896,0.000022156219],"about_ca_topic_score_codex":0.001804449,"about_ca_topic_score_gemma":0.0038810477,"teacher_disagreement_score":0.0034543541,"about_ca_system_score_codex":0.0010926583,"about_ca_system_score_gemma":0.0016287186,"threshold_uncertainty_score":0.01155597},"labels":[],"label_agreement":null},{"id":"W2090264949","doi":"10.1016/s0960-9776(13)70042-0","title":"PO29 METASTATIC BREAST CANCER IN CANADA: THE LIVED EXPERIENCE OF PATIENTS AND CAREGIVERS PRESENTED BY THE CANADIAN BREAST CANCER NETWORK","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.00799752239242615,"score_gpt":0.24683036387587753,"score_spread":0.23883284148345138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090264949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687563,0.0023551902,0.00010232318,0.010435477,0.00014240961,0.000054475284,0.00076044595,0.000009487615,0.017383972],"genre_scores_gemma":[0.9909219,0.0021829198,0.00013256179,0.002022344,0.000032393655,0.00001985415,0.00025212584,0.000012073083,0.0044237906],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9986651,0.00021751171,0.000034958477,0.00007079069,0.0002718889,0.0007397059],"domain_scores_gemma":[0.99611926,0.0002580835,0.0003594304,0.000044158354,0.0012703242,0.0019487662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085382233,0.00030755653,0.00042721728,0.0006380368,0.015208469,0.0036698284,0.0009132156,0.0008716646,0.0037922033],"category_scores_gemma":[0.0036516243,0.00027197303,0.00028650532,0.0019325746,0.002711008,0.0010180833,0.0035631068,0.0022151615,0.00032145155],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022404753,0.00018798445,0.22783485,0.00023303145,0.000049918108,0.004867794,0.6918967,0.00020393709,0.0006681925,0.0021988845,0.03883117,0.03280346],"study_design_scores_gemma":[0.0000058416044,0.000051359544,0.07099478,0.00022364956,0.000015271857,0.0010315579,0.89346653,0.00009319135,0.00008297398,0.00017076376,0.033812076,0.000052038748],"about_ca_topic_score_codex":0.9710645,"about_ca_topic_score_gemma":0.9895169,"teacher_disagreement_score":0.042952936,"about_ca_system_score_codex":0.042952936,"about_ca_system_score_gemma":0.074709944,"threshold_uncertainty_score":0.31164688},"labels":[],"label_agreement":null},{"id":"W2099968866","doi":"10.1016/j.breast.2006.12.002","title":"Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: Upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole","year":2007,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Exemestane; Medicine; Letrozole; Anastrozole; Tamoxifen; Breast cancer; Oncology; Hazard ratio; Gynecology; Aromatase inhibitor; Internal medicine; Cancer; Confidence interval","score_opus":0.004390067634372704,"score_gpt":0.22431233691575517,"score_spread":0.21992226928138248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099968866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827001,0.009949424,0.0009203065,0.0024238674,0.00009018414,0.000082129656,0.0007278047,0.00003388763,0.0030723172],"genre_scores_gemma":[0.99782556,0.0010207305,0.0003788555,0.00013563191,0.00003870223,0.000016003909,0.00020676467,0.0000035531475,0.00037416097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994997,0.0003044828,0.000029269244,0.00003093849,0.000074691896,0.00006087147],"domain_scores_gemma":[0.99855465,0.00087934325,0.00018509498,0.000040966526,0.000095843854,0.00024409413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009025206,0.00054507836,0.0006978196,0.0005150207,0.00015145267,0.0006436132,0.0004190255,0.0007052795,0.0035744861],"category_scores_gemma":[0.0043512434,0.00020013232,0.0010195475,0.00056583603,0.00023384446,0.0006232686,0.00034273294,0.00058057986,0.0001709189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19665085,0.0023140132,0.21417509,0.0005898677,0.0025618775,0.0011196919,0.00015984515,0.033775114,0.0046665706,0.001873894,0.003995599,0.53811765],"study_design_scores_gemma":[0.010348922,0.04432378,0.8398175,0.00038555666,0.01296645,0.0027281656,0.0008262781,0.07489831,0.00424761,0.0028536394,0.006472059,0.00013170428],"about_ca_topic_score_codex":0.0071565616,"about_ca_topic_score_gemma":0.011314016,"teacher_disagreement_score":0.0071565616,"about_ca_system_score_codex":0.0017624929,"about_ca_system_score_gemma":0.0013376742,"threshold_uncertainty_score":0.0142297745},"labels":[],"label_agreement":null},{"id":"W2112159509","doi":"10.1016/j.breast.2012.07.001","title":"An objective assessment of the perceived quality of life of living with bilateral mastectomy defect","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Mastectomy; Population; Quality of life (healthcare); Breast cancer; Blindness; Surgery; Cancer; Internal medicine; Optometry; Environmental health","score_opus":0.013604501741776052,"score_gpt":0.2914210248700379,"score_spread":0.2778165231282618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112159509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514353,0.00037820564,0.0010843419,0.00006441066,0.000013670471,0.000081359845,0.00094448944,0.000011943103,0.0022780916],"genre_scores_gemma":[0.99815625,0.00010544147,0.0008347056,0.000026738458,0.000007460285,0.000049690265,0.00042277508,0.0000018112006,0.0003950292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993074,0.0002569192,0.000085452535,0.00006132645,0.00022387315,0.000065070635],"domain_scores_gemma":[0.99731725,0.00059056684,0.0013116125,0.00009448803,0.00039211832,0.0002940579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011657203,0.00032546872,0.00028458223,0.0006158885,0.00014871462,0.0004684788,0.0002991699,0.00032482736,0.0028572595],"category_scores_gemma":[0.003429555,0.000075636766,0.0005886217,0.00041700897,0.00023866523,0.00036387652,0.0005956699,0.00038494894,0.00020582325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062027446,0.00060946937,0.9582482,0.00018541026,0.00032297286,0.000073742944,0.0002751435,0.00065650756,0.001733347,0.00009196225,0.0006553591,0.036527596],"study_design_scores_gemma":[0.00002589516,0.0012100806,0.9959175,0.00002510391,0.00006041304,0.00039461913,0.00025516865,0.0010030902,0.000407431,0.00007364213,0.00061158906,0.000015515086],"about_ca_topic_score_codex":0.0006646284,"about_ca_topic_score_gemma":0.001235658,"teacher_disagreement_score":0.0028572595,"about_ca_system_score_codex":0.00028545235,"about_ca_system_score_gemma":0.00017051976,"threshold_uncertainty_score":0.009558499},"labels":[],"label_agreement":null},{"id":"W2114046627","doi":"10.1016/j.breast.2010.08.006","title":"Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Mammography; Breast MRI; Population; Cancer; Radiology; Internal medicine; Environmental health","score_opus":0.03571251648455216,"score_gpt":0.35647985956461464,"score_spread":0.3207673430800625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114046627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88671595,0.002411226,0.003847947,0.002783828,0.0015081149,0.09778588,0.0010428963,0.00013498667,0.0037690774],"genre_scores_gemma":[0.8710038,0.0008674205,0.0075871316,0.0020773946,0.0007197282,0.115835,0.00042634673,0.000017778633,0.0014653666],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9780934,0.018000709,0.0014472627,0.0008782395,0.0007449522,0.00083547685],"domain_scores_gemma":[0.97354794,0.017850744,0.003546178,0.0018378049,0.0013145715,0.0019027223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024434855,0.0020013703,0.0031100917,0.0008304723,0.00086705026,0.0014117473,0.0012994213,0.004737511,0.012017379],"category_scores_gemma":[0.03209684,0.001407051,0.0032331145,0.00083203195,0.0025773065,0.0024195174,0.0013067655,0.0033669805,0.0016558187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9580892,0.023530813,0.0022065772,0.0022178525,0.0015937464,0.00009460549,0.00035124738,0.00027482308,0.0010420971,0.00036504376,0.00049921795,0.009734904],"study_design_scores_gemma":[0.7981699,0.19471644,0.0025338873,0.00018173944,0.0016803175,0.0000442673,0.00016111975,0.0005594729,0.00036040822,0.00047716856,0.0010810153,0.000034165776],"about_ca_topic_score_codex":0.00053774257,"about_ca_topic_score_gemma":0.00073882274,"teacher_disagreement_score":0.024434855,"about_ca_system_score_codex":0.0009544197,"about_ca_system_score_gemma":0.0027420812,"threshold_uncertainty_score":0.12922537},"labels":[],"label_agreement":null},{"id":"W2117243202","doi":"10.1016/j.breast.2007.07.012","title":"Adjuvant therapy and thrombosis: How to avoid the problem?","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Thrombosis; Breast cancer; Antithrombotic; Venous thrombosis; Tamoxifen; Chemotherapy; Cancer; Warfarin; Surgery; Internal medicine; Oncology","score_opus":0.09946724046062966,"score_gpt":0.35462517295915286,"score_spread":0.2551579324985232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117243202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003775533,0.997701,0.00006801542,0.0015510842,0.00036275873,0.0000012974268,0.0000058346163,0.0000034960904,0.00026879847],"genre_scores_gemma":[0.0004921242,0.9972391,0.00018474397,0.0010176363,0.00080563634,0.0000029315202,0.000011933241,0.0000011990215,0.0002446438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994423,0.00015120095,0.000110587534,0.00007033376,0.00019066384,0.000034946937],"domain_scores_gemma":[0.99824476,0.000986762,0.000287471,0.000038432427,0.00034110833,0.000101444246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013123795,0.0009771413,0.0036007245,0.0020388647,0.00040238243,0.0018576947,0.0014977911,0.003156544,0.0037717368],"category_scores_gemma":[0.0031143022,0.00042303198,0.00074789824,0.0022933478,0.00095733994,0.0029749025,0.0007219108,0.003970484,0.0020237302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010819204,0.00009502376,0.00065876276,0.016498152,0.00025988548,0.00043254887,0.000059609705,0.00029344842,0.00042592626,0.0032040807,0.08154653,0.8964178],"study_design_scores_gemma":[0.00012290214,0.00012756335,0.0026114488,0.022651108,0.000582425,0.0051076496,0.00024494162,0.00023129559,0.00017952127,0.005173557,0.96291554,0.000052059255],"about_ca_topic_score_codex":0.002860998,"about_ca_topic_score_gemma":0.005360799,"teacher_disagreement_score":0.0037717368,"about_ca_system_score_codex":0.00087407953,"about_ca_system_score_gemma":0.002125755,"threshold_uncertainty_score":0.012617648},"labels":[],"label_agreement":null},{"id":"W2118788452","doi":"10.1016/j.breast.2010.05.009","title":"Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Women's College Hospital; BC Cancer Agency; University of Ottawa","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast cancer; Alcohol consumption; BRCA mutation; Oncology; Internal medicine; Cancer; Mutation; Consumption (sociology); Population; Gynecology; Environmental health; Demography; Alcohol; Gene; Genetics","score_opus":0.006114035816957914,"score_gpt":0.2504282676444363,"score_spread":0.2443142318274784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118788452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999295,0.00044560764,0.000017771432,0.000017208755,0.0000025874267,0.0000029367993,0.000056906614,0.0000012677248,0.00016064272],"genre_scores_gemma":[0.99947435,0.00021894154,0.000032268017,0.000011414771,0.0000068990944,0.0000024174,0.000068037676,9.838876e-7,0.00018469812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973375,0.000090218025,0.000021559807,0.000050856648,0.000052409396,0.000051182644],"domain_scores_gemma":[0.9991755,0.00021117853,0.00033437504,0.000058357462,0.000058582402,0.00016195494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047091258,0.00024199045,0.0002616931,0.0011563447,0.00032534587,0.0004908192,0.00020510152,0.0004426759,0.0016202512],"category_scores_gemma":[0.0019682306,0.00042211416,0.0002766913,0.00062946905,0.00031327578,0.00031350105,0.00027845197,0.00032840733,0.00025056608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058515696,0.000074357056,0.9973085,0.000008055168,0.000097719436,0.0001137785,0.0000649076,0.000017468095,0.00045881496,0.000012602223,0.00003654226,0.0012221631],"study_design_scores_gemma":[0.000014668834,0.00018116659,0.99908316,0.0000035397534,0.000064076456,0.00028648853,0.000060525825,0.00010071186,0.000077890625,0.00002077744,0.00010434096,0.0000027348685],"about_ca_topic_score_codex":0.007774413,"about_ca_topic_score_gemma":0.0074086115,"teacher_disagreement_score":0.007774413,"about_ca_system_score_codex":0.00025435735,"about_ca_system_score_gemma":0.00013828876,"threshold_uncertainty_score":0.015458345},"labels":[],"label_agreement":null},{"id":"W2119650475","doi":"10.1016/j.breast.2015.07.014","title":"Obesity, insulin resistance and breast cancer outcomes","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Obesity; Psychological intervention; Intervention (counseling); Insulin resistance; Cancer; Oncology; Internal medicine; Clinical trial; Psychiatry","score_opus":0.027279773878883543,"score_gpt":0.29769429456136653,"score_spread":0.270414520682483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119650475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94242907,0.04312001,0.00025731383,0.003664721,0.000098478835,0.000014865499,0.0011018745,0.000014823878,0.009298774],"genre_scores_gemma":[0.9902199,0.008313513,0.00012381618,0.00025809053,0.0001262762,0.000010424961,0.00038197785,0.0000027469532,0.00056320516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996624,0.00015677836,0.00003126788,0.000039270206,0.000056332337,0.00005402378],"domain_scores_gemma":[0.9978955,0.0006062046,0.0010034054,0.00009072467,0.00012105607,0.00028299203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095109193,0.00014775334,0.0002092792,0.0007384064,0.00017655278,0.00067780144,0.00017822711,0.0003934246,0.0022057216],"category_scores_gemma":[0.004169205,0.00010661242,0.00028887126,0.0012346085,0.00025787705,0.00026069174,0.00029574978,0.0007011276,0.00024017389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041101337,0.00011289273,0.9821968,0.00010010788,0.00022092935,0.00007329254,0.00007035097,0.00013410524,0.00015663651,0.00031974973,0.0004919251,0.015712216],"study_design_scores_gemma":[0.000010316579,0.00010391332,0.9976566,0.00006834132,0.000108427266,0.00015693063,0.00007618399,0.000100704914,0.000052404554,0.0004282619,0.0012327151,0.000005175119],"about_ca_topic_score_codex":0.0024840836,"about_ca_topic_score_gemma":0.0032101795,"teacher_disagreement_score":0.0024840836,"about_ca_system_score_codex":0.00021414875,"about_ca_system_score_gemma":0.00023245398,"threshold_uncertainty_score":0.007378876},"labels":[],"label_agreement":null},{"id":"W2128957662","doi":"10.1016/j.breast.2010.06.003","title":"Defining ovarian failure in amenorrheic young breast cancer patients","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Mount Sinai Hospital; Regional Municipality of Durham; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecology; Oncology; Cancer; Breast cancer; Internal medicine; Obstetrics","score_opus":0.019701114226747377,"score_gpt":0.3043333642512791,"score_spread":0.28463225002453174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128957662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002395624,0.9990307,0.000078195175,0.00014720552,0.000056192574,0.0000042885954,0.000014457717,0.000002736995,0.00042671832],"genre_scores_gemma":[0.002299543,0.9969223,0.00024601968,0.00016064753,0.00010907256,0.0000069482476,0.000043533448,0.0000011011383,0.0002108408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997633,0.00006242376,0.00004849731,0.000036250065,0.000074335134,0.000015191558],"domain_scores_gemma":[0.9994584,0.00028198687,0.00011170302,0.000008742769,0.00010990948,0.000029311217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007342492,0.00064523553,0.0019203257,0.0025224928,0.00016697153,0.0006898012,0.00069122395,0.00078153436,0.0013492422],"category_scores_gemma":[0.0014526519,0.00021769672,0.00039914594,0.0018121566,0.00048162034,0.00079392537,0.0005320137,0.0010340933,0.00078815996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009261721,0.000030888674,0.0022271767,0.0079632625,0.00010031714,0.00034362078,0.0000641551,0.00023741726,0.00047464573,0.0008214998,0.013235627,0.97440886],"study_design_scores_gemma":[0.00014835788,0.00036968422,0.03871552,0.024761708,0.0008727847,0.025469342,0.00075836584,0.00069645315,0.0014431139,0.00414564,0.9025057,0.000113338036],"about_ca_topic_score_codex":0.002180605,"about_ca_topic_score_gemma":0.004007076,"teacher_disagreement_score":0.0025224928,"about_ca_system_score_codex":0.0005061103,"about_ca_system_score_gemma":0.0007210479,"threshold_uncertainty_score":0.004513681},"labels":[],"label_agreement":null},{"id":"W2133119224","doi":"10.1016/j.breast.2005.09.002","title":"Adjuvant endocrine therapies for pre-/perimenopausal women","year":2005,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endocrine system; Adjuvant; Hormone; Oncology; Breast cancer; Estrogen receptor; Internal medicine; Receptor; Estrogen; Hormone receptor; Cancer; Hormone therapy","score_opus":0.013815217998229518,"score_gpt":0.32167210841580673,"score_spread":0.30785689041757724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133119224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001659818,0.9988134,0.0001105868,0.00016300831,0.00014766908,0.0000033354916,0.0000110647825,0.0000039175325,0.0005810958],"genre_scores_gemma":[0.001252934,0.9971035,0.00024924148,0.00021421061,0.00019413815,0.000006645786,0.000024603192,0.0000010762529,0.00095365604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999039,0.000017776107,0.000013938861,0.000015830463,0.000038419723,0.00001018571],"domain_scores_gemma":[0.9998227,0.00009797102,0.000029565013,0.000004563631,0.000033391887,0.000011924516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044626684,0.0006151341,0.001142978,0.0011109525,0.00015686864,0.0005361129,0.0007211899,0.00084599276,0.0024645692],"category_scores_gemma":[0.0006518849,0.00019974932,0.00027200623,0.0012041917,0.000258422,0.0005019062,0.00031306976,0.0010186459,0.0011539761],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013734306,0.00006615355,0.00020475689,0.0050797234,0.00004925078,0.00033868247,0.00001741358,0.00023468239,0.001571715,0.00083734986,0.015836727,0.9756261],"study_design_scores_gemma":[0.00012289267,0.00019187357,0.0022525426,0.003608904,0.00028704776,0.004529657,0.0000772597,0.00019183093,0.0013451291,0.0015835458,0.9857911,0.000018219236],"about_ca_topic_score_codex":0.0011481522,"about_ca_topic_score_gemma":0.0033772783,"teacher_disagreement_score":0.0024645692,"about_ca_system_score_codex":0.00037111188,"about_ca_system_score_gemma":0.00052642165,"threshold_uncertainty_score":0.0082448125},"labels":[],"label_agreement":null},{"id":"W2136299543","doi":"10.1016/j.breast.2015.03.012","title":"Cost-effectiveness of breast cancer screening policies using simulation","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Public Health Ontario; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Breast cancer; Mammography; Breast cancer screening; Demography; Mammography screening; Cancer; Gerontology; Gynecology; Oncology; Internal medicine","score_opus":0.2921499684514256,"score_gpt":0.44409957702832936,"score_spread":0.15194960857690376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136299543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93280375,0.0012237565,0.047250733,0.0014995801,0.00008188921,0.00031173794,0.0009515159,0.00023438493,0.015642675],"genre_scores_gemma":[0.9933068,0.0003943818,0.005397639,0.000071852264,0.000011517586,0.000091190755,0.00017889922,0.000012111064,0.000535617],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976955,0.0016707527,0.00007254824,0.00011747397,0.00020016258,0.00024348809],"domain_scores_gemma":[0.9676514,0.029475352,0.0013085274,0.0004921854,0.00075952616,0.00031294517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003388039,0.0008589019,0.0011168804,0.0016098184,0.00046437615,0.0013738117,0.0010846531,0.0013197233,0.003208567],"category_scores_gemma":[0.01836876,0.0005291059,0.0007925153,0.0014724334,0.0006695406,0.0013333306,0.00065378565,0.0010169907,0.000108472625],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011284814,0.00006692557,0.0016137334,0.00002338554,0.000029073788,0.000015942202,0.000010987753,0.9946571,0.000060934275,0.0017908674,0.00010669055,0.0015115301],"study_design_scores_gemma":[0.00006358022,0.00010319547,0.00063566846,0.000015938936,0.000028107657,0.000011291345,0.000038656617,0.99616677,0.00014412373,0.002579118,0.00020386105,0.000009603177],"about_ca_topic_score_codex":0.036761392,"about_ca_topic_score_gemma":0.017146114,"teacher_disagreement_score":0.036761392,"about_ca_system_score_codex":0.004047774,"about_ca_system_score_gemma":0.002948469,"threshold_uncertainty_score":0.073094845},"labels":[],"label_agreement":null},{"id":"W2142010188","doi":"10.1016/j.breast.2013.01.007","title":"Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Adjuvant therapy; Internal medicine; Aromatase; Adjuvant; Hormone therapy; Hormonal therapy; Cancer; Gynecology","score_opus":0.005821622245608589,"score_gpt":0.22598039872120496,"score_spread":0.22015877647559637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142010188","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7586689,0.12016342,0.0032067248,0.08310527,0.0028382102,0.0007567326,0.0013904471,0.00026230095,0.02960803],"genre_scores_gemma":[0.94710356,0.028751655,0.004933219,0.012311043,0.0028220343,0.00026601055,0.00060244085,0.000015320365,0.0031947538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998054,0.000049563143,0.00002709361,0.000029888592,0.000050043895,0.000038079124],"domain_scores_gemma":[0.9986563,0.00048356812,0.00026065824,0.00006968525,0.00019025951,0.00033944251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079388154,0.0002072498,0.00093287905,0.0002303661,0.00038955614,0.00055617024,0.0003435673,0.001779716,0.0025060961],"category_scores_gemma":[0.004647335,0.00011445586,0.00037231404,0.00034264964,0.0003439044,0.00053254695,0.0001453418,0.000747115,0.00060779636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012269735,0.0011422478,0.4095937,0.0018808305,0.00018925473,0.0046228953,0.00032650025,0.0010146364,0.0067416662,0.00066459156,0.029728279,0.5318257],"study_design_scores_gemma":[0.004377198,0.015394047,0.8427926,0.0034085994,0.0011413561,0.01934383,0.0021821454,0.0019552044,0.00837129,0.006728449,0.09415852,0.0001467678],"about_ca_topic_score_codex":0.0017398986,"about_ca_topic_score_gemma":0.003643883,"teacher_disagreement_score":0.0025060961,"about_ca_system_score_codex":0.00032851848,"about_ca_system_score_gemma":0.0010789072,"threshold_uncertainty_score":0.008383751},"labels":[],"label_agreement":null},{"id":"W2142423329","doi":"10.1016/j.breast.2006.10.007","title":"Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen","year":2006,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Letrozole; Tamoxifen; Breast cancer; Aromatase inhibitor; Placebo; Breast density; Oncology; Internal medicine; Gynecology; Aromatase; Estrogen; Cancer; Mammography","score_opus":0.009994283177436074,"score_gpt":0.2439072352647548,"score_spread":0.23391295208731872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142423329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978636,0.00047122786,0.00012106686,0.00016766395,0.00011108003,0.00040938,0.0003028697,0.000020106278,0.0005329843],"genre_scores_gemma":[0.99742496,0.00029524748,0.00026690844,0.00013325916,0.00018838995,0.00046766063,0.0002371724,0.000006509642,0.0009799502],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985518,0.00095603993,0.000076442026,0.00012859238,0.00008116696,0.00020596306],"domain_scores_gemma":[0.9966558,0.0017455806,0.00036560843,0.00027565428,0.0001392281,0.00081814616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002598051,0.0011946544,0.0025377136,0.0005335392,0.0006740399,0.0006790778,0.0012078558,0.0015869704,0.00554464],"category_scores_gemma":[0.0037824465,0.0007115534,0.0014650564,0.00052422873,0.0014244743,0.0010528894,0.0005872468,0.0022482974,0.0005913247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.985889,0.008510093,0.000442888,0.00004586777,0.00015190325,0.000025041018,0.00003935449,0.000075675256,0.0021119907,0.000024266974,0.00006731454,0.0026167014],"study_design_scores_gemma":[0.36887583,0.6184367,0.010215138,0.000010952457,0.00060511555,0.000027801529,0.000086473294,0.00022819906,0.0011145121,0.00008539789,0.00029910303,0.000014789152],"about_ca_topic_score_codex":0.0029719423,"about_ca_topic_score_gemma":0.0035497975,"teacher_disagreement_score":0.00554464,"about_ca_system_score_codex":0.00066026906,"about_ca_system_score_gemma":0.0010796922,"threshold_uncertainty_score":0.018548667},"labels":[],"label_agreement":null},{"id":"W2143006403","doi":"10.1016/j.breast.2012.05.010","title":"ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step","year":2012,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Scopus; Metastatic breast cancer; Cancer; Disease; Oncology; Internal medicine; Family medicine; MEDLINE","score_opus":0.03580187537947058,"score_gpt":0.4063039905991022,"score_spread":0.3705021152196316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143006403","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065084995,0.12375554,0.009764883,0.7799196,0.05553385,0.0012350956,0.0017464804,0.00093011936,0.026463555],"genre_scores_gemma":[0.017643848,0.2800764,0.22276956,0.37214485,0.045681957,0.006153644,0.017019784,0.0013967133,0.037113205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95528597,0.018369373,0.007360166,0.0011914868,0.015596807,0.0021961266],"domain_scores_gemma":[0.86356497,0.025319366,0.009312186,0.004121981,0.08901112,0.008670356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053242587,0.0020621389,0.0036336624,0.0059020533,0.0023658674,0.009059099,0.0062754573,0.014562611,0.012980727],"category_scores_gemma":[0.101623,0.0014248231,0.0034567663,0.0051570563,0.0026616189,0.009426169,0.0066669923,0.02177429,0.017457822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005823283,0.000073159266,0.00034013053,0.0035397236,0.000060959548,0.00011819829,0.0002450074,0.00012837231,0.00016875025,0.004560424,0.88809896,0.10260801],"study_design_scores_gemma":[0.00006369667,0.00006335214,0.0007570637,0.01408409,0.00008270781,0.00041519722,0.00037841505,0.00017357088,0.00013065209,0.0073238215,0.97647333,0.00005404984],"about_ca_topic_score_codex":0.010332101,"about_ca_topic_score_gemma":0.018181408,"teacher_disagreement_score":0.053242587,"about_ca_system_score_codex":0.0057191676,"about_ca_system_score_gemma":0.033400275,"threshold_uncertainty_score":0.28157705},"labels":[],"label_agreement":null},{"id":"W2143196768","doi":"10.1016/j.breast.2013.04.020","title":"Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research; Ottawa Hospital; Queen's University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Medicine; Oncology; Adjuvant; Breast cancer; Stage (stratigraphy); Endocrine system; Gynecology; Internal medicine; Hormone receptor; Cancer; Hormone; Adjuvant therapy","score_opus":0.04419570259816437,"score_gpt":0.3500402727543723,"score_spread":0.3058445701562079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143196768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865404,0.0010722348,0.00028997022,0.004840222,0.000071034374,0.00025591516,0.00057626015,0.000020506577,0.0063334475],"genre_scores_gemma":[0.99493754,0.0010982417,0.0018277741,0.000862992,0.00007028789,0.00015152186,0.00025578693,0.0000034213938,0.0007924465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984296,0.0009653849,0.00014820634,0.000044535016,0.00021339454,0.00019890824],"domain_scores_gemma":[0.9892379,0.006429675,0.0023075398,0.00012740608,0.0005782438,0.0013192629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038988744,0.00022353974,0.00029336472,0.00075484684,0.0006043772,0.00083859847,0.00029813804,0.00078186655,0.010688053],"category_scores_gemma":[0.02120963,0.00017652469,0.00042992117,0.00049882656,0.00021572511,0.0009334067,0.0007746432,0.00069589633,0.0008972415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023203485,0.0016223224,0.71483094,0.0014412889,0.000104733976,0.0015169199,0.017927768,0.00039859983,0.0021762594,0.0003774958,0.021724721,0.2355586],"study_design_scores_gemma":[0.00064458663,0.003894468,0.8934801,0.0021198504,0.00024771522,0.0025099607,0.04750829,0.0021213198,0.0013249331,0.001402734,0.044635948,0.000109978646],"about_ca_topic_score_codex":0.0013655566,"about_ca_topic_score_gemma":0.0028736864,"teacher_disagreement_score":0.010688053,"about_ca_system_score_codex":0.00044751522,"about_ca_system_score_gemma":0.0010743241,"threshold_uncertainty_score":0.035755157},"labels":[],"label_agreement":null},{"id":"W2146935345","doi":"10.1016/s0960-9776(03)00107-3","title":"Management of recurrent locoregional breast cancer: oncologist survey","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Axilla; Breast cancer; Axillary lymph nodes; Radiation oncologist; Radiation therapy; Systemic therapy; Disease; Cancer; Mastectomy; Lymph; Radiology; Oncology; General surgery; Surgery; Internal medicine; Pathology","score_opus":0.0211995155002044,"score_gpt":0.2853426657060423,"score_spread":0.2641431502058379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146935345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926791,0.00052171154,0.00015463169,0.0009600023,0.000012967975,0.0001207585,0.0033225964,0.000015355063,0.0022129097],"genre_scores_gemma":[0.99512285,0.0006776288,0.00038434027,0.000678264,0.000033541426,0.00012645214,0.0022368396,0.00000531381,0.0007346085],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9982583,0.0006986816,0.00031505805,0.00013961003,0.000412891,0.0001753221],"domain_scores_gemma":[0.99302715,0.0011032013,0.0037427566,0.00014981837,0.0011390883,0.00083806034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022438788,0.00009006526,0.00022326602,0.0008567109,0.00026035344,0.0003970821,0.00027528542,0.0004934025,0.0012660578],"category_scores_gemma":[0.0050608413,0.0001518376,0.0002286662,0.0011105696,0.00013847904,0.0004927818,0.0004732948,0.00041858415,0.00045534628],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042279386,0.00006918867,0.9945456,0.00004942155,0.000024284473,0.00004634081,0.00038784946,0.00004047935,0.000107818596,0.000010573455,0.00117699,0.0034992443],"study_design_scores_gemma":[0.000009934561,0.00019992498,0.99722713,0.000022886945,0.000010375786,0.0001664006,0.0006083002,0.00009494739,0.000042207852,0.0000076886145,0.0016058405,0.000004371342],"about_ca_topic_score_codex":0.0072310832,"about_ca_topic_score_gemma":0.00978877,"teacher_disagreement_score":0.0072310832,"about_ca_system_score_codex":0.0006428815,"about_ca_system_score_gemma":0.00050570833,"threshold_uncertainty_score":0.014378011},"labels":[],"label_agreement":null},{"id":"W2149734383","doi":"10.1016/s0960-9776(03)00160-7","title":"The best use of adjuvant endocrine treatments","year":2003,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tamoxifen; Anastrozole; Oncology; Breast cancer; Internal medicine; Adjuvant; Adjuvant therapy; Aromatase inhibitor; Aromatase; Cyclophosphamide; Gynecology; Chemotherapy; Cancer","score_opus":0.030995274689780278,"score_gpt":0.30127654398046516,"score_spread":0.27028126929068486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149734383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001607533,0.99214035,0.00027591374,0.0011253979,0.000496912,0.000009767765,0.00003470247,0.000020420946,0.005735699],"genre_scores_gemma":[0.0013971752,0.9938042,0.00041276403,0.00081092,0.00055177725,0.000013606567,0.000053844433,0.0000032978114,0.0029522963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997199,0.000048082307,0.000035024586,0.000048076254,0.00012858672,0.000020294776],"domain_scores_gemma":[0.9998093,0.00006313792,0.00003594037,0.000015476924,0.000053114505,0.000022987606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045916802,0.00094806246,0.001480069,0.00161149,0.00030139202,0.00085977383,0.0010781634,0.0014962578,0.0071112737],"category_scores_gemma":[0.0007931352,0.00020075479,0.0004026936,0.0010934873,0.00040144543,0.0013011408,0.00054377073,0.0016006717,0.0059326664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057948342,0.0000633915,0.00015006465,0.0038600152,0.000043420925,0.00028737067,0.000022276547,0.00014620252,0.0007439437,0.0017677417,0.04117104,0.95168656],"study_design_scores_gemma":[0.000032322456,0.00006509594,0.00087721646,0.0036295932,0.000046199748,0.002814766,0.000041120893,0.000040521805,0.00034134858,0.0023064641,0.98979294,0.000012354116],"about_ca_topic_score_codex":0.0007692559,"about_ca_topic_score_gemma":0.0015021804,"teacher_disagreement_score":0.0071112737,"about_ca_system_score_codex":0.0005323508,"about_ca_system_score_gemma":0.0007346705,"threshold_uncertainty_score":0.023789585},"labels":[],"label_agreement":null},{"id":"W2151576006","doi":"10.1016/j.breast.2011.04.004","title":"Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Medicine; Worry; Anxiety; Breast cancer; BRCA mutation; Hospital Anxiety and Depression Scale; Distress; Magnetic resonance imaging; Depression (economics); Oncology; Internal medicine; Cancer; Psychiatry; Clinical psychology; Radiology","score_opus":0.02094765838579599,"score_gpt":0.28882585191553756,"score_spread":0.26787819352974157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151576006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991303,0.00033475077,0.000030626503,0.000096945914,0.00000912756,0.000009687591,0.00006660988,0.0000022831416,0.00031967284],"genre_scores_gemma":[0.9994611,0.00018656653,0.000052251995,0.00004981842,0.000014195107,0.0000068263894,0.000077810924,6.321346e-7,0.00015069074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999705,0.00012411567,0.000023772578,0.000026224809,0.00007298514,0.000047966772],"domain_scores_gemma":[0.99812585,0.00056549336,0.0008498093,0.00008038773,0.00013803103,0.00024042134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006374922,0.00020082103,0.00027496277,0.0002666029,0.00028255107,0.000370675,0.00013505663,0.00030337257,0.0014105035],"category_scores_gemma":[0.005436495,0.00012878847,0.0003649025,0.000313827,0.00019323306,0.00021115007,0.00032765957,0.00037666463,0.00013719259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076348765,0.0002695432,0.98354924,0.00006750981,0.00011446849,0.00032948426,0.0010660406,0.00008545222,0.0009949446,0.00001005165,0.00018617122,0.012563587],"study_design_scores_gemma":[0.000011774908,0.00125948,0.99716693,0.000011865811,0.000048193946,0.00042723116,0.0006413988,0.000059373433,0.00013015953,0.000010309422,0.0002272182,0.0000061139053],"about_ca_topic_score_codex":0.0015765821,"about_ca_topic_score_gemma":0.0022951136,"teacher_disagreement_score":0.0015765821,"about_ca_system_score_codex":0.00016598274,"about_ca_system_score_gemma":0.00019868293,"threshold_uncertainty_score":0.0047186613},"labels":[],"label_agreement":null},{"id":"W2154671238","doi":"10.1016/j.breast.2012.12.004","title":"Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hormone receptor; Oncology; Breast cancer; Human Epidermal Growth Factor Receptor 2; Hormone; Metastatic breast cancer; Internal medicine; Cancer; Regimen; Hormone therapy; Receptor","score_opus":0.08686729125714283,"score_gpt":0.3959840605294179,"score_spread":0.3091167692722751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154671238","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010954322,0.004762935,0.0037328412,0.8901518,0.09090583,0.0004492824,0.00045851173,0.00030485005,0.008138492],"genre_scores_gemma":[0.0076470673,0.0073804995,0.028854894,0.8694033,0.06692289,0.0009871797,0.00060964574,0.00017224002,0.018022297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9761969,0.006915653,0.0055119838,0.0012330489,0.008962818,0.0011796699],"domain_scores_gemma":[0.7778236,0.042339332,0.008244549,0.0049150134,0.15940155,0.007275858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020912586,0.0010378818,0.0018682656,0.0022308198,0.002333308,0.0028328637,0.0059686005,0.032077365,0.009197447],"category_scores_gemma":[0.11401742,0.0010067957,0.002652117,0.0020650004,0.0036353131,0.0038633177,0.0016186868,0.018696534,0.016901573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004033835,0.00004555333,0.00052347203,0.00026011866,0.000016496717,0.0003879244,0.00013473048,0.0001043716,0.0003301328,0.00030191304,0.97909683,0.018758187],"study_design_scores_gemma":[0.00011746223,0.000068747206,0.0020006986,0.0019544198,0.000101947895,0.0016742205,0.00073376065,0.0006801859,0.00076218706,0.0035340223,0.98821485,0.00015749813],"about_ca_topic_score_codex":0.007409646,"about_ca_topic_score_gemma":0.014131234,"teacher_disagreement_score":0.032077365,"about_ca_system_score_codex":0.0024626378,"about_ca_system_score_gemma":0.009708137,"threshold_uncertainty_score":0.11059767},"labels":[],"label_agreement":null},{"id":"W2155477677","doi":"10.1016/j.breast.2015.04.006","title":"One step forward, two steps back: The story of everolimus in advanced breast cancer","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Everolimus; Bevacizumab; Breast cancer; Drug; Anticancer drug; Cancer; Cancer drugs; Clinical trial; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Chemotherapy","score_opus":0.025772968564792453,"score_gpt":0.2992484553007128,"score_spread":0.27347548673592037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155477677","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095578085,0.38882646,0.00061059644,0.5830697,0.020887258,0.000008267209,0.0000544687,0.000027432969,0.005560082],"genre_scores_gemma":[0.021220617,0.5462169,0.001529317,0.33319372,0.08817015,0.000035287667,0.00006302453,0.00008629158,0.009484658],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977863,0.0011847846,0.00012256931,0.00018466667,0.0005300266,0.00019171555],"domain_scores_gemma":[0.9926231,0.005434775,0.00027668342,0.00016715443,0.00068792753,0.000810399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006613366,0.0007254847,0.0014043843,0.0011666268,0.002475525,0.0049546226,0.0012018307,0.008156264,0.0026180695],"category_scores_gemma":[0.012098471,0.00038809996,0.001075073,0.0010843911,0.0068113343,0.012869561,0.0032577128,0.028242134,0.0015611254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045040844,0.00010602936,0.00068498356,0.0014972164,0.0000939894,0.001589724,0.0019047508,0.00045017933,0.0008599915,0.09680239,0.7110314,0.18452896],"study_design_scores_gemma":[0.00005598806,0.00021588172,0.000593392,0.0012364793,0.000054832843,0.002336082,0.0017606022,0.00025768782,0.00025742158,0.05576313,0.93740386,0.000064687425],"about_ca_topic_score_codex":0.0026263827,"about_ca_topic_score_gemma":0.0073206644,"teacher_disagreement_score":0.008156264,"about_ca_system_score_codex":0.0028590357,"about_ca_system_score_gemma":0.0019474354,"threshold_uncertainty_score":0.03497523},"labels":[],"label_agreement":null},{"id":"W2157138888","doi":"10.1016/j.breast.2009.06.003","title":"Survivin and COX-2 expression in male breast carcinoma","year":2009,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"Dalhousie University","keywords":"Survivin; Immunohistochemistry; Tissue microarray; Medicine; Aromatase; Proportional hazards model; Oncology; Breast cancer; Breast carcinoma; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.011041185287837905,"score_gpt":0.252636334876926,"score_spread":0.2415951495890881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157138888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829894,0.0010210024,0.000059980153,0.000027584172,0.0000020927941,0.0000023327934,0.0000661303,0.0000015984458,0.0005203077],"genre_scores_gemma":[0.9992945,0.00035516388,0.000047257912,0.000008756311,0.0000028298152,0.0000012094782,0.00007596505,5.204258e-7,0.00021388331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990773,0.000013950338,0.0000055519563,0.000011110264,0.000030611835,0.000030919142],"domain_scores_gemma":[0.9997067,0.000040361374,0.00013408666,0.000012740885,0.000058426474,0.000047762125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016211226,0.00005918941,0.0001229492,0.00064176373,0.00017776345,0.00031234382,0.00008573928,0.000085323474,0.0006658502],"category_scores_gemma":[0.0005831773,0.000085287764,0.00006862289,0.00054996024,0.00017929908,0.000103438906,0.00012016592,0.00011156614,0.00010458965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002502828,0.000010277312,0.98314834,0.000022893817,0.000014246797,0.0011090124,0.00012491015,0.00007121551,0.008475785,0.00004440127,0.0001501404,0.006578462],"study_design_scores_gemma":[0.00000194508,0.000031104606,0.9968713,0.0000050001854,0.0000068021395,0.001737282,0.00010705418,0.00009300264,0.0008305798,0.000011657332,0.0003027221,0.0000015404938],"about_ca_topic_score_codex":0.02785865,"about_ca_topic_score_gemma":0.053477984,"teacher_disagreement_score":0.02785865,"about_ca_system_score_codex":0.00073922664,"about_ca_system_score_gemma":0.00036242954,"threshold_uncertainty_score":0.05539298},"labels":[],"label_agreement":null},{"id":"W2166283583","doi":"10.1016/j.breast.2006.01.002","title":"The extended adjuvant NCIC CTG MA.17 trials: Initial and rerandomization studies","year":2006,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase inhibitor; Internal medicine; Adverse effect; Placebo; Oncology; Zoledronic acid; Adjuvant; Randomized controlled trial; Cancer; Gynecology; Alternative medicine","score_opus":0.05042748622701733,"score_gpt":0.3845853797491913,"score_spread":0.334157893522174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166283583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018363603,0.9958359,0.00021344775,0.00064097927,0.00019075086,0.000057120084,0.00015470592,0.000009470264,0.0010613275],"genre_scores_gemma":[0.012635584,0.9815368,0.0010032671,0.0021608733,0.0003859415,0.00018064001,0.00035167226,0.00001294942,0.0017323351],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99972063,0.0001273389,0.000028213984,0.00004320057,0.000054480377,0.000026088319],"domain_scores_gemma":[0.99921775,0.000559729,0.00010680986,0.000025443393,0.00005013898,0.000040054423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017308309,0.0008178564,0.0032165546,0.00054854824,0.00011991924,0.00059720385,0.0010010669,0.0008893971,0.0038509527],"category_scores_gemma":[0.0018921035,0.00020423741,0.00091896503,0.0012218741,0.00027677335,0.00045182634,0.0002774894,0.0014526,0.0006032605],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070059383,0.00023679005,0.00048086888,0.020956825,0.0009320419,0.00015799211,0.00003171033,0.00077716465,0.0013848204,0.001062167,0.032556493,0.93441707],"study_design_scores_gemma":[0.037426308,0.008806686,0.013792741,0.025589524,0.010067137,0.0030668592,0.0001381682,0.00079612434,0.0023144844,0.0052317353,0.89264876,0.000121492034],"about_ca_topic_score_codex":0.0009433707,"about_ca_topic_score_gemma":0.003442878,"teacher_disagreement_score":0.0038509527,"about_ca_system_score_codex":0.0006649557,"about_ca_system_score_gemma":0.0009778221,"threshold_uncertainty_score":0.012882769},"labels":[],"label_agreement":null},{"id":"W2166444077","doi":"10.1016/j.breast.2013.07.008","title":"Obesity and endocrine therapy: Host factors and breast cancer outcome","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Anastrozole; Medicine; Tamoxifen; Letrozole; Breast cancer; Body mass index; Internal medicine; Hazard ratio; Oncology; Overweight; Aromatase inhibitor; Obesity; Cancer; Gynecology; Confidence interval","score_opus":0.0751165627732092,"score_gpt":0.3647562106218635,"score_spread":0.28963964784865426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166444077","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91941506,0.064272285,0.0003425959,0.0035845835,0.00018859089,0.000040284187,0.0016936071,0.000023256294,0.01043968],"genre_scores_gemma":[0.99199134,0.005369675,0.00012194092,0.000480795,0.00023779162,0.000017042623,0.0006973715,0.0000055939977,0.0010785038],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994905,0.00021894446,0.00005448503,0.00007427694,0.000087086104,0.00007472627],"domain_scores_gemma":[0.9977769,0.00054895366,0.0010447773,0.00008824768,0.00011977603,0.0004212258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011144042,0.00019892254,0.0003257894,0.0005879077,0.00026682313,0.00080136704,0.00024376475,0.00068578316,0.0045949602],"category_scores_gemma":[0.0029806332,0.00010877258,0.0008978675,0.001275025,0.0003316825,0.00050655555,0.0004007507,0.000961081,0.00044197365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013734329,0.00013510448,0.9786943,0.00018787639,0.000606211,0.000086460605,0.000035944486,0.00025906696,0.00020097785,0.00019121666,0.0008785215,0.01735087],"study_design_scores_gemma":[0.00005666417,0.0003587548,0.9953811,0.000097626355,0.00034217606,0.0002877918,0.000061552615,0.00032850064,0.000072312396,0.0003912573,0.0026102844,0.000011948508],"about_ca_topic_score_codex":0.0020515283,"about_ca_topic_score_gemma":0.0026936631,"teacher_disagreement_score":0.0045949602,"about_ca_system_score_codex":0.0003236666,"about_ca_system_score_gemma":0.00031871765,"threshold_uncertainty_score":0.015371621},"labels":[],"label_agreement":null},{"id":"W2167694626","doi":"10.1016/j.breast.2011.01.006","title":"Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Breast cancer; Prophylactic Mastectomy; BRCA mutation; Cohort; Cancer; Breast MRI; Risk perception; Family medicine; Family history; Mammography; Mastectomy; Obstetrics; Gynecology; Oncology; Demography; Internal medicine; Perception","score_opus":0.01448447418864692,"score_gpt":0.24977716208057904,"score_spread":0.2352926878919321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167694626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985764,0.00041948011,0.000023143743,0.0004781968,0.000020152112,0.0000077137465,0.00007844016,0.0000015100499,0.00039505286],"genre_scores_gemma":[0.99949837,0.00012158063,0.000035989586,0.00012156649,0.000020901367,0.0000038257904,0.00006106553,0.0000014168836,0.00013525634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951243,0.00017115325,0.00003782796,0.00007025864,0.000083199164,0.00012517649],"domain_scores_gemma":[0.9980995,0.00080825,0.00055245875,0.000086140884,0.000077539844,0.00037609905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007886288,0.00017708927,0.00033868532,0.00036221073,0.0005758445,0.0005824377,0.00043132406,0.0009909775,0.0020631077],"category_scores_gemma":[0.005409129,0.000222616,0.0009147248,0.00043916132,0.00026598823,0.00032921985,0.00028993105,0.00096815167,0.00013922325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013611624,0.00021193885,0.99458885,0.00001139503,0.00008851025,0.00019796251,0.00008656527,0.000051484152,0.00028023217,0.00005210186,0.00019372317,0.0028761667],"study_design_scores_gemma":[0.00009743573,0.00044623477,0.9970624,0.000015190651,0.00016243958,0.00068674446,0.0005915042,0.00046339075,0.00009684524,0.00011946264,0.00024918176,0.000009182306],"about_ca_topic_score_codex":0.0068975575,"about_ca_topic_score_gemma":0.009022441,"teacher_disagreement_score":0.0068975575,"about_ca_system_score_codex":0.00041529027,"about_ca_system_score_gemma":0.00083805487,"threshold_uncertainty_score":0.01371485},"labels":[],"label_agreement":null},{"id":"W2170856158","doi":"10.1016/j.breast.2013.10.004","title":"The impact of a breast cancer diagnosis in young women on their relationship with their mothers","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Family Support in Illness","field":"Social Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; York University; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Daughter; Breast cancer; Cancer; Young adult; Gynecology; Gerontology; Internal medicine","score_opus":0.01862182082207191,"score_gpt":0.2783743497667665,"score_spread":0.2597525289446946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170856158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512684,0.00076236564,0.000008076859,0.0009447213,0.000035579345,0.0000058166493,0.000077570636,8.412579e-7,0.0030381733],"genre_scores_gemma":[0.99898344,0.00052119745,0.000012573874,0.000098827826,0.00001189693,0.000004001573,0.00002657225,6.9078664e-7,0.00034067812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992618,0.00036579996,0.000027001286,0.00002577604,0.00007494051,0.0002446225],"domain_scores_gemma":[0.99647516,0.0011345431,0.0006774123,0.000050238923,0.00023499815,0.0014276139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007908236,0.00012510277,0.0002571964,0.0004411076,0.0016990718,0.0011148014,0.00029419575,0.00060028944,0.0033652335],"category_scores_gemma":[0.0076052174,0.00017246758,0.0003925356,0.00050886464,0.0004982249,0.0005801138,0.0010141114,0.0011556508,0.00020234907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047988325,0.00038523137,0.967584,0.000058840928,0.00007817215,0.0017244975,0.010722696,0.0000564448,0.00031308783,0.00028551702,0.00090560934,0.017406108],"study_design_scores_gemma":[0.000015524205,0.00031191963,0.9663522,0.0000699044,0.00005221083,0.0006929096,0.031029258,0.000048513626,0.00007682112,0.00009085875,0.0012501739,0.00000963723],"about_ca_topic_score_codex":0.024113337,"about_ca_topic_score_gemma":0.055343267,"teacher_disagreement_score":0.024113337,"about_ca_system_score_codex":0.0011590585,"about_ca_system_score_gemma":0.0013772217,"threshold_uncertainty_score":0.047945917},"labels":[],"label_agreement":null},{"id":"W2171244965","doi":"10.1016/j.breast.2012.03.003","title":"1st International consensus guidelines for advanced breast cancer (ABC 1)","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Medical physics; Family medicine; Cancer; Internal medicine","score_opus":0.08269649930811482,"score_gpt":0.4304189945483469,"score_spread":0.34772249524023213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171244965","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003518729,0.50477266,0.037133496,0.29268205,0.04677217,0.0044085407,0.0097872475,0.0010038946,0.09992118],"genre_scores_gemma":[0.038620636,0.40511814,0.29509258,0.12212912,0.018271696,0.013524096,0.038768042,0.0006783167,0.06779732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9821898,0.006557339,0.0050858036,0.0005804335,0.0044042915,0.0011823353],"domain_scores_gemma":[0.96674067,0.009151911,0.0058759996,0.0010022669,0.015529232,0.0016999793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019032774,0.0021381788,0.0032323587,0.008604859,0.0021015701,0.003582831,0.006064241,0.0090719275,0.008757462],"category_scores_gemma":[0.037339937,0.0010880812,0.0063926596,0.005610579,0.0016914884,0.0019889097,0.004360135,0.008948373,0.0061100265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026189492,0.00018336767,0.0024475185,0.010958435,0.0002456142,0.0004885486,0.00032550885,0.0012849409,0.0005959436,0.009030297,0.63248646,0.34169146],"study_design_scores_gemma":[0.00020553188,0.00015325994,0.0038998858,0.0266027,0.00057705323,0.0013235694,0.00026930816,0.0004809332,0.0006290268,0.00543247,0.96037066,0.000055576147],"about_ca_topic_score_codex":0.014490806,"about_ca_topic_score_gemma":0.026150402,"teacher_disagreement_score":0.019032774,"about_ca_system_score_codex":0.0060959496,"about_ca_system_score_gemma":0.018797187,"threshold_uncertainty_score":0.10065615},"labels":[],"label_agreement":null},{"id":"W2180442422","doi":"10.1016/j.breast.2015.10.010","title":"Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year period","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"123 Certification (Canada)","funders":"Università degli Studi di Firenze","keywords":"Medicine; Mastectomy; General surgery; Surgery; Total Mastectomy; Breast cancer; Cancer; Internal medicine","score_opus":0.029760906611227395,"score_gpt":0.2621248849149978,"score_spread":0.2323639783037704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180442422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986198,0.00012695315,0.00007599271,0.000015644384,0.0000023938212,0.000009978946,0.00090005284,0.0000028233558,0.00024647365],"genre_scores_gemma":[0.997787,0.00013386812,0.000082608516,0.000022831693,0.0000074872273,0.000014894276,0.0018228942,0.0000036808515,0.00012466914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989429,0.00022554414,0.00017323176,0.00029317162,0.00017478401,0.00019029743],"domain_scores_gemma":[0.9975452,0.0004672384,0.0011216166,0.00031340437,0.00023503254,0.00031754898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011812375,0.0004178906,0.0006571189,0.0013120464,0.000774372,0.00092837034,0.0006783346,0.0005472205,0.0013057349],"category_scores_gemma":[0.0019195938,0.00059654366,0.0007120452,0.0034251756,0.0005696776,0.001152767,0.0011883146,0.0005174031,0.00044491465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012689094,0.000034565586,0.998376,0.000010289773,0.00006039883,0.00024725456,0.00012326532,0.000057322824,0.00012348557,0.000010300239,0.000109123524,0.00072101934],"study_design_scores_gemma":[0.00001978983,0.00013649801,0.9975587,0.0000070668475,0.00004978338,0.0012500893,0.0005009738,0.00011491041,0.000092945615,0.0000103480725,0.00025105706,0.000007739926],"about_ca_topic_score_codex":0.0065300954,"about_ca_topic_score_gemma":0.0077572763,"teacher_disagreement_score":0.0065300954,"about_ca_system_score_codex":0.0007117925,"about_ca_system_score_gemma":0.0005796747,"threshold_uncertainty_score":0.012984216},"labels":[],"label_agreement":null},{"id":"W2215157211","doi":"10.1016/j.breast.2015.11.007","title":"The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Amgen","keywords":"Medicine; Regimen; Febrile neutropenia; Neutropenia; Internal medicine; Granulocyte colony-stimulating factor; Breast cancer; Chemotherapy; Chemotherapy regimen; Oncology; Surgery; Cancer","score_opus":0.11562767487227553,"score_gpt":0.34888635538337764,"score_spread":0.2332586805111021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215157211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931273,0.05274302,0.0006194755,0.004703999,0.00016003902,0.00014191226,0.0003050493,0.000016458787,0.010036986],"genre_scores_gemma":[0.97282356,0.022568235,0.0017873577,0.001325742,0.00026951398,0.00004111148,0.00023974454,0.000011963918,0.0009327795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999527,0.00021679756,0.000049554397,0.00003176827,0.00010192951,0.00007307479],"domain_scores_gemma":[0.99754363,0.0013518572,0.00062704366,0.0001236446,0.00016965612,0.00018404763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015173206,0.00018913728,0.0002919487,0.00040324527,0.00022310238,0.0007061138,0.0003312259,0.00038349992,0.001047959],"category_scores_gemma":[0.0033922393,0.00009087707,0.00041841302,0.0006065698,0.00047858575,0.00038733726,0.00022587029,0.0010932008,0.00009539226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023509098,0.0034780467,0.08903059,0.00056737475,0.00025842176,0.0010676829,0.0005765625,0.0008099,0.020999717,0.002029653,0.0033602414,0.8543126],"study_design_scores_gemma":[0.004135861,0.059988853,0.77133554,0.0013444228,0.0012482948,0.0048038037,0.002135476,0.0017022414,0.025844457,0.0019640534,0.12540737,0.0000896685],"about_ca_topic_score_codex":0.0052203834,"about_ca_topic_score_gemma":0.010502279,"teacher_disagreement_score":0.0052203834,"about_ca_system_score_codex":0.0010500127,"about_ca_system_score_gemma":0.0026679428,"threshold_uncertainty_score":0.01037997},"labels":[],"label_agreement":null},{"id":"W2226119970","doi":"10.1016/j.breast.2015.12.004","title":"Does breast composition influence late adverse effects in breast radiotherapy?","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Niilo Helanderin Säätiö; Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; Australian Government","keywords":"Medicine; Seroma; Breast cancer; Logistic regression; Radiation therapy; Univariate analysis; Odds ratio; Confounding; Adverse effect; Risk factor; Internal medicine; Oncology; Multivariate analysis; Cancer; Complication","score_opus":0.002745082565074225,"score_gpt":0.21535753989007378,"score_spread":0.21261245732499956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226119970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98348665,0.012031286,0.00040333287,0.00085563964,0.00011549323,0.000017444587,0.00019922659,0.000011728441,0.0028791437],"genre_scores_gemma":[0.99662244,0.0016721197,0.00021114011,0.00022857422,0.00010967279,0.0000042417905,0.00010678999,0.000012977365,0.0010320806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909484,0.0005041231,0.000075145246,0.000093672046,0.00012220729,0.00011000296],"domain_scores_gemma":[0.99604625,0.0015635707,0.0014651943,0.0002991393,0.00025861795,0.00036722442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013427915,0.0002852434,0.0005731054,0.00042745806,0.00030114473,0.0011138831,0.00037457058,0.00093235297,0.003379552],"category_scores_gemma":[0.007368929,0.0002459154,0.00091204,0.000688079,0.0003857568,0.0005830006,0.00030039603,0.00062738266,0.00056835456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053269025,0.00028986757,0.96509695,0.00009514473,0.0007254276,0.00017298752,0.00011766971,0.00014359727,0.0021995183,0.00009066815,0.00015968746,0.02558154],"study_design_scores_gemma":[0.000021511267,0.00043411375,0.99786156,0.00001876561,0.0002563447,0.00020915124,0.000115104456,0.00011285122,0.00038261295,0.00009666339,0.0004853044,0.0000059414424],"about_ca_topic_score_codex":0.0037293578,"about_ca_topic_score_gemma":0.0044140783,"teacher_disagreement_score":0.0037293578,"about_ca_system_score_codex":0.00040780727,"about_ca_system_score_gemma":0.00058235775,"threshold_uncertainty_score":0.011305749},"labels":[],"label_agreement":null},{"id":"W2305942576","doi":"10.1016/j.breast.2016.02.012","title":"Does a dedicated program for young breast cancer patients affect the likelihood of fertility preservation discussion and referral?","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Fertility; Breast cancer; Referral; Cancer; Fertility preservation; Documentation; Prospective cohort study; Gynecology; Family medicine; Internal medicine; Population","score_opus":0.017600189257271356,"score_gpt":0.29869298235254177,"score_spread":0.2810927930952704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305942576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9241739,0.004095042,0.00039200837,0.05057744,0.0005259853,0.000072923416,0.00043531694,0.00003849991,0.019688893],"genre_scores_gemma":[0.99370265,0.001192687,0.0007070602,0.0032286313,0.00028963614,0.000041417043,0.00012269698,0.000016649567,0.00069859816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998293,0.0008002822,0.00010636221,0.00011897731,0.00023993039,0.0004414687],"domain_scores_gemma":[0.98389024,0.0054779933,0.004148972,0.00024069323,0.00086592115,0.0053761574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018307683,0.000114622984,0.0002597423,0.00048969395,0.0011953412,0.0012928009,0.00068880303,0.0014759718,0.013458181],"category_scores_gemma":[0.023730708,0.00016674258,0.0004155716,0.0005134788,0.00060751,0.0011692652,0.000843158,0.0013761964,0.00061947136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021858173,0.0005651241,0.93937093,0.00012047367,0.00007429078,0.00075083005,0.0008133496,0.0001523829,0.00019058256,0.0006312248,0.008304466,0.04880775],"study_design_scores_gemma":[0.000051784038,0.0003069237,0.9779188,0.0009896556,0.00010386208,0.0030326173,0.0068856794,0.00049179007,0.00022518,0.00096980366,0.008996122,0.000027649567],"about_ca_topic_score_codex":0.0080774035,"about_ca_topic_score_gemma":0.02045089,"teacher_disagreement_score":0.013458181,"about_ca_system_score_codex":0.0013739713,"about_ca_system_score_gemma":0.0053723846,"threshold_uncertainty_score":0.04502213},"labels":[],"label_agreement":null},{"id":"W2319623115","doi":"10.1016/j.breast.2016.02.010","title":"New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Medicine; Letrozole; Vasomotor; Adjuvant; Internal medicine; Oncology; Physical therapy; Cancer; Breast cancer; Tamoxifen","score_opus":0.01360929907153333,"score_gpt":0.3073635627656535,"score_spread":0.29375426369412017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319623115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880916,0.0019158252,0.00035851577,0.00039092166,0.000037962884,0.00003164108,0.0070606386,0.00003012652,0.0020828287],"genre_scores_gemma":[0.99144614,0.00032354047,0.00016565857,0.00023473198,0.00004595608,0.000029287192,0.0061167283,0.00001774746,0.0016202299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964,0.00011471949,0.000034675915,0.000079623554,0.000064789194,0.00006620644],"domain_scores_gemma":[0.99884343,0.0002482317,0.00030949584,0.0002410572,0.00013650133,0.00022129851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062959624,0.00032829744,0.00038587503,0.00048372895,0.0003028215,0.0004917343,0.0005444854,0.00032786926,0.0034838298],"category_scores_gemma":[0.0019482716,0.00018259088,0.00071971025,0.0006760744,0.0001548977,0.00026068083,0.00041847082,0.00059967703,0.0003654806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004319702,0.000088677974,0.9754263,0.000068055015,0.0018679886,0.0002497922,0.00009762366,0.00021761202,0.005649694,0.00007834496,0.0031652641,0.008770865],"study_design_scores_gemma":[0.000068308815,0.00016213977,0.9972211,0.000011400437,0.00047113423,0.00011574674,0.0000352083,0.00010582369,0.00023888369,0.00004229439,0.0015231769,0.000004816213],"about_ca_topic_score_codex":0.018625772,"about_ca_topic_score_gemma":0.04368879,"teacher_disagreement_score":0.018625772,"about_ca_system_score_codex":0.00030645484,"about_ca_system_score_gemma":0.00041700937,"threshold_uncertainty_score":0.03703469},"labels":[],"label_agreement":null},{"id":"W2400028560","doi":"10.1016/j.breast.2016.04.013","title":"Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Overdiagnosis; Medicine; Breast cancer; Mammography; Population; Incidence (geometry); Internal medicine; Gynecology; Cancer; Oncology; Confidence interval","score_opus":0.06502274715821088,"score_gpt":0.3351735388951199,"score_spread":0.27015079173690904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400028560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915256,0.0003565837,0.0048062545,0.0007905782,0.00004195445,0.00013728891,0.0011768762,0.000058973495,0.001105829],"genre_scores_gemma":[0.9965481,0.000125263,0.0016673615,0.00013766886,0.000013071441,0.0000921934,0.0007753611,0.000013798136,0.0006271958],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9923254,0.0057600485,0.0002499268,0.00083643844,0.0002076486,0.00062058045],"domain_scores_gemma":[0.8515292,0.13110867,0.0076633343,0.00558538,0.0024550597,0.0016584633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01747197,0.0012278417,0.0018305035,0.0013091966,0.00078280334,0.0022739917,0.0026487794,0.0046245726,0.005730374],"category_scores_gemma":[0.073296174,0.001447457,0.004333577,0.0016619911,0.0018668445,0.002160884,0.0016721158,0.004266431,0.0005527454],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008254547,0.0033383886,0.2081935,0.0001955772,0.0020711585,0.00074116554,0.00037153374,0.7621522,0.00036280055,0.0054486995,0.0019361305,0.006934429],"study_design_scores_gemma":[0.0015551702,0.0019716609,0.050294198,0.000087035995,0.0011419763,0.000486165,0.00045195466,0.93828946,0.00041868855,0.0045455536,0.00061694835,0.00014128898],"about_ca_topic_score_codex":0.03982686,"about_ca_topic_score_gemma":0.016416054,"teacher_disagreement_score":0.03982686,"about_ca_system_score_codex":0.0034658222,"about_ca_system_score_gemma":0.002152661,"threshold_uncertainty_score":0.09240168},"labels":[],"label_agreement":null},{"id":"W2468316166","doi":"10.1016/j.breast.2016.06.013","title":"A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Breast cancer; Prospective cohort study; Taxane; Internal medicine; Peripheral neuropathy; Cancer; Chemotherapy; Odds ratio; Confidence interval; Surgery","score_opus":0.033388218821180156,"score_gpt":0.3313250317947832,"score_spread":0.297936812973603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468316166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973404,0.0006218399,0.000076250544,0.000026762656,0.000008040735,0.000015159655,0.0016137663,0.0000024527933,0.0002951709],"genre_scores_gemma":[0.9973252,0.0003909704,0.00008063054,0.000021199026,0.000011759022,0.000017379669,0.001961466,0.000001615014,0.00018972237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999532,0.000108573506,0.000057421385,0.00012626809,0.00008530098,0.000090497415],"domain_scores_gemma":[0.9985979,0.00014945249,0.0007407948,0.00012096499,0.00020097666,0.00018988806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006712612,0.00027425142,0.0003599833,0.0009175351,0.0003632883,0.0005787266,0.00039576623,0.00049805496,0.0009549637],"category_scores_gemma":[0.0015872068,0.00028503028,0.00082124537,0.0016287961,0.0001191885,0.00046744876,0.00044510936,0.00053244596,0.0002028991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008447945,0.000021772998,0.999212,0.000005676138,0.000051668,0.00003388073,0.000018192437,0.000011498274,0.00004283836,0.0000020952139,0.000032756627,0.0004829721],"study_design_scores_gemma":[0.000003591927,0.000041208303,0.99968505,0.0000031586144,0.000023824214,0.00009027689,0.0000420462,0.000032650467,0.00000871872,0.0000023521482,0.00006592438,0.000001251038],"about_ca_topic_score_codex":0.017828746,"about_ca_topic_score_gemma":0.016922591,"teacher_disagreement_score":0.017828746,"about_ca_system_score_codex":0.00029141284,"about_ca_system_score_gemma":0.0003679096,"threshold_uncertainty_score":0.035449922},"labels":[],"label_agreement":null},{"id":"W2474715597","doi":"10.1016/j.breast.2016.06.015","title":"Paget's disease of the male breast in the 21st century: A systematic review","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Disease; Dermatology; Pathology; Breast carcinoma; Cancer; Internal medicine","score_opus":0.0248988679470238,"score_gpt":0.31303946272035754,"score_spread":0.28814059477333376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474715597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044625922,0.99931896,0.000014582404,0.00006387064,0.000035777033,0.00001629917,0.000058465957,8.799139e-7,0.000044794455],"genre_scores_gemma":[0.0069067283,0.9926885,0.00007774435,0.00018308705,0.000048298716,0.000026784759,0.000034021046,6.085469e-7,0.000034343055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99807906,0.00050635077,0.0007355369,0.00022351781,0.00035405898,0.00010142818],"domain_scores_gemma":[0.9931599,0.004619042,0.0015938986,0.00007475031,0.00041823793,0.00013403954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002051547,0.001061312,0.0061099892,0.0058880593,0.00043910227,0.0017956952,0.0010012888,0.0018632396,0.0030276077],"category_scores_gemma":[0.01110195,0.00068776135,0.0043999,0.007324401,0.0006022924,0.0017114369,0.0011796469,0.0010035784,0.00014098146],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025679625,0.000032630334,0.002829824,0.9327959,0.012786579,0.00026631024,0.00019647049,0.00010570554,0.00016949694,0.0002264413,0.0025600856,0.047773775],"study_design_scores_gemma":[0.00042786024,0.00032036606,0.023133913,0.7737187,0.16331936,0.0024478515,0.0007665075,0.00012501347,0.00017245144,0.0005141972,0.034956545,0.000097173855],"about_ca_topic_score_codex":0.010354569,"about_ca_topic_score_gemma":0.03435797,"teacher_disagreement_score":0.010354569,"about_ca_system_score_codex":0.0017254485,"about_ca_system_score_gemma":0.0045611574,"threshold_uncertainty_score":0.020588636},"labels":[],"label_agreement":null},{"id":"W2484915095","doi":"10.1016/j.breast.2016.07.006","title":"Radiotherapy for breast cancer: The predictable consequences of an unmet need","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Commission; Cancer; Disease; Family medicine; Intensive care medicine; Surgery; Internal medicine; Finance","score_opus":0.013491777831525836,"score_gpt":0.34455280168654484,"score_spread":0.331061023855019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484915095","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053510644,0.054007377,0.0022115386,0.84902567,0.0034245912,0.00003136057,0.0016685063,0.00007570945,0.036044523],"genre_scores_gemma":[0.78835994,0.10753887,0.0035252187,0.08412797,0.0062285345,0.0001039197,0.0012529759,0.00014224458,0.008720316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689746,0.0012646829,0.00021283535,0.0001885372,0.00086017,0.00057627773],"domain_scores_gemma":[0.99112785,0.0034826961,0.002012834,0.00041248082,0.00109308,0.0018710108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003459826,0.00022376832,0.00035356765,0.000797946,0.0011711841,0.0033756418,0.00063944154,0.0022008982,0.0125006605],"category_scores_gemma":[0.020266162,0.00025182538,0.00047076223,0.001834417,0.0018533038,0.003941554,0.0030098225,0.00410013,0.0019343052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005460321,0.00018832268,0.07732956,0.0019197057,0.00018141481,0.0031159315,0.0029324137,0.0023269423,0.0018288633,0.1186546,0.3547153,0.436261],"study_design_scores_gemma":[0.00007209897,0.0004340766,0.134422,0.0036145137,0.00013693677,0.0060287183,0.011166988,0.0015038867,0.0007581051,0.1603154,0.68137527,0.00017195895],"about_ca_topic_score_codex":0.0062757195,"about_ca_topic_score_gemma":0.01696832,"teacher_disagreement_score":0.0125006605,"about_ca_system_score_codex":0.0037792353,"about_ca_system_score_gemma":0.006884997,"threshold_uncertainty_score":0.041818917},"labels":[],"label_agreement":null},{"id":"W2503815376","doi":"10.1016/j.breast.2016.07.012","title":"Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hamilton Health Sciences; Juravinski Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Guideline; Multidisciplinary approach; Breast cancer; Sentinel lymph node; Family medicine; Axillary Lymph Node Dissection; Cancer; Internal medicine; Pathology","score_opus":0.016037310819170862,"score_gpt":0.3455489956408191,"score_spread":0.3295116848216482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503815376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914494,0.0005090882,0.0013074911,0.0041638203,0.00006507281,0.00026113985,0.00011466317,0.00001031514,0.0021188702],"genre_scores_gemma":[0.9950911,0.00051402237,0.0016563811,0.0015400661,0.00002136253,0.00028183393,0.00004061264,0.000010715716,0.0008438798],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.981423,0.015525071,0.00044852684,0.00059396814,0.0008305534,0.0011788243],"domain_scores_gemma":[0.9542938,0.037851904,0.002704906,0.0006006627,0.0023751527,0.002173537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020591883,0.0003125312,0.0004147532,0.0008646539,0.004987253,0.0020009046,0.0012836569,0.0013536317,0.0013649493],"category_scores_gemma":[0.034467828,0.00045465364,0.00038024885,0.0009229432,0.0054000835,0.002044416,0.0032146657,0.0016972561,0.00015219998],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003343537,0.00003779258,0.0038055575,0.00016188508,0.000004088432,0.0005037421,0.9901087,0.000031859403,0.0006574043,0.00029378082,0.000499373,0.0038623041],"study_design_scores_gemma":[0.000012775861,0.00010328044,0.0028013773,0.00019649697,0.000005204678,0.00020535657,0.9914745,0.00007950122,0.00024949637,0.0001525737,0.0047089956,0.000010522867],"about_ca_topic_score_codex":0.010385045,"about_ca_topic_score_gemma":0.01733732,"teacher_disagreement_score":0.020591883,"about_ca_system_score_codex":0.0056406357,"about_ca_system_score_gemma":0.0073666447,"threshold_uncertainty_score":0.10890162},"labels":[],"label_agreement":null},{"id":"W2508687991","doi":"10.1016/j.breast.2016.08.012","title":"PATI: Patient accessed tailored information: A pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Anxiety; Breast cancer; Depression (economics); Demographics; Cancer; Randomized controlled trial; Physical therapy; Medical physics; Family medicine; Internal medicine; Psychiatry; Demography","score_opus":0.007619440578436137,"score_gpt":0.26222785249079067,"score_spread":0.2546084119123545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508687991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998326,0.000037295176,0.00009791237,0.000049119473,0.000014463179,0.0011470083,0.00007961731,0.000007781077,0.00024070816],"genre_scores_gemma":[0.99221694,0.0002171545,0.0017163346,0.0002586495,0.00007426287,0.004533974,0.00017447157,0.0000046299,0.00080347754],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991596,0.00041593864,0.00008007137,0.00008190395,0.00010024636,0.00016227596],"domain_scores_gemma":[0.99793077,0.0010430338,0.00021246469,0.00016304269,0.00015717748,0.00049354736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959303,0.00056873146,0.0008143135,0.00044688754,0.00060906284,0.00039142952,0.00038366488,0.000829362,0.0061610597],"category_scores_gemma":[0.0032891177,0.0003168076,0.0009121217,0.00030638033,0.00058251125,0.0005888234,0.0004603399,0.00101655,0.00061949523],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13977604,0.6555498,0.044982117,0.0020057112,0.0003916234,0.0009712102,0.005691025,0.0005327089,0.022189062,0.0002147381,0.0013937694,0.12630212],"study_design_scores_gemma":[0.019176876,0.93491197,0.041518334,0.000025448982,0.00017240849,0.00015437214,0.0006586632,0.0002478334,0.002291418,0.000047382953,0.00076946407,0.000025809051],"about_ca_topic_score_codex":0.0006228179,"about_ca_topic_score_gemma":0.00060461485,"teacher_disagreement_score":0.0061610597,"about_ca_system_score_codex":0.00028466908,"about_ca_system_score_gemma":0.00092003046,"threshold_uncertainty_score":0.02061081},"labels":[],"label_agreement":null},{"id":"W2528814032","doi":"10.1016/j.breast.2016.08.002","title":"Overview of guidelines on breast screening: Why recommendations differ and what to do about it","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Observational study; Overdiagnosis; Medicine; Breast cancer; Guideline; Psychological intervention; Breast cancer screening; Harm; Clinical study design; Observational methods in psychology; Randomized controlled trial; Clinical trial; Intensive care medicine; Family medicine; Medical physics; Mammography; Cancer; Pathology; Internal medicine; Psychiatry; Psychology","score_opus":0.3111421300673582,"score_gpt":0.46674116058760096,"score_spread":0.15559903052024276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528814032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118614116,0.9607141,0.00103082,0.029956961,0.004128948,0.000374117,0.001108758,0.00009136997,0.002476215],"genre_scores_gemma":[0.001204152,0.96461385,0.0065704635,0.022285294,0.0014449577,0.00079677266,0.0016570218,0.00006132697,0.0013661985],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98414165,0.005617706,0.0048849992,0.00087177166,0.0039512985,0.0005325495],"domain_scores_gemma":[0.95455515,0.02245424,0.0071897847,0.0008957398,0.013937149,0.00096789777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015886482,0.0015675162,0.005471114,0.010020076,0.0009658636,0.004658306,0.004775553,0.0056423713,0.010489903],"category_scores_gemma":[0.06915629,0.0013922428,0.005081917,0.0125117665,0.0015081349,0.006200804,0.002631884,0.0060663624,0.0050553386],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013579638,0.000047943973,0.00039668623,0.20164678,0.0007456763,0.0001418616,0.0005513139,0.00032383334,0.00023245908,0.0073325327,0.3745015,0.4139436],"study_design_scores_gemma":[0.00007850016,0.00003906868,0.0010046297,0.36973953,0.0012315555,0.00024650933,0.00025265457,0.00008467186,0.00007178761,0.0074876747,0.61971384,0.000049551243],"about_ca_topic_score_codex":0.012312564,"about_ca_topic_score_gemma":0.022612553,"teacher_disagreement_score":0.015886482,"about_ca_system_score_codex":0.005383156,"about_ca_system_score_gemma":0.017004227,"threshold_uncertainty_score":0.0840168},"labels":[],"label_agreement":null},{"id":"W2533474121","doi":"10.1016/j.breast.2016.09.014","title":"Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Fondation Cancer; Fondation du cancer du sein du Québec; Université Laval","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Single-nucleotide polymorphism; Lymphovascular invasion; Carcinogenesis; Genotype; Cancer; CA15-3; Pathology; Metastasis; Gene; Biology; Genetics","score_opus":0.044005681133845204,"score_gpt":0.31511709530617416,"score_spread":0.271111414172329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533474121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938536,0.00026363635,0.00012633255,0.00000856982,0.0000026263756,0.000002586427,0.000112413196,0.0000021592155,0.00009627018],"genre_scores_gemma":[0.99939144,0.00009297077,0.0001290017,0.000011281291,0.00000457393,0.000006198213,0.00017652428,0.0000020626483,0.00018611993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996062,0.00009899937,0.000046922403,0.00010950166,0.00009672127,0.00004163212],"domain_scores_gemma":[0.9994241,0.0002147026,0.00020287717,0.00003988984,0.000052136027,0.00006621569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003944047,0.00021689327,0.00023392138,0.00054231804,0.00019438527,0.0003093365,0.00014671627,0.00026766115,0.00079568935],"category_scores_gemma":[0.0009829019,0.00015637641,0.00022785377,0.00065958383,0.00015501799,0.00011245371,0.00013233454,0.0002235892,0.00014983812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010089542,0.00010058793,0.970333,0.00003133203,0.00018821911,0.00045126126,0.0001156202,0.00012026899,0.022799047,0.000041183805,0.00006485644,0.0047456753],"study_design_scores_gemma":[0.000019470477,0.00027715162,0.993751,0.000004886046,0.00010138157,0.0012599952,0.0000681789,0.00029899096,0.0038358993,0.00004590202,0.00033332495,0.000003734369],"about_ca_topic_score_codex":0.0006358406,"about_ca_topic_score_gemma":0.0006858445,"teacher_disagreement_score":0.00079568935,"about_ca_system_score_codex":0.00011530583,"about_ca_system_score_gemma":0.00010920679,"threshold_uncertainty_score":0.0026618838},"labels":[],"label_agreement":null},{"id":"W2554000772","doi":"10.1016/j.breast.2016.11.004","title":"Moving forward with obesity research in breast cancer","year":2016,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Overweight; Hazard ratio; Internal medicine; Obesity; Body mass index; Gynecology; Confidence interval; Oncology; Relative risk; Meta-analysis; Incidence (geometry); Cancer","score_opus":0.02351137024318164,"score_gpt":0.3569164618711637,"score_spread":0.3334050916279821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554000772","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044244013,0.64976996,0.0008757391,0.31606153,0.030879686,0.000029129591,0.00024169545,0.00006543017,0.0016344305],"genre_scores_gemma":[0.008971757,0.71299684,0.0037085328,0.16540095,0.106428005,0.00011737987,0.00026653733,0.000103706574,0.0020062954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98768693,0.0072027226,0.0010274079,0.0011001022,0.0022135458,0.0007693253],"domain_scores_gemma":[0.9231417,0.04815694,0.0038102479,0.0034665547,0.015853738,0.0055708066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027976759,0.0015326863,0.004973045,0.006514029,0.0017068295,0.007511367,0.002619634,0.010536724,0.015448937],"category_scores_gemma":[0.053626306,0.0009815763,0.0036920055,0.0062893685,0.00480101,0.01234473,0.0040186895,0.021811178,0.004462254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000774517,0.00021874408,0.0025323038,0.014704705,0.0013838296,0.00030546403,0.0008375692,0.00026191204,0.00060017616,0.027681729,0.5861058,0.3645932],"study_design_scores_gemma":[0.00042640365,0.0005716862,0.00452037,0.043549348,0.001339859,0.00049606996,0.0014085559,0.00036704453,0.0002691144,0.06775319,0.87910765,0.00019069188],"about_ca_topic_score_codex":0.0062824674,"about_ca_topic_score_gemma":0.01022642,"teacher_disagreement_score":0.027976759,"about_ca_system_score_codex":0.003368205,"about_ca_system_score_gemma":0.010926222,"threshold_uncertainty_score":0.14795703},"labels":[],"label_agreement":null},{"id":"W2555676011","doi":"10.1016/j.breast.2016.11.009","title":"A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Biopsy; Fine needle aspiration cytology; Radiology; Subgroup analysis; Cytology; Breast cancer; Diagnostic accuracy; Core biopsy; Pathology; Cancer; Internal medicine","score_opus":0.2049381745224407,"score_gpt":0.39754350005296213,"score_spread":0.19260532553052143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555676011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033993202,0.9954267,0.00032557454,0.00010427444,0.00012779105,0.00021471562,0.00023041027,0.00001405418,0.00015722014],"genre_scores_gemma":[0.17684409,0.81644213,0.0027245583,0.0010927686,0.00047776557,0.001303527,0.00073868776,0.00004184574,0.0003345979],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9813725,0.0083423965,0.0057907323,0.0020265228,0.0020726225,0.0003953731],"domain_scores_gemma":[0.94735706,0.042493712,0.0059861867,0.0009793106,0.0027852454,0.00039844934],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02075903,0.0036159512,0.02755209,0.009883448,0.00082973193,0.0045596617,0.0027908045,0.0033774553,0.0030187932],"category_scores_gemma":[0.056457255,0.0022259662,0.051757403,0.008192868,0.0012087368,0.002756744,0.0018507537,0.0021638286,0.00030282498],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001963065,0.000023792138,0.00325401,0.4067455,0.57903886,0.00009897597,0.00007611814,0.0003228989,0.00018387954,0.00008220794,0.000270091,0.007940612],"study_design_scores_gemma":[0.00038665088,0.0001420008,0.0021269142,0.018949943,0.97730607,0.00007790847,0.000032448726,0.00011743104,0.00008159834,0.00009352218,0.00066603516,0.000019454712],"about_ca_topic_score_codex":0.006667043,"about_ca_topic_score_gemma":0.01360165,"teacher_disagreement_score":0.97244793,"about_ca_system_score_codex":0.003263338,"about_ca_system_score_gemma":0.0034607104,"threshold_uncertainty_score":0.10978556},"labels":[],"label_agreement":null},{"id":"W2562466185","doi":"10.1016/j.breast.2016.12.012","title":"Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Cambridge Memorial Hospital; McMaster University","funders":"McMaster University","keywords":"Medicine; Guideline; Breast reconstruction; Breast cancer; Radiation therapy; Family medicine; Cancer; Clinical Practice; Adjuvant therapy; Health care; Adjuvant radiotherapy; Surgery; Internal medicine; Pathology","score_opus":0.019414836384721502,"score_gpt":0.27927086565220127,"score_spread":0.25985602926747975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562466185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978759,0.00009156272,0.000068567366,0.0004637339,0.000002331787,0.000040464856,0.0005464936,0.0000036620822,0.00090727874],"genre_scores_gemma":[0.9992317,0.00014378234,0.00013927306,0.00008529007,0.0000018233079,0.000021312515,0.00022030703,0.0000015049745,0.00015501467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984958,0.00030282125,0.00015758145,0.00010641527,0.00059533434,0.00034194122],"domain_scores_gemma":[0.99323833,0.0012169827,0.0029380342,0.00022276383,0.0012642621,0.0011195871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015064756,0.00011554941,0.00023148107,0.0007529376,0.0011607319,0.0006539361,0.00053200615,0.00030714044,0.0018879313],"category_scores_gemma":[0.0071905875,0.00031631385,0.0003343009,0.0020458417,0.0006622356,0.00039762567,0.0007661278,0.0004806036,0.0002163249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016972645,0.00004187207,0.99540734,0.000032104028,0.0000063383804,0.00003820794,0.001972782,0.00003958055,0.00011524834,0.00001970847,0.00024033243,0.0020695154],"study_design_scores_gemma":[0.0000049326213,0.000045738412,0.9945568,0.000026321728,0.000004643891,0.00006487164,0.0045466996,0.00019004785,0.000037635124,0.000010132351,0.00050763664,0.0000045709126],"about_ca_topic_score_codex":0.68786645,"about_ca_topic_score_gemma":0.72125316,"teacher_disagreement_score":0.68786645,"about_ca_system_score_codex":0.005404413,"about_ca_system_score_gemma":0.009989898,"threshold_uncertainty_score":0.6279435},"labels":[],"label_agreement":null},{"id":"W2576787462","doi":"10.1016/j.breast.2017.01.001","title":"Corrigendum to “3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)” [Breast 31 (February 2017) 244–259]","year":2017,"lang":"en","type":"erratum","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Regret; Oncology; Internal medicine; Cancer","score_opus":0.08359641699928291,"score_gpt":0.37835754730210835,"score_spread":0.29476113030282547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576787462","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015956612,0.008529742,0.0022113814,0.10887022,0.8244824,0.00023651916,0.004787741,0.0010624119,0.049660053],"genre_scores_gemma":[0.0047460003,0.031547543,0.00714195,0.15386543,0.2924589,0.00064652757,0.015277184,0.0025568698,0.4917597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748623,0.0005037864,0.0004089314,0.00024724158,0.0011616178,0.00019222243],"domain_scores_gemma":[0.9804984,0.0045682583,0.001199791,0.00057442853,0.012196808,0.0009623175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002279362,0.0011703355,0.0012161974,0.0034386904,0.0012661369,0.0031793476,0.0018558291,0.003333919,0.23834571],"category_scores_gemma":[0.04043205,0.00062882924,0.0013091724,0.0020150852,0.00097589847,0.001956352,0.0017239904,0.0061097927,0.17332454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000385658,0.0000023541127,0.000017855808,0.000049648308,0.0000011454606,0.000030198431,0.0000036791255,0.0000108115,0.000007823109,0.00010317472,0.9938735,0.005896046],"study_design_scores_gemma":[0.00001021321,0.0000059366002,0.00013774664,0.00040888155,0.0000068415206,0.00021237685,0.000015946518,0.000048734306,0.000057514626,0.00034296565,0.99874425,0.000008579152],"about_ca_topic_score_codex":0.010437046,"about_ca_topic_score_gemma":0.013285141,"teacher_disagreement_score":0.23834571,"about_ca_system_score_codex":0.002233984,"about_ca_system_score_gemma":0.0036123488,"threshold_uncertainty_score":0.7973459},"labels":[],"label_agreement":null},{"id":"W2584609353","doi":"10.1016/j.breast.2017.01.004","title":"Extended adjuvant endocrine therapy – A standard to all or some?","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Oncology; Clinical trial; Breast cancer; Endocrine system; Internal medicine; Adjuvant; Randomized controlled trial; Adjuvant therapy; Intensive care medicine; Cancer; Hormone","score_opus":0.06236989224435918,"score_gpt":0.38326811129608124,"score_spread":0.32089821905172206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584609353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009619693,0.9785605,0.0005147573,0.016182814,0.0016691678,0.000009429143,0.000046513564,0.000015846615,0.0020390893],"genre_scores_gemma":[0.007033898,0.98186344,0.001009443,0.006306149,0.0019713126,0.0000229162,0.00007711806,0.000007446424,0.0017082398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995665,0.00014805733,0.00007370853,0.00006668142,0.00011160224,0.000033350458],"domain_scores_gemma":[0.9993082,0.00036254237,0.000100596306,0.0000422188,0.00013437928,0.00005211149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017396798,0.00034995298,0.0011696962,0.00046840817,0.00024410314,0.0011854282,0.00068837515,0.0010466784,0.002375946],"category_scores_gemma":[0.0017380367,0.00016091733,0.0004965528,0.00060840783,0.0007619271,0.002300848,0.0005778108,0.0020876525,0.0011011662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003996435,0.00008451779,0.000682651,0.008962481,0.00019322457,0.00030174328,0.00015897887,0.00027860052,0.0019051057,0.010453005,0.037472166,0.93910784],"study_design_scores_gemma":[0.00013993528,0.00035399184,0.0018294016,0.0068847137,0.00018152075,0.0013060162,0.0002077802,0.00010492529,0.00051344157,0.010714158,0.97773725,0.000026801263],"about_ca_topic_score_codex":0.00042270948,"about_ca_topic_score_gemma":0.0014158296,"teacher_disagreement_score":0.002375946,"about_ca_system_score_codex":0.00038380863,"about_ca_system_score_gemma":0.000905506,"threshold_uncertainty_score":0.009200394},"labels":[],"label_agreement":null},{"id":"W2588190826","doi":"10.1016/j.breast.2017.01.018","title":"Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universidade do Porto; Fundação para a Ciência e a Tecnologia; Federación Española de Enfermedades Raras","keywords":"Medicine; Anxiety; Prospective cohort study; Montreal Cognitive Assessment; Breast cancer; Cohort; Internal medicine; Percentile; Incidence (geometry); Relative risk; Confidence interval; Depression (economics); Cohort study; Hospital Anxiety and Depression Scale; Cancer; Cognitive impairment; Psychiatry; Disease","score_opus":0.012136021005510611,"score_gpt":0.29872949919917,"score_spread":0.28659347819365943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588190826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890625,0.0002719382,0.000071950766,0.000026993866,0.00000925694,0.000021020318,0.0004883243,0.000003280404,0.00020102874],"genre_scores_gemma":[0.9989791,0.00018798481,0.0000857229,0.000028725846,0.00001527837,0.000019476385,0.0005147761,0.0000019008356,0.00016723336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992617,0.00016888714,0.00007052212,0.00020887044,0.00013726472,0.0001527613],"domain_scores_gemma":[0.99834824,0.00018558091,0.0007791023,0.00020689901,0.0001560575,0.00032421647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001255326,0.0003776489,0.00047698055,0.0008970128,0.00069035264,0.0009924108,0.00051400595,0.0005915527,0.0010949799],"category_scores_gemma":[0.0021930553,0.0004631485,0.00090431626,0.0013214691,0.00024811487,0.0006306794,0.0004909891,0.00094402756,0.000247284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012158805,0.000045989695,0.99922764,0.000004699801,0.00007802702,0.00005153874,0.000033435885,0.000015258727,0.00005432819,0.000004558528,0.000027216307,0.00033568445],"study_design_scores_gemma":[0.000011061031,0.00013012097,0.9994512,0.0000037696984,0.000040412524,0.0001498426,0.0000666792,0.000058083748,0.000017754102,0.000006194495,0.00006175582,0.0000031478633],"about_ca_topic_score_codex":0.012284806,"about_ca_topic_score_gemma":0.012327174,"teacher_disagreement_score":0.012284806,"about_ca_system_score_codex":0.00030969977,"about_ca_system_score_gemma":0.00054354477,"threshold_uncertainty_score":0.02442664},"labels":[],"label_agreement":null},{"id":"W2591609812","doi":"10.1016/j.breast.2017.02.016","title":"Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Clinical trial; Breast cancer; Internal medicine; Radiation therapy; Cancer","score_opus":0.8019048102967077,"score_gpt":0.6570336509654486,"score_spread":0.14487115933125905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591609812","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09104495,0.8943935,0.004438177,0.002105512,0.0005730477,0.0029696599,0.0027833635,0.000033967935,0.0016578635],"genre_scores_gemma":[0.86576015,0.110734984,0.009650209,0.0027009682,0.0011775407,0.0069913846,0.0024684374,0.000067304034,0.0004490859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.66567504,0.20859483,0.084903024,0.010124798,0.029025659,0.0016766463],"domain_scores_gemma":[0.19230896,0.66712976,0.12141204,0.0101726195,0.007148221,0.001828467],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.18903813,0.0010530314,0.0059735086,0.005957448,0.00071571145,0.0044505573,0.0016691453,0.0028063382,0.0036185756],"category_scores_gemma":[0.41706148,0.0007564008,0.012029856,0.010534747,0.0022062715,0.004792585,0.001974758,0.0028003252,0.0003369244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0376305,0.0003222959,0.34598288,0.2730947,0.25564146,0.0005829975,0.00078222365,0.0008554428,0.0006052597,0.002376163,0.0034451142,0.078680955],"study_design_scores_gemma":[0.02341973,0.010039437,0.38316536,0.12816377,0.41002813,0.004511748,0.001292378,0.0032629021,0.001557738,0.0075925514,0.026617594,0.00034875094],"about_ca_topic_score_codex":0.0002759605,"about_ca_topic_score_gemma":0.0006789468,"teacher_disagreement_score":0.99719363,"about_ca_system_score_codex":0.0015283048,"about_ca_system_score_gemma":0.002804648,"threshold_uncertainty_score":0.99974114},"labels":[],"label_agreement":null},{"id":"W2593967339","doi":"10.1016/j.breast.2017.02.015","title":"Validation of the electronic version of the BREAST-Q in the army of women study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Breast cancer; Cronbach's alpha; Breast reconstruction; Breast-conserving surgery; Mastectomy; Medicine; Quality of life (healthcare); Convergent validity; Checklist; Medical physics; Gynecology; Physical therapy; Psychology; Psychometrics; Clinical psychology; Cancer; Internal medicine; Internal consistency; Nursing","score_opus":0.009745345068018265,"score_gpt":0.2474612930656186,"score_spread":0.23771594799760032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593967339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304856,0.0001742931,0.0013302858,0.00046059658,0.000092585884,0.003770559,0.0051204734,0.000028322269,0.0059742266],"genre_scores_gemma":[0.97343296,0.00037551858,0.0051243915,0.0009298465,0.00010960036,0.008971164,0.007895341,0.000044614328,0.0031166119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934662,0.003606753,0.0008217635,0.0005803054,0.0011655535,0.00035933068],"domain_scores_gemma":[0.988415,0.003439537,0.00267637,0.0012658758,0.0034935353,0.0007097033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014494891,0.0004509827,0.000441405,0.0011240665,0.0007863337,0.0010619987,0.0008172815,0.0005511669,0.003614668],"category_scores_gemma":[0.023635041,0.00045736216,0.0006481814,0.0015328834,0.00056839705,0.0009381616,0.0017714428,0.0009057714,0.0017319978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00122119,0.0023597085,0.95080316,0.00015330869,0.0001582327,0.00017943303,0.0038824552,0.00022513846,0.00052444695,0.00038976525,0.0045669437,0.035536114],"study_design_scores_gemma":[0.00049756345,0.001997052,0.984934,0.00009131945,0.00005295836,0.00025036963,0.0029996345,0.00045467107,0.0002489665,0.00019611018,0.008255835,0.000021489752],"about_ca_topic_score_codex":0.004288501,"about_ca_topic_score_gemma":0.0058106775,"teacher_disagreement_score":0.014494891,"about_ca_system_score_codex":0.000590965,"about_ca_system_score_gemma":0.0013483898,"threshold_uncertainty_score":0.076657236},"labels":[],"label_agreement":null},{"id":"W2594709205","doi":"10.1016/j.breast.2017.02.012","title":"Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Population; Environmental health","score_opus":0.019062989860445953,"score_gpt":0.29621751348345543,"score_spread":0.27715452362300946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594709205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997497,0.00041294753,0.0002660339,0.000033946442,0.000005238945,0.000025411495,0.0011547635,0.0000088551105,0.0005958448],"genre_scores_gemma":[0.9984981,0.00020331975,0.00014298076,0.00002144207,0.000011496076,0.00001469692,0.0009885705,0.0000028538325,0.00011657781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999416,0.000137215,0.000074851356,0.00016250672,0.00014128756,0.000068152745],"domain_scores_gemma":[0.99900144,0.00014665068,0.00047186934,0.00010689729,0.00014324629,0.00012991365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069110136,0.00026497274,0.00041042676,0.0014008111,0.00031263757,0.0005813645,0.0003518615,0.00040299952,0.0019154195],"category_scores_gemma":[0.0020218503,0.00029353343,0.0010016408,0.0013380897,0.00022134485,0.00045067095,0.00065789436,0.00053033436,0.00031043467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007508667,0.000016735608,0.9987274,0.000008994376,0.00014385128,0.00004693716,0.000015650025,0.000047927864,0.00006641509,0.000010332972,0.00007022455,0.0007704028],"study_design_scores_gemma":[0.0000068588174,0.00006370873,0.9989164,0.0000053929666,0.0000807732,0.00042187498,0.00007777401,0.00020383818,0.00003111137,0.000021224487,0.00016843608,0.000002787607],"about_ca_topic_score_codex":0.004450289,"about_ca_topic_score_gemma":0.0048124283,"teacher_disagreement_score":0.004450289,"about_ca_system_score_codex":0.00031785952,"about_ca_system_score_gemma":0.00029765352,"threshold_uncertainty_score":0.008848786},"labels":[],"label_agreement":null},{"id":"W2594730512","doi":"10.1016/j.breast.2017.02.018","title":"Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Medicine; Biopsy; Malignancy; Radiology; Percutaneous; Breast cancer; Ultrasound; Lesion; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.051880870889845936,"score_gpt":0.3505464066924878,"score_spread":0.2986655358026419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594730512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994691,0.0001632744,0.00009697648,0.000007779778,0.0000015722728,0.0000052359032,0.000036802572,0.000002606232,0.00021675255],"genre_scores_gemma":[0.9997056,0.00004546814,0.00009393925,0.0000041925514,0.0000022098293,0.0000020736788,0.000055118908,7.197031e-7,0.00009062612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995803,0.00009139979,0.00005068022,0.00005161557,0.00016429853,0.00006174465],"domain_scores_gemma":[0.99763596,0.0006025997,0.0010418133,0.0001014552,0.00039683928,0.00022133875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007371679,0.00014776307,0.0001290562,0.00080532243,0.0002265363,0.00035090963,0.00024064608,0.00023270989,0.0009331995],"category_scores_gemma":[0.0029417414,0.00011110559,0.00022797592,0.00035527584,0.00017016454,0.00037704041,0.0002618733,0.00023277981,0.00017308012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008682197,0.000021149332,0.9971207,0.0000058775518,0.000009625776,0.0001562508,0.000038561055,0.000017491375,0.0005633161,0.000003753942,0.000017663817,0.00195887],"study_design_scores_gemma":[0.000002175518,0.00030388613,0.99550736,0.0000061468054,0.000021734535,0.0022985225,0.00013501568,0.0002104195,0.0013669588,0.0000062802646,0.00013862326,0.0000028570282],"about_ca_topic_score_codex":0.0009268178,"about_ca_topic_score_gemma":0.0017492822,"teacher_disagreement_score":0.0009331995,"about_ca_system_score_codex":0.00026284182,"about_ca_system_score_gemma":0.00018155186,"threshold_uncertainty_score":0.0038986206},"labels":[],"label_agreement":null},{"id":"W2604933613","doi":"10.1016/j.breast.2017.03.008","title":"Reirradiation for locally recurrent breast cancer","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Recurrent breast cancer; Oncology; Disease; Radiation therapy; Internal medicine; Cancer; Surgery","score_opus":0.07165201901023002,"score_gpt":0.38542364335674784,"score_spread":0.31377162434651784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604933613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000503659,0.99935573,0.000050070117,0.00011677111,0.00010969903,0.0000018902447,0.000006130096,0.0000025528639,0.00030669267],"genre_scores_gemma":[0.0004821518,0.9988638,0.00008582769,0.00017920572,0.00013976601,0.0000033120762,0.000014442293,0.0000013352231,0.000230214],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99981314,0.000041105246,0.00003137757,0.00003594589,0.00006004432,0.000018373834],"domain_scores_gemma":[0.9996265,0.00023457718,0.00004901559,0.000011796861,0.00005701476,0.000021184129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007837494,0.0006770952,0.0014177482,0.0013045439,0.00019115042,0.00083753996,0.000933977,0.0009437735,0.002115021],"category_scores_gemma":[0.0011755191,0.00024040391,0.00041282564,0.001334427,0.00057426677,0.00080411654,0.00057974295,0.0016362313,0.0009914733],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080379716,0.000039656734,0.00016417787,0.014941005,0.00009950401,0.00015192386,0.000026423631,0.00026885612,0.0008153506,0.0017797358,0.02334043,0.9582926],"study_design_scores_gemma":[0.000043755128,0.00008207349,0.0010518385,0.0055040256,0.0002513498,0.0018130281,0.000054509987,0.00008547155,0.0006150824,0.0016487348,0.9888293,0.000020920768],"about_ca_topic_score_codex":0.00097041926,"about_ca_topic_score_gemma":0.0026358664,"teacher_disagreement_score":0.002115021,"about_ca_system_score_codex":0.0006094658,"about_ca_system_score_gemma":0.0008087919,"threshold_uncertainty_score":0.007075429},"labels":[],"label_agreement":null},{"id":"W2605169409","doi":"10.1016/j.breast.2017.03.015","title":"Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Acupuncture; WOMAC; Randomized controlled trial; Breast cancer; Meta-analysis; Physical therapy; Osteoarthritis; Quality of life (healthcare); Joint pain; Aromatase inhibitor; Brief Pain Inventory; Cochrane Library; Internal medicine; Cancer; Chronic pain; Alternative medicine; Tamoxifen","score_opus":0.09676823259904971,"score_gpt":0.42608297398171635,"score_spread":0.32931474138266664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605169409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010097639,0.987922,0.0006164027,0.00019534734,0.00021021084,0.00041442423,0.00028439463,0.000028294933,0.00023129348],"genre_scores_gemma":[0.3260438,0.66555816,0.0035612986,0.0012867213,0.00044286344,0.0018260053,0.0008302003,0.000045911966,0.0004050926],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891389,0.0054618916,0.0030121377,0.0011285567,0.0009935799,0.0002649388],"domain_scores_gemma":[0.9845911,0.011023331,0.0026912189,0.00048582,0.00094636134,0.00026208526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013407905,0.0032332297,0.0227881,0.005078182,0.0007694282,0.0030515492,0.0021278772,0.0027057838,0.0036436887],"category_scores_gemma":[0.02872804,0.0015585895,0.050320745,0.005200561,0.0008049096,0.001913375,0.0013001163,0.0025605394,0.00024691084],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006898827,0.000055048815,0.0020894085,0.1486219,0.8339892,0.00007521949,0.00004926771,0.0004313698,0.0001896264,0.00007160122,0.0002203604,0.0073081283],"study_design_scores_gemma":[0.001993312,0.00038535852,0.002065132,0.006762866,0.9879226,0.000047829148,0.000023991432,0.00015271764,0.00007010056,0.00012363667,0.00043850375,0.0000139238955],"about_ca_topic_score_codex":0.0042191064,"about_ca_topic_score_gemma":0.007624067,"teacher_disagreement_score":0.0227881,"about_ca_system_score_codex":0.002470434,"about_ca_system_score_gemma":0.00218077,"threshold_uncertainty_score":0.070908606},"labels":[],"label_agreement":null},{"id":"W2607026570","doi":"10.1016/j.breast.2017.03.014","title":"The reality of economics for oncologists","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Value for money; Investment (military); Value (mathematics); Breast cancer; Health economics; Economic growth; Public economics; Cancer; Nursing; Internal medicine; Public health; Economics","score_opus":0.8252259482517306,"score_gpt":0.5715313032750519,"score_spread":0.2536946449766787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607026570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013310204,0.7574838,0.006152091,0.20361122,0.002298715,0.000014658018,0.000062653075,0.000019972218,0.02902591],"genre_scores_gemma":[0.07731651,0.8594211,0.003982172,0.04351869,0.0102770915,0.00009283503,0.000069363516,0.0000353093,0.005287044],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595696,0.0023837844,0.00017462291,0.00020611272,0.0010702919,0.0002081499],"domain_scores_gemma":[0.9839395,0.013051175,0.0008454359,0.00045395215,0.0012644137,0.00044542013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007964821,0.0005584038,0.0008184151,0.0017722077,0.0010420211,0.0057635326,0.00075663975,0.0041012457,0.0046188515],"category_scores_gemma":[0.021082444,0.00029007014,0.00048459982,0.002683648,0.0062239137,0.008845608,0.0023254403,0.0066566453,0.00085636775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036567595,0.000028071567,0.0004385016,0.0015707547,0.000056650722,0.00012952313,0.00035062767,0.0011907241,0.00007012409,0.78008133,0.053353455,0.16269359],"study_design_scores_gemma":[0.000020775016,0.000023709028,0.00069677597,0.0045084762,0.000021251906,0.00035580763,0.0005565155,0.00036090828,0.00005578479,0.4007947,0.5925798,0.000025400152],"about_ca_topic_score_codex":0.0024900485,"about_ca_topic_score_gemma":0.0019109114,"teacher_disagreement_score":0.007964821,"about_ca_system_score_codex":0.004124932,"about_ca_system_score_gemma":0.0060756532,"threshold_uncertainty_score":0.042122483},"labels":[],"label_agreement":null},{"id":"W2608878607","doi":"10.1016/j.breast.2017.04.007","title":"New agents for endocrine resistance in breast cancer","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Sherbrooke","funders":"","keywords":"Endocrine system; Breast cancer; Medicine; Disease; Acquired resistance; Estrogen receptor; Oncology; Metastatic breast cancer; Internal medicine; Blockade; Estrogen; Cancer; Bioinformatics; Cancer research; Receptor; Hormone; Biology","score_opus":0.11168353010337549,"score_gpt":0.43499997076240043,"score_spread":0.32331644065902493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608878607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024873394,0.9967104,0.00020365317,0.00030884577,0.00030698816,0.000012697515,0.0000383851,0.000014690894,0.0021555342],"genre_scores_gemma":[0.00140008,0.9960665,0.00033399364,0.00035075328,0.00018391745,0.000016130887,0.0000835878,0.0000032532178,0.001561829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998357,0.000030897754,0.000022534467,0.000025374773,0.00006842041,0.000017018152],"domain_scores_gemma":[0.99982315,0.00007890897,0.000027354969,0.0000074062787,0.0000489743,0.00001418946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036410603,0.00059014093,0.00082784134,0.0017876576,0.00023192445,0.00069318584,0.0005943542,0.00074959715,0.006808183],"category_scores_gemma":[0.00054821477,0.0001818065,0.0005507032,0.0010554001,0.00026531552,0.000893449,0.0006010982,0.0019075113,0.002888518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067295776,0.000104417275,0.000113587994,0.010540639,0.000070507136,0.00017257185,0.000051827126,0.0002097204,0.0023249746,0.003442627,0.026487844,0.95641404],"study_design_scores_gemma":[0.000022884211,0.00010121881,0.00038671322,0.0018542208,0.000068390946,0.0010499861,0.000025372146,0.00006572116,0.0005783903,0.0011070801,0.99472976,0.000010240496],"about_ca_topic_score_codex":0.00053722464,"about_ca_topic_score_gemma":0.0013438636,"teacher_disagreement_score":0.006808183,"about_ca_system_score_codex":0.0003597022,"about_ca_system_score_gemma":0.0005172685,"threshold_uncertainty_score":0.02277565},"labels":[],"label_agreement":null},{"id":"W2614270208","doi":"10.1016/j.breast.2017.04.005","title":"MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; Alberta Health Services; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Radiology; Lesion; Breast MRI; Cancer; Oncology; Mammography; Internal medicine; Pathology","score_opus":0.017272763009664033,"score_gpt":0.2891932709924163,"score_spread":0.2719205079827523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614270208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972485,0.0013038759,0.0002191346,0.00007372796,0.0000045590887,0.00002244304,0.00014341652,0.00000953801,0.00097487884],"genre_scores_gemma":[0.9990011,0.00045805995,0.0003249673,0.000024545272,0.000013628567,0.000006794306,0.000115863586,0.0000013412689,0.000053657073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.00016182777,0.000047634574,0.000043444466,0.000091042275,0.00004951856],"domain_scores_gemma":[0.99678755,0.0008799743,0.001837394,0.00010788948,0.00017750212,0.00020962105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000920158,0.00018957004,0.00018258148,0.00090628414,0.00016169544,0.00023301295,0.00026261288,0.00017084835,0.0007466598],"category_scores_gemma":[0.005081276,0.00012637307,0.00020277436,0.00055769,0.00021013581,0.00016030214,0.00022610299,0.00013257071,0.00011345356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075257696,0.000013189249,0.99408793,0.000028401888,0.000012320986,0.0001725043,0.00003858463,0.00007094553,0.00027958452,0.000006487504,0.00005623467,0.005158514],"study_design_scores_gemma":[0.0000063534117,0.00030437874,0.9951755,0.000042688465,0.000039822367,0.0030018853,0.00009802923,0.00027274032,0.0005320506,0.0000134987595,0.0005101618,0.0000029569646],"about_ca_topic_score_codex":0.0050175684,"about_ca_topic_score_gemma":0.009891262,"teacher_disagreement_score":0.0050175684,"about_ca_system_score_codex":0.00026808714,"about_ca_system_score_gemma":0.00050797977,"threshold_uncertainty_score":0.009976745},"labels":[],"label_agreement":null},{"id":"W2617889858","doi":"10.1016/j.breast.2017.05.004","title":"Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Trastuzumab; Tolerability; Discontinuation; Adverse effect; Cohort; Internal medicine; Adjuvant; Syringe; Oncology; Breast cancer; Cancer","score_opus":0.05830078814096429,"score_gpt":0.3442258103662161,"score_spread":0.2859250222252518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617889858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958389,0.0015402795,0.00033357707,0.00015608923,0.000052723415,0.0002933785,0.0005419605,0.000033031436,0.0012101848],"genre_scores_gemma":[0.99520195,0.00084528513,0.0006104026,0.0004765747,0.00015060784,0.00037350063,0.0016487914,0.000016659904,0.0006762159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983279,0.0010913736,0.000098235716,0.00020480194,0.00015923835,0.000118491276],"domain_scores_gemma":[0.997521,0.0009701313,0.00071778666,0.00039504218,0.00012950729,0.00026652205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036313792,0.00053514895,0.0012711429,0.000119050594,0.00016168156,0.00049585465,0.00045324967,0.0008166397,0.0031648865],"category_scores_gemma":[0.003938996,0.00019492034,0.001014542,0.00019674351,0.00054165424,0.00075078564,0.00025111184,0.0018002635,0.0004264338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8608679,0.009727398,0.00835724,0.00072515185,0.0019137975,0.000109916655,0.00017146526,0.0011665466,0.0106791025,0.00012894729,0.0021014144,0.10405105],"study_design_scores_gemma":[0.40053174,0.5405377,0.04442436,0.0001307149,0.002447876,0.00052881683,0.000081762475,0.0019374694,0.0042204224,0.00041997046,0.004679795,0.000059293336],"about_ca_topic_score_codex":0.00017243867,"about_ca_topic_score_gemma":0.00042533828,"teacher_disagreement_score":0.0036313792,"about_ca_system_score_codex":0.00034070795,"about_ca_system_score_gemma":0.00037759202,"threshold_uncertainty_score":0.019204795},"labels":[],"label_agreement":null},{"id":"W2719469262","doi":"10.1016/j.breast.2017.06.014","title":"Vacuum-assisted complete excision of solid intraductal/intracystic masses and complex cysts: Is follow-up necessary?","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Biopsy; Malignancy; Atypia; Cyst; Radiology; Lesion; Surgery; Pathology","score_opus":0.05712154340864791,"score_gpt":0.30880845586718636,"score_spread":0.25168691245853847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2719469262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958326,0.0033752928,0.00043720935,0.00008335725,0.000008505351,0.000005824623,0.000017289829,0.000003812242,0.00023600829],"genre_scores_gemma":[0.99877053,0.00074561965,0.00034992077,0.00002914509,0.000033753066,0.0000039101424,0.000033939992,0.0000014076123,0.0000317624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999495,0.00016665469,0.00007451582,0.000058676746,0.00013219276,0.00007307127],"domain_scores_gemma":[0.99668545,0.001411482,0.0013962224,0.00018552005,0.00015096979,0.00017041691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011899525,0.00012297065,0.0004242753,0.0003801225,0.00026013856,0.00042630133,0.0002869709,0.00031090353,0.00050241384],"category_scores_gemma":[0.004544032,0.00009971538,0.00017640655,0.00036400938,0.0005222054,0.0005736984,0.00028983128,0.00023505892,0.00008026783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031270905,0.00006900198,0.9449316,0.00014998148,0.000066738074,0.0037286596,0.00016324631,0.0001277433,0.0029785,0.00009146125,0.00014065829,0.04723965],"study_design_scores_gemma":[0.00002080604,0.00076454337,0.93776304,0.00020550127,0.0000949293,0.053090468,0.0006872417,0.0007300014,0.004744646,0.00027947503,0.0016039468,0.000015346124],"about_ca_topic_score_codex":0.00022798592,"about_ca_topic_score_gemma":0.0003879028,"teacher_disagreement_score":0.0011899525,"about_ca_system_score_codex":0.00017235318,"about_ca_system_score_gemma":0.0003460284,"threshold_uncertainty_score":0.006293118},"labels":[],"label_agreement":null},{"id":"W2729590981","doi":"10.1016/j.breast.2017.06.042","title":"Completeness of breast cancer operative reports in a community care setting","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ontario Stroke Network; University of British Columbia; Dalhousie University","funders":"BC Cancer Agency; Canadian Cancer Society","keywords":"Medicine; Breast cancer; Completeness (order theory); Narrative; Narrative review; Health care; General surgery; Family medicine; Cancer; Medical physics; Surgery; Intensive care medicine; Internal medicine","score_opus":0.027476967231121818,"score_gpt":0.3578288017967606,"score_spread":0.33035183456563877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729590981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945133,0.0020267267,0.0009988893,0.00013323179,0.000019868421,0.00024358429,0.00095162506,0.00002086112,0.0010918751],"genre_scores_gemma":[0.9967435,0.0007239387,0.0016563144,0.00003099042,0.000021931324,0.00008878798,0.0006415629,0.000008516971,0.00008448939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94428813,0.020603102,0.01441562,0.0032464005,0.016318938,0.0011277491],"domain_scores_gemma":[0.5505058,0.18390608,0.18511562,0.017796263,0.059716612,0.0029596395],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036603946,0.00028973926,0.00057981117,0.011384232,0.00091466156,0.0021158291,0.0012156873,0.00043860442,0.0012489145],"category_scores_gemma":[0.22561625,0.00059429044,0.0004733823,0.00809099,0.0016771044,0.00200797,0.003046091,0.00043453253,0.0002330003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018323494,0.0000312679,0.98490185,0.0005517781,0.000085199885,0.00037343436,0.0029754306,0.00010058646,0.0005022932,0.00005751294,0.00015759109,0.010079959],"study_design_scores_gemma":[0.000010399781,0.00039338696,0.9874034,0.0004271313,0.00009088884,0.002717959,0.0057953787,0.000347176,0.0012917138,0.000057874364,0.0014354992,0.000029311825],"about_ca_topic_score_codex":0.0043535745,"about_ca_topic_score_gemma":0.0068707597,"teacher_disagreement_score":0.9633961,"about_ca_system_score_codex":0.0017123293,"about_ca_system_score_gemma":0.0028990638,"threshold_uncertainty_score":0.19358248},"labels":[],"label_agreement":null},{"id":"W2732206834","doi":"10.1016/j.breast.2017.06.001","title":"Impact of physical activity in group versus individual physical activity on fatigue in patients with breast cancer: A pilot study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Breast cancer; Physical activity; Physical therapy; Quality of life (healthcare); Randomized controlled trial; Cancer; Aerobic exercise; Internal medicine; Nursing","score_opus":0.04999265612660535,"score_gpt":0.348315206130503,"score_spread":0.2983225500038976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732206834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999079,0.00010301492,0.00008346414,0.000037896603,0.0000152211705,0.0004581118,0.00004858712,0.000007773108,0.00016682396],"genre_scores_gemma":[0.99720216,0.00019400318,0.0007293394,0.00013407,0.00008026334,0.0012996028,0.00015057976,0.0000032124658,0.00020685395],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99899226,0.0005597009,0.00006608692,0.00011203812,0.00007034179,0.00019956827],"domain_scores_gemma":[0.99828726,0.0006080595,0.00018849943,0.00015460946,0.00009864581,0.0006628419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019773666,0.00064709474,0.0011476802,0.00039122865,0.0004578402,0.00033015903,0.00041672902,0.0006571261,0.0040078484],"category_scores_gemma":[0.0018612674,0.00033051046,0.0010636979,0.00044205663,0.000652374,0.00045420637,0.00050275656,0.0009977088,0.00040305557],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50638497,0.3347127,0.037247587,0.0007106614,0.0009319356,0.0001604684,0.00076662813,0.0009029348,0.010702468,0.000066121545,0.0007289088,0.10668458],"study_design_scores_gemma":[0.070222214,0.8962816,0.03227903,0.000017206617,0.00017313815,0.000040387473,0.0001138532,0.00021180179,0.0004006471,0.00002410009,0.00022812015,0.000007909441],"about_ca_topic_score_codex":0.0008569517,"about_ca_topic_score_gemma":0.0014414473,"teacher_disagreement_score":0.0040078484,"about_ca_system_score_codex":0.0003180711,"about_ca_system_score_gemma":0.000859921,"threshold_uncertainty_score":0.013407588},"labels":[],"label_agreement":null},{"id":"W2741986458","doi":"10.1016/j.breast.2017.07.011","title":"Re: Secondary gastric cancer following a breast cancer diagnosis; beware of metastatic breast cancer","year":2017,"lang":"en","type":"letter","venue":"The Breast","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Internal medicine; CA15-3","score_opus":0.03860122394789683,"score_gpt":0.31136561504176563,"score_spread":0.2727643910938688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741986458","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052502405,0.0129980175,0.00092524214,0.8488845,0.025237331,0.00024436667,0.0004656223,0.00017131671,0.058571234],"genre_scores_gemma":[0.46807146,0.01411255,0.0018109583,0.3766999,0.098433204,0.0002217983,0.00030428648,0.00010939947,0.040236454],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992582,0.00030136126,0.00008421854,0.00011404291,0.00011599381,0.00012608335],"domain_scores_gemma":[0.99852055,0.00063034624,0.00020961955,0.00008310233,0.00022343357,0.00033298298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053043774,0.0006641906,0.0007451124,0.0007868662,0.0020855067,0.0010923091,0.0011039738,0.009381833,0.009883424],"category_scores_gemma":[0.007050036,0.00038054187,0.00073189626,0.0006800493,0.0010433233,0.0016672775,0.0005218019,0.0080438,0.004291436],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017825273,0.00012382123,0.018836007,0.00019687359,0.000050119645,0.6842318,0.00045971738,0.00014253841,0.00071018306,0.002531422,0.2818506,0.010688669],"study_design_scores_gemma":[0.00007909335,0.00015352457,0.013046073,0.00052855496,0.00005739766,0.89191884,0.0012971413,0.00063536834,0.00039593922,0.004472522,0.08735389,0.00006157787],"about_ca_topic_score_codex":0.0024360546,"about_ca_topic_score_gemma":0.004213757,"teacher_disagreement_score":0.009883424,"about_ca_system_score_codex":0.0018890693,"about_ca_system_score_gemma":0.0009139294,"threshold_uncertainty_score":0.033063352},"labels":[],"label_agreement":null},{"id":"W2745262430","doi":"10.1016/j.breast.2017.07.002","title":"Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; Mount Sinai Hospital; Thunder Bay Regional Health Sciences Centre; Kingston General Hospital; Juravinski Hospital; London Health Sciences Centre; Systems, Applications & Products in Data Processing (Canada); Health Sciences Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Lumpectomy; Mastectomy; Breast-conserving surgery; Radiation therapy; Ductal carcinoma; Breast cancer; Population; Cohort; Oncology; Proportional hazards model; Internal medicine; Hazard ratio; Surgery; Gynecology; Cancer; Confidence interval","score_opus":0.009709941076713701,"score_gpt":0.26045766151521865,"score_spread":0.25074772043850496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745262430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627466,0.010480056,0.00043711212,0.00048005357,0.00015729252,0.000032287153,0.00010177704,0.00002771997,0.0020090635],"genre_scores_gemma":[0.99565095,0.0027595065,0.0003673788,0.00019684146,0.00013808129,0.000010221446,0.000110577916,0.000011861655,0.00075463054],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994773,0.0002812094,0.000035337634,0.00005257189,0.00008741338,0.000066099274],"domain_scores_gemma":[0.99734867,0.0014865871,0.00047491345,0.00036875985,0.00008099776,0.00024009672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011993815,0.0004169885,0.0012536299,0.00026606282,0.00020981325,0.00039015728,0.00056646304,0.0006137482,0.0027718158],"category_scores_gemma":[0.0027187297,0.00018721976,0.00081115955,0.00038769114,0.00039289708,0.00049392175,0.00017710008,0.00097544945,0.00033244546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19688383,0.010676865,0.18098186,0.0018312422,0.0032563554,0.001026306,0.00043605923,0.0013567675,0.17835972,0.00091477006,0.0016635262,0.42261273],"study_design_scores_gemma":[0.0031293174,0.14568636,0.7885559,0.00037916686,0.0045645903,0.0023359915,0.00043974767,0.0009661749,0.040926937,0.0011620532,0.011810403,0.000043454344],"about_ca_topic_score_codex":0.0006676462,"about_ca_topic_score_gemma":0.0016517894,"teacher_disagreement_score":0.0027718158,"about_ca_system_score_codex":0.00019941933,"about_ca_system_score_gemma":0.0005405729,"threshold_uncertainty_score":0.009272695},"labels":[],"label_agreement":null},{"id":"W2745905123","doi":"10.1016/j.breast.2017.07.017","title":"ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Family medicine; MEDLINE; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.030736206921722766,"score_gpt":0.3427459615247155,"score_spread":0.31200975460299274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745905123","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009862431,0.3961104,0.070552155,0.3142775,0.04800053,0.01315604,0.0330592,0.0017120437,0.113269776],"genre_scores_gemma":[0.054709192,0.29498628,0.35321054,0.11109475,0.015416915,0.03539844,0.06862046,0.0011957511,0.06536772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9716063,0.010408862,0.008220204,0.00090291654,0.00708806,0.0017736406],"domain_scores_gemma":[0.94807667,0.013234801,0.0076529323,0.0013985116,0.02673898,0.0028981206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03704039,0.0021128776,0.0030038687,0.010191665,0.0021462005,0.003444074,0.005541807,0.0084695835,0.007130052],"category_scores_gemma":[0.06447575,0.0012100432,0.007633001,0.0047677886,0.0016129345,0.0015712155,0.005897671,0.0059971567,0.0050758524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039658492,0.00036355236,0.01041819,0.014832646,0.00071174157,0.0006672491,0.0006848558,0.0012745037,0.0011267957,0.0071159224,0.60771555,0.3546923],"study_design_scores_gemma":[0.00036370457,0.00018698585,0.020014267,0.055164784,0.001148881,0.0013911215,0.00069737004,0.0006618684,0.0011372669,0.007230874,0.9118859,0.00011702749],"about_ca_topic_score_codex":0.027259264,"about_ca_topic_score_gemma":0.033914533,"teacher_disagreement_score":0.03704039,"about_ca_system_score_codex":0.005595539,"about_ca_system_score_gemma":0.023575896,"threshold_uncertainty_score":0.19589067},"labels":[],"label_agreement":null},{"id":"W2757511999","doi":"10.1016/j.breast.2016.10.001","title":"3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Overall survival; Cancer","score_opus":0.06115132011510013,"score_gpt":0.41052325189541666,"score_spread":0.34937193178031656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757511999","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063481247,0.4791287,0.044863865,0.26637787,0.037578627,0.004548012,0.017297307,0.0014446274,0.14241293],"genre_scores_gemma":[0.047314372,0.39824373,0.2547043,0.13054596,0.015541276,0.012434447,0.05387093,0.00093116047,0.08641389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881931,0.00386585,0.00289529,0.00037828018,0.0037532405,0.0009141579],"domain_scores_gemma":[0.9816684,0.004212653,0.0031463571,0.0005605229,0.0092352005,0.0011769227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01460144,0.0017265223,0.0021478238,0.007290609,0.0014000515,0.0030366902,0.004297445,0.006896336,0.0069559324],"category_scores_gemma":[0.028955694,0.0008121015,0.0056807874,0.003357295,0.0011798723,0.0014997593,0.0044820253,0.0056579923,0.005623931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002911409,0.0001807059,0.0032586507,0.0076086638,0.00035364373,0.00042836444,0.0002292451,0.0015130885,0.00087360886,0.0074341567,0.6500341,0.3277946],"study_design_scores_gemma":[0.00019321256,0.0001107259,0.0046341443,0.020143447,0.00058417965,0.0010650757,0.00020039988,0.00055082934,0.0007067708,0.004655419,0.96709865,0.000057119352],"about_ca_topic_score_codex":0.013290374,"about_ca_topic_score_gemma":0.02321098,"teacher_disagreement_score":0.01460144,"about_ca_system_score_codex":0.0042537567,"about_ca_system_score_gemma":0.014334396,"threshold_uncertainty_score":0.07722074},"labels":[],"label_agreement":null},{"id":"W2765099943","doi":"10.1016/s0960-9776(17)30667-7","title":"Creating a Novel Drug Navigation Tool for Metastatic Breast Cancer Drugs in Canada","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Metastatic breast cancer; Breast cancer; Oncology; Cancer drugs; Cancer; Internal medicine; Medical physics; Intensive care medicine; Pharmacology","score_opus":0.022026568746454204,"score_gpt":0.329341557099641,"score_spread":0.3073149883531868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765099943","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19050214,0.0049212333,0.14796627,0.04271556,0.0016588158,0.0019096476,0.04062031,0.14390151,0.42580453],"genre_scores_gemma":[0.39358,0.0064231437,0.3756441,0.0044164513,0.0002926022,0.0004188921,0.01504153,0.005763226,0.19842012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993685,0.00010121943,0.00004987089,0.000072988,0.0003049941,0.000102387],"domain_scores_gemma":[0.99680483,0.0011246718,0.00017027989,0.0001912397,0.0012235041,0.00048555483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011990091,0.0005625541,0.0003659218,0.00214793,0.0019416949,0.002780548,0.001026995,0.001032028,0.030428067],"category_scores_gemma":[0.0048750546,0.00037344426,0.0005333061,0.001988939,0.00043521237,0.0015017728,0.0014303705,0.00082743674,0.0052027446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065998494,0.0003392283,0.021012334,0.00059544656,0.00006983909,0.0012923935,0.0017941097,0.0066726776,0.0058354745,0.012578211,0.4093983,0.53975195],"study_design_scores_gemma":[0.00018796582,0.00014166259,0.010401354,0.00030775386,0.000117016556,0.0005612846,0.0015263591,0.031755466,0.006583758,0.0043838024,0.9438124,0.00022130157],"about_ca_topic_score_codex":0.68663114,"about_ca_topic_score_gemma":0.84076095,"teacher_disagreement_score":0.31336886,"about_ca_system_score_codex":0.0073335557,"about_ca_system_score_gemma":0.02640474,"threshold_uncertainty_score":0.6304287},"labels":[],"label_agreement":null},{"id":"W2766236538","doi":"10.1016/j.breast.2017.10.015","title":"Editorial: Approaches of the treatment of DCIS","year":2017,"lang":"en","type":"editorial","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Colorectal cancer; Mammography; Cancer; Internal medicine; Population; Stage (stratigraphy); Oncology; Colonoscopy; Concomitant; Adenomatous polyps","score_opus":0.016662939474928626,"score_gpt":0.254539978383062,"score_spread":0.2378770389081334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766236538","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019135052,0.00815249,0.00009120286,0.027889326,0.96271217,0.000016165168,0.0000334344,0.000026522013,0.0010595898],"genre_scores_gemma":[0.0002118299,0.0045791864,0.00006499398,0.0156153245,0.97465706,0.000016763126,0.00001921255,0.000016931474,0.0048186155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940491,0.0014383114,0.000797454,0.0006057642,0.0027186074,0.0003907007],"domain_scores_gemma":[0.97656745,0.011454478,0.0017066047,0.00060555217,0.0066517084,0.0030142101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007683818,0.0045103515,0.0046308367,0.0038965363,0.00314615,0.0076894844,0.004238362,0.01815272,0.013071805],"category_scores_gemma":[0.027286299,0.0014678478,0.0031527188,0.0014543986,0.003140142,0.0046446887,0.0018633052,0.024363428,0.010015617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055461358,0.00001621986,0.000017959004,0.00021134147,0.000023440005,0.00010903834,0.000005800287,0.00002746673,0.000041682928,0.00030343042,0.9949581,0.0042300634],"study_design_scores_gemma":[0.00013969022,0.00004835864,0.00024447663,0.0005455022,0.00009802852,0.00033521035,0.00002894533,0.00018970136,0.00013177072,0.0014470872,0.9967668,0.000024408466],"about_ca_topic_score_codex":0.0018922114,"about_ca_topic_score_gemma":0.005375749,"teacher_disagreement_score":0.01815272,"about_ca_system_score_codex":0.004339295,"about_ca_system_score_gemma":0.0035843279,"threshold_uncertainty_score":0.043729544},"labels":[],"label_agreement":null},{"id":"W2769509722","doi":"10.1016/j.breast.2017.11.004","title":"Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Body mass index; Internal medicine; Cancer; Index (typography)","score_opus":0.031749542178073034,"score_gpt":0.3798423642163952,"score_spread":0.3480928220383222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769509722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596006,0.0013046372,0.000043707685,0.00037747202,0.000036326703,0.0000037130062,0.00034001845,0.0000042372535,0.0019298396],"genre_scores_gemma":[0.9990465,0.00027816868,0.000016577806,0.00006344804,0.000053720036,0.0000022324489,0.00028849754,0.000001988279,0.000248736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966097,0.00011469214,0.000027555634,0.000042365937,0.00006399421,0.00009045103],"domain_scores_gemma":[0.99878055,0.0003327557,0.00039933083,0.00006163632,0.00009367135,0.0003319655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003940653,0.00026929655,0.000395614,0.00036884288,0.00034495577,0.0007904826,0.00027315388,0.0004570658,0.0021302525],"category_scores_gemma":[0.002898715,0.00016117438,0.0006632885,0.00068934116,0.00024168148,0.0004147178,0.0004940774,0.001046984,0.00025928603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070885656,0.00007575362,0.99448156,0.0000129136515,0.00016520993,0.00013294298,0.000027162157,0.00013734815,0.00022575707,0.00003463705,0.00020063495,0.0037973472],"study_design_scores_gemma":[0.000012344239,0.00012225437,0.9990491,0.000006166709,0.000078791134,0.00015848374,0.000078880155,0.00023210181,0.00003562871,0.000062322266,0.00015984835,0.0000041849385],"about_ca_topic_score_codex":0.003072685,"about_ca_topic_score_gemma":0.0044803084,"teacher_disagreement_score":0.003072685,"about_ca_system_score_codex":0.00037823454,"about_ca_system_score_gemma":0.0003994834,"threshold_uncertainty_score":0.007126391},"labels":[],"label_agreement":null},{"id":"W2774001440","doi":"10.1016/j.breast.2017.12.008","title":"A retrospective review of phyllodes tumours of the breast: A single institution experience","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Institution; Retrospective cohort study; Phyllodes tumor; Oncology; Internal medicine","score_opus":0.08382066367347908,"score_gpt":0.35421380441322986,"score_spread":0.2703931407397508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774001440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.191736,0.80379593,0.00059579674,0.0001930145,0.000102923776,0.00010041441,0.0013404264,0.00002209033,0.0021134012],"genre_scores_gemma":[0.48785612,0.50701827,0.0012784363,0.0006974263,0.0001961795,0.000071656315,0.0020471667,0.00003493326,0.00079985335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890196,0.00012218648,0.00051128137,0.00022898433,0.00016272004,0.000072858464],"domain_scores_gemma":[0.99790215,0.0008400962,0.00073656964,0.00014834618,0.0002506659,0.0001221479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064512977,0.0005048299,0.0013475869,0.0042327046,0.00051222055,0.0013544777,0.0008146666,0.00056990405,0.0016015253],"category_scores_gemma":[0.0033065276,0.0004084975,0.00082203065,0.0057064863,0.0005681582,0.0010070077,0.0007374437,0.00039368198,0.0004899842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097547285,0.00022897667,0.497903,0.06673321,0.0045217737,0.0834198,0.0024924497,0.00036635745,0.009594632,0.00078304386,0.008479644,0.32450163],"study_design_scores_gemma":[0.00010841459,0.0004689555,0.41983458,0.020582957,0.0133740865,0.44001582,0.0044763307,0.00017849289,0.0035274068,0.00064720423,0.09662829,0.00015748359],"about_ca_topic_score_codex":0.0013797337,"about_ca_topic_score_gemma":0.0035367834,"teacher_disagreement_score":0.0042327046,"about_ca_system_score_codex":0.00042212338,"about_ca_system_score_gemma":0.001232584,"threshold_uncertainty_score":0.005357623},"labels":[],"label_agreement":null},{"id":"W2790201825","doi":"10.1016/j.breast.2018.03.003","title":"Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association”","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Underweight; Metastatic breast cancer; Oncology; Trastuzumab; Internal medicine; Overweight; Cancer; Gynecology","score_opus":0.049871077709294255,"score_gpt":0.36922296582124153,"score_spread":0.31935188811194726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790201825","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030943245,0.0006634827,0.00003783016,0.98557657,0.01251487,0.0000059665767,0.000093660914,0.000013713988,0.0007843875],"genre_scores_gemma":[0.0023295623,0.00055885856,0.00007968136,0.96694213,0.027772985,0.000022051425,0.00004846479,0.00001887686,0.0022272435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958831,0.0015206697,0.0006285332,0.00057483854,0.0008325791,0.0005603517],"domain_scores_gemma":[0.9839627,0.010407806,0.0012763592,0.00036866814,0.0025744503,0.0014099767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044929166,0.00085369294,0.0018177398,0.0008979141,0.0031503818,0.002958886,0.0022138592,0.048351653,0.006255255],"category_scores_gemma":[0.042402912,0.00089390244,0.0011486028,0.00097277464,0.002170398,0.0029452539,0.0016419832,0.038050517,0.005887222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096168464,0.0000281766,0.0012465786,0.000050342293,0.000029787709,0.001167229,0.00014356662,0.000033460252,0.0000906482,0.00088634435,0.9923814,0.0038462689],"study_design_scores_gemma":[0.0004604767,0.00020482112,0.0055811554,0.0010321885,0.00017436038,0.003369961,0.0011743108,0.00072609575,0.0005452612,0.008211959,0.97831774,0.00020163316],"about_ca_topic_score_codex":0.0077026016,"about_ca_topic_score_gemma":0.008963668,"teacher_disagreement_score":0.048351653,"about_ca_system_score_codex":0.0033068925,"about_ca_system_score_gemma":0.004031834,"threshold_uncertainty_score":0.023993313},"labels":[],"label_agreement":null},{"id":"W2790590882","doi":"10.1016/j.breast.2018.02.030","title":"Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Metastatic breast cancer; Underweight; Oncology; Trastuzumab; Internal medicine; Overweight; Cancer","score_opus":0.05443320802663595,"score_gpt":0.37996930203087353,"score_spread":0.3255360940042376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790590882","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06353784,0.010250729,0.0003822615,0.9078911,0.006303656,0.000013603001,0.00045487328,0.000031433017,0.01113449],"genre_scores_gemma":[0.4857856,0.008864307,0.00083509163,0.43345284,0.06627821,0.0000464171,0.00039381493,0.00003660881,0.004307178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986083,0.00060997135,0.00019707624,0.00017519266,0.000257029,0.00015250963],"domain_scores_gemma":[0.98940945,0.0075500924,0.00093291624,0.00037198278,0.0011355815,0.0005999254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018321648,0.00023065798,0.0008493173,0.00055615115,0.00088398077,0.0011384441,0.0008322813,0.006535602,0.0036501433],"category_scores_gemma":[0.017789545,0.00022608877,0.0005383993,0.0012390947,0.00078484055,0.0011638624,0.0005143488,0.006533314,0.0009936644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018175477,0.0002913046,0.5694096,0.00042076793,0.00061351544,0.0295396,0.0008636019,0.00039691242,0.00091187924,0.006739649,0.31173825,0.077257276],"study_design_scores_gemma":[0.002195103,0.0011499088,0.50619936,0.0025237848,0.0014909322,0.09533778,0.004687406,0.006534935,0.0013489929,0.06046729,0.3177563,0.00030817708],"about_ca_topic_score_codex":0.0035530766,"about_ca_topic_score_gemma":0.0049964497,"teacher_disagreement_score":0.006535602,"about_ca_system_score_codex":0.00087565917,"about_ca_system_score_gemma":0.0007503619,"threshold_uncertainty_score":0.012210906},"labels":[],"label_agreement":null},{"id":"W2793113650","doi":"10.1016/j.breast.2018.02.027","title":"Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Palbociclib; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Hormone receptor; Endocrine system; Hazard ratio; Population; Cancer; Gynecology; Hormone; Confidence interval","score_opus":0.02977192552836007,"score_gpt":0.32005924517608986,"score_spread":0.2902873196477298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793113650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026525,0.0035518908,0.000116340394,0.0014442217,0.000049824906,0.00005271862,0.00008520887,0.000012224217,0.004422362],"genre_scores_gemma":[0.99631894,0.0018874209,0.0002370909,0.00043018992,0.00008390244,0.000033237447,0.00014911396,0.0000044009007,0.0008557878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998456,0.00006483238,0.000009428877,0.000014504478,0.000021686863,0.000043943237],"domain_scores_gemma":[0.9997826,0.00004912326,0.0000411677,0.000007483009,0.000008800019,0.00011088239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277372,0.00010816213,0.000274058,0.000118299184,0.00021045722,0.0003444269,0.00019415593,0.00025159234,0.0019568494],"category_scores_gemma":[0.0006951973,0.00006447626,0.0002378105,0.00028570692,0.00018717282,0.00027597893,0.00021272645,0.0005645665,0.00014876456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.094325066,0.008248294,0.14865041,0.0005003409,0.00057405577,0.002543239,0.00035847208,0.0047107954,0.010933464,0.0010845979,0.010158195,0.7179131],"study_design_scores_gemma":[0.01998673,0.09058573,0.81937826,0.000372245,0.001128606,0.0073896623,0.0012273553,0.008917801,0.0051741046,0.0024675352,0.043318838,0.00005319899],"about_ca_topic_score_codex":0.0013725426,"about_ca_topic_score_gemma":0.008121063,"teacher_disagreement_score":0.0019568494,"about_ca_system_score_codex":0.00060752296,"about_ca_system_score_gemma":0.000801094,"threshold_uncertainty_score":0.0065463185},"labels":[],"label_agreement":null},{"id":"W2800546213","doi":"10.1016/j.breast.2018.05.002","title":"The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Hormone replacement therapy (female-to-male); Internal medicine; Meta-analysis; Confidence interval; Observational study; Oncology; Randomized controlled trial; Gynecology; Hormone therapy; Rate ratio; Incidence (geometry); Cancer","score_opus":0.08021355174970679,"score_gpt":0.4220523243763472,"score_spread":0.3418387726266404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800546213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007225443,0.99880445,0.000032261247,0.00008634965,0.00006035443,0.000049044364,0.00013263288,0.0000020952964,0.00011019408],"genre_scores_gemma":[0.016049955,0.9829775,0.00019769995,0.00047077847,0.000060946328,0.00007406068,0.000086483036,0.000001941227,0.00008069905],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99815243,0.0005523374,0.0006651433,0.00020800561,0.00032331282,0.000098711724],"domain_scores_gemma":[0.99292326,0.0053668674,0.0011405832,0.000080255675,0.00036993876,0.00011917861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026932238,0.00102404,0.0053393524,0.0031787206,0.00038419705,0.0016988461,0.0011290443,0.001826255,0.004594797],"category_scores_gemma":[0.016416285,0.00079971313,0.0070176776,0.0044302535,0.0005350949,0.0012935633,0.0010793842,0.0016057992,0.00021145587],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049530296,0.00002745663,0.0014712483,0.9322502,0.026835779,0.00009505744,0.000138974,0.00010206309,0.00014435087,0.00013776422,0.0013359119,0.03696603],"study_design_scores_gemma":[0.0010268448,0.00043914362,0.011732772,0.5933033,0.36805624,0.00046845138,0.00044169463,0.000112619025,0.0001795036,0.00046076713,0.023707336,0.00007130551],"about_ca_topic_score_codex":0.012144035,"about_ca_topic_score_gemma":0.03985212,"teacher_disagreement_score":0.012144035,"about_ca_system_score_codex":0.0018910536,"about_ca_system_score_gemma":0.0043800506,"threshold_uncertainty_score":0.024146676},"labels":[],"label_agreement":null},{"id":"W2800769618","doi":"10.1016/j.breast.2018.04.008","title":"Valid assessment of women's satisfaction with breast cancer screening programs","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Medicine; Mammography; Checklist; Breast cancer; Scopus; Breast cancer screening; Family medicine; Medical physics; Patient satisfaction; Cancer; Gynecology; MEDLINE; Nursing; Internal medicine; Psychology","score_opus":0.054226211015562915,"score_gpt":0.34299956436716217,"score_spread":0.28877335335159926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800769618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5537897,0.002539005,0.0015816333,0.38307825,0.0034919214,0.0003183311,0.0022011227,0.00006475481,0.052935254],"genre_scores_gemma":[0.9261085,0.00071981124,0.0016640613,0.064752795,0.0010649408,0.000284084,0.0005981427,0.000018531387,0.0047892295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912042,0.0047476944,0.0011971417,0.00030081748,0.0016215487,0.0009286767],"domain_scores_gemma":[0.9644652,0.020675078,0.0038327689,0.001660577,0.007854001,0.0015123129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008619862,0.00013938293,0.00046272023,0.00060618576,0.0011381491,0.0011079282,0.0006311036,0.0030800104,0.0027596215],"category_scores_gemma":[0.052852917,0.00017667118,0.0005220233,0.0007388319,0.00090931717,0.00071029016,0.0010654472,0.0025631373,0.0008540188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032041327,0.0003151844,0.8513183,0.0001565754,0.00008393715,0.0014757697,0.003018385,0.00011461464,0.0006692573,0.0015733677,0.076030985,0.064923264],"study_design_scores_gemma":[0.00013946138,0.00096800586,0.8671975,0.0005698178,0.000108031534,0.004928064,0.014566425,0.001422801,0.0010776407,0.0035592779,0.10536504,0.000097956065],"about_ca_topic_score_codex":0.0054162988,"about_ca_topic_score_gemma":0.009361575,"teacher_disagreement_score":0.008619862,"about_ca_system_score_codex":0.0019602487,"about_ca_system_score_gemma":0.0019322095,"threshold_uncertainty_score":0.045586705},"labels":[],"label_agreement":null},{"id":"W2809625159","doi":"10.1016/j.breast.2018.06.007","title":"The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lakeridge Health; Hamilton Regional Laboratory Medicine Program; Regional Municipality of Waterloo; Champlain Regional College; North York General Hospital; Cancer Care South East; Sunnybrook Health Science Centre; St. Michael's Hospital; Health Sciences Centre; University of Toronto; Barrie Urology Group; St. Clair College; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Internal medicine; Cancer; Gynecology","score_opus":0.03320413301882735,"score_gpt":0.3583362316166302,"score_spread":0.32513209859780284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809625159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994568,0.0014868377,0.0000870768,0.001157807,0.0000419148,0.000008331822,0.00046318967,0.0000067240935,0.0021800802],"genre_scores_gemma":[0.99903905,0.00029228773,0.00003482965,0.00011044998,0.000031808046,0.0000026668156,0.00026011092,0.0000020883026,0.00022668116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990778,0.00042649204,0.000039998504,0.00008775096,0.00009975951,0.00026812026],"domain_scores_gemma":[0.9959506,0.001849935,0.00093090726,0.00020844214,0.00026288792,0.00079728436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010927677,0.00024137429,0.0002942106,0.0003549397,0.00029853938,0.00066830195,0.00043937613,0.00062718295,0.0019770006],"category_scores_gemma":[0.009286671,0.00015455573,0.0013353702,0.0006404988,0.0003248475,0.00070648507,0.0007904857,0.00089820544,0.00014779293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007971663,0.0001332625,0.9888847,0.000022302936,0.00016008924,0.00005495118,0.000073175885,0.0003295062,0.000055002976,0.00007626844,0.00033992584,0.009073554],"study_design_scores_gemma":[0.00001651418,0.00026963366,0.99855095,0.000015733058,0.0001675348,0.00005077265,0.00020885548,0.00044897664,0.00002247919,0.00009055132,0.00015399524,0.000003856104],"about_ca_topic_score_codex":0.024129694,"about_ca_topic_score_gemma":0.045165237,"teacher_disagreement_score":0.024129694,"about_ca_system_score_codex":0.0007546375,"about_ca_system_score_gemma":0.0013552946,"threshold_uncertainty_score":0.04797846},"labels":[],"label_agreement":null},{"id":"W2869455612","doi":"10.1016/j.breast.2018.07.002","title":"Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Univariate analysis; Oncology; Cohort; Multivariate analysis; Logistic regression; Gynecology; Gastroenterology; Cancer","score_opus":0.003990784049060356,"score_gpt":0.21362464043381427,"score_spread":0.2096338563847539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2869455612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885714,0.00072994106,0.00004271791,0.000015428042,0.0000035787195,0.00001149918,0.000018890809,9.458854e-7,0.000319905],"genre_scores_gemma":[0.9985947,0.0006431941,0.00004033867,0.000031181924,0.0000071899008,0.000010948348,0.000041537514,0.0000015026991,0.00062939944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988365,0.000046555164,0.0000053144367,0.000011902701,0.000021967626,0.00003059936],"domain_scores_gemma":[0.9998084,0.00009006099,0.00003196591,0.000006117346,0.000017736547,0.00004572717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003491108,0.00013306452,0.00030999607,0.00021036292,0.00024710372,0.00016852512,0.000094144096,0.00018088799,0.00087457185],"category_scores_gemma":[0.0007303655,0.00010399415,0.00022540023,0.0002004029,0.00017291449,0.00011130378,0.000108207,0.00018744911,0.00009174299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03818432,0.0038656003,0.771314,0.00044949085,0.00021387475,0.0032643138,0.006192468,0.00078164716,0.093078665,0.00023050203,0.00036764055,0.08205741],"study_design_scores_gemma":[0.0004110783,0.025273407,0.9631742,0.00002481352,0.000231753,0.0012784887,0.0011839534,0.00018775433,0.0067935027,0.00005655829,0.0013730217,0.000011432985],"about_ca_topic_score_codex":0.0057549677,"about_ca_topic_score_gemma":0.0069984286,"teacher_disagreement_score":0.0057549677,"about_ca_system_score_codex":0.00028255567,"about_ca_system_score_gemma":0.00040933405,"threshold_uncertainty_score":0.011442959},"labels":[],"label_agreement":null},{"id":"W2890786262","doi":"10.1016/j.breast.2018.08.105","title":"Prevalence of pain in patients with breast cancer post-treatment: A systematic review","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Joey and Mary Furfari Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Oncology; Cancer; Internal medicine; Physical therapy","score_opus":0.0156313098014423,"score_gpt":0.2765933767966427,"score_spread":0.2609620669952004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890786262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031524876,0.99606675,0.000046908513,0.000107313535,0.000057507666,0.00005599285,0.00038142534,0.0000027292313,0.00012887944],"genre_scores_gemma":[0.032111008,0.96677786,0.00030824915,0.0003645358,0.000054022665,0.00009568001,0.00021884983,0.0000025686863,0.00006721152],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973707,0.0005524064,0.0012189527,0.00030192494,0.00043692708,0.000119123295],"domain_scores_gemma":[0.9919797,0.005425542,0.0019112802,0.000088953966,0.00047054407,0.00012398124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018018589,0.0008934707,0.0043758354,0.0045460337,0.00043488125,0.0017402768,0.0009884353,0.0016262872,0.0029922472],"category_scores_gemma":[0.014611756,0.000846456,0.0073067304,0.0066613927,0.0005065596,0.0014864017,0.0012308459,0.0012512947,0.00015194983],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043418902,0.00005340652,0.01409086,0.90740716,0.032520212,0.00019302324,0.0003732688,0.000108103915,0.00017853723,0.00018935175,0.0020091156,0.042442784],"study_design_scores_gemma":[0.00055656635,0.00038838663,0.0836313,0.6383972,0.2531221,0.0018625329,0.0013486483,0.00015363618,0.0001758173,0.00044019034,0.01977672,0.00014692916],"about_ca_topic_score_codex":0.011884701,"about_ca_topic_score_gemma":0.040943287,"teacher_disagreement_score":0.011884701,"about_ca_system_score_codex":0.0016042993,"about_ca_system_score_gemma":0.0036297971,"threshold_uncertainty_score":0.023631036},"labels":[],"label_agreement":null},{"id":"W2895782917","doi":"10.1016/j.breast.2018.10.001","title":"Targeting CDK4/6 pathways and beyond in breast cancer","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Palbociclib; Oncology; Metastatic breast cancer; Internal medicine; Fulvestrant; Breast cancer; Neutropenia; Cancer; Clinical trial; Disease; Adjuvant; Adjuvant therapy; Toxicity; Tamoxifen","score_opus":0.031651075078762796,"score_gpt":0.3233811829162637,"score_spread":0.2917301078375009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895782917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082269486,0.9982827,0.00006909482,0.0002828781,0.00020373332,0.0000051796064,0.000027728282,0.000006620049,0.0010398077],"genre_scores_gemma":[0.000643347,0.9979842,0.000105396255,0.00033837208,0.00013015953,0.000006156618,0.000038893773,0.0000016187681,0.00075182354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998448,0.000025140727,0.000023547404,0.000026935562,0.0000547692,0.000024637233],"domain_scores_gemma":[0.99976283,0.00012011324,0.000041214807,0.000006449719,0.000048184997,0.000021201307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047741042,0.00084137183,0.0013799999,0.001663419,0.0002151516,0.0011058484,0.00078562513,0.0009893229,0.0070365765],"category_scores_gemma":[0.00090554747,0.00033680766,0.0005718136,0.0013873212,0.00036874006,0.0013048347,0.0007507309,0.0022227038,0.0021694945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013858582,0.00007259697,0.00013296728,0.023607314,0.00015026069,0.00012302144,0.000046430618,0.00039960624,0.0015444022,0.0031695997,0.04808308,0.9225321],"study_design_scores_gemma":[0.00006193827,0.00010565304,0.00046196426,0.0046982705,0.0002783648,0.0005431685,0.000037539343,0.00010570917,0.00040802782,0.0015372889,0.99174565,0.000016386233],"about_ca_topic_score_codex":0.0010476545,"about_ca_topic_score_gemma":0.0034862675,"teacher_disagreement_score":0.0070365765,"about_ca_system_score_codex":0.00053917064,"about_ca_system_score_gemma":0.0011465449,"threshold_uncertainty_score":0.023539662},"labels":[],"label_agreement":null},{"id":"W2902876869","doi":"10.1016/j.breast.2018.11.012","title":"Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Cancer Care Ontario; McMaster University; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Mammography; Breast cancer; Family history; Logistic regression; Hormone therapy; Breast density; Cohort; Breast cancer screening; Gynecology; Oncology; Mammography screening; Internal medicine; Hormone replacement therapy (female-to-male); Cancer","score_opus":0.11091578725150852,"score_gpt":0.4085162621348857,"score_spread":0.29760047488337715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902876869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878795,0.0024031142,0.0014654855,0.0013345669,0.00003366363,0.0002559633,0.00093386706,0.000019569103,0.0047658547],"genre_scores_gemma":[0.99851173,0.00035944066,0.0006172339,0.00010640541,0.000023558792,0.000039769744,0.00015800548,0.000001046987,0.00018274935],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9900441,0.007824502,0.00041671356,0.00035888952,0.0008685069,0.00048725068],"domain_scores_gemma":[0.9729327,0.021143332,0.0034792596,0.0010736887,0.00067243,0.0006985967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009799739,0.00066500483,0.0007929633,0.0012766538,0.00027900178,0.00081387593,0.0005855871,0.0013429493,0.0016628942],"category_scores_gemma":[0.03979721,0.00042950705,0.0018314046,0.0011645195,0.0010142946,0.0011952957,0.0013417719,0.0012413225,0.00017348822],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009602801,0.0015927453,0.9209612,0.00047703137,0.0025053911,0.00018499997,0.0002098805,0.019755995,0.000410957,0.0012848844,0.0004791492,0.042535007],"study_design_scores_gemma":[0.0004866263,0.009782236,0.952438,0.00016967919,0.0033437717,0.0003317902,0.00074579817,0.028233455,0.00063095434,0.0028409143,0.0009544442,0.000042412517],"about_ca_topic_score_codex":0.0060146577,"about_ca_topic_score_gemma":0.007886013,"teacher_disagreement_score":0.009799739,"about_ca_system_score_codex":0.0014765328,"about_ca_system_score_gemma":0.0013736521,"threshold_uncertainty_score":0.051826537},"labels":[],"label_agreement":null},{"id":"W2903411408","doi":"10.1016/j.breast.2018.11.008","title":"Why upfront use of CDK inhibitors for the treatment of advanced breast cancer may be wasteful, and how we can increase their value","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Breast cancer; Value (mathematics); Cyclin-dependent kinase; Cancer; Oncology; Internal medicine","score_opus":0.02622463847702784,"score_gpt":0.2785753223596665,"score_spread":0.25235068388263865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903411408","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01591421,0.26917797,0.0059130997,0.6680361,0.007541766,0.000053245945,0.00035661267,0.00018452402,0.032822467],"genre_scores_gemma":[0.3341457,0.38438946,0.015152669,0.2211729,0.027797159,0.00014317821,0.00047675986,0.000362997,0.016359167],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9972355,0.0010465153,0.0002548145,0.00024824654,0.0009316381,0.00028340396],"domain_scores_gemma":[0.9788167,0.013106902,0.0025905997,0.00093055604,0.0030238666,0.0015313069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051025846,0.00041230198,0.0007582858,0.0007565763,0.0009368227,0.004542063,0.000913036,0.0023357791,0.012205401],"category_scores_gemma":[0.027439233,0.00024070713,0.0008764723,0.0006402139,0.0035944872,0.005619157,0.0014285287,0.006993211,0.003171026],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014921661,0.0004652106,0.0108659845,0.0013837155,0.00039920444,0.0010405884,0.0004132061,0.001716698,0.0053961645,0.056254413,0.17648053,0.7440922],"study_design_scores_gemma":[0.00048598458,0.0010578659,0.015229716,0.004278555,0.00069938303,0.004154823,0.0017536974,0.0013609077,0.005896685,0.14546074,0.81942564,0.00019598687],"about_ca_topic_score_codex":0.0034109012,"about_ca_topic_score_gemma":0.008357951,"teacher_disagreement_score":0.012205401,"about_ca_system_score_codex":0.0022619555,"about_ca_system_score_gemma":0.0034650024,"threshold_uncertainty_score":0.04083109},"labels":[],"label_agreement":null},{"id":"W2913547072","doi":"10.1016/j.breast.2019.01.007","title":"Taking the pulse of multidisciplinary cancer conferences for breast cancer care in Canada: A stocktake of current practice","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Toronto; Sunnybrook Hospital; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Medicine; Cancer; Multidisciplinary approach; Breast cancer; Family medicine; Oncology; Gynecology; Internal medicine","score_opus":0.07425731377741926,"score_gpt":0.3832132460460257,"score_spread":0.3089559322686064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913547072","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043475907,0.024985626,0.00041942458,0.9032092,0.0106332265,0.000101642756,0.00028938183,0.00012004482,0.016765572],"genre_scores_gemma":[0.6372234,0.054976344,0.0053829434,0.2756766,0.0058415043,0.00015086375,0.00044423563,0.0002425877,0.02006141],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.992508,0.0010283728,0.0004469172,0.0005637284,0.0027563956,0.002696585],"domain_scores_gemma":[0.924445,0.004592276,0.003468755,0.00081752456,0.017713595,0.048962817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060925153,0.00043924188,0.00064637733,0.0013781709,0.016156867,0.010094046,0.005413708,0.00861183,0.016602034],"category_scores_gemma":[0.020562503,0.00064101303,0.0007142785,0.0028930327,0.0061188997,0.003494426,0.0045864168,0.01623616,0.0009595553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003761935,0.0007740455,0.06094278,0.0016289287,0.00011509978,0.001907678,0.014822258,0.00039960624,0.0013103149,0.0058376724,0.50428504,0.40760046],"study_design_scores_gemma":[0.0003820543,0.0004942118,0.25761452,0.010865939,0.00023496327,0.0016325244,0.14184299,0.0011245565,0.00080608187,0.0043592565,0.58011705,0.000525848],"about_ca_topic_score_codex":0.96326965,"about_ca_topic_score_gemma":0.9896464,"teacher_disagreement_score":0.10097745,"about_ca_system_score_codex":0.10097745,"about_ca_system_score_gemma":0.3837892,"threshold_uncertainty_score":0.7326461},"labels":[],"label_agreement":null},{"id":"W2946676747","doi":"10.1016/j.breast.2019.05.012","title":"Mepitel Film and Mepilex Lite for the prophylaxis and treatment of skin toxicities from breast radiation","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Breast cancer; Cancer; Internal medicine","score_opus":0.0058469806162081295,"score_gpt":0.22640957488285682,"score_spread":0.22056259426664868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946676747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71775794,0.2371439,0.005955568,0.0022386413,0.00037821213,0.0002526553,0.00064803986,0.00028305175,0.035341997],"genre_scores_gemma":[0.95203114,0.037405733,0.002140337,0.00041269456,0.00014810933,0.00008574773,0.00026278998,0.000029020077,0.007484399],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999933,0.00002710353,0.0000043858126,0.000005606096,0.000014937432,0.000014994923],"domain_scores_gemma":[0.9999355,0.000020853831,0.000020841306,0.000004023092,0.000004081255,0.000014711314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015394138,0.00015248221,0.00030878343,0.000248818,0.00011858132,0.0001666137,0.00021734934,0.0002696146,0.0025083811],"category_scores_gemma":[0.00020696838,0.00006901566,0.00021735246,0.0001658353,0.00008772641,0.00012211729,0.00012142489,0.000644903,0.00032829933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018015042,0.0013788221,0.003276144,0.0011053164,0.00020504194,0.0014362971,0.00009173726,0.0008142739,0.07912539,0.0018072996,0.005523395,0.88722116],"study_design_scores_gemma":[0.02102727,0.14530492,0.18913235,0.0012903558,0.0014827602,0.058963705,0.00044193226,0.007692333,0.25148118,0.001994066,0.3210316,0.00015755506],"about_ca_topic_score_codex":0.00035526857,"about_ca_topic_score_gemma":0.0010291679,"teacher_disagreement_score":0.0025083811,"about_ca_system_score_codex":0.0001209977,"about_ca_system_score_gemma":0.00018732208,"threshold_uncertainty_score":0.008391321},"labels":[],"label_agreement":null},{"id":"W2950576577","doi":"10.1016/j.breast.2019.06.004","title":"Patient-reported fatigue in breast cancer patients receiving radiation therapy","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Multivariate analysis; Univariate analysis; Radiation therapy; Cancer; Cancer-related fatigue; Anxiety; Disease; Oncology","score_opus":0.014374575204214134,"score_gpt":0.2626253431247604,"score_spread":0.24825076792054623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950576577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793065,0.00058401737,0.00002771549,0.00016664031,0.000014703915,0.0000098479895,0.00021034353,0.0000022694849,0.001053811],"genre_scores_gemma":[0.9994221,0.00018030437,0.000022976335,0.00009975174,0.00001346185,0.000006019731,0.00012859267,6.827662e-7,0.00012622026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950135,0.00022381968,0.00007044491,0.000038773258,0.000075863325,0.0000896872],"domain_scores_gemma":[0.99853444,0.0003885681,0.0007031951,0.000029902965,0.000097441574,0.0002465043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055920513,0.00016704208,0.0003358057,0.0004919087,0.0003820662,0.0005656446,0.00017017183,0.000519543,0.0023413918],"category_scores_gemma":[0.004283111,0.00014444141,0.00051507616,0.00062504486,0.00020090894,0.00045230056,0.00046531775,0.0005389084,0.0001518292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021967609,0.00009528785,0.9958162,0.000040989125,0.00009687698,0.00014783349,0.00029095166,0.00006274545,0.0000950671,0.00001413595,0.00019823476,0.0029220467],"study_design_scores_gemma":[0.000011940191,0.00023941403,0.9984301,0.000018754861,0.00004432382,0.000328298,0.0005723959,0.00009076851,0.000023411227,0.00001433211,0.00022076436,0.000005535246],"about_ca_topic_score_codex":0.0021116964,"about_ca_topic_score_gemma":0.0049984483,"teacher_disagreement_score":0.0023413918,"about_ca_system_score_codex":0.00029428297,"about_ca_system_score_gemma":0.00024277758,"threshold_uncertainty_score":0.007832706},"labels":[],"label_agreement":null},{"id":"W2969944916","doi":"10.1016/j.breast.2019.08.003","title":"A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University Health Network; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Metformin; Placebo; Internal medicine; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Population; Progression-free survival; Cancer; Gastroenterology; Confidence interval; Pathology","score_opus":0.01188174010589312,"score_gpt":0.3308717787892518,"score_spread":0.3189900386833587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969944916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013865,0.0033524923,0.0003969228,0.0010226001,0.0006856811,0.0020989464,0.0007231069,0.000073100964,0.0015086014],"genre_scores_gemma":[0.989894,0.001975171,0.0010373,0.0010560598,0.00057473185,0.002180495,0.00081329513,0.000018193627,0.002450797],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994486,0.0003265768,0.0000274351,0.000099204044,0.000026055763,0.00007217426],"domain_scores_gemma":[0.99886155,0.00040192239,0.00022216444,0.00009020819,0.00005014569,0.00037406842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016589669,0.001790709,0.003377131,0.000539182,0.00047665514,0.0009465479,0.0010693765,0.0020399583,0.007263362],"category_scores_gemma":[0.0022369323,0.0006877413,0.0016395693,0.00046332006,0.001358055,0.001244381,0.00052896544,0.003428242,0.0007192704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99127555,0.0032186436,0.00024495303,0.00014414996,0.0002743064,0.000011871397,0.000014624073,0.00012447592,0.00077941443,0.000037714955,0.00018515169,0.0036891724],"study_design_scores_gemma":[0.9515789,0.046570305,0.00095901144,0.000014131119,0.00024628793,0.000010999293,0.000014231903,0.00018498593,0.00015206111,0.000079905076,0.00018227019,0.000006996085],"about_ca_topic_score_codex":0.0010204487,"about_ca_topic_score_gemma":0.0019087482,"teacher_disagreement_score":0.007263362,"about_ca_system_score_codex":0.0008073016,"about_ca_system_score_gemma":0.00094284053,"threshold_uncertainty_score":0.02429837},"labels":[],"label_agreement":null},{"id":"W2972178862","doi":"10.1016/j.breast.2019.09.001","title":"Does timing of alloplastic breast reconstruction in older women impact immediate postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; National database; General surgery; Breast reconstruction; Database; Surgery; Breast cancer; Internal medicine; Cancer","score_opus":0.01693794918358189,"score_gpt":0.3171130099093767,"score_spread":0.3001750607257948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972178862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900767,0.0025541375,0.00015477798,0.00020242509,0.000026661935,0.000028491939,0.006345824,0.000004530815,0.00060639385],"genre_scores_gemma":[0.9947843,0.0008353639,0.00019936603,0.0001460266,0.000035022997,0.000024632918,0.0038631826,0.0000052437613,0.00010684574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772865,0.0005638179,0.00066354335,0.0004155446,0.00039460228,0.00023376146],"domain_scores_gemma":[0.98729116,0.0025565054,0.008227693,0.00060196256,0.00078188,0.0005408422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002155658,0.00027702338,0.00077397254,0.0019460133,0.00033985378,0.00097528397,0.0006833177,0.0005966176,0.0013561357],"category_scores_gemma":[0.009203316,0.0002955663,0.0019364274,0.0053532626,0.00022137903,0.0009638443,0.00068883714,0.00080506917,0.00015298728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013323272,0.000019887744,0.99846315,0.000031851407,0.0002825585,0.00001858225,0.000025351568,0.000028614573,0.000022568802,0.000013776614,0.00012631797,0.0008341317],"study_design_scores_gemma":[0.000012620901,0.00004498496,0.999181,0.000020524481,0.00017215859,0.0000664855,0.00013577924,0.00013713719,0.0000174249,0.000014292804,0.00019357252,0.0000040232244],"about_ca_topic_score_codex":0.012963075,"about_ca_topic_score_gemma":0.02201022,"teacher_disagreement_score":0.012963075,"about_ca_system_score_codex":0.0007320634,"about_ca_system_score_gemma":0.0008570852,"threshold_uncertainty_score":0.025775254},"labels":[],"label_agreement":null},{"id":"W2973847581","doi":"10.1016/j.breast.2019.09.009","title":"A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis","year":2019,"lang":"en","type":"review","venue":"The Breast","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Dermatology; Meta-analysis; Adverse effect; Telangiectasia; Edema; Internal medicine; Cancer","score_opus":0.0900676372164974,"score_gpt":0.3830994691184503,"score_spread":0.29303183190195287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973847581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004985506,0.99374604,0.00034127943,0.00008230746,0.00014843344,0.00019490399,0.00032024403,0.000011354026,0.0001698513],"genre_scores_gemma":[0.14791758,0.8477941,0.0018356272,0.00079854304,0.0002195318,0.0005683941,0.000487488,0.000023364082,0.00035543437],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98956096,0.0045272354,0.00342248,0.0011139282,0.0010924912,0.00028294223],"domain_scores_gemma":[0.9843337,0.011619994,0.0024869023,0.000469027,0.000916175,0.0001741243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010275079,0.0025163193,0.01641945,0.0041737766,0.0005870868,0.0032251398,0.0018343246,0.0023922054,0.0034906866],"category_scores_gemma":[0.03645554,0.0013551564,0.03142039,0.0054513165,0.00088155875,0.0017718476,0.0017610531,0.002597505,0.00032420893],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002475595,0.000030719217,0.0030407738,0.39634213,0.5870669,0.00010372424,0.00008417053,0.00026444206,0.00016025935,0.00009321353,0.00037422564,0.009963807],"study_design_scores_gemma":[0.0008545343,0.0002165998,0.003604376,0.020863602,0.9726862,0.000097859054,0.000054016986,0.00008015699,0.000071059665,0.00013728901,0.0013111284,0.000023295579],"about_ca_topic_score_codex":0.008356513,"about_ca_topic_score_gemma":0.019396761,"teacher_disagreement_score":0.01641945,"about_ca_system_score_codex":0.0023646634,"about_ca_system_score_gemma":0.0034262564,"threshold_uncertainty_score":0.05434048},"labels":[],"label_agreement":null},{"id":"W2979495041","doi":"10.1016/j.breast.2019.10.001","title":"The ethical, legal and social implications of using artificial intelligence systems in breast cancer care","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; UK Research and Innovation; University of Wollongong; Canadian Institute for Advanced Research; Centre National de la Recherche Scientifique; National Breast Cancer Foundation","keywords":"Deliberation; Confidentiality; Medicine; Health care; Government (linguistics); Informed consent; Engineering ethics; Public relations; Political science; Alternative medicine; Law","score_opus":0.1318606227581367,"score_gpt":0.4332914254438005,"score_spread":0.3014308026856638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495041","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019805524,0.0063609197,0.0040130257,0.92161196,0.0010068608,0.000027857257,0.000021750691,0.000011302246,0.04714087],"genre_scores_gemma":[0.8464819,0.0070715947,0.006111082,0.13422361,0.0025065432,0.00011744505,0.000019721638,0.00003888322,0.0034292077],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.91895425,0.064906575,0.0020589544,0.0013864319,0.009858779,0.002834965],"domain_scores_gemma":[0.71443033,0.24667622,0.011795127,0.0064346413,0.011836821,0.008826857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07946636,0.0002045506,0.0003230864,0.0011563397,0.0070385756,0.01387987,0.0017668214,0.013480541,0.0034339207],"category_scores_gemma":[0.1697315,0.0004769153,0.00050851604,0.00094484864,0.039410718,0.006508255,0.0058917613,0.018545033,0.00043857892],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013160611,0.00033822897,0.01633465,0.00036622267,0.000103666935,0.001232052,0.021552566,0.002081815,0.0005205237,0.81839806,0.051763427,0.087177105],"study_design_scores_gemma":[0.00009477597,0.00018677747,0.00825877,0.0027599433,0.00007353688,0.002004509,0.0316124,0.0037571362,0.0010985156,0.7590986,0.19091971,0.0001353877],"about_ca_topic_score_codex":0.0064398837,"about_ca_topic_score_gemma":0.010702891,"teacher_disagreement_score":0.07946636,"about_ca_system_score_codex":0.006540504,"about_ca_system_score_gemma":0.021958461,"threshold_uncertainty_score":0.4202633},"labels":[],"label_agreement":null},{"id":"W2996716426","doi":"10.1016/s0960-9776(19)31116-6","title":"Identifying research priorities in the treatment of patients with early breast cancer: from the patient perspective","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Perspective (graphical); Oncology; Cancer; Intensive care medicine; Internal medicine; Family medicine; Medical physics; Artificial intelligence","score_opus":0.01811634053481083,"score_gpt":0.29368160491009143,"score_spread":0.2755652643752806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996716426","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15596704,0.2045005,0.004520233,0.60491014,0.0015800019,0.0002698493,0.00083935,0.000034263183,0.0273787],"genre_scores_gemma":[0.7744264,0.15940693,0.008980692,0.050408285,0.0046561477,0.00036845036,0.00034188942,0.000019225403,0.0013919752],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9850786,0.012772924,0.0006819662,0.00022415651,0.0007768567,0.00046557488],"domain_scores_gemma":[0.95874625,0.030608106,0.0038146614,0.0004275016,0.0032072882,0.003196125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01914752,0.0004340219,0.0017039923,0.0026111186,0.001635272,0.0059283404,0.0007807796,0.0031432945,0.004264511],"category_scores_gemma":[0.04217929,0.0003585882,0.00065114995,0.003271396,0.0017071831,0.0034615626,0.0022515848,0.003320117,0.0005891546],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004890673,0.0023770018,0.4130896,0.013870994,0.0016091868,0.003968656,0.008441404,0.0023257062,0.00370661,0.055402875,0.051130444,0.43918678],"study_design_scores_gemma":[0.003032033,0.01090115,0.34353364,0.028041424,0.005135827,0.009861043,0.12966526,0.0035544552,0.007824749,0.16927312,0.28862083,0.00055647397],"about_ca_topic_score_codex":0.0025576549,"about_ca_topic_score_gemma":0.005961659,"teacher_disagreement_score":0.01914752,"about_ca_system_score_codex":0.0021709504,"about_ca_system_score_gemma":0.0082303155,"threshold_uncertainty_score":0.10126293},"labels":[],"label_agreement":null},{"id":"W3015700607","doi":"10.1016/j.breast.2020.04.002","title":"Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Institut Gustave-Roussy; European Society for Medical Oncology; Memorial Sloan-Kettering Cancer Center; Susan G. Komen; Agence Nationale de la Recherche","keywords":"Medicine; Weight loss; Weight change; Breast cancer; Quality of life (healthcare); Weight gain; Prospective cohort study; Internal medicine; Anthropometry; Psychosocial; Cancer; Exacerbation; Obesity; Physical therapy; Body weight","score_opus":0.04908684853192525,"score_gpt":0.36597876378364225,"score_spread":0.316891915251717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015700607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906737,0.00014238336,0.000038465605,0.000031490094,0.0000031668455,0.000022577915,0.00051553204,0.0000014989922,0.00017748866],"genre_scores_gemma":[0.998492,0.00011905949,0.000082022074,0.000054223416,0.000010902547,0.0000499947,0.0010572948,0.0000015388366,0.00013282528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937266,0.00021350975,0.00006160655,0.00012479785,0.000121500554,0.00010588688],"domain_scores_gemma":[0.9987979,0.00014398195,0.0005649639,0.000084130304,0.00017670299,0.0002323528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010825961,0.0002935628,0.0003328336,0.0006158374,0.0006406109,0.0005359744,0.0004193426,0.00040871312,0.0010947494],"category_scores_gemma":[0.0013742666,0.0002683894,0.00039413787,0.0012934579,0.00036099384,0.00039403,0.00058355153,0.00051059603,0.00022683003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109529385,0.00008636175,0.99893385,0.00000953265,0.000046897636,0.00002333566,0.000034989338,0.00000955989,0.00009282359,0.0000028720833,0.000072983734,0.0005772283],"study_design_scores_gemma":[0.000016491203,0.00007639599,0.99959725,0.0000035832431,0.000026556241,0.000051998508,0.000079690944,0.000039815935,0.000012530888,0.0000029472649,0.000090671274,0.000002102484],"about_ca_topic_score_codex":0.015378368,"about_ca_topic_score_gemma":0.025651982,"teacher_disagreement_score":0.015378368,"about_ca_system_score_codex":0.00053630886,"about_ca_system_score_gemma":0.0005676938,"threshold_uncertainty_score":0.03057766},"labels":[],"label_agreement":null},{"id":"W3021990204","doi":"10.1016/j.breast.2020.04.011","title":"A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Breast Cancer Network","funders":"Eli Lilly and Company","keywords":"Metastatic breast cancer; Medicine; Quality of life (healthcare); Stakeholder; Disease; Breast cancer; Intensive care medicine; Cancer; Oncology; Internal medicine; Nursing; Political science","score_opus":0.15362467482816022,"score_gpt":0.3314302479767575,"score_spread":0.1778055731485973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021990204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041306186,0.8637219,0.020905187,0.093585536,0.001880353,0.0018779283,0.0001019867,0.000035452915,0.013761058],"genre_scores_gemma":[0.18116651,0.717463,0.06816899,0.025186654,0.0017074457,0.004134705,0.00013620248,0.000030572566,0.0020058956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92599815,0.06684374,0.002774285,0.00052193255,0.003107997,0.00075393537],"domain_scores_gemma":[0.931429,0.059057783,0.003060534,0.0006473008,0.00490161,0.00090369605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07597774,0.00088871346,0.0022953835,0.0028090978,0.0010044752,0.004464998,0.0014880827,0.0034421284,0.0032559652],"category_scores_gemma":[0.06982482,0.0005322668,0.002667991,0.0019384089,0.0013622293,0.0045163245,0.0042093974,0.0048985183,0.00036013743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003791505,0.00022392631,0.0014623479,0.09572102,0.0025993665,0.0004447649,0.0033236926,0.004640625,0.000834375,0.07268379,0.020818412,0.79686856],"study_design_scores_gemma":[0.0009449908,0.0006471767,0.0049261306,0.25307897,0.0052745924,0.0011180285,0.006445657,0.0051494935,0.0012993524,0.13142608,0.58950514,0.00018442908],"about_ca_topic_score_codex":0.0026284081,"about_ca_topic_score_gemma":0.007696347,"teacher_disagreement_score":0.07597774,"about_ca_system_score_codex":0.004825678,"about_ca_system_score_gemma":0.01760937,"threshold_uncertainty_score":0.4018135},"labels":[],"label_agreement":null},{"id":"W3033981055","doi":"10.1016/j.breast.2020.05.012","title":"Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Ipsen; Kræftfonden; National Institute for Health and Care Research; National Health and Medical Research Council; Cancer Research UK; University of South Alabama; AstraZeneca; National Cancer Research Institute; Universiteit Stellenbosch; American College of Radiology Imaging Network; ASCRS Research Foundation; Royal Marsden NHS Foundation Trust; Breast Cancer Research Foundation; Pfizer; Gateway for Cancer Research","keywords":"De-escalation; Estimation; Statistics; Mathematics; Economics; Medicine; Internal medicine; Management","score_opus":0.02506510687249958,"score_gpt":0.2931817826740381,"score_spread":0.26811667580153853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033981055","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13738851,0.0064304583,0.81899303,0.002643062,0.001544577,0.019585371,0.0023262873,0.0010734313,0.01001528],"genre_scores_gemma":[0.78049004,0.00069055177,0.19749716,0.0015639942,0.00035103512,0.01563212,0.0015725117,0.00020562777,0.001996853],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6869624,0.2841812,0.007002176,0.011343,0.009374174,0.0011369387],"domain_scores_gemma":[0.4983672,0.39366958,0.045136034,0.051561598,0.009268418,0.001997221],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.37632358,0.0018712976,0.0032545526,0.0030415778,0.0008179624,0.0026548216,0.0046421103,0.0034831576,0.006239239],"category_scores_gemma":[0.5128246,0.0010136097,0.007613244,0.0019909572,0.0034579458,0.0030147387,0.0031848429,0.004480981,0.0006905102],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07254687,0.0012984695,0.28438908,0.007802347,0.024909925,0.0014793742,0.0034329598,0.09456015,0.0034533446,0.12690586,0.020181168,0.3590404],"study_design_scores_gemma":[0.017740557,0.021707918,0.10352264,0.0036978999,0.020862866,0.0027179436,0.0010241118,0.65907556,0.010829437,0.10315699,0.05502582,0.0006383322],"about_ca_topic_score_codex":0.0013816706,"about_ca_topic_score_gemma":0.0005007056,"teacher_disagreement_score":0.37632358,"about_ca_system_score_codex":0.0012715184,"about_ca_system_score_gemma":0.0015647156,"threshold_uncertainty_score":0.76910406},"labels":[],"label_agreement":null},{"id":"W3049246635","doi":"10.1016/j.breast.2020.08.002","title":"Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Docetaxel; Oncology; Internal medicine; Cyclophosphamide; Proportional hazards model; Cancer; Population; Chemotherapy; Confidence interval; Gynecology","score_opus":0.013330600194873513,"score_gpt":0.273761792519244,"score_spread":0.26043119232437045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049246635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965863,0.0024596553,0.00004471983,0.00013684086,0.000010471994,0.00011370835,0.0003266842,0.0000020847995,0.0003195563],"genre_scores_gemma":[0.99779344,0.0012890811,0.00012716945,0.0001622627,0.000024101548,0.000078839555,0.0004235573,0.0000020606212,0.00009948685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855226,0.00056677073,0.000111493246,0.00022780028,0.00031874925,0.00022286669],"domain_scores_gemma":[0.9953501,0.0011948535,0.0019429615,0.0001986286,0.0004971071,0.00081619265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017723368,0.00035186688,0.00072137505,0.00044249318,0.0006764202,0.00084787596,0.0007582176,0.000704215,0.0011535864],"category_scores_gemma":[0.005679573,0.0002839026,0.0007823227,0.0017000644,0.00073487015,0.00041950913,0.00038438258,0.0007724447,0.00013439976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016403427,0.002070808,0.9535198,0.00081768667,0.0010566333,0.000448141,0.0007927328,0.0005951495,0.00048101123,0.000114379254,0.0016872406,0.022012873],"study_design_scores_gemma":[0.0022571965,0.005837701,0.98444116,0.0002422109,0.000771524,0.0005496704,0.0010367455,0.0010264877,0.0001497183,0.000084523264,0.0035535824,0.000049491737],"about_ca_topic_score_codex":0.19158745,"about_ca_topic_score_gemma":0.25073525,"teacher_disagreement_score":0.19158745,"about_ca_system_score_codex":0.0072858213,"about_ca_system_score_gemma":0.0060533118,"threshold_uncertainty_score":0.38094455},"labels":[],"label_agreement":null},{"id":"W3081095386","doi":"10.1016/j.breast.2020.07.007","title":"A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Case-control study; Cancer; Internal medicine; Gynecology; Radiation therapy; Obstetrics","score_opus":0.01776318632635906,"score_gpt":0.2798722651584156,"score_spread":0.2621090788320566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081095386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997767,0.00084324664,0.00047759188,0.000054063516,0.0000203289,0.00006399051,0.00046095016,0.0000062700815,0.00030657122],"genre_scores_gemma":[0.9985593,0.00022092098,0.0004203722,0.000054400953,0.000022981647,0.0000876331,0.00043100823,0.0000048253073,0.00019860272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602795,0.0018898122,0.000343319,0.0009635772,0.0005262222,0.0002491926],"domain_scores_gemma":[0.99407816,0.002042326,0.001667711,0.0013330891,0.0005214988,0.0003572577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030462719,0.0006127651,0.0008784583,0.0009935616,0.0012881965,0.00097361195,0.0010386746,0.00077942695,0.0017743821],"category_scores_gemma":[0.011095189,0.00081908517,0.0010998689,0.0013686157,0.00063428143,0.00044743315,0.0006102511,0.00080491503,0.0001719766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012744037,0.0002775384,0.9943599,0.000043327615,0.0008494591,0.0003849021,0.00025128588,0.000044995148,0.00038626266,0.00012007441,0.00039339392,0.0016144447],"study_design_scores_gemma":[0.00030726247,0.0005855104,0.9960163,0.000029563615,0.0006095842,0.00088205707,0.00019772814,0.0003380474,0.00016693657,0.000077087294,0.00077444006,0.000015536125],"about_ca_topic_score_codex":0.027678791,"about_ca_topic_score_gemma":0.02208439,"teacher_disagreement_score":0.027678791,"about_ca_system_score_codex":0.0008347378,"about_ca_system_score_gemma":0.00082042324,"threshold_uncertainty_score":0.055035353},"labels":[],"label_agreement":null},{"id":"W3082907133","doi":"10.1016/j.breast.2020.08.013","title":"The impact on clinical outcomes of post-operative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: A multicentric international study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Chemotherapy; Stage (stratigraphy); Internal medicine; Surgery; Neoadjuvant therapy; Cancer; Oncology","score_opus":0.008989130148440565,"score_gpt":0.314509113048479,"score_spread":0.30551998290003846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082907133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900633,0.00054768485,0.00002737859,0.000022219037,0.0000030725191,0.000009357317,0.00012706869,7.319794e-7,0.00025612363],"genre_scores_gemma":[0.9994949,0.00022351043,0.000036252608,0.000016252567,0.000006839412,0.000009161331,0.00016616652,0.0000010039627,0.00004591884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994023,0.00021799697,0.00007643093,0.00012674973,0.000075670694,0.00010081265],"domain_scores_gemma":[0.9972874,0.00059546455,0.0015275587,0.00014577074,0.00017397576,0.00026985674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000993052,0.00021850356,0.00034629868,0.000701289,0.00028715288,0.00058113376,0.0002921127,0.00034978671,0.00092176686],"category_scores_gemma":[0.0032062363,0.00018683172,0.0005925563,0.0012037479,0.0003569875,0.0003540117,0.00042613942,0.00031720742,0.00011272287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003344383,0.000038722388,0.9982424,0.000016457485,0.000045514433,0.000030143512,0.0000787363,0.000026843658,0.000055341927,0.000008051008,0.000029949693,0.0010933172],"study_design_scores_gemma":[0.000018874993,0.00026568945,0.99893016,0.000013347205,0.00006771834,0.00015599621,0.00025927846,0.000064468586,0.00002800987,0.0000118142025,0.00018105129,0.0000037035438],"about_ca_topic_score_codex":0.00422984,"about_ca_topic_score_gemma":0.0047522285,"teacher_disagreement_score":0.00422984,"about_ca_system_score_codex":0.00049697777,"about_ca_system_score_gemma":0.00046387262,"threshold_uncertainty_score":0.008410454},"labels":[],"label_agreement":null},{"id":"W3093752709","doi":"10.1016/j.breast.2020.10.003","title":"Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Mount Sinai Hospital; Western University","funders":"Janssen Canada; Novartis; Bayer","keywords":"Trastuzumab; Medicine; Breast cancer; Meta-analysis; Internal medicine; Adjuvant; Oncology; Adjuvant therapy; Randomized controlled trial; Subgroup analysis; Cancer; Surgery","score_opus":0.10818742444388223,"score_gpt":0.39569247456465007,"score_spread":0.2875050501207678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093752709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031489255,0.99537694,0.00030523373,0.00023216683,0.00013277875,0.00016445645,0.00039862577,0.00001246962,0.0002283404],"genre_scores_gemma":[0.16291095,0.83149457,0.0015281086,0.0015709435,0.00030197747,0.00082322356,0.000955425,0.000031317475,0.00038346843],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99100083,0.0041712937,0.002640206,0.0009799238,0.0009407617,0.0002669824],"domain_scores_gemma":[0.9817514,0.013286166,0.0030465776,0.00056063145,0.0011336851,0.00022154255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013268175,0.0022644503,0.018432308,0.004469256,0.0004981438,0.0030811366,0.0019402391,0.002066359,0.00346476],"category_scores_gemma":[0.030328687,0.0015044198,0.03830362,0.005044823,0.0006783268,0.002083512,0.0012786685,0.0019794474,0.00033919894],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023617374,0.000022814811,0.0033511273,0.36054552,0.62054133,0.000104924504,0.00006953126,0.0004807747,0.00015779119,0.00017005547,0.00071429164,0.011480015],"study_design_scores_gemma":[0.00073999335,0.0001726622,0.0034093787,0.02681491,0.96637636,0.00010153472,0.000036957943,0.00013635057,0.00007818709,0.00027042945,0.001841485,0.00002168636],"about_ca_topic_score_codex":0.0069973217,"about_ca_topic_score_gemma":0.015944414,"teacher_disagreement_score":0.018432308,"about_ca_system_score_codex":0.0028571372,"about_ca_system_score_gemma":0.0030094534,"threshold_uncertainty_score":0.07016963},"labels":[],"label_agreement":null},{"id":"W3093770202","doi":"10.1016/j.breast.2020.10.005","title":"Eligibility of real-world patients with metastatic breast cancer for clinical trials","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Metastatic breast cancer; Medicine; Oncology; Breast cancer; Clinical trial; Internal medicine; Cancer","score_opus":0.1608991240040951,"score_gpt":0.4737175903520319,"score_spread":0.31281846634793686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093770202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9303031,0.017412433,0.0028486184,0.014493723,0.00022544926,0.0041175094,0.008758406,0.00006065119,0.021780165],"genre_scores_gemma":[0.9875295,0.0015786958,0.0021059448,0.0028680002,0.00014000302,0.0018335788,0.0032268693,0.000009678466,0.0007077515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97596234,0.015859487,0.0032907561,0.0010678764,0.0028221784,0.0009973515],"domain_scores_gemma":[0.9486694,0.019872412,0.021917256,0.0027978525,0.0031939684,0.0035491276],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03204814,0.00023599919,0.00066469336,0.0007992956,0.0008128254,0.0026972562,0.00096454064,0.0010622719,0.005119841],"category_scores_gemma":[0.047495987,0.00017532529,0.00059081713,0.0012115377,0.0013285391,0.0009626238,0.0010909723,0.0007404432,0.0007736691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014216497,0.0006387907,0.8474415,0.0040423363,0.000924228,0.0009189975,0.0020875684,0.0015271856,0.0014881302,0.0052148686,0.014391788,0.10710814],"study_design_scores_gemma":[0.00617721,0.0037448343,0.86198837,0.0046770764,0.00089009304,0.0036485237,0.0022615276,0.0029382065,0.0018245297,0.0074845213,0.10423367,0.00013142134],"about_ca_topic_score_codex":0.003132421,"about_ca_topic_score_gemma":0.005462885,"teacher_disagreement_score":0.96795183,"about_ca_system_score_codex":0.0020270024,"about_ca_system_score_gemma":0.007533995,"threshold_uncertainty_score":0.16948879},"labels":[],"label_agreement":null},{"id":"W3101785640","doi":"10.1016/j.breast.2020.11.002","title":"A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Nausea and vomiting management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Kingston General Hospital; University of Ottawa; Markham Stouffville Hospital; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Medicine; Antiemetic; Nausea; Vomiting; Chemotherapy-induced nausea and vomiting; Chemotherapy; Breast cancer; Randomized controlled trial; Oncology; Cancer; Internal medicine","score_opus":0.02788678472772144,"score_gpt":0.3059523390972795,"score_spread":0.27806555436955804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101785640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567456,0.0032077099,0.0007707389,0.0007026678,0.0009801658,0.00637224,0.0006570304,0.00013946577,0.0014953907],"genre_scores_gemma":[0.9852245,0.0014120246,0.002356107,0.00088968687,0.00053363875,0.007168668,0.00048559136,0.00001621326,0.0019135727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864143,0.00080140104,0.0001122369,0.00023143033,0.00008970084,0.00012377641],"domain_scores_gemma":[0.99797136,0.00068920286,0.0005647312,0.00015956692,0.00010409154,0.00051106233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019418012,0.0015003462,0.0037718066,0.00056829606,0.00046388924,0.0010895312,0.0010724886,0.0022184027,0.009743624],"category_scores_gemma":[0.003530754,0.0007370499,0.0017339843,0.0004297843,0.0013544622,0.0011022221,0.00061389594,0.0024929591,0.0009226359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9925484,0.0023265413,0.00010201901,0.00024121394,0.000284955,0.000010880709,0.000015144276,0.00010596549,0.0005008135,0.00003509985,0.00012053011,0.0037084501],"study_design_scores_gemma":[0.9682565,0.03080464,0.00033628347,0.000016096166,0.00013827211,0.000010260796,0.0000075770863,0.00019240307,0.000081467726,0.00005560652,0.00009505006,0.000005764712],"about_ca_topic_score_codex":0.0009153905,"about_ca_topic_score_gemma":0.0021690011,"teacher_disagreement_score":0.009743624,"about_ca_system_score_codex":0.00077429594,"about_ca_system_score_gemma":0.0012641299,"threshold_uncertainty_score":0.032595694},"labels":[],"label_agreement":null},{"id":"W3102261601","doi":"10.1016/j.breast.2020.11.009","title":"Older women’s experience with breast cancer treatment: A systematic review of qualitative literature","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; University of Toronto","funders":"","keywords":"CINAHL; PsycINFO; Medicine; Breast cancer; MEDLINE; Systematic review; Qualitative research; Health care; Cochrane Library; Family medicine; Coping (psychology); Alternative medicine; Clinical psychology; Nursing; Cancer; Psychological intervention; Internal medicine; Pathology","score_opus":0.0411928876502815,"score_gpt":0.3847233339232084,"score_spread":0.3435304462729269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102261601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018303802,0.9692843,0.0024945082,0.002348701,0.00027508644,0.0030947214,0.0025506676,0.000022563485,0.0016256381],"genre_scores_gemma":[0.16453159,0.8114759,0.0103172045,0.0026788292,0.00011037006,0.009244918,0.0011306119,0.000027841672,0.00048283068],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9654677,0.021060448,0.008606861,0.0011634134,0.002974862,0.0007266287],"domain_scores_gemma":[0.8637234,0.11212191,0.011378939,0.0016641439,0.0101235,0.0009880132],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.048730984,0.0010591899,0.0045527457,0.019159911,0.0016127886,0.0029460115,0.0018396799,0.001321198,0.0031605358],"category_scores_gemma":[0.12015408,0.0010719325,0.005001912,0.01808975,0.002064682,0.004346565,0.0037570626,0.0012534765,0.00024738495],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024177744,0.000032153966,0.0034956133,0.8892301,0.0030630515,0.00054240064,0.034013677,0.00018439915,0.00037334222,0.0010402567,0.002253111,0.06553021],"study_design_scores_gemma":[0.00011160788,0.00019908613,0.0055182376,0.9167414,0.008616464,0.00070126855,0.039782137,0.00009491797,0.0002928934,0.0010439444,0.026815362,0.00008275599],"about_ca_topic_score_codex":0.0142283095,"about_ca_topic_score_gemma":0.03579363,"teacher_disagreement_score":0.9954473,"about_ca_system_score_codex":0.009196256,"about_ca_system_score_gemma":0.026604256,"threshold_uncertainty_score":0.25771713},"labels":[],"label_agreement":null},{"id":"W3111250988","doi":"10.1016/j.breast.2020.11.023","title":"A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Queen Mary University of London","keywords":"Medicine; Chemotherapy; Oncology; Meta-analysis; Breast reconstruction; Neoadjuvant therapy; Breast cancer; Internal medicine; General surgery; Cancer","score_opus":0.0379412719852355,"score_gpt":0.3109041916159927,"score_spread":0.2729629196307572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111250988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030528523,0.9954248,0.00035431763,0.00018606773,0.00015729558,0.00025014498,0.00034667342,0.000013505747,0.0002143868],"genre_scores_gemma":[0.1173615,0.8774914,0.0019926995,0.0008835747,0.00029552274,0.0011214217,0.0005821,0.00002260239,0.00024915667],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9852577,0.007386078,0.0042853467,0.0011870298,0.0015073274,0.0003765481],"domain_scores_gemma":[0.9640209,0.027410772,0.0053708055,0.0007628559,0.0021043092,0.00033033759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01837086,0.0032497782,0.020519784,0.008163631,0.0007340851,0.0038268804,0.0021925943,0.0025258642,0.0040228413],"category_scores_gemma":[0.05018072,0.0015632809,0.044125464,0.0082576135,0.0008477552,0.0020313428,0.0015566332,0.0023237085,0.0003509789],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018158334,0.000027541673,0.0026619046,0.445215,0.53906304,0.00014292022,0.000059233334,0.00044526104,0.000150491,0.00010810895,0.00039640782,0.009914246],"study_design_scores_gemma":[0.0004915713,0.00021106782,0.0025257186,0.031683043,0.96352595,0.00009359756,0.00003125051,0.000105254934,0.00008262594,0.00013656444,0.0010963206,0.000017031423],"about_ca_topic_score_codex":0.007899358,"about_ca_topic_score_gemma":0.01502252,"teacher_disagreement_score":0.020519784,"about_ca_system_score_codex":0.0032877752,"about_ca_system_score_gemma":0.0051201135,"threshold_uncertainty_score":0.09715551},"labels":[],"label_agreement":null},{"id":"W3130416374","doi":"10.1016/j.breast.2021.02.009","title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Meta-analysis; Breast cancer; Internal medicine; Oncology; Subgroup analysis; Adjuvant therapy; Population; Randomized controlled trial; MEDLINE; Cancer","score_opus":0.019520902889589277,"score_gpt":0.2870374293321055,"score_spread":0.2675165264425162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130416374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009583718,0.9883613,0.0007081693,0.00023271708,0.000117915595,0.00025342032,0.00049369555,0.00002424001,0.00022480034],"genre_scores_gemma":[0.29448888,0.69843465,0.0033922703,0.0007651788,0.0002716894,0.0013205139,0.0010018979,0.000031008185,0.0002938739],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98710424,0.00626576,0.00354448,0.0012866905,0.0014366972,0.00036214685],"domain_scores_gemma":[0.9786943,0.015136311,0.0036655506,0.00062162825,0.001621994,0.00026031942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018091224,0.0031280853,0.018349761,0.008871615,0.000655379,0.0037052492,0.0020751748,0.0024558464,0.001978776],"category_scores_gemma":[0.035540115,0.001832329,0.05319665,0.008416809,0.0006251923,0.0016443055,0.0014883421,0.0018085901,0.0002365155],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013442744,0.000028010125,0.008029012,0.2147013,0.7672533,0.00017040543,0.0000854688,0.0009067201,0.0001838052,0.00009382525,0.0003817006,0.0068222107],"study_design_scores_gemma":[0.00024145926,0.00012830067,0.0040471694,0.012978507,0.98141986,0.00011003251,0.000035617482,0.00024697866,0.000078678546,0.0001057801,0.0005881102,0.000019515803],"about_ca_topic_score_codex":0.0077978424,"about_ca_topic_score_gemma":0.013877332,"teacher_disagreement_score":0.018349761,"about_ca_system_score_codex":0.0029305373,"about_ca_system_score_gemma":0.0035162235,"threshold_uncertainty_score":0.09567666},"labels":[],"label_agreement":null},{"id":"W3135009976","doi":"10.1016/j.breast.2021.02.013","title":"Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Medicine; Oncoplastic Surgery; Breast cancer; Breast-conserving surgery; Cancer; General surgery; Oncology; Breast surgery; Internal medicine; Mastectomy; Biology","score_opus":0.3377252705418814,"score_gpt":0.45660589737202406,"score_spread":0.11888062683014267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135009976","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011891745,0.36554042,0.07749679,0.44977468,0.03855096,0.024699299,0.0063706185,0.00070785155,0.024967615],"genre_scores_gemma":[0.13288984,0.231289,0.4734504,0.12218272,0.011179387,0.01919961,0.0050978404,0.00031957362,0.004391681],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.8471984,0.06905173,0.055593997,0.0057766796,0.02054358,0.0018355474],"domain_scores_gemma":[0.63091433,0.21426195,0.04649094,0.010038515,0.09225072,0.0060436013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15709719,0.0018832952,0.0053788708,0.012528898,0.002427869,0.0076046563,0.00813299,0.008263415,0.004670371],"category_scores_gemma":[0.37645766,0.0020969464,0.010447447,0.006477345,0.003860097,0.008303637,0.006975987,0.009579235,0.002033884],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009422954,0.000152671,0.012275237,0.36855954,0.012639266,0.0008261877,0.0070016375,0.0018833242,0.0026795822,0.024680808,0.16166477,0.4066947],"study_design_scores_gemma":[0.0012444173,0.00070175366,0.007774308,0.45693305,0.019438965,0.0007245864,0.0044215173,0.0034922117,0.0015055641,0.056913417,0.44629985,0.00055036036],"about_ca_topic_score_codex":0.0073685315,"about_ca_topic_score_gemma":0.012030367,"teacher_disagreement_score":0.15709719,"about_ca_system_score_codex":0.0075114984,"about_ca_system_score_gemma":0.028888779,"threshold_uncertainty_score":0.83081925},"labels":[],"label_agreement":null},{"id":"W3138361250","doi":"10.1016/s0960-9776(21)00144-2","title":"Efficacy of fulvestrant in hormone refractory metastatic breast cancer (mBC): a Canadian province experience","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Metastatic breast cancer; Oncology; Refractory (planetary science); Cancer; Internal medicine; Breast cancer; Gynecology; Tamoxifen","score_opus":0.0176664327392084,"score_gpt":0.2939968056899863,"score_spread":0.2763303729507779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138361250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642531,0.013435962,0.00015477245,0.004155314,0.00009287591,0.00018633032,0.0016806729,0.000016878848,0.016023992],"genre_scores_gemma":[0.9854683,0.009898645,0.000405725,0.00076678686,0.000058479225,0.000035096753,0.00088961684,0.000015992193,0.0024613806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995409,0.00005989194,0.000017028002,0.00004002285,0.00019328781,0.0001488962],"domain_scores_gemma":[0.99896324,0.00011546353,0.00010732938,0.000023196202,0.00041234217,0.00037844852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076098385,0.0002921545,0.00049348996,0.00034387354,0.0021369015,0.0009479861,0.00063559425,0.0003917427,0.0017663277],"category_scores_gemma":[0.0017689713,0.00013116955,0.00036898057,0.0014755988,0.0007685236,0.00024932047,0.00040779755,0.0007259886,0.00018791313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027462976,0.0041291565,0.43506533,0.0017403266,0.0006821069,0.0045471955,0.009051828,0.0040416834,0.01602163,0.0042821034,0.039418392,0.45355716],"study_design_scores_gemma":[0.0043975655,0.007675392,0.88108486,0.000621793,0.0008217944,0.0032140082,0.006063839,0.0011573724,0.0025338337,0.0006359929,0.09162184,0.00017171832],"about_ca_topic_score_codex":0.93947446,"about_ca_topic_score_gemma":0.97547525,"teacher_disagreement_score":0.060525537,"about_ca_system_score_codex":0.033994507,"about_ca_system_score_gemma":0.036971323,"threshold_uncertainty_score":0.24664861},"labels":[],"label_agreement":null},{"id":"W3138903897","doi":"10.1016/s0960-9776(21)00240-x","title":"Reproductive outcomes in young breast cancer survivors treated (15–39) in Ontario, Canada: a population-based study","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Demography; Gynecology; Oncology; Population; Cancer; Gerontology; Obstetrics; Internal medicine; Environmental health","score_opus":0.017200923387374643,"score_gpt":0.2696917564832178,"score_spread":0.25249083309584314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138903897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920838,0.0007913945,0.00007695917,0.00035137648,0.000012740627,0.00006844257,0.0041928594,0.000006849529,0.0024156182],"genre_scores_gemma":[0.99639326,0.00064626796,0.000094197974,0.00015923165,0.0000073123583,0.000029988472,0.0013530039,0.0000039412203,0.0013127077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993717,0.00004507958,0.000043819902,0.00009520304,0.0001914999,0.00025273242],"domain_scores_gemma":[0.99874085,0.000060146554,0.00030428355,0.000044434553,0.00044152865,0.00040874584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039407605,0.00032545382,0.00049508625,0.0011045124,0.0032177013,0.0012067695,0.0011615444,0.0006673326,0.0019736025],"category_scores_gemma":[0.0012705565,0.0005502095,0.0007467477,0.004596815,0.0006872801,0.00049141684,0.0007992203,0.0007906691,0.00027419132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041761003,0.000035631885,0.99668103,0.00002335397,0.000038435875,0.00008051562,0.0010561309,0.00003046118,0.00010785398,0.000047610443,0.00055975607,0.0012974379],"study_design_scores_gemma":[0.0000060140096,0.000016649947,0.998139,0.00002083233,0.00001832387,0.000035768782,0.0012385475,0.000042267082,0.000015037986,0.000010704335,0.00045157457,0.0000052129176],"about_ca_topic_score_codex":0.9918761,"about_ca_topic_score_gemma":0.9959053,"teacher_disagreement_score":0.018779106,"about_ca_system_score_codex":0.018779106,"about_ca_system_score_gemma":0.021003397,"threshold_uncertainty_score":0.13625258},"labels":[],"label_agreement":null},{"id":"W3149251690","doi":"10.1016/j.breast.2021.03.011","title":"Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St Joseph's Health Care; University of Toronto; London Health Sciences Centre; Western University","funders":"Terry Fox Research Institute; Ontario Institute for Cancer Research; Stand Up To Cancer Canada","keywords":"Medicine; Triple-negative breast cancer; Radiation therapy; In vivo; Breast cancer; Cancer; Cancer research; Oncology; Kinase; Ex vivo; Clinical endpoint; Internal medicine; Clinical trial","score_opus":0.003520738151201363,"score_gpt":0.2200889338834454,"score_spread":0.21656819573224403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149251690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908687,0.0070174253,0.0007370297,0.00015911077,0.000055498876,0.000053985306,0.0001671533,0.00008766115,0.0026351246],"genre_scores_gemma":[0.9957557,0.0022729957,0.0006587555,0.000036175374,0.000012704699,0.00002437243,0.00014995335,0.000008580409,0.0010807943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.00001597478,0.0000050069566,0.000013142125,0.000016337664,0.000019019104],"domain_scores_gemma":[0.9999696,0.0000064833157,0.00000821456,0.0000032683615,0.0000025578274,0.000009924075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012600992,0.00029695284,0.00043836114,0.00039961596,0.00015544976,0.00020735513,0.00024265193,0.00024765846,0.0014466984],"category_scores_gemma":[0.00007409376,0.000121760546,0.00020643939,0.0002242551,0.00014238758,0.00017580423,0.00018440437,0.00046774474,0.0001720504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002392363,0.00076038967,0.0009384523,0.0002986891,0.000082651844,0.00021744295,0.0000596745,0.0018609314,0.9546534,0.0002215752,0.00065012934,0.03786436],"study_design_scores_gemma":[0.00045354766,0.009259213,0.010083437,0.000027957574,0.00019313642,0.001016751,0.00005872447,0.0028775858,0.96739453,0.0000800305,0.008538044,0.000017004022],"about_ca_topic_score_codex":0.0008423622,"about_ca_topic_score_gemma":0.0019519271,"teacher_disagreement_score":0.0014466984,"about_ca_system_score_codex":0.00030490386,"about_ca_system_score_gemma":0.0002587003,"threshold_uncertainty_score":0.0048396587},"labels":[],"label_agreement":null},{"id":"W3149636610","doi":"10.1016/j.breast.2021.03.012","title":"A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Alberta; Ottawa Hospital; Northeast Cancer Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Ottawa Hospital; Cancer Care Ontario","keywords":"Medicine; Febrile neutropenia; Internal medicine; Docetaxel; Clinical endpoint; Neutropenia; Ciprofloxacin; Chemotherapy; Granulocyte colony-stimulating factor; Cyclophosphamide; Antibiotics; Randomized controlled trial","score_opus":0.0433929551540049,"score_gpt":0.3064668189717604,"score_spread":0.26307386381775555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149636610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436885,0.002390593,0.00021130494,0.00012928384,0.00007451605,0.001843168,0.0004772223,0.000009049103,0.0004960377],"genre_scores_gemma":[0.99657756,0.0006632641,0.00051490293,0.0002756408,0.00008886086,0.0012411481,0.00037901188,0.00000416894,0.0002554673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99448085,0.0032183235,0.00055869936,0.00073653396,0.00057695026,0.00042862218],"domain_scores_gemma":[0.99191624,0.0026057553,0.0021601925,0.00052248326,0.0007242117,0.0020709783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046424232,0.0011017155,0.00296882,0.00056001754,0.00070577406,0.0015595618,0.0008443631,0.001571065,0.006055493],"category_scores_gemma":[0.010810782,0.0008577953,0.003394792,0.0011307041,0.0009801764,0.0008346933,0.0006937294,0.0016696985,0.00058363186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8985506,0.020711543,0.04117527,0.0030074145,0.008520389,0.00038500002,0.000633828,0.00075980334,0.0016376746,0.0001750874,0.000994498,0.023448883],"study_design_scores_gemma":[0.5862992,0.29371428,0.109116256,0.0003894161,0.006565243,0.00037661433,0.00039702165,0.0009681988,0.00042373742,0.0001972869,0.0014397284,0.000113039154],"about_ca_topic_score_codex":0.00903267,"about_ca_topic_score_gemma":0.012795548,"teacher_disagreement_score":0.00903267,"about_ca_system_score_codex":0.0038038509,"about_ca_system_score_gemma":0.0038114332,"threshold_uncertainty_score":0.027598977},"labels":[],"label_agreement":null},{"id":"W3154821758","doi":"10.1016/j.breast.2021.04.005","title":"Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"North York General Hospital; Mount Sinai Hospital; Princess Margaret Cancer Centre; Queen's University; Hospital for Sick Children; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Sinai Health System; Hamilton Health Sciences; SickKids Foundation; University of Toronto; Health Sciences Centre","funders":"Canadian Cancer Society","keywords":"Medicine; Pediatrics; Neurocognitive; Cohort; Context (archaeology); Pregnancy; Prospective cohort study; Pediatric cancer; Gestational age; Cohort study; Cancer; Cognition; Internal medicine; Psychiatry","score_opus":0.02033280582521499,"score_gpt":0.3154858419035457,"score_spread":0.29515303607833077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154821758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663,0.00040278662,0.00010433838,0.00014228177,0.000006365544,0.000054787906,0.001992562,0.0000050373565,0.0006617197],"genre_scores_gemma":[0.99720496,0.00058301864,0.00028581257,0.00008348924,0.000004504089,0.00003740167,0.0014975271,0.000004095485,0.000299088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923456,0.000060832812,0.000037910817,0.0001750082,0.00027360165,0.00021808807],"domain_scores_gemma":[0.99883384,0.000083654886,0.00027704766,0.00008587293,0.00042891898,0.0002907322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008513603,0.00047485947,0.00046852053,0.0010801377,0.002595786,0.0008276575,0.0011035826,0.0005122408,0.0011430668],"category_scores_gemma":[0.0015782319,0.00039057463,0.0005605598,0.0030786886,0.0005566693,0.00037016702,0.0008401253,0.00069306797,0.00013564774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005087223,0.000024459025,0.99732095,0.00001948218,0.000059716076,0.00011614858,0.0004785866,0.000033633758,0.00017072636,0.000030235055,0.00031688774,0.0013784595],"study_design_scores_gemma":[0.000005334301,0.000030207271,0.99911827,0.0000138540145,0.000029265524,0.000080681886,0.00038328994,0.000059324866,0.00002558202,0.000007718639,0.00024134784,0.000005164436],"about_ca_topic_score_codex":0.96825343,"about_ca_topic_score_gemma":0.9750157,"teacher_disagreement_score":0.031746566,"about_ca_system_score_codex":0.010493503,"about_ca_system_score_gemma":0.011019639,"threshold_uncertainty_score":0.07613605},"labels":[],"label_agreement":null},{"id":"W3160352463","doi":"10.1016/j.breast.2021.04.011","title":"Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Ovarian cancer; Breast cancer; Medicine; Population; Genetic testing; Oncology; Gynecology; Cancer; Internal medicine; Environmental health","score_opus":0.03194031188855451,"score_gpt":0.35859860630793416,"score_spread":0.32665829441937966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160352463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047264264,0.9994765,0.000045594177,0.00018099645,0.00005029576,0.0000054207685,0.000019273264,0.000001342907,0.00017339257],"genre_scores_gemma":[0.00043323843,0.9992054,0.000121234974,0.00012503055,0.00004883373,0.000009341544,0.000017624778,7.833335e-7,0.000038647533],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99868983,0.0004985606,0.00027554386,0.00013426002,0.00034404488,0.000057787707],"domain_scores_gemma":[0.99293244,0.00589307,0.0005252236,0.0000627128,0.00051314314,0.00007351446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034450185,0.0012026661,0.003051703,0.005031127,0.00021915998,0.0017747603,0.0013714123,0.0016224688,0.0044635884],"category_scores_gemma":[0.008901379,0.0004844174,0.0020419892,0.0060705184,0.0005302446,0.0015570482,0.0007429403,0.0014678835,0.0006923467],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017699484,0.000067614936,0.0002767204,0.20936769,0.0011741761,0.0001605768,0.0000787395,0.00075492775,0.00025276278,0.0046022395,0.018026257,0.7650613],"study_design_scores_gemma":[0.00014839186,0.0003320989,0.0035098167,0.2931193,0.004752914,0.0016329084,0.00019618536,0.0004044878,0.00035167203,0.005355965,0.69011927,0.00007687976],"about_ca_topic_score_codex":0.0024371059,"about_ca_topic_score_gemma":0.0036645283,"teacher_disagreement_score":0.005031127,"about_ca_system_score_codex":0.0017544565,"about_ca_system_score_gemma":0.0030717405,"threshold_uncertainty_score":0.018219173},"labels":[],"label_agreement":null},{"id":"W3163713040","doi":"10.1016/j.breast.2021.05.006","title":"Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Montreal Cognitive Assessment; Conventional PCI; Cohort; Receiver operating characteristic; Baseline (sea); Cognition; Quartile; Cognitive test; Breast cancer; Physical therapy; Demography; Internal medicine; Cognitive impairment; Cancer; Psychiatry","score_opus":0.004548131539697643,"score_gpt":0.23424186398158298,"score_spread":0.22969373244188535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163713040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992575,0.00010284917,0.000044341818,0.000026598558,0.000003380882,0.000005196718,0.0003934868,0.000001734561,0.00016480405],"genre_scores_gemma":[0.9991953,0.00008704627,0.00006536435,0.000010255632,0.000002860028,0.000006585317,0.0004959203,0.0000010811264,0.00013569457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999841,0.000025318657,0.000016925787,0.000044716027,0.000028898108,0.000043179694],"domain_scores_gemma":[0.99940586,0.000055807235,0.00027219305,0.000048159432,0.000095313306,0.00012260959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040121132,0.00026606966,0.00021491766,0.0006975088,0.0004880762,0.0006279372,0.00027332996,0.0003396204,0.000881515],"category_scores_gemma":[0.0019573895,0.00020136153,0.00042145135,0.0007793501,0.00015332918,0.00043752938,0.00056698004,0.00054654205,0.00022899894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055288325,0.000017439568,0.99913186,0.0000028476213,0.000012240431,0.000032277578,0.000045524197,0.0000233642,0.000046690475,0.000005602106,0.000031757256,0.00059507537],"study_design_scores_gemma":[0.0000022089114,0.0000706414,0.9992799,0.000005577214,0.0000116355795,0.00015852928,0.0001763932,0.00014680646,0.000023430392,0.000016082126,0.00010663858,0.0000020990303],"about_ca_topic_score_codex":0.020264577,"about_ca_topic_score_gemma":0.019467862,"teacher_disagreement_score":0.020264577,"about_ca_system_score_codex":0.00033793238,"about_ca_system_score_gemma":0.00042119712,"threshold_uncertainty_score":0.040293217},"labels":[],"label_agreement":null},{"id":"W3174949713","doi":"10.1016/j.breast.2021.05.003","title":"Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Breast cancer; Confidence interval; Metastatic breast cancer; Population; Meta-analysis; Cancer; Randomized controlled trial; Adjuvant therapy","score_opus":0.07876204760154336,"score_gpt":0.3646114644662783,"score_spread":0.2858494168647349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174949713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020650066,0.9969298,0.0002593089,0.00013676521,0.00006056085,0.000083785126,0.000273274,0.0000137471425,0.00017775226],"genre_scores_gemma":[0.11122333,0.8853456,0.0012443019,0.00068922795,0.00020192428,0.00044164233,0.000621712,0.000024256058,0.00020793588],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948133,0.002671089,0.0012085488,0.0005709166,0.0005495552,0.00018662818],"domain_scores_gemma":[0.9871427,0.009622479,0.0020123075,0.00035645047,0.00071879075,0.00014736586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010516733,0.002347995,0.0155110145,0.0054461025,0.00041263053,0.00262238,0.0014870882,0.0014253381,0.0033956168],"category_scores_gemma":[0.021282416,0.00094205845,0.029020132,0.006294687,0.0005195903,0.0012480477,0.0011544747,0.0014725842,0.0002610815],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020482878,0.000024371919,0.0029739353,0.4191668,0.5529123,0.00012321494,0.000065680986,0.0008993835,0.0002728426,0.00019823456,0.0010221822,0.02029279],"study_design_scores_gemma":[0.00053956104,0.0001953283,0.0038428695,0.031502903,0.96042025,0.00013040415,0.000029216139,0.00020175328,0.00011251173,0.0003177335,0.0026872184,0.000020355112],"about_ca_topic_score_codex":0.0048890626,"about_ca_topic_score_gemma":0.0108774025,"teacher_disagreement_score":0.0155110145,"about_ca_system_score_codex":0.0023107622,"about_ca_system_score_gemma":0.00232717,"threshold_uncertainty_score":0.055618465},"labels":[],"label_agreement":null},{"id":"W3177968379","doi":"10.1016/j.breast.2021.07.005","title":"Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Trastuzumab; Proportional hazards model; Oncology; Radiation therapy; Systemic therapy; Cancer; Hormonal therapy; Population; Chemotherapy; Cancer registry; Confidence interval; Gynecology","score_opus":0.011340067968934126,"score_gpt":0.24514122542037875,"score_spread":0.2338011574514446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177968379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996227,0.0023434407,0.00009104288,0.00013926033,0.000009684991,0.0000102682125,0.0005299745,0.0000028522713,0.0006463771],"genre_scores_gemma":[0.9990096,0.00047660526,0.000047356578,0.000041900665,0.000017170712,0.0000063823923,0.00029054217,9.887482e-7,0.00010941377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995326,0.00014392745,0.000027613018,0.000070889495,0.00009652461,0.00012852377],"domain_scores_gemma":[0.9984224,0.0004399313,0.0007248698,0.00007384432,0.0001464,0.00019258971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096271455,0.00022901312,0.00032118475,0.00065981894,0.00028018613,0.00044247505,0.00039255168,0.0004075071,0.0011905029],"category_scores_gemma":[0.0027806552,0.00014167617,0.0008019052,0.0009860774,0.00023460844,0.0003458498,0.00028628935,0.00048233932,0.00013136759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001862709,0.00002088575,0.9981249,0.0000148003855,0.00007975371,0.00001867744,0.000022667848,0.00003752879,0.00003329423,0.000009782439,0.000054506203,0.0013968807],"study_design_scores_gemma":[0.000006963112,0.000107287146,0.99933714,0.000011172597,0.00009777134,0.00005390859,0.000053586027,0.00012038623,0.000016239497,0.000020176909,0.00017372124,0.0000017492002],"about_ca_topic_score_codex":0.029780792,"about_ca_topic_score_gemma":0.04168336,"teacher_disagreement_score":0.029780792,"about_ca_system_score_codex":0.00073813414,"about_ca_system_score_gemma":0.0007550483,"threshold_uncertainty_score":0.05921495},"labels":[],"label_agreement":null},{"id":"W3186455232","doi":"10.1016/j.breast.2021.07.017","title":"Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Post-hoc analysis; Internal medicine; Oncology; Adverse effect; Placebo; Breast cancer; Fulvestrant; Cancer; Common Terminology Criteria for Adverse Events; Estrogen receptor; Metastatic breast cancer; Aromatase; Pathology","score_opus":0.007593714205128284,"score_gpt":0.26553065339647824,"score_spread":0.25793693919134997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186455232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782723,0.0004581177,0.00014627268,0.00008864131,0.00002753133,0.00047869122,0.0004516695,0.000014711914,0.0005070617],"genre_scores_gemma":[0.9963469,0.00028545852,0.00038220853,0.0001583733,0.00011050177,0.0006423662,0.0012602326,0.000010150957,0.00080388953],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99886644,0.00063384173,0.00006819333,0.00014970009,0.00011308474,0.00016869127],"domain_scores_gemma":[0.9983656,0.0005927655,0.00037914407,0.0001677835,0.00013409347,0.00036062335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030817022,0.0012809944,0.0023518319,0.00039673308,0.0003157143,0.00076888874,0.00075692247,0.0006053708,0.0043429593],"category_scores_gemma":[0.0019970797,0.0003752037,0.0028854802,0.00036468968,0.0007104658,0.0007440719,0.00044990194,0.0017672898,0.00053670566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94601476,0.007458376,0.016947776,0.0003492803,0.0031688637,0.00014989903,0.000072170165,0.0011337007,0.008989809,0.000055919765,0.0006499163,0.015009622],"study_design_scores_gemma":[0.41747683,0.4880606,0.080261566,0.000027511142,0.0045969686,0.00028686825,0.0000880826,0.0022443791,0.0049333703,0.00015772013,0.0018225535,0.0000434389],"about_ca_topic_score_codex":0.0006081197,"about_ca_topic_score_gemma":0.0016492436,"teacher_disagreement_score":0.0043429593,"about_ca_system_score_codex":0.00081225444,"about_ca_system_score_gemma":0.0015666464,"threshold_uncertainty_score":0.016297817},"labels":[],"label_agreement":null},{"id":"W3187853271","doi":"10.1016/j.breast.2021.07.021","title":"Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; NRG Oncology; ECOG-ACRIN Cancer Research Group; Emory University; American College of Radiology Imaging Network","keywords":"Medicine; Tamoxifen; Breast cancer; Pregnancy; Fertility preservation; Obstetrics; Fertility; Gynecology; Mastectomy; Cancer; Breastfeeding; Internal medicine; Population; Pediatrics","score_opus":0.02011653005674881,"score_gpt":0.3023161623035004,"score_spread":0.2821996322467516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187853271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97507167,0.0068068234,0.00022057325,0.0069566662,0.00024406223,0.0009209846,0.003454737,0.000025280759,0.0062991716],"genre_scores_gemma":[0.9846332,0.0037713915,0.00043613,0.0060810023,0.00030747682,0.001229827,0.0018335773,0.000020332018,0.0016870454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942017,0.00033363726,0.00004060055,0.000047849815,0.0000526352,0.000105118874],"domain_scores_gemma":[0.99815875,0.00032012857,0.00056448666,0.00007602988,0.0000952664,0.0007853499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023486689,0.00027117453,0.0004990406,0.0003466863,0.0006134687,0.0010024885,0.000424428,0.000753304,0.00273306],"category_scores_gemma":[0.0041585555,0.00024784295,0.00042486435,0.0007145092,0.00046476896,0.0014149338,0.0009468258,0.0009115027,0.0007369214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009162963,0.0016327614,0.8774352,0.0010596734,0.00035827715,0.000383344,0.0018283803,0.0001394488,0.00064515474,0.0007995505,0.014580532,0.091974646],"study_design_scores_gemma":[0.010408337,0.012379329,0.93038255,0.0015549148,0.0013201016,0.001245083,0.007113042,0.00041432647,0.00029610042,0.0017540167,0.03304298,0.000089289024],"about_ca_topic_score_codex":0.002318426,"about_ca_topic_score_gemma":0.0036779689,"teacher_disagreement_score":0.00273306,"about_ca_system_score_codex":0.00023320968,"about_ca_system_score_gemma":0.0011847386,"threshold_uncertainty_score":0.012421131},"labels":[],"label_agreement":null},{"id":"W3203775877","doi":"10.1016/j.breast.2021.09.009","title":"Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001)","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of British Columbia; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Mastectomy; Breast cancer; Breast reconstruction; Oncology; General surgery; Cancer; Medical physics; Internal medicine","score_opus":0.01374698479601957,"score_gpt":0.23565210267009035,"score_spread":0.22190511787407077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203775877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716955,0.00016784208,0.0015890507,0.00012224008,0.000010871298,0.0000306261,0.00060756906,0.000025549927,0.00027677708],"genre_scores_gemma":[0.99677926,0.00005666367,0.0019977556,0.00003188487,0.000007774632,0.000034756766,0.00092520623,0.0000030012066,0.00016378345],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99946207,0.00026754587,0.000049273953,0.00009851854,0.00007308448,0.00004953587],"domain_scores_gemma":[0.9963904,0.002084046,0.0008268345,0.00016253474,0.00037240496,0.00016379358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026953046,0.00033278475,0.00031323844,0.0006095202,0.00014040539,0.00040880468,0.0003460411,0.00046430086,0.0008377611],"category_scores_gemma":[0.007574423,0.00013799238,0.00055800984,0.00048431882,0.00014774545,0.00029654318,0.0003624527,0.0006074489,0.00026101532],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000463101,0.00022811211,0.9714229,0.000024252771,0.00011265348,0.000021229996,0.000048759586,0.005463391,0.00023185465,0.00003234858,0.0004884851,0.021462964],"study_design_scores_gemma":[0.000058561578,0.0011282169,0.8873657,0.000023120248,0.00008414197,0.00016088645,0.00009881262,0.10970904,0.00067924126,0.00021541555,0.00046114202,0.000015747193],"about_ca_topic_score_codex":0.002060243,"about_ca_topic_score_gemma":0.0025820718,"teacher_disagreement_score":0.0026953046,"about_ca_system_score_codex":0.00042154753,"about_ca_system_score_gemma":0.0002773627,"threshold_uncertainty_score":0.014254332},"labels":[],"label_agreement":null},{"id":"W3209188040","doi":"10.1016/j.breast.2021.09.010","title":"The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Canadian Centre for Applied Research in Cancer Control; CancerCare Manitoba; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Tamoxifen; Medicine; Aromatase inhibitor; Breast cancer; Hazard ratio; Internal medicine; Osteoporosis; Oncology; Anastrozole; Proportional hazards model; Aromatase; Cancer; Gynecology; Confidence interval","score_opus":0.004528635657235276,"score_gpt":0.20555662643288372,"score_spread":0.20102799077564845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209188040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850735,0.0032531985,0.00018239924,0.0014893829,0.000031105505,0.000081484024,0.006448841,0.000012717542,0.003427285],"genre_scores_gemma":[0.9969207,0.0010221773,0.0001464544,0.00015513047,0.00001180816,0.000017649903,0.0008776591,0.0000035263465,0.0008450026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914813,0.000075909455,0.00007825883,0.00011140328,0.00035349134,0.00023279943],"domain_scores_gemma":[0.99665207,0.00029552865,0.0010054976,0.000079472135,0.0013411103,0.000626344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006196948,0.00018967419,0.00036110435,0.0007835224,0.0015039302,0.0008541258,0.0011581365,0.00037847026,0.0022562633],"category_scores_gemma":[0.0028556853,0.00026714816,0.00057093764,0.0026150097,0.0005122774,0.00021879503,0.00044030877,0.00055375765,0.00011706594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006753085,0.000015900714,0.9968267,0.000057543584,0.00004396324,0.000059518177,0.00020046833,0.000058177375,0.00008720476,0.000041755156,0.00067869225,0.0018625293],"study_design_scores_gemma":[0.000011552136,0.000016849748,0.9987342,0.000036476275,0.000034220768,0.000056622368,0.00031217595,0.00013692588,0.000024328443,0.000011550561,0.0006209533,0.0000040609593],"about_ca_topic_score_codex":0.9940095,"about_ca_topic_score_gemma":0.99679023,"teacher_disagreement_score":0.022186799,"about_ca_system_score_codex":0.022186799,"about_ca_system_score_gemma":0.03219392,"threshold_uncertainty_score":0.16097724},"labels":[],"label_agreement":null},{"id":"W3209816014","doi":"10.1016/j.breast.2021.10.007","title":"Response to Soran et al.","year":2021,"lang":"en","type":"letter","venue":"The Breast","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine","score_opus":0.025517602676456187,"score_gpt":0.29945844350591333,"score_spread":0.27394084082945713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209816014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002410948,0.00089819287,0.000040019968,0.97907066,0.0148128215,0.000017809056,0.00010061374,0.000036352794,0.0047824583],"genre_scores_gemma":[0.0015674283,0.000605463,0.000072396535,0.97750956,0.011859576,0.00003285237,0.000048757847,0.000017312215,0.008286517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768233,0.00063582615,0.00018548685,0.00029897815,0.0006828016,0.00051446474],"domain_scores_gemma":[0.99640405,0.0012683515,0.00021440808,0.00008581547,0.0009073464,0.0011200905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027261933,0.000989665,0.0014689288,0.0008372128,0.0052056108,0.004034119,0.0019746348,0.049272705,0.014150418],"category_scores_gemma":[0.016795944,0.0006011998,0.0012044717,0.00075353193,0.002148337,0.0034462283,0.0015849657,0.033114698,0.012135887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045963745,0.00002183283,0.00020576353,0.000023818471,0.000005370568,0.00092844135,0.000047913203,0.000033726457,0.000039307975,0.00068436,0.9954917,0.0024717352],"study_design_scores_gemma":[0.00012680156,0.00007442027,0.0010238074,0.0003012504,0.00002268528,0.002104079,0.0005119291,0.00038778715,0.00014561127,0.0054209097,0.9898212,0.00005938238],"about_ca_topic_score_codex":0.011234768,"about_ca_topic_score_gemma":0.020991098,"teacher_disagreement_score":0.049272705,"about_ca_system_score_codex":0.0045781913,"about_ca_system_score_gemma":0.005909374,"threshold_uncertainty_score":0.04733783},"labels":[],"label_agreement":null},{"id":"W3211935866","doi":"10.1016/j.breast.2021.11.007","title":"Development of novel agents for the treatment of early estrogen receptor positive breast cancer","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Oncology; Adjuvant; Disease; PI3K/AKT/mTOR pathway; Cancer; Internal medicine; Biomarker; Estrogen; Targeted therapy; Adjuvant therapy; Bioinformatics; Signal transduction","score_opus":0.08722767617663327,"score_gpt":0.38408548017142,"score_spread":0.2968578039947868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211935866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024052084,0.99819523,0.00017435731,0.00016802161,0.00015395945,0.000010710841,0.000029360875,0.00000916957,0.0010186828],"genre_scores_gemma":[0.001047545,0.9976732,0.00026829672,0.00019881707,0.00007290366,0.000012359291,0.000043604978,0.0000017844975,0.000681477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985814,0.000028119784,0.000017906148,0.000022598802,0.000056398254,0.000016880696],"domain_scores_gemma":[0.99983895,0.000072717135,0.000028474698,0.000005346739,0.000042079308,0.000012343811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004331368,0.00063427264,0.0010323643,0.0016841167,0.00018251342,0.00071403215,0.00060027343,0.00075053883,0.0037096683],"category_scores_gemma":[0.0005795662,0.00022860299,0.00059729576,0.001054028,0.00022783403,0.0008543501,0.00046841422,0.0017057704,0.0016906736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008556177,0.00010685413,0.00009279453,0.02101872,0.0001244183,0.00016436877,0.000050686707,0.00048133568,0.00368558,0.004046255,0.02028746,0.9498559],"study_design_scores_gemma":[0.000034338165,0.00019359875,0.0004948862,0.0042011766,0.00014703615,0.0008221057,0.000032049757,0.00013247503,0.0011727485,0.0013107527,0.9914442,0.00001474468],"about_ca_topic_score_codex":0.0005778375,"about_ca_topic_score_gemma":0.001332251,"teacher_disagreement_score":0.0037096683,"about_ca_system_score_codex":0.00036385117,"about_ca_system_score_gemma":0.0005575059,"threshold_uncertainty_score":0.012410104},"labels":[],"label_agreement":null},{"id":"W4212945590","doi":"10.1016/j.breast.2022.02.012","title":"Exploring breast surgeons’ reasons for women not undergoing immediate breast reconstruction","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Breast reconstruction; Referral; General surgery; Breast surgery; Retrospective cohort study; Cancer; Surgery; Family medicine; Internal medicine","score_opus":0.051835408763934124,"score_gpt":0.24129692482208995,"score_spread":0.1894615160581558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212945590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230266,0.0009146415,0.00013293247,0.0021023047,0.000029107052,0.00004821663,0.000660973,0.000011336194,0.0037978163],"genre_scores_gemma":[0.9979183,0.0007761243,0.00022399901,0.00035410761,0.000016978016,0.0000151784525,0.00022456734,0.0000035944017,0.00046704977],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9985196,0.00022679612,0.00018328297,0.000090548645,0.00065262394,0.00032714847],"domain_scores_gemma":[0.9926604,0.0018054962,0.0035227465,0.000115189476,0.0009699607,0.0009262565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011458216,0.00014194295,0.0001361186,0.0008848437,0.0011524716,0.00077222945,0.0006110735,0.00031602266,0.004304923],"category_scores_gemma":[0.006619007,0.00015030059,0.00031452818,0.0013026623,0.00065863243,0.00027625271,0.0007279404,0.00058043347,0.00023640861],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026712274,0.000019089362,0.9876124,0.00008532672,0.000015968968,0.0003578116,0.0017891629,0.000043901742,0.00018407192,0.000047901354,0.0010933763,0.008724264],"study_design_scores_gemma":[0.0000029024015,0.000050219143,0.9803725,0.0001608268,0.000015878986,0.0013544061,0.014697657,0.0001011895,0.00015689508,0.000040338786,0.0030346587,0.000012618632],"about_ca_topic_score_codex":0.20368063,"about_ca_topic_score_gemma":0.37822023,"teacher_disagreement_score":0.20368063,"about_ca_system_score_codex":0.002746731,"about_ca_system_score_gemma":0.0071483566,"threshold_uncertainty_score":0.40499014},"labels":[],"label_agreement":null},{"id":"W4230263812","doi":"10.1016/j.breast.2014.08.009","title":"ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Disease; Oncology; Quality of life (healthcare); Family medicine; Cancer; Internal medicine; Intensive care medicine; Medical physics; Nursing","score_opus":0.022116237763396898,"score_gpt":0.3237934648715714,"score_spread":0.3016772271081745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230263812","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010132951,0.54277366,0.05000422,0.21865603,0.022932906,0.004876156,0.017593447,0.0013675902,0.13166304],"genre_scores_gemma":[0.0680857,0.3963103,0.24988723,0.106908314,0.013309095,0.016329575,0.06683876,0.00096642564,0.08136465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864101,0.0055945492,0.0034196947,0.00045324015,0.0032790566,0.0008433129],"domain_scores_gemma":[0.9802254,0.0064604944,0.0028015762,0.0007135137,0.008723719,0.0010753913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019316847,0.0015154782,0.002446472,0.005822267,0.0012265841,0.002919071,0.004062101,0.0059631173,0.0066777216],"category_scores_gemma":[0.029505217,0.0007579709,0.004567744,0.0035351452,0.0012104224,0.0013288093,0.0034625297,0.0041445685,0.004586079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000608501,0.0002242023,0.006434761,0.010676917,0.0005230189,0.00054963183,0.00023406808,0.001082489,0.0013759844,0.010370503,0.5640353,0.40388465],"study_design_scores_gemma":[0.0003405496,0.00015378762,0.009173717,0.018951295,0.00088386406,0.0015568153,0.00022373449,0.00058463425,0.0013853167,0.006107832,0.96058685,0.00005167093],"about_ca_topic_score_codex":0.010805985,"about_ca_topic_score_gemma":0.015453436,"teacher_disagreement_score":0.019316847,"about_ca_system_score_codex":0.0035088432,"about_ca_system_score_gemma":0.010512081,"threshold_uncertainty_score":0.10215849},"labels":[],"label_agreement":null},{"id":"W4237328149","doi":"10.1016/s0960-9776(13)70002-x","title":"Speakers' Abstracts","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dermatology","score_opus":0.007845878108867157,"score_gpt":0.23814446719075277,"score_spread":0.2302985890818856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237328149","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012712609,0.010847027,0.0019013839,0.09937264,0.64944506,0.0006992833,0.0048377807,0.00097875,0.23064674],"genre_scores_gemma":[0.009035801,0.008776393,0.00133599,0.034718875,0.22641183,0.0007805647,0.0039944695,0.0009449166,0.7140011],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982876,0.00023452632,0.00014067466,0.00026080568,0.0008330172,0.00024335696],"domain_scores_gemma":[0.9901916,0.0013853597,0.00037714298,0.0002951281,0.005368704,0.0023821434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026233504,0.0011568916,0.0008837083,0.0015338558,0.0014726284,0.0049543777,0.0016664681,0.0033231052,0.44816917],"category_scores_gemma":[0.0144284805,0.00033580392,0.00084607175,0.00088763447,0.00053532695,0.0020946774,0.0022015246,0.0034442341,0.25017923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039092633,0.0000094995,0.000040700066,0.00010522719,0.0000021906917,0.000056911405,0.000023454788,0.000015789778,0.00015006533,0.0004510441,0.98031116,0.01879489],"study_design_scores_gemma":[0.000016358406,0.000016276508,0.00023197597,0.000119410535,0.0000033688177,0.00012817272,0.00005530512,0.00003372262,0.00010632541,0.0004539037,0.9988293,0.000005908525],"about_ca_topic_score_codex":0.0012954613,"about_ca_topic_score_gemma":0.0016419207,"teacher_disagreement_score":0.44816917,"about_ca_system_score_codex":0.0016937185,"about_ca_system_score_gemma":0.0029430771,"threshold_uncertainty_score":0.7871197},"labels":[],"label_agreement":null},{"id":"W4245399092","doi":"10.1016/j.breast.2010.06.008","title":"Following the case of fat grafting in glandular tissue, a comment on “lipomodelling of the breast: A review” in the breast volume 19, issue 3, 2010","year":2010,"lang":"en","type":"letter","venue":"The Breast","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Volume (thermodynamics); Breast tissue; Breast cancer; Internal medicine; Cancer","score_opus":0.030197682746736627,"score_gpt":0.31145301576754514,"score_spread":0.2812553330208085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245399092","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006118382,0.0042145415,0.00022608133,0.9580442,0.03577323,0.000011372297,0.000033325665,0.000020296951,0.0010651285],"genre_scores_gemma":[0.003032532,0.0026180306,0.00020654379,0.9393188,0.05266004,0.000018859251,0.000012681829,0.000014761491,0.0021177493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975237,0.0006654347,0.00041495165,0.00039459122,0.0006564177,0.00034476927],"domain_scores_gemma":[0.99262625,0.0052892296,0.00051460316,0.00018022815,0.00088849495,0.0005010809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032904234,0.00088667,0.0014172845,0.00073661696,0.0028273785,0.0029466487,0.0020891947,0.0631661,0.0019951018],"category_scores_gemma":[0.023946125,0.0007502375,0.0018473028,0.0007333499,0.002986795,0.0038894392,0.0015033925,0.048860624,0.0020272154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012269475,0.000040613602,0.0005738592,0.00019040104,0.000038627575,0.0142690195,0.00034329534,0.00009761287,0.00049306673,0.004155342,0.96859086,0.011084685],"study_design_scores_gemma":[0.00019236167,0.00020375146,0.0014554971,0.00083623664,0.00012251973,0.020007167,0.00108908,0.0006564808,0.001119392,0.008866879,0.96530914,0.00014151701],"about_ca_topic_score_codex":0.0041096406,"about_ca_topic_score_gemma":0.009267737,"teacher_disagreement_score":0.0631661,"about_ca_system_score_codex":0.0038880464,"about_ca_system_score_gemma":0.0022008198,"threshold_uncertainty_score":0.028209865},"labels":[],"label_agreement":null},{"id":"W4290997184","doi":"10.1016/j.breast.2022.08.004","title":"Response to comment on: “Global guidelines for breast cancer screening: A systematic review”","year":2022,"lang":"en","type":"review","venue":"The Breast","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Centre International de Recherche sur le Cancer","keywords":"Scopus; Guideline; Medicine; Breast cancer; Task force; Systematic review; Family medicine; Health care; Citation; Breast cancer screening; Alternative medicine; Cancer; Library science; MEDLINE; Gynecology; Mammography; Internal medicine; Pathology; Political science; Computer science","score_opus":0.5626471825821608,"score_gpt":0.5992041882873362,"score_spread":0.036557005705175394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012302358,0.00092559936,0.00018826638,0.9165053,0.07951568,0.00020827445,0.0016386196,0.00026773644,0.00062749506],"genre_scores_gemma":[0.0007157612,0.0007098441,0.00038969505,0.9760164,0.01798299,0.0006509763,0.00033284593,0.00010995781,0.0030915507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9767213,0.0059416587,0.005532254,0.0023932648,0.0077052014,0.0017063553],"domain_scores_gemma":[0.90465647,0.038214404,0.009768848,0.0025098936,0.040059377,0.004790931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0260591,0.0023200149,0.0046605505,0.0034847623,0.004278564,0.005149004,0.00684242,0.039951872,0.04563458],"category_scores_gemma":[0.20792592,0.0017980823,0.0055979723,0.003658746,0.003785997,0.007910764,0.006906928,0.034287557,0.029717125],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027527258,0.000003853275,0.00006300637,0.00042238418,0.000021284199,0.000048847494,0.00007879087,0.000014894603,0.00003725791,0.00021503908,0.9979517,0.0011154745],"study_design_scores_gemma":[0.00033909018,0.000080884354,0.001305311,0.0049541276,0.00015638923,0.0003821109,0.0007387012,0.0002474169,0.00028778016,0.0021738352,0.9891616,0.00017271726],"about_ca_topic_score_codex":0.02212398,"about_ca_topic_score_gemma":0.018557161,"teacher_disagreement_score":0.04563458,"about_ca_system_score_codex":0.014343669,"about_ca_system_score_gemma":0.018107133,"threshold_uncertainty_score":0.15266281},"labels":[],"label_agreement":null},{"id":"W4293311778","doi":"10.1016/j.breast.2022.08.003","title":"The Canadian Task Force on Preventive Health Care should not receive high ranking based on AGREEII or GRADE","year":2022,"lang":"en","type":"letter","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Guideline; Task force; Disappointment; Breast cancer; Rigour; Family medicine; Health care; Alternative medicine; Scopus; MEDLINE; Cancer; Pathology; Psychology; Social psychology; Law; Internal medicine","score_opus":0.06363400810665079,"score_gpt":0.32344902214630994,"score_spread":0.2598150140396591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293311778","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014161102,0.06241407,0.013474701,0.7195718,0.13160169,0.008420335,0.014895383,0.00094984414,0.04725598],"genre_scores_gemma":[0.07855663,0.10316008,0.18611133,0.47383592,0.052544285,0.04548436,0.026690952,0.0036977022,0.029918794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.5970638,0.110434026,0.1048005,0.008815135,0.16826056,0.0106259],"domain_scores_gemma":[0.24071099,0.1751102,0.055301942,0.026155874,0.48157573,0.021145301],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22386867,0.002141179,0.010250348,0.021148998,0.009664893,0.018618071,0.009555883,0.016664531,0.02017481],"category_scores_gemma":[0.67867106,0.0030129808,0.009583768,0.022604918,0.00717854,0.01004532,0.007835893,0.020243647,0.011914308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002566024,0.000033232332,0.0021373043,0.017610684,0.0008056473,0.00004611917,0.0006482949,0.00013177957,0.00014456987,0.0068657165,0.8886653,0.082654685],"study_design_scores_gemma":[0.0010425381,0.0002697695,0.0122994175,0.08689418,0.0018259801,0.00020028913,0.0019631162,0.0009866605,0.00049570855,0.026318539,0.866964,0.00073985424],"about_ca_topic_score_codex":0.17658883,"about_ca_topic_score_gemma":0.26826873,"teacher_disagreement_score":0.960805,"about_ca_system_score_codex":0.03919499,"about_ca_system_score_gemma":0.16091251,"threshold_uncertainty_score":0.95710814},"labels":[],"label_agreement":null},{"id":"W4306739715","doi":"10.1016/j.breast.2022.10.007","title":"Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Genentech; PharmaMar; G1 Therapeutics; MacroGenics; Pfizer; Incyte; NuCana; Seagen; Relay Therapeutics; Plexxikon; Ontario Brain Institute; Syndax Pharmaceuticals; Regeneron Pharmaceuticals; Amgen; Radius Health; Gilead Sciences; Merck; Mersana Therapeutics; Novartis; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Roche; Astellas Pharma US","keywords":"Medicine; Metastatic breast cancer; Antibody-drug conjugate; Drug; Cancer; Antibody; Breast cancer; Oncology; Conjugate; Drug development; Cancer research; Internal medicine; Pharmacology; Immunology; Monoclonal antibody","score_opus":0.05927251587468007,"score_gpt":0.42484980232567876,"score_spread":0.3655772864509987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306739715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6910909,0.23811089,0.02640375,0.0042301673,0.00077842124,0.0019550861,0.0015847969,0.0010956706,0.03475032],"genre_scores_gemma":[0.8755597,0.09617613,0.014127999,0.0016048313,0.00026271658,0.00063909177,0.0021558108,0.00008758259,0.00938612],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998466,0.00004304499,0.0000073694205,0.000022266693,0.000045683148,0.000035076697],"domain_scores_gemma":[0.99983,0.000026508014,0.000026468128,0.0000078053845,0.00004034641,0.00006876942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092874584,0.00040584354,0.00041608795,0.00038151606,0.00013638273,0.0005634024,0.0003281041,0.0006336247,0.002194352],"category_scores_gemma":[0.0005622419,0.00019320947,0.00023824032,0.00039462018,0.000251719,0.00042500877,0.0003144311,0.0009133875,0.0008060725],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030093323,0.0026289236,0.0022302312,0.0010041167,0.000092433496,0.0008567265,0.00037103813,0.0027151362,0.2729343,0.003298296,0.0107472185,0.70011234],"study_design_scores_gemma":[0.013097428,0.07298602,0.023070585,0.00056810013,0.00029975772,0.00986474,0.0001821946,0.00895739,0.29663777,0.0020190228,0.57220465,0.00011228571],"about_ca_topic_score_codex":0.00072932395,"about_ca_topic_score_gemma":0.0012133468,"teacher_disagreement_score":0.002194352,"about_ca_system_score_codex":0.0004312106,"about_ca_system_score_gemma":0.00054885313,"threshold_uncertainty_score":0.007340789},"labels":[],"label_agreement":null},{"id":"W4309348334","doi":"10.1016/j.breast.2022.11.005","title":"Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Medicine; Palbociclib; Oncology; Human Epidermal Growth Factor Receptor 2; Hormone receptor; Internal medicine; Cancer; Chemotherapy; Breast cancer; Endocrine system; Hormone; Receptor; Metastatic breast cancer","score_opus":0.008396602502152975,"score_gpt":0.2926130271226839,"score_spread":0.2842164246205309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309348334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745864,0.0008981793,0.00016093336,0.000114488146,0.00008225026,0.0003513807,0.0004832098,0.000015996011,0.00043493052],"genre_scores_gemma":[0.9968304,0.00035208426,0.000307834,0.00020945701,0.00009646382,0.00065285846,0.0008062433,0.000010583869,0.00073404633],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99821484,0.0010388896,0.00012403211,0.00025797662,0.000092518865,0.00027185987],"domain_scores_gemma":[0.9962316,0.0017411831,0.0006818454,0.00039692628,0.00018001233,0.0007684574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041834833,0.0012759555,0.003204685,0.00044098235,0.000355223,0.00091982057,0.00081007933,0.00092372304,0.003474963],"category_scores_gemma":[0.0033528751,0.00046211877,0.0050935172,0.00042364968,0.00067505526,0.00094678515,0.00051092566,0.0026902694,0.0002921261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98094785,0.003021579,0.00438992,0.00011193418,0.0024528804,0.00002340415,0.000036052163,0.0005045969,0.001815721,0.00002806466,0.00029744374,0.0063705994],"study_design_scores_gemma":[0.3920308,0.5141401,0.073444724,0.00004616965,0.01078639,0.00010089372,0.0001333883,0.0034384239,0.0039900816,0.00034399997,0.0014751932,0.00006978693],"about_ca_topic_score_codex":0.0011005402,"about_ca_topic_score_gemma":0.0032305368,"teacher_disagreement_score":0.0041834833,"about_ca_system_score_codex":0.0010811486,"about_ca_system_score_gemma":0.0018338059,"threshold_uncertainty_score":0.022124648},"labels":[],"label_agreement":null},{"id":"W4311302338","doi":"10.1016/j.breast.2022.12.003","title":"Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Puma Biotechnology","keywords":"Neratinib; Medicine; Loperamide; Diarrhea; Internal medicine; Incidence (geometry); Discontinuation; Gastroenterology; Tolerability; Oncology; Breast cancer; Adverse effect; Cancer; Trastuzumab","score_opus":0.02128492988764032,"score_gpt":0.31009708585149054,"score_spread":0.28881215596385024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311302338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95681643,0.014918544,0.0023681375,0.0020982753,0.0007017392,0.010323791,0.004900684,0.0002128494,0.0076595615],"genre_scores_gemma":[0.9822165,0.0023306378,0.002019002,0.0015590499,0.00039890996,0.0045388904,0.00389962,0.000027077205,0.0030103738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984871,0.00084950746,0.00015220579,0.00023777845,0.00013072832,0.00014266605],"domain_scores_gemma":[0.99821067,0.0005877791,0.0004377937,0.00020116809,0.00024101157,0.00032166843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037348699,0.0012939108,0.0018444406,0.000281087,0.0002578596,0.0010550397,0.0008655289,0.0011147493,0.004549842],"category_scores_gemma":[0.0037998452,0.00026313544,0.0024389904,0.00023062983,0.00049277925,0.00062356296,0.00032434217,0.001806649,0.00046776189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9252587,0.0057753953,0.0024631852,0.0010820738,0.0034096774,0.00007156679,0.000067732624,0.0006144312,0.0034922305,0.00021910113,0.0037862097,0.05375974],"study_design_scores_gemma":[0.9068494,0.0788233,0.008154871,0.00010748395,0.0017482502,0.00006250916,0.000017237677,0.00039457003,0.0010975477,0.00021145791,0.0025162562,0.000017067294],"about_ca_topic_score_codex":0.0006711934,"about_ca_topic_score_gemma":0.0013433383,"teacher_disagreement_score":0.004549842,"about_ca_system_score_codex":0.00052515464,"about_ca_system_score_gemma":0.0010501471,"threshold_uncertainty_score":0.019752145},"labels":[],"label_agreement":null},{"id":"W4318825455","doi":"10.1016/j.breast.2023.01.014","title":"Decision regret in breast cancer patients after adjuvant radiotherapy","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regret; Medicine; Breast cancer; Radiation therapy; Decision aids; Cancer; Family medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.09029501513942356,"score_gpt":0.41219364437273887,"score_spread":0.3218986292333153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318825455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694604,0.001134347,0.00018908552,0.0005794725,0.000023457425,0.000010831352,0.00004684343,0.0000044593976,0.0010655945],"genre_scores_gemma":[0.99940073,0.00023305934,0.000094277166,0.00011174485,0.000013249411,0.0000048589304,0.00003370416,7.049232e-7,0.00010769553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845695,0.00091798074,0.000109205044,0.000075330536,0.00027278427,0.0001677795],"domain_scores_gemma":[0.9943112,0.002402747,0.002548577,0.000106932916,0.00021819888,0.00041238344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001875043,0.00016584639,0.0003733891,0.00039204513,0.0005557566,0.00073433877,0.00022616099,0.00045258732,0.0013816456],"category_scores_gemma":[0.013339738,0.000092695096,0.0004871204,0.0005128121,0.00039781904,0.00036984708,0.00057751924,0.00070661464,0.00011208523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007888475,0.00035059568,0.93091434,0.00015346204,0.00027338916,0.0009856406,0.0044435156,0.0012299005,0.00052901806,0.0004053104,0.0013248427,0.05860121],"study_design_scores_gemma":[0.000097384785,0.0013354109,0.97398835,0.00022790587,0.00020102228,0.005112737,0.0074614696,0.0045802468,0.00061526254,0.0019807925,0.004324974,0.00007455117],"about_ca_topic_score_codex":0.001142498,"about_ca_topic_score_gemma":0.0015676813,"teacher_disagreement_score":0.001875043,"about_ca_system_score_codex":0.000512253,"about_ca_system_score_gemma":0.0004714855,"threshold_uncertainty_score":0.009916306},"labels":[],"label_agreement":null},{"id":"W4319872582","doi":"10.1016/j.breast.2023.02.005","title":"Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Northeast Cancer Centre; University of Ottawa; Health Sciences Centre; London Health Sciences Centre; McMaster University","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Context (archaeology); Confidence interval; Randomized controlled trial; Breast-conserving surgery; Radiation therapy; Oncology; Cancer; Surgery; Mastectomy","score_opus":0.007469719082759991,"score_gpt":0.273344885973577,"score_spread":0.26587516689081697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319872582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682524,0.024457322,0.001253599,0.0010191504,0.00077768654,0.0021970808,0.00088345405,0.000063280146,0.0010959735],"genre_scores_gemma":[0.98967314,0.004734783,0.00072876154,0.00082011684,0.00055466744,0.0020760824,0.00062594307,0.000014513002,0.0007720639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99466455,0.0039448934,0.0003877773,0.00046500712,0.00022350173,0.00031430606],"domain_scores_gemma":[0.99314475,0.0033424017,0.002062001,0.0005986641,0.00022740591,0.00062475615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072803088,0.0014329479,0.0038032457,0.00040211744,0.00043007758,0.0014940782,0.0009576141,0.0019208117,0.0040093563],"category_scores_gemma":[0.009155004,0.00048485142,0.0068390374,0.0005748886,0.0012415373,0.0011179178,0.00060877757,0.002805467,0.0004074886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97734886,0.0012171917,0.0022514784,0.0011038895,0.009314852,0.00004146125,0.000028104187,0.00047126246,0.00049420155,0.00008565446,0.00028985046,0.0073529924],"study_design_scores_gemma":[0.92702216,0.049814954,0.0074084033,0.00022791486,0.013028027,0.00007311022,0.000042621763,0.0009380013,0.00029019002,0.00050934404,0.0006120697,0.00003324417],"about_ca_topic_score_codex":0.00071905286,"about_ca_topic_score_gemma":0.0012236842,"teacher_disagreement_score":0.0072803088,"about_ca_system_score_codex":0.00090459414,"about_ca_system_score_gemma":0.0011557384,"threshold_uncertainty_score":0.038502395},"labels":[],"label_agreement":null},{"id":"W4323545813","doi":"10.1016/j.breast.2023.03.004","title":"Regularly scheduled physical examinations and the detection of breast cancer recurrences","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Physical exam; Health care; Cancer; Cancer recurrence; General surgery; Pediatrics; Surgery; Internal medicine","score_opus":0.008723617018628088,"score_gpt":0.25745588878212783,"score_spread":0.24873227176349974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323545813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968849,0.001222619,0.00013733727,0.00018704355,0.000013677139,0.000025949004,0.00033344564,0.000011842358,0.0011832085],"genre_scores_gemma":[0.99908495,0.00029154282,0.00021102389,0.000044617536,0.000018514975,0.000009503337,0.00024773282,0.000002350346,0.00008980352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985322,0.00051631546,0.00025817778,0.0001664916,0.00037939887,0.00014745598],"domain_scores_gemma":[0.9855767,0.0032790997,0.009578388,0.00029634015,0.0006883475,0.00058114727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010967614,0.00018308967,0.00020459526,0.0011988088,0.00025973486,0.0004942578,0.00042759295,0.0004184453,0.001752034],"category_scores_gemma":[0.011615906,0.00018126093,0.00027313878,0.0007990611,0.0002706262,0.0003721712,0.00053631887,0.00059894787,0.00020187213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003423103,0.000020721322,0.99744105,0.00002271501,0.000012695581,0.00006347101,0.00004195702,0.00001750786,0.00005516419,0.0000043950977,0.000104421204,0.0021815998],"study_design_scores_gemma":[0.0000023323757,0.00005858475,0.99893636,0.000024460845,0.0000123966975,0.0005953097,0.00009113573,0.00006871437,0.000057718407,0.0000051916504,0.00014585647,0.000002011349],"about_ca_topic_score_codex":0.0032700128,"about_ca_topic_score_gemma":0.0057915584,"teacher_disagreement_score":0.0032700128,"about_ca_system_score_codex":0.0003471907,"about_ca_system_score_gemma":0.00045065934,"threshold_uncertainty_score":0.006501913},"labels":[],"label_agreement":null},{"id":"W4324131925","doi":"10.1016/s0960-9776(23)00380-6","title":"P262 How patients prioritize features of different potential treatment pathways in early breast cancer: a best-worst scaling study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Medicine; Breast cancer; Oncology; Scaling; Cancer; Internal medicine","score_opus":0.011028462127131424,"score_gpt":0.24217250126201273,"score_spread":0.2311440391348813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324131925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897251,0.0005476985,0.001864381,0.0030046217,0.000081964106,0.00032692353,0.0005959218,0.000036172245,0.0038171527],"genre_scores_gemma":[0.9976172,0.00008409987,0.0013166943,0.00031609615,0.000032414515,0.00015247165,0.00013776793,0.0000110096935,0.00033213996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99311733,0.0050717876,0.00028855764,0.00053770485,0.00069777,0.00028687372],"domain_scores_gemma":[0.98154277,0.009218397,0.0037706965,0.001677136,0.0018552575,0.0019356522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01160475,0.00037732377,0.00056009035,0.0006845115,0.0010099097,0.0027578152,0.00087541225,0.0008098559,0.014029301],"category_scores_gemma":[0.040392507,0.0003110233,0.001342491,0.00097132666,0.001201913,0.0032527153,0.001806638,0.0010612721,0.0009861952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061073983,0.005007078,0.838647,0.00041074186,0.0007608275,0.00029384144,0.0054607843,0.002928606,0.00063810806,0.002926413,0.012282818,0.124536425],"study_design_scores_gemma":[0.0023599346,0.020318577,0.88618463,0.00038038552,0.0009271811,0.0010517103,0.029774997,0.03376426,0.0011564072,0.012671207,0.011210688,0.00020003374],"about_ca_topic_score_codex":0.004590298,"about_ca_topic_score_gemma":0.004934219,"teacher_disagreement_score":0.014029301,"about_ca_system_score_codex":0.0020512629,"about_ca_system_score_gemma":0.001542891,"threshold_uncertainty_score":0.06137258},"labels":[],"label_agreement":null},{"id":"W4324132198","doi":"10.1016/s0960-9776(23)00177-7","title":"P058 Outcomes of Rural Men With Breast Cancer: A Multicenter Population Based Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Retrospective cohort study; Breast cancer; Oncology; Gynecology; Cohort study; Internal medicine; Demography; Cancer","score_opus":0.010276856039041393,"score_gpt":0.27553135792528544,"score_spread":0.26525450188624405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908864,0.00007800731,0.00004177187,0.00003107655,0.0000024264505,0.000007967246,0.0004736875,0.0000017798892,0.00027465174],"genre_scores_gemma":[0.9993931,0.00006301512,0.000032592416,0.00002329068,0.000008201866,0.000010091094,0.00035716227,0.0000013808466,0.00011118325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976605,0.000061641156,0.000016872786,0.000061554965,0.000037758968,0.000056013363],"domain_scores_gemma":[0.9995152,0.000059829083,0.000224451,0.000055747376,0.000048671096,0.00009616771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027551962,0.00023698139,0.00022348156,0.0004769919,0.00046628946,0.0004715156,0.00031356953,0.00035224413,0.0017882173],"category_scores_gemma":[0.0010234046,0.00036021296,0.00031662913,0.0010703966,0.00019682005,0.00046073744,0.0004528206,0.00040401134,0.00027431812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114724106,0.000049625087,0.9986149,0.0000065774757,0.00004828718,0.000120455355,0.0000866615,0.00001960975,0.00018553439,0.000019334453,0.00015937391,0.0005748821],"study_design_scores_gemma":[0.000019091369,0.00014373347,0.99868447,0.0000045037305,0.00003516758,0.00036784925,0.00037237068,0.000112324604,0.000037843216,0.00001979573,0.00019959014,0.0000033077633],"about_ca_topic_score_codex":0.0079197725,"about_ca_topic_score_gemma":0.008612868,"teacher_disagreement_score":0.0079197725,"about_ca_system_score_codex":0.00023544273,"about_ca_system_score_gemma":0.00032027537,"threshold_uncertainty_score":0.015747309},"labels":[],"label_agreement":null},{"id":"W4324132274","doi":"10.1016/s0960-9776(23)00123-6","title":"P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Medicine; Trastuzumab; Open label; Oncology; Adjuvant; Breast cancer; Internal medicine; Adjuvant therapy; Clinical trial; Cancer","score_opus":0.04864517656838026,"score_gpt":0.3922865478377956,"score_spread":0.34364137126941535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925598,0.0013386604,0.0002928442,0.0006034385,0.0001286343,0.0011832262,0.00089007645,0.00007802943,0.0029254274],"genre_scores_gemma":[0.9881919,0.0012347198,0.0012029441,0.00077326345,0.0002316293,0.0012662733,0.0018471952,0.000017893251,0.0052341213],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974793,0.00014262255,0.000010150475,0.000027546708,0.000027112937,0.000044670356],"domain_scores_gemma":[0.99968696,0.000077878845,0.000071988055,0.000022825638,0.000019044199,0.000121299425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010687979,0.0006426261,0.00065883744,0.00025667023,0.0002091348,0.0007008594,0.0004635171,0.0007518066,0.0063281907],"category_scores_gemma":[0.00092445605,0.00015394269,0.0005608981,0.0002879666,0.00037766653,0.00059668015,0.00019526243,0.0014788356,0.0007386369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73904455,0.034499176,0.0070524383,0.0007529947,0.0010636005,0.0002530233,0.000133678,0.0019470307,0.014655279,0.00044514137,0.0056913765,0.19446176],"study_design_scores_gemma":[0.67193,0.30221668,0.016357854,0.00005481068,0.00037926005,0.00023922062,0.00005949064,0.001571832,0.0024170268,0.00040171333,0.0043488415,0.000023293538],"about_ca_topic_score_codex":0.0004737789,"about_ca_topic_score_gemma":0.0014768718,"teacher_disagreement_score":0.0063281907,"about_ca_system_score_codex":0.0005416196,"about_ca_system_score_gemma":0.00092154474,"threshold_uncertainty_score":0.0211699},"labels":[],"label_agreement":null},{"id":"W4366825031","doi":"10.1016/j.breast.2023.04.007","title":"Partial Breast Irradiation","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Stage (stratigraphy); Intensive care medicine; Oncology; Medical physics; Surgery; Internal medicine","score_opus":0.04154735797831621,"score_gpt":0.32771374149377075,"score_spread":0.28616638351545454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366825031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022118668,0.9959252,0.00017144026,0.00019951513,0.00025072103,0.000009149634,0.000044093624,0.000016641052,0.003162106],"genre_scores_gemma":[0.0020051296,0.9955056,0.00018364882,0.00035296928,0.00021912661,0.000014091047,0.00011639158,0.0000050873155,0.0015979297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997472,0.000045498615,0.00002373018,0.000060715724,0.00009857109,0.000024325172],"domain_scores_gemma":[0.9997986,0.00010014607,0.000033227643,0.000013245827,0.000040104354,0.000014774279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003750092,0.0007438354,0.00108366,0.0017019633,0.00025187002,0.00062216975,0.00092142576,0.000825041,0.0067861],"category_scores_gemma":[0.0007758086,0.00017859951,0.0006334804,0.0015137668,0.0004839512,0.00066798896,0.0006322752,0.0012197073,0.0032183866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010637594,0.000054879976,0.0002450113,0.013150209,0.00013509623,0.00017940697,0.000033415232,0.0002849538,0.0011611058,0.00216315,0.039924398,0.9425619],"study_design_scores_gemma":[0.000028759554,0.00010757207,0.0014750288,0.004236292,0.00010616937,0.0041740285,0.000038189926,0.0000446076,0.00068251655,0.0016192677,0.9874741,0.000013653708],"about_ca_topic_score_codex":0.00092420506,"about_ca_topic_score_gemma":0.0013362283,"teacher_disagreement_score":0.0067861,"about_ca_system_score_codex":0.0005950618,"about_ca_system_score_gemma":0.0006523917,"threshold_uncertainty_score":0.0227018},"labels":[],"label_agreement":null},{"id":"W4367625869","doi":"10.1016/j.breast.2023.04.008","title":"Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; Montreal Neurological Institute and Hospital; Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Medicine; Trastuzumab; Intrathecal; Breast cancer; Oncology; Cancer; Internal medicine; Surgery","score_opus":0.04405675240668845,"score_gpt":0.3281233339356311,"score_spread":0.28406658152894265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367625869","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011933211,0.9866614,0.00019105614,0.0002187843,0.00007336391,0.00014528549,0.00029146756,0.0000064948085,0.0004789963],"genre_scores_gemma":[0.33286455,0.6633573,0.0010492468,0.0011041692,0.0002234296,0.0004372287,0.00063102675,0.000016811115,0.00031621495],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962734,0.001770357,0.001148673,0.00033590375,0.00038184243,0.00008986135],"domain_scores_gemma":[0.9920866,0.005361378,0.002008048,0.00013159112,0.0003210512,0.00009127194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005526279,0.0006402596,0.0050333645,0.002140076,0.00018700265,0.0016435103,0.0006471287,0.0006776355,0.0019320144],"category_scores_gemma":[0.009844681,0.00035291738,0.008299848,0.0032690337,0.00043686296,0.0008782617,0.000590494,0.00072989275,0.00015940574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018574573,0.00010878435,0.008861256,0.5799432,0.27568585,0.0002062471,0.00016694659,0.0007574376,0.0014782308,0.00036237075,0.0010330137,0.112822115],"study_design_scores_gemma":[0.010611363,0.004211546,0.023579303,0.10216367,0.8418134,0.00062536384,0.0002322362,0.000532322,0.0011857648,0.0010098682,0.013981614,0.00005350421],"about_ca_topic_score_codex":0.001506302,"about_ca_topic_score_gemma":0.00396281,"teacher_disagreement_score":0.005526279,"about_ca_system_score_codex":0.0011871035,"about_ca_system_score_gemma":0.0013556683,"threshold_uncertainty_score":0.029226065},"labels":[],"label_agreement":null},{"id":"W4379179922","doi":"10.1016/j.breast.2023.05.008","title":"Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Benchmarking; Medicine; Breast cancer; Proportional hazards model; Stage (stratigraphy); Demography; Retrospective cohort study; Cohort; Population; Cancer; Internal medicine; Environmental health","score_opus":0.005951133295760421,"score_gpt":0.23550581238406515,"score_spread":0.22955467908830474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379179922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997063,0.000711453,0.0004257095,0.00003994092,0.000017368175,0.000014505925,0.0014246658,0.0000071473864,0.00029617935],"genre_scores_gemma":[0.997074,0.00026811895,0.00026205686,0.000022877955,0.000009629118,0.000024814159,0.002192867,0.000007817554,0.00013777016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987727,0.0003599391,0.00019510459,0.00033045714,0.00017147994,0.00017035461],"domain_scores_gemma":[0.9979723,0.00032171397,0.00082517666,0.00039471767,0.0003210452,0.00016495476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018247371,0.00037714178,0.00047662563,0.0010233481,0.00043708892,0.00094528886,0.0005399511,0.0003837228,0.0008191063],"category_scores_gemma":[0.0040505254,0.0002525373,0.0010244728,0.0016647213,0.00020737294,0.00041692352,0.00078943704,0.00049879827,0.0001870112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019636317,0.000014990032,0.99712855,0.000027907381,0.0002231274,0.00010622811,0.000104042716,0.00019647779,0.00009579272,0.000041141586,0.00017727571,0.0016882374],"study_design_scores_gemma":[0.000013575124,0.000117364834,0.9971432,0.000047728965,0.00024632688,0.0004720772,0.0004541,0.00042683675,0.000096194555,0.00009255828,0.0008782787,0.000011621989],"about_ca_topic_score_codex":0.010861827,"about_ca_topic_score_gemma":0.011890991,"teacher_disagreement_score":0.010861827,"about_ca_system_score_codex":0.0006030377,"about_ca_system_score_gemma":0.0008897277,"threshold_uncertainty_score":0.021597207},"labels":[],"label_agreement":null},{"id":"W4379229810","doi":"10.1016/j.breast.2023.06.001","title":"Does age affect outcome with breast cancer?","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Pathological; Cohort; Disease; Mastectomy; Retrospective cohort study; Population; Chemotherapy; Hormonal therapy","score_opus":0.011888363476697542,"score_gpt":0.2749742049590731,"score_spread":0.26308584148237557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379229810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460642,0.03663074,0.0007876626,0.0053151436,0.0005241298,0.00003089664,0.0021856932,0.000022797336,0.008438858],"genre_scores_gemma":[0.9947525,0.003469298,0.0001119368,0.000372977,0.00035403107,0.000008729847,0.0005106209,0.000010837834,0.0004091586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860865,0.00049900555,0.00018950149,0.0002588499,0.0002208266,0.00022313172],"domain_scores_gemma":[0.99311984,0.0022427547,0.0029501012,0.00048191723,0.00047124212,0.00073423254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021579713,0.00022833855,0.0005679224,0.0008341904,0.00031763595,0.00091888587,0.00053902215,0.00074849644,0.002903612],"category_scores_gemma":[0.011927019,0.00012421055,0.0008440905,0.0017438775,0.00040812444,0.0013252774,0.00053834415,0.0009430399,0.0006080168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016236167,0.000027801349,0.99022067,0.000055056804,0.00016286755,0.00011953557,0.000114095914,0.000059842932,0.000069234615,0.00014324693,0.000505274,0.008359975],"study_design_scores_gemma":[0.0000050245317,0.000098172786,0.9967526,0.00008219722,0.00011144802,0.0004104544,0.0002140315,0.0001234176,0.000056225712,0.00042952763,0.0017090578,0.000008011013],"about_ca_topic_score_codex":0.002590489,"about_ca_topic_score_gemma":0.0035548443,"teacher_disagreement_score":0.002903612,"about_ca_system_score_codex":0.00035661773,"about_ca_system_score_gemma":0.0003629091,"threshold_uncertainty_score":0.011412561},"labels":[],"label_agreement":null},{"id":"W4382794593","doi":"10.1016/j.breast.2023.06.010","title":"Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"AstraZeneca; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Oncology; Radiation therapy; Internal medicine; Cancer","score_opus":0.04843570531051944,"score_gpt":0.3313331753465822,"score_spread":0.28289747003606275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382794593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017125394,0.99853563,0.00017689634,0.000471567,0.00008977744,0.0000055954747,0.000015024763,0.00000345765,0.0005307113],"genre_scores_gemma":[0.002038771,0.996833,0.00039390402,0.00031192155,0.00017079555,0.000011135761,0.000030128238,0.0000012002971,0.00020912463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995523,0.00016947006,0.000071640665,0.000062760104,0.000118801676,0.00002504845],"domain_scores_gemma":[0.9986539,0.0009868646,0.00014999992,0.000017229297,0.00016591414,0.000026039466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011833231,0.0005379087,0.0011552843,0.0016845824,0.00015648393,0.0009606476,0.0005987481,0.0010134117,0.0017144058],"category_scores_gemma":[0.0033461605,0.00017830989,0.0006093578,0.0012085951,0.000342063,0.0007986858,0.00048278391,0.0010811816,0.000690763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008350052,0.000032657572,0.0007697088,0.016114661,0.00022565489,0.00013399351,0.00007177124,0.0004595324,0.0006108589,0.0019753077,0.010030613,0.9694919],"study_design_scores_gemma":[0.000056005847,0.00029059147,0.0058797714,0.03257105,0.00092975487,0.0031989678,0.00024915105,0.0005203318,0.0011933076,0.005385722,0.94966197,0.00006333536],"about_ca_topic_score_codex":0.000851719,"about_ca_topic_score_gemma":0.0018769464,"teacher_disagreement_score":0.0017144058,"about_ca_system_score_codex":0.0006006411,"about_ca_system_score_gemma":0.00096722646,"threshold_uncertainty_score":0.0062580705},"labels":[],"label_agreement":null},{"id":"W4386047410","doi":"10.1016/j.breast.2023.08.006","title":"Explaining risks and benefits of loco-regional treatments to patients","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Sentinel lymph node; Multidisciplinary approach; Modalities; Breast cancer; Intensive care medicine; Sentinel node; Quality of life (healthcare); Radiation therapy; Medical physics; Cancer; Surgery; Internal medicine; Nursing","score_opus":0.03801203491805294,"score_gpt":0.2804020069672601,"score_spread":0.24238997204920715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386047410","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13825135,0.051865473,0.064560056,0.6498343,0.0058416314,0.00075846043,0.0017915241,0.0004807528,0.08661643],"genre_scores_gemma":[0.8199077,0.05171525,0.058615755,0.047612824,0.0067468714,0.0008093679,0.0009154209,0.00025841556,0.013418461],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9918247,0.006636046,0.00041090304,0.00017934084,0.0007255426,0.00022354307],"domain_scores_gemma":[0.97546947,0.019083027,0.0020468011,0.0010756068,0.001592542,0.00073257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013724404,0.0005761563,0.0005724764,0.00078556786,0.0011572042,0.0028116808,0.0007150505,0.0022960138,0.011358785],"category_scores_gemma":[0.054241266,0.00030518332,0.0008812064,0.00038780374,0.0016773152,0.0033318459,0.0018555933,0.0036333948,0.0025198562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020698959,0.00074269954,0.049735434,0.0018820742,0.0004353308,0.0014731477,0.012781589,0.006165102,0.002753562,0.050472897,0.14893906,0.72254914],"study_design_scores_gemma":[0.00073831924,0.0022000289,0.03816689,0.0075801746,0.0009584587,0.0038038546,0.019415362,0.00876113,0.00872365,0.2574355,0.65177125,0.00044535074],"about_ca_topic_score_codex":0.0014899714,"about_ca_topic_score_gemma":0.0025213403,"teacher_disagreement_score":0.013724404,"about_ca_system_score_codex":0.0017682592,"about_ca_system_score_gemma":0.002096185,"threshold_uncertainty_score":0.07258242},"labels":[],"label_agreement":null},{"id":"W4388536914","doi":"10.1016/s0960-9776(23)00621-5","title":"PO55 IDENTIFYING THE EDUCATION, INFORMATION AND SUPPORT NEEDS OF CANADIANS DIAGNOSED WITH BREAST CANCER: A CANADIAN BREAST CANCER NETWORK (CBCN) ASSESSMENT PROJECT","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Family medicine; Internal medicine; Cancer; Gynecology","score_opus":0.01647969720470941,"score_gpt":0.24954873400062685,"score_spread":0.23306903679591745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68825155,0.0019928638,0.0014989995,0.01467976,0.00024882008,0.005410502,0.23112446,0.00012160397,0.056671377],"genre_scores_gemma":[0.88689286,0.003357669,0.008320613,0.0028602134,0.00007336041,0.004230029,0.070718005,0.000047117792,0.023500063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974655,0.0002270568,0.000109536755,0.0001140787,0.001212285,0.0008715813],"domain_scores_gemma":[0.9895028,0.00034995054,0.0004841992,0.00011074497,0.0074539473,0.0020983133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032951056,0.00074434205,0.0005191371,0.003717964,0.0056364913,0.0019134424,0.0021613953,0.0008094794,0.0047342274],"category_scores_gemma":[0.009129545,0.00034966005,0.001556754,0.007892392,0.00052736275,0.0006787339,0.0025643676,0.0011723606,0.000623815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000546316,0.00085879245,0.7538418,0.0011172174,0.00035664067,0.00018747924,0.003941186,0.0020485553,0.0002647042,0.0030186167,0.12969117,0.1041274],"study_design_scores_gemma":[0.00014463878,0.00026108927,0.9370075,0.00056706736,0.0003376195,0.00006229647,0.012091543,0.0026808432,0.0002713672,0.000447975,0.04606563,0.00006251924],"about_ca_topic_score_codex":0.9980215,"about_ca_topic_score_gemma":0.9984999,"teacher_disagreement_score":0.08531975,"about_ca_system_score_codex":0.08531975,"about_ca_system_score_gemma":0.26561558,"threshold_uncertainty_score":0.619041},"labels":[],"label_agreement":null},{"id":"W4388536916","doi":"10.1016/s0960-9776(23)00609-4","title":"IN37 INEQUITIES IN ACCESS TO NEW CANCER DRUGS: ROLE OF REGULATORS AND CLINICAL TRIALS","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical trial; Cancer drugs; Oncology; Cancer; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.29638580323579866,"score_gpt":0.5522378578766761,"score_spread":0.25585205464087746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536916","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011491513,0.24113706,0.0037185415,0.6846807,0.0050966954,0.0006140534,0.0012828343,0.000056180488,0.05192241],"genre_scores_gemma":[0.51214963,0.17565398,0.012443838,0.27057645,0.015389732,0.0029079085,0.0012861171,0.00015234797,0.009440029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.813215,0.15290272,0.0076365257,0.005876256,0.016282167,0.0040873466],"domain_scores_gemma":[0.3281811,0.5612931,0.044072516,0.01753034,0.033883974,0.01503899],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25736013,0.0007891584,0.0024278888,0.0033842397,0.002832597,0.01698313,0.003532291,0.010035045,0.02633604],"category_scores_gemma":[0.381381,0.0006392974,0.0011728957,0.0054997285,0.009122391,0.015013803,0.007925971,0.007900943,0.0013801516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048578666,0.0010139858,0.052050296,0.0068211644,0.0014236084,0.00024513243,0.0021341767,0.0014577784,0.00029774843,0.24279983,0.14921594,0.53768253],"study_design_scores_gemma":[0.002815449,0.0015784971,0.03948169,0.043580413,0.0015394684,0.00042267004,0.0054433327,0.0041982722,0.0011201837,0.26341158,0.6361714,0.00023709123],"about_ca_topic_score_codex":0.0062397094,"about_ca_topic_score_gemma":0.008573213,"teacher_disagreement_score":0.25736013,"about_ca_system_score_codex":0.009679574,"about_ca_system_score_gemma":0.030861514,"threshold_uncertainty_score":0.9158072},"labels":[],"label_agreement":null},{"id":"W4388536933","doi":"10.1016/s0960-9776(23)00591-x","title":"Poster Session","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Session (web analytics); Medical physics; World Wide Web","score_opus":0.01910894706484904,"score_gpt":0.28104695670949525,"score_spread":0.2619380096446462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536933","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007774112,0.0035692363,0.0019808516,0.009554505,0.05373078,0.0004858396,0.004386856,0.0016617639,0.92385274],"genre_scores_gemma":[0.0027579917,0.0020304539,0.0009050069,0.0033374773,0.0079782605,0.00023156742,0.0027050818,0.0005300848,0.97952396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916303,0.00012770349,0.000045918445,0.00020653715,0.00032883926,0.00012784729],"domain_scores_gemma":[0.9981635,0.00015519964,0.000054665532,0.00015767044,0.00073073275,0.00073826977],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010857949,0.0011237587,0.00095270947,0.0011336618,0.0019152408,0.004599604,0.0017248959,0.0028062342,0.8587212],"category_scores_gemma":[0.0026188765,0.00043310047,0.0010954307,0.0008840502,0.00035980472,0.0025588449,0.00335082,0.0028545503,0.687246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006084948,0.00004622232,0.000069755035,0.00013087454,0.000003446053,0.00005296758,0.000025272273,0.00002424933,0.00020172223,0.0010840397,0.9459926,0.052308],"study_design_scores_gemma":[0.000009480075,0.000020241738,0.00020215704,0.00006440405,0.0000018014115,0.000059906262,0.000040817275,0.000020040841,0.00005319963,0.0004204167,0.9991042,0.0000033625029],"about_ca_topic_score_codex":0.0014773534,"about_ca_topic_score_gemma":0.0028030602,"teacher_disagreement_score":0.1412788,"about_ca_system_score_codex":0.0010909692,"about_ca_system_score_gemma":0.0018676069,"threshold_uncertainty_score":0.2015171},"labels":[],"label_agreement":null},{"id":"W4388536952","doi":"10.1016/s0960-9776(23)00602-1","title":"IN27 REVISITING OLIGOMETASTATIC DISEASE","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.011710682113753337,"score_gpt":0.25900233389492366,"score_spread":0.24729165178117032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536952","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5046218,0.2883216,0.0030167159,0.02749006,0.005593159,0.0005694873,0.004866187,0.00043660396,0.16508432],"genre_scores_gemma":[0.88493204,0.050047494,0.0031662036,0.015022444,0.0024766782,0.00027990335,0.005231331,0.00017012506,0.038673807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964476,0.0001081717,0.000049013353,0.00006213425,0.00006829575,0.00006770839],"domain_scores_gemma":[0.99907255,0.00021824638,0.00028614362,0.00007728572,0.00012749602,0.00021813258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005179928,0.00022198414,0.0006109742,0.0004668167,0.0004734638,0.001013766,0.00031265308,0.00049577054,0.017879777],"category_scores_gemma":[0.0027194137,0.00010682112,0.0005159058,0.0010790305,0.0004283009,0.0006194019,0.0006229518,0.00073634257,0.0033424224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003737581,0.00047164477,0.100987524,0.0037841853,0.00039905854,0.0069651986,0.00046763624,0.00035118355,0.0076007717,0.0031030243,0.0658499,0.80628234],"study_design_scores_gemma":[0.0014293827,0.0033406338,0.27063513,0.0030066636,0.0012669803,0.05790469,0.0015178525,0.0005429481,0.0059360224,0.008587136,0.64576477,0.0000677915],"about_ca_topic_score_codex":0.00248222,"about_ca_topic_score_gemma":0.0080073,"teacher_disagreement_score":0.017879777,"about_ca_system_score_codex":0.00079010276,"about_ca_system_score_gemma":0.0009824679,"threshold_uncertainty_score":0.059813857},"labels":[],"label_agreement":null},{"id":"W4388537066","doi":"10.1016/s0960-9776(23)00632-x","title":"PO66 ASSESSING SELECT EMOTIONAL AND PSYCHOLOGICAL STATES OF STAGE IV BREAST CANCER PATIENTS: A CANADIAN BREAST CANCER NETWORK (CBCN) ASSESSMENT PROJECT","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.01530091572164715,"score_gpt":0.3020152930271996,"score_spread":0.28671437730555244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388537066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122417,0.000117447584,0.00016924262,0.00012122259,0.000006603098,0.0006985501,0.005487408,0.000009599739,0.0021656766],"genre_scores_gemma":[0.98759043,0.0003098073,0.0010523993,0.00007762618,0.000011613701,0.0007234538,0.0075375447,0.0000052455694,0.0026918566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977463,0.0000363032,0.00001289689,0.0000297134,0.0000650691,0.00008138774],"domain_scores_gemma":[0.9996158,0.000017670565,0.00006411012,0.000010018052,0.00015187485,0.00014039672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004979311,0.00039431071,0.00024472884,0.0012161036,0.0014476996,0.00040922343,0.0005615914,0.00023439135,0.002348861],"category_scores_gemma":[0.0010159266,0.00021060437,0.0003277658,0.0015596256,0.00018394938,0.0001457109,0.0006979982,0.00032568787,0.00027298255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013058803,0.00022998787,0.98372066,0.00005665173,0.000026093629,0.00015014515,0.0005392657,0.00012737598,0.00029499165,0.000047018995,0.0024866292,0.012190416],"study_design_scores_gemma":[0.000011378238,0.00005539594,0.99827373,0.000008512297,0.00001252564,0.000057450317,0.00040574037,0.000171333,0.000056151173,0.000012824058,0.0009308367,0.0000041374406],"about_ca_topic_score_codex":0.809957,"about_ca_topic_score_gemma":0.87754565,"teacher_disagreement_score":0.19004297,"about_ca_system_score_codex":0.006012019,"about_ca_system_score_gemma":0.0074433363,"threshold_uncertainty_score":0.38232434},"labels":[],"label_agreement":null},{"id":"W4388541367","doi":"10.1016/s0960-9776(23)00671-9","title":"PO107 TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS RECEIVING CDK4/6 INHIBITORS FOR HR+/HER2-ADVANCED/METASTATIC BREAST CANCER IN A SINGLE-CENTRE, CANADIAN REAL-WORLD SETTING USING AI-EXTRACTED DATA","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Metastatic breast cancer; Internal medicine; Real world data; Breast cancer; Cancer; Gynecology; Data science","score_opus":0.06498576353557098,"score_gpt":0.3755091171562621,"score_spread":0.31052335362069117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388541367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72810984,0.002848882,0.00044723088,0.0007502244,0.000046643658,0.00021681089,0.26337704,0.00007177627,0.0041316603],"genre_scores_gemma":[0.9336379,0.0009872853,0.0010836736,0.0002776516,0.000020180898,0.0001600014,0.06315692,0.000026417722,0.0006500017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982665,0.00013405703,0.00023085087,0.00043361553,0.00047615176,0.00045884092],"domain_scores_gemma":[0.9952238,0.00054397795,0.0014176277,0.0002832631,0.0019276941,0.0006036541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090653845,0.0004990494,0.00079971395,0.0023772698,0.0011062267,0.0016329553,0.0015254893,0.000601303,0.00267172],"category_scores_gemma":[0.0072323256,0.0003577979,0.0015992412,0.00911554,0.0005241043,0.00054081954,0.0008594962,0.0010805374,0.00036590296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006690119,0.000043693377,0.9803992,0.0005102677,0.0008358028,0.00008426265,0.00027881996,0.00066900864,0.00017584652,0.00020215852,0.0101672495,0.005964709],"study_design_scores_gemma":[0.00009618201,0.00005695624,0.99226475,0.00020247602,0.00044893127,0.000150195,0.00057889294,0.0009826132,0.00012800594,0.000074434916,0.0049739317,0.000042557884],"about_ca_topic_score_codex":0.9659887,"about_ca_topic_score_gemma":0.97722614,"teacher_disagreement_score":0.034011304,"about_ca_system_score_codex":0.01571094,"about_ca_system_score_gemma":0.027247222,"threshold_uncertainty_score":0.11399138},"labels":[],"label_agreement":null},{"id":"W4391544428","doi":"10.1016/j.breast.2024.103678","title":"“The Uncertainty Principle”– studying immediate lymphatic reconstruction impacts the natural history of breast cancer related lymphedema","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lymphedema; Sequela; Medicine; Breast cancer; Natural history; Lymphatic system; Axillary Lymph Node Dissection; Surgery; General surgery; Cancer; Sentinel lymph node; Internal medicine; Pathology","score_opus":0.014337550091481174,"score_gpt":0.26900190397925394,"score_spread":0.25466435388777275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391544428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41944298,0.18177964,0.117461495,0.23488979,0.0057862177,0.0012668924,0.003532131,0.00013493518,0.03570585],"genre_scores_gemma":[0.94928664,0.010372724,0.01619319,0.019792981,0.0021054093,0.00068396743,0.0004241827,0.000068642934,0.0010722806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.90253335,0.07685674,0.0040959907,0.007127853,0.007797578,0.0015884569],"domain_scores_gemma":[0.63294655,0.31395575,0.025245486,0.015780859,0.009161645,0.0029096175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10713725,0.0007718785,0.0013933616,0.0013174778,0.0015198904,0.004421022,0.002245016,0.002697533,0.005974845],"category_scores_gemma":[0.25833082,0.00050340395,0.0036470853,0.0014455684,0.0076000625,0.007938482,0.0043663625,0.004827719,0.00053779926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033721158,0.00050747994,0.5750862,0.008542163,0.0110392645,0.00041930456,0.009693964,0.0028283698,0.00082246965,0.095258825,0.015587068,0.27684286],"study_design_scores_gemma":[0.00047746563,0.004072252,0.3872377,0.020532595,0.008740757,0.002244262,0.009381426,0.00806391,0.002124076,0.46683845,0.08987529,0.00041181155],"about_ca_topic_score_codex":0.0029775426,"about_ca_topic_score_gemma":0.0024919903,"teacher_disagreement_score":0.10713725,"about_ca_system_score_codex":0.001630732,"about_ca_system_score_gemma":0.005781592,"threshold_uncertainty_score":0.5666027},"labels":[],"label_agreement":null},{"id":"W4391694263","doi":"10.1016/j.breast.2024.103689","title":"Acceptance of outpatient enhanced recovery after surgery (ERAS©) protocols for implant-based breast reconstruction nudged on by the COVID-19 pandemic","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Implant; Outpatient surgery; 2019-20 coronavirus outbreak; Outpatient visits; Breast reconstruction; Emergency medicine; Outpatient clinic; Breast surgery; Retrospective cohort study; Health care; General surgery; Medical emergency; Surgery; Internal medicine; Breast cancer; Disease; Pathology; Ambulatory","score_opus":0.03261693403500457,"score_gpt":0.3068541239689837,"score_spread":0.27423718993397916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391694263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964355,0.00036482344,0.0001430874,0.00018690113,0.000025952351,0.00015991625,0.0007381696,0.0000064763303,0.0019391822],"genre_scores_gemma":[0.9978695,0.00024901915,0.00030780246,0.00022496082,0.000028272692,0.00015783384,0.0008343098,0.00000533378,0.0003229482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806005,0.0005152353,0.00035534473,0.0002616028,0.0004559302,0.00035182483],"domain_scores_gemma":[0.99221003,0.0015964432,0.0044658342,0.00037692717,0.00051029987,0.0008405832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013838961,0.00014131848,0.00022986191,0.00056566723,0.0004578884,0.0006268044,0.00039270366,0.00029231358,0.0026463128],"category_scores_gemma":[0.006851583,0.00021224486,0.00023529147,0.0006346239,0.00035094895,0.00032494756,0.00080454885,0.0005472875,0.00026055955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002314333,0.00009601526,0.9905501,0.000062170024,0.00001130874,0.00033129577,0.0003236408,0.000051154344,0.00017845447,0.000070198854,0.0007819415,0.0073122485],"study_design_scores_gemma":[0.00002920101,0.0006930162,0.9921062,0.00012048353,0.000014888893,0.0012776604,0.0022408245,0.00028794043,0.00024480294,0.000042037547,0.002929803,0.000013113577],"about_ca_topic_score_codex":0.0046530846,"about_ca_topic_score_gemma":0.006149797,"teacher_disagreement_score":0.0046530846,"about_ca_system_score_codex":0.0010978758,"about_ca_system_score_gemma":0.0018023066,"threshold_uncertainty_score":0.009252012},"labels":[],"label_agreement":null},{"id":"W4392948130","doi":"10.1016/j.breast.2024.103715","title":"Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Biomarker; Immunohistochemistry; Oncology; Internal medicine; Single Center; Staining; Cancer; Pathology; Biology","score_opus":0.05407487999830693,"score_gpt":0.3393136598317154,"score_spread":0.2852387798334085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392948130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94000095,0.05548247,0.000472123,0.000388579,0.000055847016,0.00010997103,0.0015306806,0.000022407135,0.0019370246],"genre_scores_gemma":[0.98245895,0.015420469,0.00034128592,0.00041214295,0.000059626997,0.00005494757,0.0010916062,0.000009699923,0.0001512071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587566,0.0010591595,0.0013035255,0.00062954857,0.0009132041,0.00021891769],"domain_scores_gemma":[0.97873586,0.0067279586,0.010079799,0.0007606263,0.0031810796,0.00051461684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026233115,0.00022886078,0.00061985786,0.0033013835,0.0003701688,0.0008355635,0.00064393505,0.00057658815,0.0008883795],"category_scores_gemma":[0.011477201,0.00037167003,0.00038018214,0.0036035192,0.00041975733,0.0004595251,0.0004904666,0.00022770283,0.0003637206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018471658,0.00003523321,0.97340494,0.0014534275,0.0001518904,0.004039049,0.00043976353,0.00004055615,0.0016297102,0.000037377296,0.0010133132,0.017570028],"study_design_scores_gemma":[0.000023460021,0.00024648258,0.96782815,0.0011968028,0.00046860392,0.021899417,0.001348588,0.00010771436,0.0010404838,0.00001186531,0.005810915,0.000017546832],"about_ca_topic_score_codex":0.0035711043,"about_ca_topic_score_gemma":0.0043268404,"teacher_disagreement_score":0.0035711043,"about_ca_system_score_codex":0.000680966,"about_ca_system_score_gemma":0.0011283015,"threshold_uncertainty_score":0.0138735175},"labels":[],"label_agreement":null},{"id":"W4393970104","doi":"10.1016/j.breast.2024.103727","title":"Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Representativeness heuristic; Breast cancer; Oncology; Cancer; Intensive care medicine; Internal medicine","score_opus":0.17853200373280306,"score_gpt":0.4579822645300993,"score_spread":0.2794502607972963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393970104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004786863,0.99038434,0.000789355,0.000896972,0.00028229755,0.0009223273,0.0011670896,0.00001566573,0.00075508887],"genre_scores_gemma":[0.19719996,0.7910071,0.0038127555,0.001561986,0.00035320883,0.00445301,0.0013753403,0.00004490204,0.00019182583],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.85890126,0.07180579,0.04572708,0.0056013875,0.016204638,0.0017598859],"domain_scores_gemma":[0.51999116,0.39951238,0.05318679,0.0051628486,0.021062784,0.0010839497],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.11297477,0.002299189,0.015070667,0.024672829,0.0009317372,0.006843515,0.002672823,0.0032270595,0.0042382455],"category_scores_gemma":[0.3674761,0.0019110442,0.018520305,0.024003554,0.0025616884,0.0059186053,0.003243121,0.002101513,0.00030188583],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073005474,0.000017237337,0.0047824085,0.89393276,0.06640774,0.00009853216,0.00038292576,0.0002440949,0.00008130086,0.0004706791,0.00082037656,0.032031916],"study_design_scores_gemma":[0.0009085093,0.00019871243,0.009524561,0.6993374,0.28162244,0.00029527923,0.00053786807,0.00025538792,0.0002236693,0.0009338162,0.0061070016,0.000055474393],"about_ca_topic_score_codex":0.007723393,"about_ca_topic_score_gemma":0.015701491,"teacher_disagreement_score":0.9753272,"about_ca_system_score_codex":0.008319625,"about_ca_system_score_gemma":0.015887026,"threshold_uncertainty_score":0.5974748},"labels":[],"label_agreement":null},{"id":"W4393970330","doi":"10.1016/j.breast.2024.103725","title":"Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"","keywords":"Medicine; Breast cancer; Oncology; Anthracycline; Chemotherapy; Cancer; Internal medicine; Randomized controlled trial; Clinical trial; Paclitaxel; Intensive care medicine","score_opus":0.027479019557511437,"score_gpt":0.34786666042149866,"score_spread":0.32038764086398724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393970330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799706,0.0034765056,0.00042177836,0.0011778803,0.00042041295,0.0024712293,0.0015350301,0.00012833872,0.002371688],"genre_scores_gemma":[0.9859642,0.0014148789,0.0014009712,0.00185887,0.00038587622,0.0039815693,0.0023022261,0.000027045186,0.0026643556],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994215,0.00038978975,0.000022998374,0.00006895542,0.00003304075,0.00006380291],"domain_scores_gemma":[0.9991763,0.00021979329,0.00025145698,0.00006440574,0.000038758837,0.0002493424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020009752,0.0011555039,0.0022083898,0.00032646256,0.00028058336,0.00075564644,0.00076743716,0.0011362897,0.0059007835],"category_scores_gemma":[0.0014739345,0.0003696122,0.001397828,0.00041546626,0.0007559021,0.000569104,0.00035853233,0.0019685717,0.00076671975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9799226,0.0039038146,0.0010307701,0.0002850694,0.00061189954,0.000032849217,0.00002202185,0.00046546443,0.0013420796,0.00009353232,0.0013695159,0.010920393],"study_design_scores_gemma":[0.9629285,0.03324686,0.0021981602,0.00002819152,0.0003044455,0.00003916787,0.000009659612,0.0004852729,0.000180542,0.00010748513,0.0004644983,0.0000073266997],"about_ca_topic_score_codex":0.0009417223,"about_ca_topic_score_gemma":0.0023207841,"teacher_disagreement_score":0.0059007835,"about_ca_system_score_codex":0.0010189925,"about_ca_system_score_gemma":0.0012597512,"threshold_uncertainty_score":0.019740045},"labels":[],"label_agreement":null},{"id":"W4399068599","doi":"10.1016/j.breast.2024.103756","title":"6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Comprehensive Cancer Network; European Oncology Nursing Society; American Society of Clinical Oncology","keywords":"Medicine; Guideline; Breast cancer; Consensus conference; Alliance; Expert opinion; Cancer; Family medicine; Intensive care medicine; Medical physics; Internal medicine; Pathology","score_opus":0.035208989634672415,"score_gpt":0.3513847015563822,"score_spread":0.3161757119217098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399068599","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003912613,0.52349913,0.07166473,0.21492042,0.040732797,0.0076889666,0.021150524,0.002511073,0.11391969],"genre_scores_gemma":[0.028341455,0.48618788,0.29380554,0.056885947,0.010526745,0.012891134,0.05509562,0.0011219166,0.055143666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98318577,0.007012774,0.0034846684,0.0005320198,0.004861064,0.00092372],"domain_scores_gemma":[0.9687788,0.009146666,0.0027648844,0.0009028154,0.016956346,0.0014504715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019966174,0.0013998043,0.0020619996,0.008110162,0.0014322979,0.0035938006,0.0047542523,0.005748224,0.01252322],"category_scores_gemma":[0.046335306,0.0009732952,0.004740158,0.0044434136,0.0013686664,0.0018152791,0.0030708,0.0077415244,0.010469383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013546726,0.00011025999,0.001038466,0.008657367,0.00020771459,0.0003070657,0.00036303743,0.00072532945,0.0004914464,0.007830171,0.7606378,0.21949577],"study_design_scores_gemma":[0.0001219821,0.00009134277,0.0023159562,0.019985422,0.00031055696,0.0010245963,0.00027623933,0.0003782745,0.00034397593,0.0059371535,0.9691515,0.0000630877],"about_ca_topic_score_codex":0.014313318,"about_ca_topic_score_gemma":0.019965274,"teacher_disagreement_score":0.019966174,"about_ca_system_score_codex":0.0047824066,"about_ca_system_score_gemma":0.019411387,"threshold_uncertainty_score":0.10559249},"labels":[],"label_agreement":null},{"id":"W4399360795","doi":"10.1016/j.breast.2024.103758","title":"Capturing longer term surgical outcome measures as part of routine care of breast cancer patients","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Health and Social Care; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden Cancer Charity; Association of Breast Surgery; Royal Marsden NHS Foundation Trust","keywords":"Oncoplastic Surgery; Medicine; Breast cancer; Population; Family medicine; Patient-reported outcome; General surgery; Cancer; Breast surgery; Quality of life (healthcare); Nursing; Internal medicine","score_opus":0.01998252014009268,"score_gpt":0.30548683153378936,"score_spread":0.2855043113936967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563567,0.0032431127,0.005945792,0.004585823,0.00031124675,0.0025128894,0.010876589,0.00035629104,0.015811602],"genre_scores_gemma":[0.9734284,0.0018658016,0.013011972,0.00091922656,0.00022646552,0.0041616596,0.0046296637,0.00007533449,0.0016815001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99372464,0.00334859,0.0011160956,0.0004484399,0.0010260986,0.00033603449],"domain_scores_gemma":[0.97350997,0.007151113,0.011139992,0.001554606,0.0047132303,0.0019311162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00999777,0.00033560197,0.00056822,0.00179983,0.00055752235,0.0012811627,0.0008509232,0.0005384709,0.0056188265],"category_scores_gemma":[0.02260306,0.00021374546,0.00061318657,0.0015196681,0.00041103814,0.00090814265,0.0015746895,0.00066026335,0.0012437997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005856887,0.0003232445,0.829958,0.0020178617,0.00015025586,0.00033529667,0.005177165,0.0002969131,0.0015700104,0.00021566263,0.014598401,0.14477143],"study_design_scores_gemma":[0.00002839765,0.0007304027,0.9837811,0.00056822575,0.000051532348,0.0003869688,0.0037681458,0.00042186724,0.00077736285,0.00028291886,0.009158346,0.000044754917],"about_ca_topic_score_codex":0.0030995407,"about_ca_topic_score_gemma":0.005100319,"teacher_disagreement_score":0.00999777,"about_ca_system_score_codex":0.0012102165,"about_ca_system_score_gemma":0.0015318671,"threshold_uncertainty_score":0.05287391},"labels":[],"label_agreement":null},{"id":"W4401371497","doi":"10.1016/j.breast.2024.103784","title":"Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hubei Agricultural Science and Technology Innovation Center; Youth Innovation Team Project for Talent Introduction and Cultivation in Universities of Shandong Province","keywords":"Medicine; Breast-conserving surgery; Oncoplastic Surgery; Breast cancer; Meta-analysis; Mastectomy; Breast surgery; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.0810175731642195,"score_gpt":0.3347189798190219,"score_spread":0.2537014066548024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401371497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010889267,0.9850952,0.0014261008,0.00036253774,0.00034436127,0.0002443916,0.0010886723,0.000062163475,0.0004872455],"genre_scores_gemma":[0.44522268,0.5418949,0.0047463067,0.0023105857,0.0008960796,0.0012702375,0.0026622184,0.00012609601,0.0008709192],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9899732,0.004948173,0.0024773423,0.001291218,0.0010150344,0.00029509733],"domain_scores_gemma":[0.9755189,0.018324396,0.0036255599,0.0009316373,0.0012951104,0.00030427668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017728087,0.0029690177,0.016610881,0.0051998133,0.00048461437,0.0034799003,0.0022491768,0.002160221,0.0048186486],"category_scores_gemma":[0.03510498,0.0012829668,0.06104046,0.00455585,0.00064865913,0.001987655,0.0014734237,0.0024106072,0.0004097436],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047251326,0.000026068092,0.0033361446,0.081514224,0.90096456,0.00008055623,0.000029819572,0.0006740444,0.0001524019,0.00009202873,0.00043326188,0.007971787],"study_design_scores_gemma":[0.0007861735,0.00016926005,0.0024066456,0.003464879,0.99196833,0.000056025307,0.0000128105985,0.00019674884,0.00006202649,0.00016151245,0.00070033805,0.000015189028],"about_ca_topic_score_codex":0.004535533,"about_ca_topic_score_gemma":0.0063764127,"teacher_disagreement_score":0.017728087,"about_ca_system_score_codex":0.002055511,"about_ca_system_score_gemma":0.0017567622,"threshold_uncertainty_score":0.0937562},"labels":[],"label_agreement":null},{"id":"W4403679785","doi":"10.1016/j.breast.2024.103826","title":"Adjuvant denosumab for early breast cancer–Evidence and controversy","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Denosumab; Adjuvant; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.026056213707314573,"score_gpt":0.3317920827648059,"score_spread":0.3057358690574913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403679785","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007312229,0.9805149,0.00008118742,0.016480092,0.0011085909,0.000021181933,0.00008470108,0.0000041585386,0.00097397],"genre_scores_gemma":[0.017825268,0.94752,0.00092042075,0.026420806,0.006512743,0.00008400535,0.00016985674,0.000018773897,0.000528043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99027,0.0044766176,0.0024496585,0.0006993691,0.0018594875,0.0002448925],"domain_scores_gemma":[0.9329308,0.05365627,0.0057697487,0.0013080129,0.0052143955,0.0011206967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027813664,0.00072191696,0.005073002,0.0016382795,0.0006206355,0.0038971268,0.003287422,0.0048907544,0.0051447777],"category_scores_gemma":[0.045545507,0.0006198313,0.0031342593,0.0027049002,0.0025721902,0.0036032929,0.0014836998,0.0059103575,0.00183145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070956033,0.00030579616,0.0027262748,0.10890077,0.007050069,0.00023337227,0.00027533414,0.0006187062,0.0008148002,0.011094691,0.0491954,0.8116892],"study_design_scores_gemma":[0.0044779764,0.0024036819,0.007868411,0.27188122,0.012853841,0.00090625463,0.00075275265,0.00050619163,0.0010104569,0.026892167,0.6703482,0.0000987472],"about_ca_topic_score_codex":0.0021017862,"about_ca_topic_score_gemma":0.0044523217,"teacher_disagreement_score":0.027813664,"about_ca_system_score_codex":0.0020505874,"about_ca_system_score_gemma":0.0031461737,"threshold_uncertainty_score":0.14709443},"labels":[],"label_agreement":null},{"id":"W4408080074","doi":"10.1016/j.breast.2025.104432","title":"A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Association of Schools and Colleges of Optometry; Breakthrough Cancer Research; Translational Breast Cancer Research Consortium; Susan G. Komen; AbbVie; Breast Cancer Research Foundation; National Cancer Institute; Conquer Cancer Foundation; Sidney Kimmel Comprehensive Cancer Center; Genentech; Susan G. Komen for the Cure","keywords":"Medicine; Pertuzumab; Trastuzumab; Breast cancer; Oncology; Biomarker; Internal medicine; Neoadjuvant therapy; Cancer","score_opus":0.015187110065405239,"score_gpt":0.34014640719778816,"score_spread":0.3249592971323829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408080074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991091,0.00017929076,0.000267172,0.00004912346,0.000003817042,0.000016641732,0.00019600407,0.00000970901,0.00016913179],"genre_scores_gemma":[0.998483,0.00004005926,0.00070254947,0.00002277092,0.000007115037,0.000017113922,0.00059881917,0.0000028450609,0.0001256878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996853,0.00008709029,0.00003116,0.00007233581,0.00008610127,0.000038158956],"domain_scores_gemma":[0.99898785,0.0002446401,0.00029604134,0.000056191824,0.00016885214,0.0002463231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013854066,0.0005954817,0.0005763439,0.0006212095,0.00019123209,0.000707313,0.00054923183,0.0004744529,0.00081002444],"category_scores_gemma":[0.0027522172,0.00020302819,0.0004470143,0.0005147814,0.00022396875,0.00025305478,0.00043555687,0.0005664326,0.0003908676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002907478,0.00014967748,0.9828765,0.000025777723,0.00009561332,0.00013548593,0.00003240768,0.0011918038,0.003532773,0.000014950862,0.00021927054,0.008818289],"study_design_scores_gemma":[0.00027526342,0.0024444663,0.9658925,0.000017405679,0.0001688147,0.001953954,0.000095597126,0.023237366,0.0051606675,0.00008936571,0.0006435884,0.000021204609],"about_ca_topic_score_codex":0.0015952574,"about_ca_topic_score_gemma":0.002766668,"teacher_disagreement_score":0.0015952574,"about_ca_system_score_codex":0.00050439895,"about_ca_system_score_gemma":0.00036361226,"threshold_uncertainty_score":0.0073268414},"labels":[],"label_agreement":null},{"id":"W4408165382","doi":"10.1016/j.breast.2025.104429","title":"Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2− early breast cancer","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Meta-analysis; Aromatase; Tamoxifen; Oncology; Breast cancer; Internal medicine; Gynecology; Cancer","score_opus":0.022054445923889283,"score_gpt":0.2943155683501745,"score_spread":0.2722611224262852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408165382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007311754,0.98738164,0.0015152906,0.00045845937,0.00038321572,0.0012171181,0.0010852142,0.000051331674,0.00059598533],"genre_scores_gemma":[0.32876155,0.65220255,0.0074680313,0.0024549793,0.0006123446,0.0055429013,0.0021207884,0.000076097924,0.00076078],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9730795,0.016387353,0.005735652,0.0020303037,0.0021636414,0.000603613],"domain_scores_gemma":[0.96421236,0.027163994,0.00515536,0.0010191519,0.002082031,0.0003670497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02728107,0.0033541406,0.019559432,0.006748687,0.0007310093,0.003917096,0.00248135,0.0027435161,0.0047306297],"category_scores_gemma":[0.06495562,0.0015904057,0.04614248,0.0062472713,0.0008259117,0.0021849961,0.0017617221,0.0024915696,0.00045346378],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019646902,0.00002170578,0.0022244805,0.2735986,0.71495295,0.00009486276,0.00005809815,0.0006092003,0.00016498807,0.0001696505,0.00046601176,0.0056747813],"study_design_scores_gemma":[0.0007850506,0.00016906598,0.0014914795,0.01972939,0.9762123,0.000053442956,0.00002427237,0.00019445426,0.00007437432,0.00023851336,0.0010134465,0.000014287728],"about_ca_topic_score_codex":0.0070486506,"about_ca_topic_score_gemma":0.015564296,"teacher_disagreement_score":0.02728107,"about_ca_system_score_codex":0.003976638,"about_ca_system_score_gemma":0.005904723,"threshold_uncertainty_score":0.14427787},"labels":[],"label_agreement":null},{"id":"W4410774867","doi":"10.1016/j.breast.2025.104509","title":"Intellectual or developmental disabilities and curative female breast cancer treatment: A population-based retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Down syndrome and intellectual disability research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Retrospective cohort study; Breast cancer; Cohort; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.038157220014991264,"score_gpt":0.3508706628714092,"score_spread":0.31271344285641794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410774867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956729,0.00026328824,0.00016894375,0.00007890982,0.000009612817,0.0000638433,0.0032812236,0.0000053617496,0.00045584457],"genre_scores_gemma":[0.9972153,0.0002533243,0.0002140004,0.00007353045,0.000009981603,0.000064850734,0.0019700527,0.000002732897,0.00019627408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926215,0.00012451633,0.00009247693,0.0002117785,0.00016265224,0.00014648514],"domain_scores_gemma":[0.9987104,0.000109892695,0.0005185286,0.00024313331,0.00022342065,0.00019461373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011096436,0.00031412096,0.00037718547,0.0007272089,0.0008418702,0.0007599073,0.0007116873,0.00036060944,0.0011113764],"category_scores_gemma":[0.0019019037,0.0004926989,0.0006858099,0.0019554277,0.00028735006,0.00038399326,0.00064367364,0.00071092846,0.00024059675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005189833,0.000029800773,0.99895006,0.000010378814,0.000088423345,0.000060821756,0.00008475269,0.000019554636,0.000062974505,0.00002076245,0.00021970329,0.0004008834],"study_design_scores_gemma":[0.000024011733,0.00007397961,0.99861026,0.00002056533,0.000101655634,0.00022611955,0.00029707918,0.0001473746,0.000026441106,0.000023080189,0.00044350472,0.000005772931],"about_ca_topic_score_codex":0.0905931,"about_ca_topic_score_gemma":0.110859945,"teacher_disagreement_score":0.0905931,"about_ca_system_score_codex":0.0010046058,"about_ca_system_score_gemma":0.0014563514,"threshold_uncertainty_score":0.18013155},"labels":[],"label_agreement":null},{"id":"W4411989599","doi":"10.1016/j.breast.2025.104528","title":"Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research; McMaster University; University of Ottawa","funders":"Daiichi Sankyo Europe; LEO Pharma; Eisai; Puma Biotechnology; Genomic Health; GlaxoSmithKline; Pfizer; Celgene; PharmaMar; Government of Ontario; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Tamoxifen; Cohort; Population; Gynecology; Cancer","score_opus":0.004593320587251226,"score_gpt":0.24602974150859971,"score_spread":0.24143642092134848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411989599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96928823,0.008456264,0.0036545873,0.0022997046,0.0003286786,0.00011379234,0.0039487276,0.0002854874,0.011624493],"genre_scores_gemma":[0.9912949,0.00086454966,0.00329676,0.0004982302,0.00034436502,0.000035106208,0.0029170136,0.00003768987,0.00071135216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951449,0.0024916595,0.0004075959,0.00061852287,0.0010707858,0.00026648422],"domain_scores_gemma":[0.97635967,0.012116431,0.006061773,0.0018295841,0.0024826212,0.001149922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011765434,0.0009306711,0.0014106521,0.0021036041,0.0002926638,0.0020641359,0.00075037975,0.0008217711,0.0036360852],"category_scores_gemma":[0.025158362,0.00024473024,0.0015929139,0.0020581433,0.0005477559,0.0011420578,0.0008962426,0.000565691,0.0012945202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002900424,0.00008065351,0.9212749,0.00025785505,0.00059498276,0.000043787575,0.000054848802,0.0010129317,0.0003078742,0.00024892692,0.0022598782,0.0709629],"study_design_scores_gemma":[0.00038801096,0.0035438638,0.9631569,0.0003274556,0.0020511819,0.00079637725,0.00022929824,0.01602693,0.0016336604,0.0016217892,0.010108048,0.00011663469],"about_ca_topic_score_codex":0.0016454502,"about_ca_topic_score_gemma":0.0052394927,"teacher_disagreement_score":0.011765434,"about_ca_system_score_codex":0.0005265812,"about_ca_system_score_gemma":0.0008104193,"threshold_uncertainty_score":0.062222302},"labels":[],"label_agreement":null},{"id":"W4412535807","doi":"10.1016/j.breast.2025.104545","title":"Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancer","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Santé Montérégie","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cancer; Immune system; Cancer research; Internal medicine; Immunology","score_opus":0.016240443658560786,"score_gpt":0.31449669898182714,"score_spread":0.29825625532326633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412535807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010072452,0.9990429,0.00007291546,0.00015103896,0.00009859657,0.000004791012,0.000018880975,0.0000041076305,0.0005059688],"genre_scores_gemma":[0.00087079615,0.9982015,0.00016623976,0.00017812742,0.000090063,0.000010153174,0.00004421987,0.000001165225,0.00043768992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997557,0.00006328282,0.000036921207,0.00003719198,0.00008532202,0.000021576097],"domain_scores_gemma":[0.9996586,0.00017022416,0.00006115791,0.000007786539,0.000086713204,0.00001552825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072888384,0.00084151217,0.0016141813,0.0020482098,0.00013451387,0.0007580915,0.00060639926,0.000780989,0.002229325],"category_scores_gemma":[0.0008733664,0.00024821068,0.0006635917,0.0015288624,0.00026666696,0.00072373933,0.0004934194,0.0013295391,0.0012164209],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009119725,0.000048331,0.00030132846,0.014295401,0.00016075358,0.000078956786,0.000029265182,0.00028936722,0.0010788435,0.0015224292,0.015854059,0.9662502],"study_design_scores_gemma":[0.00004750284,0.00024405478,0.0029224136,0.011136171,0.00046810394,0.001420054,0.00006200746,0.00023346911,0.00084730954,0.0020297985,0.9805567,0.000032413805],"about_ca_topic_score_codex":0.0008604242,"about_ca_topic_score_gemma":0.0015396219,"teacher_disagreement_score":0.002229325,"about_ca_system_score_codex":0.0005847798,"about_ca_system_score_gemma":0.0007389523,"threshold_uncertainty_score":0.0074578524},"labels":[],"label_agreement":null},{"id":"W4412658536","doi":"10.1016/j.breast.2025.104547","title":"Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; ECOG-ACRIN Cancer Research Group; National Institutes of Health; Rising Tide Foundation; American College of Radiology Imaging Network; NRG Oncology; Fonds De La Recherche Scientifique - FNRS; Fondazione Umberto Veronesi; Gateway for Cancer Research; Rising Tide Foundation for Clinical Cancer Research; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Breast Cancer Research Foundation","keywords":"Medicine; Ovarian reserve; Pregnancy; Anti-Müllerian hormone; Hormone; Prolactin; Follicle-stimulating hormone; Breast cancer; Gynecology; Infertility; Fertility; Obstetrics; Cancer; Internal medicine; Population; Luteinizing hormone","score_opus":0.014981135986165763,"score_gpt":0.2908316096341852,"score_spread":0.27585047364801946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412658536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930187,0.005371954,0.00010883638,0.00024444904,0.00005099575,0.000090165646,0.00022301554,0.000005343791,0.00088651397],"genre_scores_gemma":[0.9983909,0.0007731129,0.000114337425,0.00012825265,0.000054130713,0.000060845767,0.00028013915,0.000001556765,0.0001967637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937445,0.00043039175,0.000036780497,0.000053193522,0.00006040955,0.000044771616],"domain_scores_gemma":[0.99830604,0.0009404762,0.0004582049,0.00007319995,0.00004420426,0.0001779586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020570934,0.00020939417,0.0006448046,0.00012337175,0.00015006046,0.0005118889,0.00020565024,0.00034085265,0.0011103896],"category_scores_gemma":[0.0043992875,0.000113802016,0.0004997313,0.0002663379,0.00028316918,0.00023704466,0.00018644874,0.0006126945,0.00010805708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28940964,0.0015972924,0.6205724,0.0007998634,0.0014861067,0.0003261033,0.00014433691,0.0006464036,0.0019597637,0.00027006865,0.0018099884,0.08097798],"study_design_scores_gemma":[0.038744494,0.09332204,0.84706026,0.00040869025,0.003641288,0.001799746,0.00023981444,0.002631229,0.002068811,0.0010876233,0.008949209,0.00004679445],"about_ca_topic_score_codex":0.0002698684,"about_ca_topic_score_gemma":0.00043459923,"teacher_disagreement_score":0.0020570934,"about_ca_system_score_codex":0.0001854295,"about_ca_system_score_gemma":0.0003630281,"threshold_uncertainty_score":0.01087904},"labels":[],"label_agreement":null},{"id":"W4413201858","doi":"10.1016/j.breast.2025.104558","title":"Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Instituto de Salud Carlos III; Associazione Italiana di Oncologia Medica","keywords":"Medicine; Cancer; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Radiology; Medical physics","score_opus":0.008059041160481175,"score_gpt":0.2778434102466243,"score_spread":0.2697843690861431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413201858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606878,0.0057031964,0.00007709983,0.026080618,0.00013115838,0.000008260525,0.00018856334,0.000004167647,0.0071190423],"genre_scores_gemma":[0.9953661,0.0020327193,0.00005678514,0.00212294,0.00016596877,0.000005432246,0.000052040734,0.0000013578091,0.00019663676],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9980033,0.00119732,0.00007750517,0.000095711766,0.00032104083,0.0003051831],"domain_scores_gemma":[0.9938362,0.001906568,0.0019748586,0.000042554817,0.0006652555,0.0015745853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001928195,0.00010182627,0.00016598274,0.00046427012,0.0008164284,0.0011464068,0.00018295145,0.00079158845,0.0025307431],"category_scores_gemma":[0.0074232696,0.000096352545,0.00023898153,0.0005767351,0.00060861633,0.00095786137,0.0007327586,0.0007566917,0.00026553872],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038876032,0.00024536095,0.8972035,0.0004725682,0.00009646558,0.0026761633,0.03558278,0.0001461281,0.00064758706,0.00057737716,0.017538404,0.044424977],"study_design_scores_gemma":[0.00007397142,0.00068170147,0.84038013,0.00072331546,0.00009698337,0.006277843,0.1208086,0.00029093388,0.00026931526,0.0007143005,0.029614098,0.000068724956],"about_ca_topic_score_codex":0.0029961616,"about_ca_topic_score_gemma":0.004851688,"teacher_disagreement_score":0.0029961616,"about_ca_system_score_codex":0.000691504,"about_ca_system_score_gemma":0.00075508637,"threshold_uncertainty_score":0.010197401},"labels":[],"label_agreement":null},{"id":"W4414446280","doi":"10.1016/j.breast.2025.104570","title":"Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]","year":2025,"lang":"en","type":"erratum","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Breast cancer; Fertility; Adjuvant; Pregnancy; Endocrine system","score_opus":0.023547799776237523,"score_gpt":0.29089738645089797,"score_spread":0.26734958667466047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414446280","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089392175,0.0019353757,0.00015511063,0.08422361,0.9038642,0.00006347468,0.0012330404,0.00013084315,0.008305001],"genre_scores_gemma":[0.003552518,0.0071092453,0.0009345117,0.20836988,0.5630107,0.0003259063,0.0027375051,0.00027254494,0.21368721],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714416,0.00065970456,0.000530963,0.00040031938,0.000921103,0.0003437259],"domain_scores_gemma":[0.9872722,0.0043061282,0.0006964643,0.00063297193,0.0058312053,0.0012609803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033446103,0.0018832333,0.00303272,0.0031830901,0.002319428,0.0030634853,0.0025532478,0.009155137,0.06873852],"category_scores_gemma":[0.024219511,0.0012047671,0.002572803,0.0017898789,0.0011830257,0.0010891095,0.0011913651,0.008237516,0.04024743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030747786,0.000009142092,0.00006609102,0.000035951503,0.0000073538677,0.0000939608,0.0000022699244,0.000012896129,0.000010716439,0.00009540707,0.9972627,0.0023726944],"study_design_scores_gemma":[0.00024042535,0.00009068622,0.00395366,0.00058468623,0.000119317956,0.0005423919,0.000040985993,0.0003091424,0.0001754257,0.0010300836,0.9928611,0.000052071253],"about_ca_topic_score_codex":0.03133668,"about_ca_topic_score_gemma":0.05444487,"teacher_disagreement_score":0.06873852,"about_ca_system_score_codex":0.0035254564,"about_ca_system_score_gemma":0.005171721,"threshold_uncertainty_score":0.22995323},"labels":[],"label_agreement":null},{"id":"W4414622121","doi":"10.1016/j.breast.2025.104593","title":"Opportunities to improve the environmental sustainability of breast cancer care: A scoping review","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Canada Research Chairs","funders":"","keywords":"Breast cancer; Sustainability; Health care; MEDLINE; Healthcare system","score_opus":0.07497958448967627,"score_gpt":0.3815790261966443,"score_spread":0.306599441706968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414622121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024023237,0.9962282,0.0002716717,0.0017270399,0.00032234014,0.00017906555,0.00009014008,0.000008379961,0.00093288935],"genre_scores_gemma":[0.0018347425,0.9965682,0.0005946148,0.0005194953,0.00008996049,0.0002274999,0.000067553075,0.0000030673714,0.00009481327],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9887861,0.0052732583,0.002802752,0.00049443345,0.0021853244,0.00045804286],"domain_scores_gemma":[0.95379704,0.03386597,0.0053164563,0.00062378263,0.005876584,0.000520229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01791133,0.001706967,0.0039211116,0.01874667,0.0013225311,0.0061282883,0.0021562818,0.0037523052,0.006186516],"category_scores_gemma":[0.0557871,0.001121911,0.0058371266,0.019677656,0.0013334735,0.0060519087,0.0034481122,0.0025366093,0.0008281222],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060595383,0.000037397152,0.0005163582,0.7611231,0.0012925998,0.00017022327,0.0007882236,0.00037344964,0.00023036369,0.0030396557,0.009622854,0.22274521],"study_design_scores_gemma":[0.000015631209,0.000029564426,0.0006256307,0.92984855,0.0025069264,0.00010642571,0.0005416846,0.00007231797,0.00006892611,0.0010101964,0.0651579,0.000016427237],"about_ca_topic_score_codex":0.008986447,"about_ca_topic_score_gemma":0.023830373,"teacher_disagreement_score":0.01874667,"about_ca_system_score_codex":0.0064351563,"about_ca_system_score_gemma":0.029174184,"threshold_uncertainty_score":0.09472531},"labels":[],"label_agreement":null},{"id":"W4415532641","doi":"10.1016/j.breast.2025.104621","title":"Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Joint Research Centre; European Commission; World Health Organization","keywords":"Breast cancer; Breast cancer screening; Performance indicator; Association (psychology); Cancer","score_opus":0.03912520745066936,"score_gpt":0.34411501128583677,"score_spread":0.3049898038351674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415532641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017274,0.001622875,0.004582373,0.00035113553,0.000014619565,0.0001442953,0.0017118539,0.00004553588,0.0013545346],"genre_scores_gemma":[0.99731714,0.00012690683,0.001590775,0.000025527135,0.00001224246,0.000054059088,0.00075692317,0.0000053541066,0.000111083165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98779964,0.008449274,0.0009241176,0.00084566296,0.0014681622,0.0005130663],"domain_scores_gemma":[0.9720452,0.0139527535,0.0094897775,0.0015057682,0.0021878886,0.00081865984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018397233,0.00051396654,0.00059868675,0.0016777704,0.00021260438,0.0008507837,0.0005335975,0.000475609,0.00094339804],"category_scores_gemma":[0.038343575,0.00013606799,0.0009693626,0.0030009043,0.00036935048,0.00057066395,0.0009473726,0.00051270245,0.00011832085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014980992,0.00007189624,0.9919138,0.00008521117,0.0003065679,0.0000068788713,0.00004817136,0.00073272537,0.000049561848,0.000060041486,0.00007525756,0.0065001827],"study_design_scores_gemma":[0.000011255089,0.0003430908,0.99660254,0.00004015643,0.00018366,0.000021025951,0.000052420928,0.0021984538,0.0001635105,0.00009285652,0.0002863703,0.0000046908167],"about_ca_topic_score_codex":0.0036501156,"about_ca_topic_score_gemma":0.003927419,"teacher_disagreement_score":0.018397233,"about_ca_system_score_codex":0.0007454661,"about_ca_system_score_gemma":0.0010996368,"threshold_uncertainty_score":0.097294986},"labels":[],"label_agreement":null},{"id":"W4415680787","doi":"10.1016/j.breast.2025.104619","title":"Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"Medical Research and Materiel Command; Division of Graduate Education; NIHR Cambridge Biomedical Research Centre; Servicio Gallego de Salud; Instituto de Salud Carlos III; Cancer Council Tasmania; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Programme Grants for Applied Research; Manchester Biomedical Research Centre; U.S. Army; National Institutes of Health; Cancer Council Victoria; Ministry of Science and Higher Education of the Russian Federation; Xunta de Galicia; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Institut National Du Cancer; Deutsche Krebshilfe; Medizinischen Hochschule Hannover; Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; University of Utah; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Fondation de France; Ministero della Salute; University of Crete; Kuopion Yliopistollinen Sairaala; University of Wisconsin-Madison; Karolinska Institutet; Deutsche Forschungsgemeinschaft; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Deutsche Gesetzliche Unfallversicherung; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Cancer Australia; Agence Nationale de la Recherche; Robert Bosch Stiftung; Cancerfonden; National Cancer Institute; Cancer Institute NSW; National Breast Cancer Foundation; European Commission; University of Cambridge; Ministerio de Sanidad, Servicios Sociales e Igualdad; Government of Canada; Wellcome Trust; Fondation du cancer du sein du Québec; KWF Kankerbestrijding; Cancer Research UK; Itä-Suomen Yliopisto; Genome Canada; Deutsches Krebsforschungszentrum; Fondazione AIRC per la ricerca sul cancro ETS; National Institute for Health and Care Research; Scottish Government; Division of Cancer Prevention, National Cancer Institute; Department of Health and Social Care; Freistaat Sachsen; Huntsman Cancer Institute; Agency for Science, Technology and Research; University of Pennsylvania; Scottish Funding Council; Kreftforeningen; Cancer Council South Australia; American Cancer Society; Ministerie van Volksgezondheid, Welzijn en Sport; U.S. Department of Health and Human Services; Breast Cancer Research Foundation; Cancer Council NSW; Susan G. Komen for the Cure; Research Promotion Foundation; European Regional Development Fund; King's College London","keywords":"Breast cancer; Germline; Disease; Cancer; Mutation; Genetic testing","score_opus":0.04476582959621345,"score_gpt":0.3426895326240133,"score_spread":0.29792370302779986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415680787","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37459898,0.60236704,0.011734168,0.0012828582,0.00057763205,0.0001513396,0.0068228384,0.00030696447,0.0021581682],"genre_scores_gemma":[0.9736058,0.021797862,0.0019511951,0.00038147837,0.000130013,0.00008870209,0.001633978,0.00007609381,0.0003348297],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929188,0.0031978786,0.0009140005,0.0019976804,0.0005869874,0.0003846268],"domain_scores_gemma":[0.98295504,0.012646151,0.0018014808,0.0016316043,0.0006542613,0.00031146826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011335183,0.0020293796,0.0046321494,0.002817054,0.0007047948,0.0022371407,0.001310066,0.0016333518,0.0023107096],"category_scores_gemma":[0.015536135,0.0008815755,0.022679212,0.004261977,0.0006251262,0.0008378952,0.0011606257,0.0016979915,0.00021999406],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00623877,0.000030197562,0.2145152,0.013460247,0.74123144,0.00052508793,0.0001082635,0.0029061188,0.003437178,0.00051554723,0.0012512108,0.015780801],"study_design_scores_gemma":[0.0004559052,0.00038807213,0.1685258,0.000987573,0.82072073,0.000513,0.00010104937,0.0021992757,0.0013484779,0.0011035954,0.0036119577,0.000044518343],"about_ca_topic_score_codex":0.0054785907,"about_ca_topic_score_gemma":0.007657482,"teacher_disagreement_score":0.011335183,"about_ca_system_score_codex":0.000855288,"about_ca_system_score_gemma":0.0007191981,"threshold_uncertainty_score":0.059946895},"labels":[],"label_agreement":null},{"id":"W4415961645","doi":"10.1016/s0960-9776(25)00694-0","title":"#MAKEMECOUNT: ADDRESSING THE NEED FOR COMPLETE AND HARMONIZED CANCER DATA IN CANADA","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; MEDLINE; Real world data","score_opus":0.25428833617257046,"score_gpt":0.38777107684933737,"score_spread":0.1334827406767669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415961645","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039072137,0.008013294,0.014400756,0.43624574,0.00527889,0.0015609594,0.33251834,0.004966439,0.15794343],"genre_scores_gemma":[0.39054084,0.015230294,0.12783933,0.121183455,0.0031598543,0.0019729408,0.22909917,0.0047488553,0.10622532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9832472,0.0026650138,0.0014151306,0.0012381733,0.008994027,0.002440459],"domain_scores_gemma":[0.86541796,0.012582487,0.004550936,0.005166695,0.09516782,0.017114043],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013298224,0.0007067093,0.0011713939,0.005929245,0.004371212,0.008570935,0.0049081948,0.0020211365,0.019928323],"category_scores_gemma":[0.07072036,0.000794214,0.001321011,0.012574583,0.0013971307,0.0029756534,0.004339196,0.003875317,0.0031721806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014313881,0.000053043354,0.034903355,0.0004874279,0.00013360071,0.000095506635,0.0003808459,0.0015034856,0.00019078395,0.012978871,0.8706676,0.07846241],"study_design_scores_gemma":[0.00011633215,0.00006514779,0.092714444,0.0013119727,0.0001458794,0.00012370758,0.0014600501,0.005422391,0.00081711035,0.004657642,0.8930026,0.00016268251],"about_ca_topic_score_codex":0.9887111,"about_ca_topic_score_gemma":0.9914629,"teacher_disagreement_score":0.9867018,"about_ca_system_score_codex":0.06678269,"about_ca_system_score_gemma":0.3273159,"threshold_uncertainty_score":0.48454458},"labels":[],"label_agreement":null},{"id":"W4416091508","doi":"10.1016/j.breast.2025.104642","title":"The Breast International Group (BIG) Patient Partnership: Embedding meaningful patient involvement in the design and conduct of breast cancer clinical research","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"Breast Cancer Research Foundation","keywords":"General partnership; Clinical research; Breast cancer; Work (physics); Value (mathematics); Alternative medicine; Research design","score_opus":0.47775741543762434,"score_gpt":0.5456380337938939,"score_spread":0.06788061835626952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416091508","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07299315,0.009288518,0.25335327,0.5089798,0.005974635,0.0073089153,0.0004059051,0.0015847067,0.14011109],"genre_scores_gemma":[0.5770438,0.008490572,0.3031225,0.08248103,0.0019145189,0.009804168,0.00036050167,0.0007707046,0.016012238],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.596133,0.38413262,0.003314374,0.0038516645,0.00796367,0.004604665],"domain_scores_gemma":[0.74976826,0.14387877,0.011250974,0.026233342,0.009888327,0.058980387],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23452006,0.0008492323,0.00074241235,0.002225474,0.011832993,0.015230945,0.0031581798,0.006166928,0.0068803946],"category_scores_gemma":[0.14096668,0.0012593337,0.0010682427,0.002056512,0.02442093,0.012488841,0.048958313,0.011867142,0.0027780451],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058624416,0.0016248556,0.011976222,0.0026876945,0.0002942453,0.0017589213,0.2703914,0.00087155995,0.003854465,0.12833817,0.12577042,0.45184582],"study_design_scores_gemma":[0.0006117565,0.0021033285,0.0055221026,0.0034934229,0.00016041241,0.0027874035,0.13704562,0.0009334674,0.0023594473,0.1752572,0.6694413,0.0002845042],"about_ca_topic_score_codex":0.0011094449,"about_ca_topic_score_gemma":0.0032309792,"teacher_disagreement_score":0.23452006,"about_ca_system_score_codex":0.0044209315,"about_ca_system_score_gemma":0.060663592,"threshold_uncertainty_score":0.94397306},"labels":[],"label_agreement":null},{"id":"W4417535527","doi":"10.1016/j.breast.2025.104676","title":"Beyond survival: Confronting the unmet needs in oncofertility care for young women with breast cancer","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Oncofertility; Breast cancer; MEDLINE; Cancer; Young adult","score_opus":0.011125617682673875,"score_gpt":0.2811530932693606,"score_spread":0.2700274755866867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417535527","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06077876,0.036959086,0.0005209668,0.88173294,0.003937472,0.000053662185,0.00018902172,0.000043125438,0.015784977],"genre_scores_gemma":[0.75068694,0.08639587,0.0043571233,0.14031726,0.01086189,0.00027721073,0.00038134327,0.00010234295,0.0066201393],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99776065,0.000946461,0.000120903234,0.000089938,0.00039318425,0.0006888487],"domain_scores_gemma":[0.98846686,0.0027666306,0.0008563685,0.00009173909,0.00094308227,0.0068753064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004106246,0.00023571965,0.00056975905,0.0006403148,0.004423474,0.0032381,0.0010638655,0.003504754,0.0078114746],"category_scores_gemma":[0.020868791,0.00025647256,0.00057479524,0.00053078466,0.0015868706,0.0040718815,0.005459482,0.0059469636,0.0006944779],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032909407,0.00063288066,0.097178146,0.0017945048,0.0001319519,0.006357314,0.01789857,0.0007800938,0.0006490795,0.015303406,0.34259906,0.516346],"study_design_scores_gemma":[0.00024632175,0.0015454893,0.16376115,0.015404085,0.0003030185,0.011299528,0.17953648,0.002002365,0.00050200924,0.076686665,0.5484187,0.00029421673],"about_ca_topic_score_codex":0.012466261,"about_ca_topic_score_gemma":0.057600446,"teacher_disagreement_score":0.012466261,"about_ca_system_score_codex":0.0027730102,"about_ca_system_score_gemma":0.017979793,"threshold_uncertainty_score":0.026132047},"labels":[],"label_agreement":null},{"id":"W7117382419","doi":"10.1016/j.breast.2025.104682","title":"Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"AstraZeneca","keywords":"Multidisciplinary approach; Breast cancer; Multidisciplinary team; MEDLINE","score_opus":0.011649647930743752,"score_gpt":0.31112864123488176,"score_spread":0.299478993304138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117382419","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003910357,0.04501675,0.019541308,0.8742674,0.013813711,0.0040518166,0.0020103236,0.0008635137,0.036524795],"genre_scores_gemma":[0.046460442,0.12783986,0.38216403,0.36382213,0.013165332,0.017700322,0.009139833,0.00044403152,0.039264053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849392,0.008215125,0.002671417,0.0004798825,0.0026677675,0.0010265894],"domain_scores_gemma":[0.96416783,0.010370441,0.004678425,0.00087725313,0.0136140585,0.0062920935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014578981,0.0010011957,0.0008031934,0.0031636923,0.0010351479,0.0024905116,0.0039231963,0.0067453217,0.017994098],"category_scores_gemma":[0.039379206,0.00055031595,0.002711248,0.0024036143,0.0008158269,0.0035099336,0.004219559,0.0069079916,0.009513365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011074242,0.00034796057,0.004310939,0.0039621135,0.00007487136,0.00037286387,0.00046556743,0.0008245033,0.00036581422,0.002438795,0.7636497,0.22307622],"study_design_scores_gemma":[0.00026662176,0.0002050698,0.017745446,0.033331882,0.00016736845,0.00077207026,0.002039677,0.0010337498,0.00037961442,0.0052251997,0.93873847,0.000094925956],"about_ca_topic_score_codex":0.007338258,"about_ca_topic_score_gemma":0.01502099,"teacher_disagreement_score":0.017994098,"about_ca_system_score_codex":0.00380611,"about_ca_system_score_gemma":0.014755113,"threshold_uncertainty_score":0.077101946},"labels":[],"label_agreement":null}]}